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Abstract: Both centrally and systemically administered dopamine agonists and 
antagonists decrease ingestive behaviour. The aim of this thesis was to examine 
whether drugs acting at different receptor subtypes decreased intake in different 
ways. A microstructural analysis was used to examine dopaminergic drug effects 
on licking behaviour. A dopamine D3 receptor agonist, 7-OH-DPAT, a dopamine 
D2 receptor antagonist raclopride and a mixed dopamine D2/D3 agonist quinpirole 
were compared in this paradigm. These drugs reduced the number of licks by 
differentially decreasing parameters which are thought to reflect the palatabiliry of 
the stimulus such as mean bout duration of licking and the initial rate of licking. 
Follow-up experiments were conducted to further examine the possibility that motor 
deficits were underlying decreases in licking parameters. The effects of raclopride 
and 7-OH-DPAT were compared to the effects of a dopamine D l antagonist SCH-
23390 and were analysed using a brief contact licking test. Again, the behavioural 
expression of anorexia induced by these drugs seemed to rely on a differential 
decrease in mean bout duration. Results also revealed that the three drugs used 
differed in the extent to which they produced a motoric deficit Attempts to block 
the effects of 7-OH-DPAT on licking parameters were made by using the putative 
D3 receptor antagonists PNU-99194A and amisulpride. In addition, the effects of 
these drugs alone on licking behaviour were examined. PNU-99194A failed to 
block the effects of 7-OH-DPAT and was relatively ineffective in producing 
changes in licking behaviour when administered alone. Amisulpride blocked the 
effects of 7-OH-DPAT only at high doses and when injected alone produced an 
increase in intake through an increase in mean bout duration of licking. Results 
from Chapters 4,5 and 6 suggested that 7-OH-DPAT was having an effect on 
palatability. Therefore, Chapter 7 presents an experiment which examines the effect 
of 7-OH-DPAT on the licking behaviour of rats which encounter a devaluation of 
reward (successive negative contrast). 7-OH-DPAT reduced successive negative 
contrast leading to the proposal that D3 receptors may mediate relative as well as 
absolute reinforcer value. These results bear important implications for 
understanding the role of dopamine receptor subtypes in components of food 
reward and appetitive behaviour in general and may well have implications for the 
treatment of eating disorders. 
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Chapter 1 
Chapter 1: The pharmacology of dopamine receptor 
subtypes 
1.1 Chapter overview 
There are two main aims of Chapter 1. The first is to provide a brief 
historical overview of the main milestones in the study of dopamine as a 
neurotransmitter in the central nervous system, and to describe the anatomy of 
dopamine-containing neuronal pathways, as well as the distinctions drawn between 
dopamine receptor subtypes. There will be a particular emphasis placed on the 
dopamine D3 receptor subtype, which has attracted a great deal of attention, having 
been implicated in the mediation of reward (Caine and Koob, 1993,1995) and in 
the potential alleviation of psychotic symptoms (Sokoloff, 1990). Currently, the 
properties and functions of the dopamine D3 receptor have been extensively studied 
using a variety of approaches, including behavioural, physiological, neurochemical, 
pharmacological, and, more recently, molecular approaches both in vivo and in 
vitro. 
The second aim of this chapter will therefore be to bring together the 
evidence derived from these several approaches to characterise the attributes of the 
D3 receptor subtype in comparison with those of other distinct dopamine receptor 
subtypes. In doing so, an introduction to the role(s) of the dopamine D3 receptor 
subtype in several types of behavioural response will be provided. In bringing 
together several lines of evidence it may prove possible to characterise better the 
role(s) of this important receptor subtype in more complex psychological functions, 
for example the motivational bases of behaviour (see Chapter 2). 
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1.2 A brief history of dopamine 
Dopamine, is a major catecholamine in the central nervous system. The 
study of dopamine, from the molecular to the behavioural level, has provided an 
empirical and conceptual cornerstone in psychopharmacology. This widely 
distributed neurotransmitter has been the focus of much research during the past 40 
years primarily because alterations in dopamine neurotransmission are involved, 
directly or indirectly, in several brain dysfunctions such as schizophrenia and 
Parkinson's disease. However, since dopamine has also been identified as having 
a role in the mediation of several behaviours, having a particular role to play in the 
regulation of emotion, motivation, cognition and reward, it is also of interest to 
those who wish to elucidate the role of dopamine in psychological functions. 
Since the discovery of dopamine in the brain and its high degree of 
localisation within the basal ganglia (Carlsson, 1959), evidence has steadily 
accumulated to indicate that this catecholamine is a neurotransmitter in its own right 
and that it has consequential functions in the brain. This hypothesis has 
subsequently been reliably confirmed as evidence has accumulated from disciplines 
including biochemistry, pharmacology, histology and neurology. Prior to 
Carlsson's pioneering work, dopamine had been conceived of as an intermediate in 
the biosynthesis of the already acknowledgedjjeurotransmitter noradrenaline. 
The introduction of the histochemical fluorescence technique by Hillarp and 
colleagues (Falck, 1962; Falck et al., 1962) provided neuroscience with methods 
which facilitated the demonstration of the occurrence of monoamines, including 
dopamine, in nerve cell bodies and terminals within the central nervous system. 
This technique also helped to confirm dopamine's functional status as a 
neurotransmitter (Carlsson et al., 1962) since the concentration of dopamine in 
brain was approximately the same as noradrenaline, its distribution was different, 
suggesting that dopamine might have a neurotransmitter action of its own. Not only 
did this technique increase knowledge about the morphology and organisation of 
these neurons, it also outlined a system within which experimental data could be 
interpreted As new evidence accrued, the fluorescence technique showed itself to 
be an adequate method of tracing the monoamine pathways in the central nervous 
system, (e.g.Anden et al., 1964a; Dahlstrom et al., 1964; Dahlstrom and Fuxe, 
1964; Fuxe 1965; Ungerstedt 1971; for review see Dahlstrom and Carlsson, 
1986). 
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In their classic mapping studies of central monoaminergic cell groups, 
Dahlstrom and Fuxe (1964) began to identify dopaminergic cells of origin and 
delineate ascending and descending projections from these cells. The early studies 
by Dahlstrom and Fuxe gave rise to the nomenclature used to distinguish 
dopaminergic cell groups from adrenergic and serotonergic cell groups. Groups 
were designated with letters and numbers. Current nomenclature relies heavily on 
these original Findings, therefore, groups A1-A7 are noradrenergic, A8-15 are 
dopaminergic and C1-C3 are adrenergic. Owing to these original successes, 
histochemical methods were developed and refined, such as the glyoxilic acid 
fluorescence method (Lindvall and Bjorklund, 1974a), which allowed researchers 
to discover previously unknown dopamine-containing fibre systems. In the 1980s 
and 90s, histochemical fluorescence was largely supplanted by 
ifnmunohistochemical staining for catecholamine-synthesising enzymes and more 
recently, the transmitters themselves (Hokfelt et al., 1984a; Decavel et al., 1987). 
Originally, two distinct dopamine systems were identified, separating the 
telencephalic projections arising from dopamine containing neurons in the 
mesencephalon (Dahlstrom and Fuxe, 1964). The first was the nigrostriatal system 
originating in the dopamine cells of the pars compacta of the substantia nigra (SNC 
or A9). The second system was named the mesolimbic system to be found in areas 
medial to the substantia nigra in the ventral tegmental area of Tsai (VTA or A10), 
(see Figure 1.1 a and d repectively). These systems were collectively named the 
mesotelencephalic system reflecting all ascending telencephalic projections from the 
mesencephalic dopaminergic neurons (Bjorklund and Lindvall, 1978; Moore and 
Bloom, 1986). This general projection system could be further subdivided into the 
mesostriatal complex, which projects to the striatum proper and the ventral striatum, 
and the mesocorticolimbic system the pathways of which project to the limbic 
system, and specific regions of allocortex and neocortex. 
Further neuroanatomical developments have suggested that previous 
distinctions between dopaminergic systems such as the meso-striatal, meso-Iimbic 
and meso-cortical pathways may no longer be valid. Although meso-limbic 
dopamine neurons had been defined as those which originated in the in the A10 
region of the VTA, evidence was presented to suggest that the projections of the 
A10 neurons are not confined to structures such as olfactory tubercule or nucleus 
accumbens, but also innervate the ventromedial half of the striatum throughout its 
rostrocaudal extent; the latter region also being innervated by A9 Dopamine 
neurons in the SNC (substantia nigra), (Beckstead et al. 1979; Fallon and Moore, 
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1978). The discovery of such overlap blurred the prior distinction between the 
meso-striatal and meso-limbic systems. 
More recently, spurred by the above inconsistencies, researchers such as 
Fuxe et al. (1985) and Bjorklund and Lindvall (1986) helped to describe the 
dopaminergic projections extensively. They distinguished between several different 
forebrain projections from mesencephalic (midbrain) dopamine cell groups, (see 
Figure 1.1 a, b, c and d). 
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Figure 1.1 Dopaminergic pathways in the rat brain: Dopaminergic cell bodies 
are represented by small black triangles and axonal fibres by solid lines, (a) Dorsal 
mesostriatal (nigrostriatal) system, (b) Ventral mesostriatal (mesolimbic) system, 
(c) Mesolimbocortical and mesodiencephalic (mesothalamic) systems, (d) 
Periventricular, diencephalospinal, incertohypothalamic, and tuberohypophyseal 
systems. Groups A8-A15 represent dopaminergic cell groups. 
(Adapted from Fuxe et al., 1985). 
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Although it is beyond the scope of this thesis to discuss the functional 
significance of the separation of distinct dopaminergic projections, throughout this 
thesis there will be emphasis on a number of the structures to be found on these 
distinct pathways. The extent of this emphasis will be determined by the relevance 
of these structures to the mediation of several psychological functions which are 
central to the empirical thread of the thesis. Due to further technological 
refinements, dopaminergic receptor distribution is now appreciably more complex 
than originally believed. Therefore, more specific issues of distibution will be 
discussed in relation to dopamine receptor subtypes later in this chapter. 
The original elucidation of such tracts led to rudimentary hypotheses as to 
their function, (Andenetal., 1966; Carlsson, 1959). Arising from the 
observation that dopamine was concentrated in the basal ganglia, a relationship 
between this catecholamine and extrapyramidal function was postulated, (Carlsson, 
1959). The development of the selective neurotoxin 6-OHDA for 
catecholaminergic neurons (Ungerstedt, 1968) coincided with the histochemical 
analyses of catecholaminergic systems which conspired to provide a method of 
determining the functional correlates of such systems. A functional correlate of the 
ablation of catecholaminergic neurones by 6-OHDA was a Parkinson's-type 
syndrome. Earlier, Carlsson (1959) had also noted that the depletion of brain 
dopamine by reserpine led to Parkinson-like tremors. This led to clinical 
verification of the correlation between the degeneration of nigrostriatal pathways 
and the onset of Parkinson's disease (Hornykiewicz, 1975). Further work in this 
area revealed that connections between the nigrostriatal/mesolimbic systems 
appeared to play an important role in the regulation of several aspects of motor 
function such as locomotor activity, stereotyped behaviour, muscular tone and 
posture (for review see Iversen, 1977). 
The study of stereotyped behavior became a research field in its own right 
largely based on the descriptions of stereotypy observed after the administration of 
amphetamine, in humans during the Second World War (Randrup et al., 1963). 
The stimulant effects of this drug in animals was well established but when 
administered at high doses (i.e. 3 mg/kg) behaviours were also noted that were 
abnormal in their invariant and repetitive nature (Randrup et al., 1963). 
Stereotyped sniffing, licking, mouth movements or biting had been observed in the 
absence of locomotor activity, grooming, eating and drinking. Pharmacological 
analysis of the behavioural effect produced by d-amphetamine seemed sensible and 
antagonists were postulated which might block the induction of amphetamine 
stereotypy (i.e. perphenazine) (Randrup and Munkvad, 1965). The success of this 
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drug to inhibit stereotypy created a theoretical link between drugs which were 
effective in treating symptoms of schizophrenia and those which antagonised 
amphetamine-induced stereotypy in rats. Therefore, one of the first clues to the 
cellular actions of antipsychotic agents provided the empirical links needed to 
establish what was later to be known as the dopamine hypothesis of schizophrenia 
(Snyder, 1974). 
The study of schizophrenia is one of the most thoroughly researched areas 
of clinical psychopharmacology. Hypotheses which favoured an explanation of 
schizophrenia in terms of physiological mechanisms were parallelled by those 
which proposed a possible genetic aetiology of the disease. Until the 1950s there 
had been a lack of drug treatments which were specifically aimed at the treatment of 
schizophrenia. However, during the 1950s antipsychotic drugs were discovered 
which produced an alleviation of the psychotic symptoms of schizophrenia. 
The first of these drugs was reserpine which was a forerunner of the group 
of antipsychotics known as the typical antipsychotics. This group constituted the 
phenothiazines (beginning with chlorpromazine), the butyrophenones (haloperidol) 
and the thioxanthenes. Developments in this area led to the synthesis of a further 
group of compounds named atypical antipsychotics of which clozapine was a 
prototypical example. These drugs were so-called as they were able to alleviate 
antipsychotic symptoms without producing the motor side-effects which afflicted 
patients treated by the more traditional antipsychotic compounds. Therefore, the 
search for novel antipsychotic agents with less marked extrapyramidal side effects 
was intensified and produced a large number of new dopamine antagonists. These 
drugs varied significantly in their chemical structure but shared the functional 
homogeneity of facilitating dopamine blockade. However, findings concerning the 
localisation and possible differential function of dopamine receptors made it difficult 
to construe dopamine receptors as a homogeneous group. 
On the strength of such evidence, systems of classification under which 
dopamine receptors could be redefined as separate populations of neurons, began to 
emerge. Of the various classifications of dopamine receptors to have been 
proposed, the division into pre- and post-synaptic seems to have been one of the 
most consistent (Carlsson, 1975). The idea that dopaminergic receptors may play a 
part in regulating the release, metabolism and synthesis of dopamine was originally 
formulated in 1963 (Carlsson and Lindquist, 1963). The evidence for the existence 
of central presynaptic dopamine receptors is now based on a large body of 
electrophysiological and biochemical (see reviews by Seeman, 1980; Horn, 1981) 
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and behavioural data (see later in this chapter and also Chapter 2), but was 
originally conceived in the light of studies which showed the ability of 
chlorpromazine and haloperidol to stimulate the metabolism and synthesis of brain 
catecholamines. Carlsson et al. (1963) speculated that the ability of these 
antipsychotic agents to block dopamine receptors might influence a negative 
feedback loop leading to activation of dopaminergic neurons. 
However, it was studies in the behavioural field which championed a unique 
perspective on the functional significance of the localisation of dopaminergic 
receptors; a perspective which had heretofore been relatively obscured by the more 
reductionist neuroscience methods being used. Much of the evidence for the 
existence of self-inhibitory dopamine receptors has been gained from studies with 
apomorphine. This drug was identified as an agonist at dopamine receptors. This 
agonist generated a biphasic dose-response relationship with respect to behaviour 
with behavioural inhibition occuring in the lower dose-range. Higher doses were 
shown to stimulate behaviour and this was presumed to be a consequence of 
preferential post-synaptic action. The threshold doses for inhibition of behaviour 
and for inhibition of DOPA formation were approximately the same, which would 
fit the hypothesis of preferential activation of putative autoreceptors (Carlsson, 
1975). Also, the firing rate of dopaminergic cell bodies was inhibited by 
apomorphine in very low dosage (Aghajanian.and Bunney, 1974, 1977). 
The functional term "autoreceptor " has been said to include: a) the 
presynaptic dopamine receptor, located on the dopaminergic nerve terminals, 
controlling the synthesis and release of the transmitter; b) somatic and dendritic 
receptors, whose stimulation results in decreased rates of firing of the dopaminergic 
neuron (Carlsson, 1975). The stimulation of these receptors lead to a decrease in 
dopaminergic function and therefore helped to provide a model for the interpretation 
of accrued behavioural data (i.e. from studies showing a differential effect of high 
and low doses of drugs such as apomorphine). Table 1.1 lists some of the original 
observations which could be attributed to either presynaptic or post-synaptic 
dopaminergic activity. 
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Table 1.1 Location of pre and postsynaptic dopamine receptors and their 
mediation of behaviours in the rat 
RECEPTOR TYPE 
PRESYNAPTIC POSTSYNAPTIC 
Location in brain -thought to be located on -thought to be on various 
the nerve terminals cell parts of other neurons (i.e. 
bodies and dendrites of the cholinergic neurons) 
dopamine neurons 
Effects as a result of -inhibition of dopamine -induction of stereotyped 
dopamine agonist action release from tissue slices behaviour 
(Starke et al., 1978) (Ungerstedt, 1979). 
-the inhibition of dopamine -the reversal of reserpine 
synthesis in slices induced hypomotility 
(Westfalletal., 1976) (Andenetal., 1973). 
-the reduction of electrical -the induction of 
dopamine cell activity contralateral rotation after 
(Skirboll et al,: 1979). unilateral nigrostriatal 
lesions (Ungerstedt, 1979). 
-the inhibition of the -increase in striatal 
increased dopamine acetylcholine 
synthesis in vivo after the concentrations 
reduction of impulse flow (Sethyetal., 1974) 
by administration of (GBL) 
(Walters and Roth, 1974) 
-by axotomy of 
nigrostriatal neurons 
(Carlsson, 1975). 
-decrease in locomotor 
activity (Strombom, 1975). 
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More recently, studies on the functional dissociations within the extensive 
dopamine systems have highlighted ways in which this system can be further 
taxonomised. In ascribing functional roles to dopamine transmission much 
emphasis has been on the massive character of the dopamine projection to its major 
forebrain area, (the striatum and in particular the nucleus accumbens) (Bjorklund 
and Lindvall, 1978, 1984) not least because interference with dopamine 
transmission in this area disrupts behaviour motivated by both conventional and 
non-conventional reinforcers (see Chapter 2). 
However, what must not be underemphasised are the differential spatial and 
temporal characteristics of dopaminergic transmission within this area, (Di Chiara et 
al., 1994, 1996b; DiChiara, 1995). For example, within the striatum, dopamine 
acts by two separate modalities, a tonic/non-synaptic mode and a phasic/synaptic 
mode (Di Chiara et al., 1996b; Di Chiara, 1995). More specifically, striatal 
dopamine is not only released in the synaptic cleft on junctional low-affinity 
receptors but diffuses to the extra-cellular fluid outside the synaptic compartment 
reaching concentrations sufficient to activate extra-junctional high affinity receptors. 
By acting in the tonic mode, extracellular dopamine exerts modulatory 
influences that may be critical for the transmission of information by phasic 
ionotropic receptors (GABA A, AMPA, NMDA etc.) (Di Chiara et al., 1994). An 
impairment of tonic dopamine transmission in a given striatal area might ultimately 
result in an overall impaiment of the function of that area (Di Chiara, 1998). There 
are several techniques which allow the quantification of the tonic and phasic modes 
of dopamine transmission in animals. These in vivo monitoring techniques are 
brain microdialysis (Ungerstedt, 1984; Westerink et al., 1987; Di Chiara, 1990), 
voltammetry (Kissinger et al., 1973; Marsden et al., 1984; Stamford, 1986) and 
single unit recording (Miller etal., 1981; Steinfels et al., 1981; Schultz, 1992). 
By their nature, these methodologies constitute a direct approach to the issue of the 
behavioural relevance of differential dopamine transmission. 
By virtue of the "online" characteristics of these methodologies, further 
taxcmomisation of dopamine structures and pathways has arisen from studying the 
activity of dopamine neurons in several critical brain sites in response to differential 
rewarding stimuli. The findings from such studies are to be discussed in more 
detail in Chapter 2 (see Section 2.5), therefore at this point it is sufficient to say that 
there is convergent evidence to suggest that the precise location of dopaminergic 
neurons bears important implications for their capacity for information coding 
(Schultz, 1998). More concisely, the functional capacity of dopaminergic neurons 
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is dependent upon their location along the dopamine projections in brain. Therefore, 
the possibility that dopaminergic neurons may represent dissociable aspects of 
behavioural processes probably has a definable neuraoanatomical basis. 
Summary 
The neuroscience methods and models which have evolved over the last 50 
years have led to the establishment of well defined maps of dopaminergic 
projections. In turn, the functional role of dopamine has been further elucidated. 
However, a reliance upon strictly neuroanatomical data in the endeavour to discover 
a role for dopamine in behaviour has limitations. Pharmacological differences 
between dopamine receptor populations were beginning to emerge by the late 1970s 
due to further technological advances and these differences were beginning to be 
associated with differential physiological, biochemical and behavioural 
consequences. More contemporary methods such as radioligand binding and/or 
electron microscope autoradiography have furthered knowledge of the nature and 
location of dopaminergic neurons and most recently their receptor subtypes. 
The next section of the chapter will introduce the notion of dopamine 
receptor subtypes which may be differentiated in terms of their pharmacological 
idiosyncracies and also their anatomical distribution. Most recent research which 
has associated particular dopamine receptor subtypes with certain aspects of 
behaviour, will also be discussed. 
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1.3 Dopamine receptor subtypes 
Until recently, only two dopamine receptor subtypes had been definitively 
shown to exist, (Sibley and Monsma, 1992). Kebabian and Calne (1979) 
distinguished between these two receptor subtypes: these were the D l receptors, 
which activate the enzyme adenylyl cyclase and increase intracellular levels of 
cAMP, and the D2 receptors, which exert an inhibitory influence on this enzyme. 
Both of these receptor subtypes belong to a large superfamily of neurotransmitter 
and hormone receptors that are coupled to their specific effector functions by means 
of guanine nucleotide regulatory proteins (G-proteins) (Dohlman et al., 1991). The 
way in which membership of these families has been organised bears important 
implications for the study of the functional role of dopamine receptors. Before the 
advent of molecular cloning techniques, receptor subtypes were defined primarily 
by their pharmacological profiles in eliciting a physiological or biochemical 
response (Sibley and Monsma, 1992). 
Recent isolation of cDNAs and / or genes encoding novel receptor subtypes 
has confirmed that the dopamine receptor family is more diverse than previously 
imagined. Five pharmacologically distinct dopamine receptors have now been 
defined through molecular cloning techniques (Sokoloffetal., 1990; Sibley and 
Monsma, 1992). These are the dopamine Dl JD2, D3, D4 and D5 receptor 
subtypes. These receptors have been conventionally split into two distinct families: 
the "Dl-like" with D l and D5 receptor subtypes as constituents, and the "D2-like" 
family with D2, D3 and D4 receptors as members (Sokoloff et al., 1990). 
Receptor taxonomy 
•v Based on amino acid sequence and gene organisation, the D3 receptor has 
been classified as a member of the family of the D2-like dopamine receptors 
(Sokoloff et al., 1990; Sibley etal., 1993). Based on these criteria, it has been 
shown that the rat D l and D2 receptors possess only 41% homology with each 
other (Monsma et al., 1990), while, contrasting with this, the rat D3 receptor 
possesses 52% homology with the rat D2 receptor (Sokoloff et al., 1990). The D2 
and D3 receptors exhibit 39% and 41% overall homology with the D4 receptor, 
respectively (Van Tol et al., 1991). Therefore, the evidence above goes some way 
to justifying the taxonomy employed in dividing the dopamine receptor subtypes. 
This system of classification facilitates the endeavour to discover similarities and 
differences between the D2 and the D3 receptor in terms of pharmacology, 
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transmission and function. Being of the same receptor family renders some 
potential physiological and functional distinctions less salient than they might be. 
One of the ways in which these distinctions can be understood is through the study 
of anatomical distribution of receptor subtype populations. 
1.4 Localisation and distribution of dopamine receptor subtypes 
A variety of approaches may be employed to study the localisation of the 
dopamine receptor subtypes. These have recently included molecular, 
pharmacological and immunological methods. Since selective radioligands capable 
of discriminating each member of the dopamine family are unavailable, the study of 
dopamine receptor distribution in the brain by classic autoradiography binding 
techniques has been difficult. Much of what is known of the regional distribution 
of the most novel receptor subtypes (D3, D4, D5) for which selective 
pharmacological tools have only recently been identified, is based on the localisation 
of receptor mRNA (Levant, 1997). However, it is well known that the distribution 
and relative abundance of mRNA does not necessarily covary exactly with the 
distribution and density of the receptor it encodes (Levant, 1997). Nevertheless, 
the detection of mRNA with appropriate probes is often presumed to be specific for 
the receptor of interest. Thus, in situ hybridisation has been used extensively as 
the method of choice to localise the various receptor mRNAs (Levant, 1997). 
The dopamine Dl-like receptor subtypes 
The dopamine D l receptor is the most widespread dopamine receptor and is 
expressed more abundantly than any other dopamine receptor subtype (Weiner et 
al., 1991). D l mRNA is found in areas known to be under dopaminergic control 
such as the striatum, nucleus accumbens and olfactory tubercule. It is also found in 
the limbic system, hypothalamus and thalamus. In other areas with numerous 
binding sites for the D l receptor, no mRNA is detected, suggesting that in these 
areas the D l receptor is present in projections only. Examples of such areas are the 
entopenduncular nucleus, globus pallidus and in the substantia nigra pars reticulata, 
where D l dopamine receptors originate from striatal GABAergic neurons co-
expressing substance P (Le Moine et al., 1991). 
The dopamine D5 receptor 
The dopamine D5 receptor, as a member of the Dl-like receptor family, is 
expressed at a much lower level than the D l receptor, and shows a distribution 
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restricted to the hippocampus and to two sets of nuclei: the lateral mamillary 
nucleus and the parafascicular nucleus of the thalamus (Meador-Woodruff et al., 
1992). However, the D l receptor mRNA shows no significant expression in these 
nuclei. Moreover, these regions are not detected by radioligand binding, suggesting 
that the D5 receptor is either translocated axonally to other brain regions or that its 
level of expression is too low to be detected by standard binding procedures (Jaber, 
1996). 
The dopamine D2-like receptor subtypes 
The dopamine D2 receptor has been found mainly in the striatum, olfactory 
tubercule and nucleus accumbens where it is expressed by dopaminoceptive 
GABAergic neurons co-expressing enkephalins (Le Moine and Bloch, 1995). It is 
also found in the substantia nigra pars compacts, and in the ventral tegmental area, 
where it is expressed by dopaminergic neurons (Weiner et al., 1991). Thus, the D2 
receptor is found at both presynaptic and postsynaptic levels in the brain. The D2 
receptor has long been known to be expressed in the pituitary (Creese et al., 1977) 
where it regulates the production and secretion of prolactin. 
The dopamine D4 receptor 
The dopamine D4 receptor along with the ,D3 receptor seems to be restricted 
to the mesolimbic system where this system is thought to serve a role in modulating 
emotion and cognition. D4 receptor mRNA is abundant in frontal cortex, 
amygdala, thalamus, hypothalamus and pituitary with lower levels found in the 
hippocampus (Joyce and Meador-Woodruff, 1997). 
\ The dopamine 133 receptor 
The dopamine D3 receptor has received much attention, mainly because of 
its specific distribution around the limbic brain areas such as the shell of the nucleus 
accumbens, olfactory tubercule and Islands of Calleja, and its low expression in the 
striatum (Sokoloff et al., 1990, Bouthenet et al., 1991). Therefore, it seems that 
there is not a complete overlap between the D3 receptor and its closest homologue 
the D2 receptor in terms of neuroanatomical distribution. 
In brief, D3 mRNA has been found mainly in the ventral striatal complex, 
the substantia nigra pars compacta the ventral tegmental area and the cerebellum 
(Diaz et al 1994). In the Islands of Calleja, both D3 receptor binding and 
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messenger mRNA are abundant in the entire population of granule cells, which are 
known to make sparse contacts with dopaminergic axons. A minor proportion of 
these granule cells appear to be in direct synaptic contact with dopamine axons, 
mainly those surrounding the islands (Fallon et al., 1993). 
In the archicerebellum, Purkinje cell perikarya in lobules 9 and 10 express 
D3 mRNA, whereas binding sites were found only in the molecular layer. 
Surprisingly, no known dopaminergic projections are known to exist in this area, 
suggesting that the D3 receptor may mediate non-synaptic actions of dopamine 
(Diaz etal,1995). 
Within the nucleus accumbens, D3 receptor markers are more extensively 
expressed in selected subterritories and subsets of neurons. Within this nucleus, 
three main areas can be distinguished: the rostral pole, the shell and the core 
(Landwehrmeyer et al., 1993). D3 receptor markers were both present in the rostral 
pole and parts of the shell (the ventromedial portion) but were almost absent from 
the core and from the septal pole of the shell (also known as the shell cone), 
(Griffon etal., 1995). 
Griffon et al., (1995), futher showed a co-localisation of D3 receptor and 
neurotensin gene transcription the ventromedial shell with double in situ 
hybridisation studies. They also demonstrated the presence of dense D3 receptor 
binding accompanied by low mRNA levels in subcommisural ventral pallidium. 
These observations strongly suggest that a subpopulation of accumbopallidial 
neurotensin neurons (Sugimoto et al., 1987) expresses D3 receptors at 
somatodendritic level as well as at the terminal projections. 
Distribution of the D3 receptor in human brain 
The distribution of D3 receptors in human brain have recently been 
implicated in pathologies such as schizophrenia and drug addiction (see General 
Discussion). Therefore, a brief outline of their localisation will give some idea of 
the possible functional significance in such pathology in humans. 
The overall pattern of distribution of the D3 receptor in human brain seems 
to be somewhat less restricted than the distribution of this receptor subtype in the rat 
brain (Herreolen et al., 1994). Highest densities of putative D3 sites are reported 
in the nucleus accumbens and the Islands of Calleja (Landwehrmeyer et al., 1993b; 
Murray et al., 1994). Moderate amounts of D3 binding have been observed in the 
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basal ganglia, parietal, temporal and occipital cortex, and cerebellar cortex, followed 
by substantia nigra, hippocampus, and the basolateral, lateral and basomedial 
amygdaloid nuclei (Herroelenetal., 1994; Murray etal., 1994; Lahtietal, 1995). 
D3 receptors have also been detected in moderate density in the pituitary, with 
somewhat greater labelling in the posterior lobe than the anterior (Herroelen et al., 
1994). 
Functional implications of the regional distribution of the D3 receptor 
The evidence from in situ hybridisation studies reveals that there is 
uncertainty surrounding the possibility that the D3 receptor like the D2 receptor, is 
located presynaptically and/or postsynaptically. Therefore, the pre- or postsynaptic 
localisation of D3 receptors in the brain is a matter of controversy. A wealth of 
behavioural data has been brought to bear in order to address this question and will 
be discussed more fully later in this chapter. However, at the cellular level, 
evidence that the D3 receptor is located presynaptically comes from the detection of 
D3 mRNA in the substantia nigra and the ventral tegmental area. The detection of 
putative binding sites in dopaminergic terminal fields also suggests that a subset of 
D3 receptors may be presynaptic (Levant, 1997). Further corroboration comes 
from lesion studies. Unilateral dopaminergic lesions produced a marked decrease in 
D3 receptor density in the nucleus accumbens* suggesting the loss of presynaptic 
rather than postsynaptic sites (Levesque et al., 1995). Neurochemical studies also 
suggest a role for the D3 site as a synthesis and/or release-modulating autoreceptor 
(Waters etal., 1993). 
Unlike the D2 receptor, which is abundant in the caudate/putamen or 
pituitary as well as limbic brain regions (Levant, 1996), very low levels of 
expression of the D3 receptor are detected in either caudate putamen or pituitary. 
The caudate putamen site is associated with negative side effects produced by most 
conventional antipsychotics, such as the extrapyramidal symptom, tardive 
dyskinesia. These observations suggest that neuroleptic drugs which have a high 
affinity for the D3 receptor could achieve their antipsychotic effects without 
encumbent extrapyramidal and neuroendocrine effects (Sokoloff et al., 1990). 
The high densities of D3 receptors in lobules 9 and 10 of the cerebellum 
(coupled with the sparsity of D2 receptors) (Bouthenet et al., 1996) has led to 
investigations into a functional role for this cerebellar dopamine system. Recently, 
Barik and Beaurepaire (1996) showed that microinjections into the 
vestibulocerebellum produces alterations in locomotor activity in rats. This system 
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has not often been directly associated with the control of locomotion, rather it has 
been consistently related to the vestibular control of posture. Clinically, disorders 
involving these brain regions produce symptoms such as ataxia, whereas lesions of 
this brain region cause rigidity (Ghez and Fahn, 1981). These symptoms are 
obviously similar to those encountered in patients treated with antipsychotic drugs. 
Therefore, the substrate underlying these effects may not be exclusively striatal 
(Levant, 1997). 
It has been also been suggested that the archicerebellum plays a part in the 
control of eye movements, abnormalities of which occur in a large proportion of 
schizophrenic patients. The participation of dopamine D3 receptors in this 
pathophysiology is partly supported by the observation of a genetic association 
between homozygosity at the D3 receptor gene and familial schizophrenia (Crocq et 
al 1992). However, this genetic linkage to schizophrenia remains inconclusive (see 
General Discussion.) 
Dopaminergic receptor localisation studies around the nucleus accumbens 
are coupled with recent evidence for the functional and anatomical heterogeneity 
within mis brain structure. The nucleus accumbens has been compartmentalised 
leading to a functional dichotomy between the more rostrally located core and the 
caudomedially located shell subregions (Zahm and Brog, 1992). Dissociations 
between these regions in terms of anatomical, behavioural, neurochemical and 
electrophysiological characteristics have been well documented. Of particular 
relevence here is the finding that D3 receptors are selectively distributed around the 
shell but are absent from the core (Landwehrmeyer, 1993). The shell has been 
shown to project primarily to limbic structures while the core preferentially sends 
efferent projections to motor related structures (Deutch and Cameron, 1992). Also, 
there is at least one report of two neurochemically distinct divisions in the human 
nucleus accumbens which display many of the characteristics of the rat nucleus 
accumbens, including a selective distribution of D3 receptor receptor density (Voorn 
etal., 1994). 
Furthermore, several behavioural studies using animals have made use of 
the compartmentalisation of the nucleus accumbens in order to study the effects of 
stimulation of these discrete subregions some which are of particular interest here. 
For example, strong supporting evidence for the idea that the shell may play a more 
important role than the core in the mediation of feeding behaviour comes from a 
study which blockade of glutamate in the shell but not the core, induces a powerful 
feeding response (Maldonado-Irizarry et al., 1995); an effect which was partially 
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reversed by dopamine antagonists. Consequently, it was hypothesised that 
dopamine in the shell may have a modulatory effect on feeding behaviour. Further 
work from the Maldonado-Irizarry laboratory has shown that local microinjections 
of dopamine agonists into these subregions did not significantly affect feeding or 
drinking responses. Rather, using these compounds it seemed that the shell 
appeared to be relatively more sensitive to the motor activating effects of dopamine 
agonists than the core (Swanson et al., 1997). 
The density of D3 receptors in the olfactory bulb has given rise to the 
targeting of this brain site in the search for the behavioural significance of this 
receptor subtype. The olfactory bulb is endowed with a strictly intrinsic source of 
dopamine and therefore this structure contrasts with the brain structures wherein 
dopamine is secreted from the terminals of projection neurons, like striatum, 
cerebral cortex, nucleus accumbens and olfactory tubercule (Lindvall and 
Bjorklund, 1983). Dopamine involvement in olfactory processing has been 
suggested recently by several lines of evidence. Single injection of a dopamine 
agonist in vivo reduces odour detection (Doty and Risser, 1989) and abolishes 
odour-induced metabolic activation pattern in olfactory bulb (Sallaz and Jourdan, 
1992). Such data could indicate that dopamine could exert an inhibitory control on 
olfactory input. Dopamine may also be implied in olfactory memory since 
dopamine release increases during learning (Kendrick et al., 1988; Coopersmith et 
al., 1991; Keverae et al., 1993) and since injection of dopamine antagonists 
inhibits olfactory memory formation (Weldon et al., 1991). 
In the light of the recent cloning of novel receptor subtypes, it is interesting 
to investigate the extent to which these subtypes may contribute to olfactory 
function by determining their locale and extent of distribution. For instance, 
Coronas et al. (1997) used a combined approach to characterise the formerly known 
population of D2-like binding sites in olfactory bulb as a major contingent of D2 
receptors with a minor amount of D3 receptor but no D4 receptors. They 
discovered a striking overlap of subregional distributions of either mRNAs or 
specific binding sites of the two receptor subtypes. This could imply that D2 and 
D3 receptors might be co-expressed in the same neurons in olfactory bulb (Coronas 
etal., 1997). 
Evidence of receptor colocalisation has led researchers such as Barik and 
Beaurepaire (1998) to hypothesise interactions which heretofore have been difficult 
to predict owing to a lack of refined techniques. The brain area under study was the 
Island of Calleja Magna which has the highest density of D3 receptors in the brain, 
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and which does not contain D2 receptors and therefore render this structure is an 
appropriate target for studies on the functional selectivity of D3 receptor stimulation. 
However, this brain structure does contain dopamine DI receptors (Mengod et al., 
1992). It is well established that DI and D2 receptors interact in certain parts of the 
brain (i.e. D2 effectiveness being potentiated by concomitant DI activation, Walters 
et al., 1987). Barik and Beaurepaire chose thermoregulation as their dependent 
variable as this was a response which had been related to D3 receptor function 
several times (see Table 1.3). Their results show that D3 receptor agonists 
microinjected into the island of Calleja Magna decreased body temperature and that 
this effect was potentiated by simultaneous injection of the DI receptor agonist SKF 
38393 (Barik and Beaurepaire, 1998). Therefore there is apparent synergy in the 
activation of these co-localised receptors despite their pharmacological contrariety. 
1.5 Dopamine receptor pharmacology 
Functional assays 
As has already been mentioned, the original dissociation of DI and D2 
receptor subtypes was based on their opposing effects (stimulation and inhibition 
respectively) on adenylyl cyclase activity (Kebabian and Calne, 1979). Since these 
early discoveries, the use of functional or physiological assays has been invaluable 
in correctly classifying ligand specificity at the Dl-like and D2-like receptors. 
However, the validity of this simple dissociative assay has been questioned 
(Downes and Waddington, 1993). 
Since the cloning of novel dopamine receptor subtypes, much of the 
confirmation of agonist or antagonist activity of novel dopaminergic compounds at 
the D3 receptor comes from the use of functional assays. Levant (1997,1998) 
reviews such data and highlights some of the most salient results with respect to the 
D3 receptor. D2 agonists, such as dopamine, quinpirole, and bromocriptine, have 
been shown to possess agonist activity at the D3 receptor as assessed by several 
physiological assays such as the induction of CHO (Chinese hamster ovary) cell 
mitogenesis, melanocyte aggregation or extracellular acidification (Chio et al., 1994; 
Sautel et al., 1995a). The putatively D3 selective compounds 7-OH-DPAT and 
PD128907 also exhibit differential agonist activity in the mitogenesis test (Chio et 
al., 1994; Pilonetal., 1994; Potenza et al., 1994; Sautel etal., 1995a; Pugsley 
et al., 1995). In contrast, antagonists such as spiperone, sulpiride and nafadotride, 
block agonist induced activity in these tests (Sautel et al., 1995b). The D2/D3 
ligand (+)-UH 232 has been shown to be a partial agonist at the D3 receptor in the 
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mitogenesis assay (Griffon et al., 1995). Therefore such assays have proven 
useful in determining the functional boundaries between novel and existing 
dopamine receptor subtypes. 
Radioligand Binding Studies 
One of the greatest breakthroughs in Neuroscience has been the emergence 
of a technique which provides the ability to localise and measure neurotransmitter 
receptors in homogenised brain tissue. The radioligand binding procedure 
represents a relatively simple method of achieving this aim. A ligand is selected 
which will bind to the receptor of interest. This ligand is then labelled with a 
radioactive substance (hence radioligand). The radioligand is incubated with the 
tissue (homogenate or tissue slice) under empirical conditions which have been 
shown to optimize binding. Radioligand which remains unbound after application 
is removed and the amount of radioligand bound to the tissue is men measured by a 
gamma counter. Several criteria are essential for concluding that receptor binding 
has occurred (i.e. specificity of binding to the receptor of interest alone; saturability, 
whereby binding steadily increases until all the receptors are occupied, reversibility 
of the ligand-receptor association and finally, the biological relevance of the binding 
in the assessment of the relationship between the ligand/receptor interaction and a 
consequent biological response). It is in this way.that many of the dopamine 
receptor subtypes currently recognised have been located and measured since the 
1960s and 70s. 
At this stage of the thesis it is useful to provide a selection of ligands, 
which is by no means exhaustive but will contain some of those compounds which 
will be referred to throughout the text as having specificity for certain dopamine 
receptor subtypes. Table 1.2 provides some of the pharmacological tools used to 
study D l and D2 receptors on the basis of their published specificity for these 
receptor subtypes. 
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Table 1.2 traditional functional classification of dopamine receptor subtypes and 
prototypical pharmacological compounds selective for D l and D2 receptors 
D l D2 
Prototype receptor Parathyroid gland 
location 
Anterior and intermediate 
pituitary gland 
Adenylate cyclase 
association 
Stimulatory Inhibitory or unlinked 
Prototype selective 
agonists SKF 38393 
[+f-]-l-Phenyl-2,3,4,5-tetrahydro-
[lH]-3-benzazepine-7,8-diol 
bromocriptine 
(+)-2-Bromo-12 '-hydroxy-2 '-(/-
methyllethyl)-5'-(2-methyl-propyl)-
ergotaman-3',6'-18-trione 
methanesulfonate 
SKF-82958 
(±)-6-Chloro-7,8-dihydroxy-3-
allyl-l-phenyl-2,3,4,5-tetrahydro-
lH-3-benzazepine hydrobromide; 
6-Chloro-N-altyl-SKF-38393 
hydrobromide 
quinpirole 
LY 171555 
Prototype selective 
antagonists SCH-23390 
R(+)-7-Chloro-8-hydroxy-3-
methyl-l-phenyl-2,3,4,5-
tetrahydro-lH-3-benzazepine 
hydrochloride 
raclopride 
S(-)-Raclopride lAartrate 
SCH-39166 
(6aS,13bR)-ll-chloTo-
6,6a, 7,8,9,13b-hexahydro-7-
methyl-5H-benzo 
[d]naphth[2,l-b]azepin-12-ol 
sulpiride 
(+/-)-5-(Aminosulfonyl)-N-[(l-ethyl-
2-pyrrolidinyl)methyl]-2-
methoxybenza mide 
SKF-83566 
(±)-7-Bromo-8-hydroxy-3-methyl-
1 -phenyl-2,3,4,5-tetrahydro-lH-3-
benzazepine hydrochloride 
spiperone 
N-Methyl-8-[4-(4-Fluorophenyl )-4-
oxobutyl]-l-phenyl-l,3,8-triazaspiro-
[4.5]decan-~4-one hydrochloride 
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(Table 1.2 continued) 
Location Postsynaptic Pre- and postsynaptic 
Electrophysio- Inhibitory Inhibitory 
logical effect 
(Extracellular) 
Table 1.2 adapted from Clark and White (1987) 
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Until recently, however, few pharmacological tools were available to 
properly discern an exclusive functional role for each of the dopamine receptor 
subtypes. Nevertheless, since the original cloning of the D3 receptor in 1990 
(Sokoloff et al., 1990) several studies have examined the specificities and relative 
affinities of dopaminergic compounds for D2 and D3 receptors in various 
expression systems and in brain. The relatively extensive homology between the 
D2 and D3 sites leads to the prediction that the pharmacological profile of the D3 
receptor should be generally similar to that of the D2 receptor. However, in her 
extensive review of such evidence (Levant, 1997) results of radioligand binding 
studies vary considerably. This variation seems to partially depend on the 
expression system or tissue, the radioligand used and the in vitro assay conditions 
used (Tang et al., 1994a; Burris etal., 1995; Levant etal., 1995). 
However, some general conclusions seem to be currently accepted. The D3 
receptor exhibits high affinity for non-selective and D2 selective agonists such as 
dopamine, quinpirole and apomorphine, and significantly lower affinity for the D l 
selective agonist SKF 38393 (Sokoloff et al., 1990). The D3 site also possesses 
significantly higher affinity for D2 selective antagonists, such as spiperone and 
haloperidol, than the D l selective antagonist SCH 23390 (Freedman et al., 1994b). 
Recently, racemic 7-hydroxy-2-(iV,iV - di -n ^ pro -pylamino)tetraUn (7-OH-
DPAT) was reported as a selective ligand for the dopamine D3 receptor: the Ki 
values for dopamine D2, D4 and D l receptor subtypes were approximately 2,3 and 
4 orders of magnitude lower, respectively (Levesque et al., 1992). These findings 
led to speculation that this compound may be useful as the first limbic-selective 
dopamine agonist for probing the behavioural function of the dopamine D3 
receptors in vivo (Caine and Koob, 1993; Daly and Waddington, 1993). 
However, D2 receptors exist in multiple states having high and low 
affinities for D2 agonists (Burris et al., 1995). The G-protein coupled state of D2 
receptors is believed to be the functional state of these receptors. More precisely, 
putative D3 receptor -selective agonists also interact with high-affinity, G-protein 
coupled state of D2 receptors. During labelling, by providing conditions which 
promote uncoupling of receptors from G proteins , it becomes possible to 
differentially affect affinities of D3 receptors in comparison to those of the D2 
receptor, (Burris et al., 1995). The similarities in affinities of the agonist-preferring 
state of D2 and D3 receptors means that available agonists cannot be used to 
discriminate between behavioural effects mediated by D2 and D3 receptors. 
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Although it is beyond the scope of this thesis to list all of the radioligand 
binding data published to date (see Levant, 1997, for review), it is worthy of note 
that there are several ligands which are commonly used in determining the 
functional role of the D3 receptor. Therefore, several agonists and antagonists are 
listed below which have been shown to have equal or higher selectivity for D3 
receptors over D2 receptors. 
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Table 1.3 Agonists and antagonists selective for the D3 receptor in vivo and in 
vitro. 
D3 receptor author D3 receptor author 
agonists antagonists 
PD-128907 Corbinetal. (1994) LU-201640 Gross etal (1997) 
Pugsleyetal. (1995) 
(+)- 7-OH-DPAT Damsmaetal.(1993) (+)-S 14297 Millanetal. (1995) 
(+)-AJ76 Svensson et al. (1986) 
(-)- Quinpirole Sokoloffetal. (1990) (+)-UH 232 Svensson etal. (1986) 
S-14297 Gobertetal. (1994) nafadotride Sauteletal. (1995) 
Schwatrz et al. (1995) 
PNU 99194A Waters etal. (1993) 
pirebidil Cagnotto etal. (1996) 
PD-152255 Corbinetal. (1998) 
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Results from binding studies are inconclusive (Levant, 1997, 1998) and too 
numerous to mention here. However, in brief, PD 152255 seems to be the most 
potent antagonist available for the D3 receptor (Corbin et al., 1998) being 28- to 
45-fold more potent at D3 receptors than at D2 receptors. This contrasts with the 5-
20 fold selectivity for other antagonists available for the D3 receptor (Corbin et al., 
1998). According to published literature, in terms of selectivity compared with D2 
receptors, quinelorane is a more potent D3 receptor agonist than 7-OH-DPAT or 
quinpirole and 7-OH-DPAT is more potent at the D3 receptor man quinpirole 
(Sautel et al., 1995). Many agonist compounds have been claimed to have a higher 
selectivity for the D3 receptor but 7-OH-DPAT and quinpirole seem to have been 
adopted as the prototypical D3 receptor agonists. This is the case despite the 
considerably different reports on the selectivity of 7-OH-DPAT for the D3 receptor. 
While early reports claimed a 100-fold selectivity for the D3 receptor over the D2 
receptor, (Levesque et al., 1992), more contemporary studies report, at best, a 
sevenfold selectivity for the D3 receptor, (Gonzalez and Sibley, 1995). 
Also, it has recently been observed that 7-OH-DPAT binds with high 
affinity to the a receptor site (Schoemaker, 1993; Wallace and Booze, 1995). The 
ratio of D3 receptor to a binding sites in brain subregions were calculated by 
Wallace and Booze (1995). They showed that there was a 4: 1 ratio of D3 receptor 
to o binding sites in the core of the nucleus accumbens and a 1: 1 ratio in the shell 
of the nucleus accumbens. Therefore, these authors acknowledge that behavioural 
effects of 7-OH-DPAT could feasibly be the result of an interaction between a and 
D3 receptors. Sethyetal. (1996) conducted a neurochemical study which indicated 
that, at high doses, 7-OH-DPAT has both D-l and D-2 agonist activities. 7-OH-
DPAT-induced increases in Ach at high doses (0.3 to 30 mu mol/kg) and these 
effects were antagonised by the D2 receptor antagonist raclopride and also by the 
D l receptor antagonist SCH-23390. Despite these caveats, many behaviours have 
been repeatedly associated with the effects of putative D3 receptor agonist 
compounds such as the above and a selection are listed in Table 1.3. 
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Table 1.3 Some of the simple behavioural and physiological effects of putauvely 
D3 receptor-preferring compounds 
Agonist induced behaviour Reference 
-induction of hypothermia 
-induction of yawning 
Damsmaetal. (1993); Alhenius and 
Salmi (1994); Millanetal. (1994,1995 
a,b); Ferrari and Guiliani (1995); 
Khroyan et al. (1995); Kurashima et al. 
(1995) 
-decreased sniffing Daly and Waddington (1993) 
-decreased grooming Khroyan et al. (1995) 
-decreased climbing in mice Sauteletal. (1995 b) 
-increased penile erection and 
ejaculatory behaviour 
Ferrari and Guiliani (1995) 
-disruption of social behaviour 
-modulation of anxiety 
Kagayaetal. (1996) 
Rodgersetal. (1996) 
-inhibition of pilocarpine induced 
limbic seizures 
Alam and Starr (1994) 
-induction of emesis in the dog Yoshidaetal. (1995) 
-depression of 
electroencephalogram patterns 
-induction of catalepsy 
Popolietal. (1996) 
Millanetal. (1995b); 
Sautel et al.(1995 b) 
-increased oxytocin secretion 
-decreased prepulse inhibition 
Uvnas Moberg et al. (1995) 
Caineetal. 1995 
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(Table 1.3 continued) 
-increase in blood pressure VandenBuuse (1992) 
Is the D3 receptor an autoreceptor ? 
Models of presynaptic and postsynaptic activity 
The evidence for the existence of central presynaptic dopamine receptors is 
based on a large body of electrophysiological, biochemical and behavioural data. 
Autoreceptors on presynaptic nerve terminals participate in the local control of 
transmitter release. According to a review by Starke et al. (1989) dopamine release 
modulating autoreceptors exist in various brain areas of different animal species and 
belong to the D2 type. The high affinity of D3 receptors for dopamine supports the 
hypothesis that D3 receptors function as synthesis inhibiting autoreceptors in the 
striatum, (Meller et al 1993). However, there are several studies which cast doubt 
on an exclusively presynaptic location for the D3 receptor. For example, dopamine 
denervation downregulates D3 receptors (Levesque et al., 1995), a finding 
consistent with a post-synaptic localisation of the D3 receptor. 
Most studies have been performed in the mesostriatal system, whereas few 
investigations have concerned dopamine autoreceptors in the terminal regions of the 
mesolimbic dopaminergic pathway. However, recent work by Barik and 
Beaurepaire (1998), using microinjections of D l and D3 receptor agonists into the 
island of Calleja Magna, revealed that in dopamine-depleted animals reacted in the 
same way as non-depleted animals in a test for the D3 receptor mediated function of 
thermoregulation. They conclude that, at least in this brain area, D3 receptors are 
located post-synaptically. Therefore, evidence from a number of in vivo and in 
vitro assays will be reviewed to attempt to evaluate the controversial speculation 
surrounding the neuroanatomical location of the D3 receptor. 
Evidence for a role of the D3 receptor in neuronal activity 
As the "prototypical" D3 agonist, 7-OH-DPAT has been used to probe the 
effects of D3 receptor stimulation on neuronal activity. 7-OH-DPAT has been 
shown to inhibit firing of neurons in both the substantia nigra and ventral tegmental 
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areas, as well as in brain slice preparations (Bowery etal., 1994; Liu etal., 
1994a; Devotoetal., 1995; Kreissetal., 1995; Lejeune and Millan, 1995). 
Kreiis et al. (1995) found a strong relationship between the potency of ten 
dopamine agonists to inhibit neurons in the substantia nigra pars compacta and their 
affinities at D3 rather than D2 receptors. 7-OH-DPAT has also been reported to 
decrease firing of spontaneously active neurons in the nucleus accumbens, (Amano 
etal., 1994; Liu etal., 1994a). 
Further electrophysiological studies seem to reinforce the idea that the 
effects of low doses of 7-OH-DPAT are mediated through D3 autoreceptors. The 
activation of these receptors decrease dopamine release / synthesis as is the case for 
the D2 autoreceptor. Lejeune and Millan, (1995) discovered that the firing rate of 
dopaminergic neurons in the VTA of anaesthetised rats was dose-dependently 
inhibited by 7-OH-DPAT (0.31-5.0 ng/kg IV). This effect was reversed by the 
selective D3 antagonist (+)-S14297. When administered alone, this antagonist did 
not modify firing rate. Haloperidol (16(xg/kg IV) fully reversed the effects of 7-
OH-DPAT and alone significantly increased the firing rate. Taken together these 
latter data suggest that the inhibitory (dendritic) dopamine D3 autoreceptors control 
the electrical activity of ventral tegmental area localised dopamine neurons. 
Evidence for a role of the D3 receptor in neurochemistrv 
As autoreceptors on presynaptic nerve terminals participate in the local 
control of transmitter release, it is worthy of note that 7-OH-DPAT produced 
decreases in dopamine release as assessed by microdialysis or voltammetry as well 
as in accumbal slice preparations (Damsma et al., 1993; Rivet et al., 1994; 
Yamadaetal., 1994; Devotoetal., 1995; Gilbert et al., 1995; Pateletal., 
1995; Gainetdinov etal., 1996). Similar results have been demonstrated with the 
administration of the D3-selective agonist PD 128907 (Pugsley et al., 1995). 
The D3 receptor has been implicated in the modulation of dopamine 
synthesis. In vivo, D3-selective drugs 7-OH-DPAT and PD 128907 have been 
reported to decrease dopamine synthesis, (Aretha et al., 1995; Gobert et al., 1995; 
Gainetdinov etal., 1996; Pugsley etal., 1995). There is evidence that this effect 
is presynaptic as it is observed in both normal and animals treated with gamma-
butyrolactone which blocks impulse flow in nigrostriatal and mesolimbic dopamine 
neurons (Aretha et al., 1995; Pugsley etal., 1995). The involvement of the D3 
receptor in such an effect is confirmed by the observation that 7-OH-DPAT 
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produced a greater decrease in dopamine synthesis in the nucleus accumbens (where 
D3 receptors are relatively abundant) than in the caudate nucleus (where D3 
receptors are relatively sparse) (Aretha etal., 1995; Pugsley etal., 1995). 
1.6 Evidence of a role for the D3 receptor in behaviour 
There is anatomical, pharmacological, neurochemical and 
electrophysiological evidence to suggest both a presynaptic (Van Oene et al., 1984; 
Timmerman et al., 1991; Damsma et al., 1993; Meller et al., 1993) and also a 
postsynaptic (Waters et al., 1993; Svensson et al., 1994) preferential localisation 
for the dopamine D3 receptor. It has been suggested that the effects of putative D3 
receptor agonists such as 7-OH-DPAT in the nucleus accumbens would act 
primarily on the postsynaptic D3 receptor and in the ventral tegmental area on the 
D3 autoreceptor (Freedman et al., 1994). These effects are manifest as changes in 
locomotion. Consequently, the D3 receptor has been widely cited in the modulation 
of locomotor activity. 
At the behavioural level, attenuation of locomotor activities in response to 
low doses of dopamine agonists have been classically interpreted as resulting from 
selective stimulation of dopamine autoreceptors. On the other hand, potentiation of 
locomotor activities by intermediate dosages of dopamine agonists and the induction 
of stereotypies with high doses has been interpreted as resulting from postsynaptic 
effects, (Strombrom et al., 1976). The triphasic effect on locomotion, of 
compounds such as 7-OH-DPAT is described by Waddington and Daly (1993); 
Starr and Starr (1995); Franz et al. (1996) and is taken to reflect this differential 
stimulation of pre- and post-synaptic sites. However, as Meyer (1996) and Kling-
Petersen et al. (1995) have demonstrated, the cause of this biphasic effect is not as 
obvious as the above assumptions imply. 
Meyer (1996) questioned the hypothesis that the D3 receptor is both a 
presynaptic and a postsynaptic receptor. He found that microinjections of 7-OH-
DPAT directly into the nucleus accumbens resulted in the potentiation of 
locomotion. These data support the hypothesis that the D3 receptors are 
postsynaptic receptors. However, microinjections of 7-OH-DPAT directly into the 
ventral tegmental area did not result in the attenuation of locomotor behaviours, but 
rather resulted in the potentiation of the behaviour. These behavioural data did not 
support the hypothesis that the D3 receptor in the VTA functions as an autoreceptor. 
Therefore, it seems that distinctions between the functional significance of a 
presynaptic and a postsynaptic D3 receptor is not clearly definable. 
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Also using intracerebral injections, Kling-Petersen et al., (1995) found that 
R-(+) 7-OH-DPAT inhibited spontaneous locomotor activity over a wide dose range 
after injection into the nucleus accumbens. Conversely, the D3 antagonist 
U99194A (30 x more selective for D3 than for D2 receptors) produced an increase 
in activity when injected into the nucleus accumbens. Local application of 7-OH-
DPAT into the ventral tegmental area did not produce any significant behavioural 
effects. Using another D3 receptor antagonist /-Nafadotride (Sautel et al., 1995b) 
found that at low doses (0.1-lmg/kg) nafadotride, unlike haloperidol, increases 
spontaneous locomotion of habituated rats and climbing behaviour of mice, at doses 
that do not modify striatal HVA levels. At high doses (1-100 mg/kg) nafadotride, 
like haloperidol, produces catalepsy and antagonises apomorphine-induced 
climbing. 
This clearly contrasts the behavioural effects of D2 and D3 antagonists 
suggesting that dopamine D3 receptor blockade results in motor activation while 
dopamine D2 receptor blockade gives rise to motor sedation. The above evidence 
lends weight to the idea that the D3 receptors, in contrast with D2 receptors are in 
the main, located postsynaptically where they display an inhibitory action on 
locomotor activity. 
Neurochemical correlates of D3 receptor agonist-induced behaviours 
Stahle (1992) presented compelling evidence that suppression of locomotor 
activity is mediated by a postsynaptic receptor rather than an autoreceptor as 
dopamine agonist-induced hypoactivity can be demonstrated even in the presence of 
substantially increased synaptic dopamine concentration. Svensson et al. (1994) 
also dispute the role of the D3 autoreceptor in hypolocomotion, as 7-OH-DPAT 
produced this phenomenon at doses which did not affect dopamine release or 
synthesis. 
In manipulating the D3 antagonist U99194 (20 x more selective for D3 than 
for D2 receptors) Waters et al, (1993), have been able to demonstrate that the effects 
of this,antagonist is most likely due to the blocking of a postsynaptic inhibitory 
dopamine £>3 receptor. U99194 was able to increase locomotor activity in rats and 
to potentiate the stimulatory effects of amphetamine whereas the classical effects of 
the D2 receptor blockade is antagonism of amphetamine induced locomotion. 
Further confirmation of this comes from studies employing voltammetry (Gilbert et 
al., 1995). Their study revealed that 7-OH-DPAT had its effects at dopamine 
autoreceptors to decrease intracranial dopamine levels and to decrease behaviours 
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that are dopamine dependent such as self-stimulation to the ventral tegmental area. 
Systemic injections of 7-OH-DPAT (0.01-0.3 mg/kg IP) quickly and dose-
dependently decreased responding for stimulation. Several in-vivo experiments 
support this finding by showing that 7-OH-DPAT decreases dopamine release 
using microdialysis (Mulder etal., 1987; Timmerman et al., 1991; Damsmaetal. 
1993). Similar results were reported for the potent D3 agonist PD 128,907 (Millan 
et al, 1996; Gobert et al.,1996) and the converse is reported for the D3 antagonist 
PD 156,586 (Bristow et al, 1996) which seems to be acting as an antagonist at D3 
synthesis regulating autoreceptors. 
Again, many of the results of the functional corollaries of D3 receptor 
stimulation are inconclusive. Without confirmation of the pharmacological 
specificity of novel compounds it is difficult to conclude whether the D3 receptor is 
indeed a pre-synaptic autoreceptor or a post-synaptic receptor. Indeed, as Levant 
points out, in vivo interaction of the putative D3 receptor agonists with the D3 
receptor has yet to be demonstrated (Levant, 1997). 
A role for postsynaptic D2 receptors in the biphasic effects of putative D3 receptor 
agonists? 
Owing to reports of putative D3 receptor receptor selective compounds 
having a partial affinity at dopamine D2 receptors (Burns etal., 1995), it seems 
plausible that higher doses of D3 agonists such as 7-OH-DPAT may exert their 
effects at postsynaptic D2 rather than D3 receptors. Evidence underlying this 
assumption comes from observations of stereotyped behaviour at these higher 
doses. These stereotyped effects are classically attributed to postsynaptic D2 or 
mixed D l and D2 receptor stimulation (Waddington and Daly, 1993) Waddington 
and Daly (1993) and Kurashima et al, (1995) attribute 7-OH-DPAT-induced 
stereotypy to a D2 receptor stimulation at high doses, (0.25, 5.0 mg/kg, SC). 
These researchers also observed that low doses of 7-OH-DPAT (10-250 fAg/kg, 
SC) elicited yawning which is commonly attributed to the stimulation of 
dopaminergic autoreceptors (Strombom, 1976). 
Therefore, behaviours which have been reliably elicited using relatively 
high doses of 7-OH-DPAT may be under the control of a post-synaptic population 
of D2 receptors. Koshikawa et al. (1996), show that this is the case for some of the 
sterotypy seen with the administration of 7-OH-DPAT. They showed that in the 
case of dopamine-dependent (nucleus accumbens shell specific) turning behaviour 
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and repetitive jaw movements, the effects of 7-OH-DPAT are solely due to its 
ability to activate D2 receptors. 
However, this stereotypy whether mediated by the D2 receptor the D3 
receptor or both, has not been universally observed with 7-OH-DPAT, even at high 
doses. For example, Waddington and Daly (1993) showed that higher doses of 7-
OH-DPAT (0.1-10.0 mg/kg, SC) stimulated non-stereotyped sniffing, locomotion 
and chewing which were attenuated by the Dl antagonist BW 737C (without 
release of any atypical behaviours). Gilbert and Cooper (1995) did not note any 
signs of hyperlocomotion or stereotypical behaviours normally associated with 
mixed D1/D2 stimulation when systemically injecting 7-OH-DPAT (0.1-3.0, mg/kg 
IP), or when administering this compound intra accumbens (0.3-3.0 mg/kg, total 
dose). 
Contrary to the above study, Smith et al. (1996) demonstrated the biphasic 
effects of 7-OH-DPAT on locomotor behaviour in the marmoset and found D2 
antagonists to be effective in attenuating the stimulatory action of 7-OH-DPAT. 
However, these same antagonists failed to reverse the inhibitory effects of 7-OH-
DPAT on locomotion. This supports previous work in the rat (Storey et al. 1995) 
and may, once more indicate a differential action of low and high doses of 7-OH-
DPAT at D3 and D2 receptors respectively. Smith et al. (1996) do not consider that 
the D2 like effect that they seem to have isolated could be an inhibitory postsynaptic 
D3 effect, already identified by Svensson et al. (1994). It is plausible that the 
induction of hypolocomotion is mediated by the D3 postsynaptic receptor found in 
limbic structures (Depoortere et al, 1996) as well as/instead of the presynaptic D3 
autoreceptor. The recruitment of such an explanation would not preclude 
contribution of behaviours mediated by non-D3-receptor subtypes. 
It is worth mentioning here that the discrepancies in data that have been 
discussed herein may often be attributable to substantial differences in drug dosages 
and in methodological approaches (Storey et al., 1995). An observer rated 
behavioural check list used to study well habituated rats can produce drastically 
different data to that which is collected using unhabituated rats and an automated 
system (Storey et al. 1995). 
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Summary and Caveats 
Progress in understanding the potential physiological and therapeutic 
significance of D3 receptors has long been hampered by the lack of a selective 
agonist at the D3 receptor rather than the D2 receptor. Thus, although (+)- 7-OH-
DPAT is a preferential agonist at D3 receptors versus D2 receptors (Levesque et al., 
1992) its use alone may be insufficient to unequivocally identify dopamine D3 
receptor-mediated responses (Freedman etal., 1994a; Large and Stubbs, 1994; 
Millan et al., 1995). 
Recent pharmacological characterisation of the D3 receptor suggests that 
D2/D3 -selectivity of many compounds varies depending on the in vitro assay 
conditions used (Burris et al., 1995; Levant et ai.,1995) and such compounds may 
not exert their effects exclusively at dopamine receptor subtypes (Wallace and 
Booze, 1995). Accordingly, there has been concern over the selectivity of these 
drugs in vivo and the attribution of pharmacological effects to the D3 receptor 
(Freedman et al., 1994a; Large and Stubbs, 1994). In addition, the vast majority 
of studies have used 7-OH-DPAT as the "prototype" compound for D3 receptor 
agonism. Therefore, some of the observed effects may be idiosyncratic to this drug 
(Levant, 1997). However, inasmuch as agonists and antagonists are selective for 
the D3 receptor, this receptor has now been associated with many physiological and 
psychological functions, not least with the mediation of reward and reinforcement. 
Chapter 2 provides a theoretical background to the association between 
dopamine and reward and continues to outline a role for dopamine receptor 
subtypes in particular aspects of reward, specifically components of food reward. 
Chapter 2 also contains descriptions and explanations of the various methodologies 
which have been utilised for the study of the neural bases of the control of ingestive 
behaviour, accompanied by the theoretical assumptions which are applicable to 
these empirical paradigms. 
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Chapter 2: The role of dopamine in motivated behaviour 
2.1 Chapter overview 
Dopamine projections from the substantia nigra and ventral tegmentum to 
forebrain structures such as the nucleus accumbens and neostriatum constitute some 
of the most thoroughly studied of all brain substrates for reward. Despite the 
established significance of these projections in sensorimotor function many authors 
have concluded that dopamine projections play a role in mediating the reward value 
of food, drink, sex, social reinforcers, drugs of abuse and brain stimulation above 
and beyond sensorimotor contributions (Wise, 1978, 1982). 
Considerable evidence has shown that brain reward is dependent on the 
functional integrity of dopamine neurotransmission within the mesotelencephalic 
dopamine system in the brain. Among the many terminal loci of the 
mesotelencephalic dopamine system, the nucleus accumbens has been shown to be 
perhaps the most critically involved in brain reward (Salamone, 1993). 
As early as 1954, Olds and Millner reported that rats would avidly self-
deliver electrical stimulation through electrodes implanted in specific brain areas. 
This self-delivery was anatomically restricted to areas of the mesotelencephalic 
dopamine system implying that these brain areas were specialised for mediating 
brain reward. Indeed, laboratory animals will ignore a wide range of alternative 
reinforcers (i.e. food and water) in order to self-administer this rewarding electrical 
stimulation. The importance of discrete brain sites to intra-cranial self-stimulation 
(ICSS) was judged by measuring those which produced the highest rates of operant 
responding (i.e. lever pressing) for the lowest current levels. Drugs of abuse have 
been shown to lower brain stimulation reward thresholds in various 
mesotelencephalic loci and therefore drugs of abuse can be said to derive their 
rewarding properties by activating brain reward circuits. 
Further confirmation of a "reward pathway" came from studies into 
intracranial self-microinjection of addictive drugs. These drugs of abuse will be 
readily self-administered into brain-reward loci within the mesotelencephalic 
dopamine system, but not into other brain loci. Examples include self-
administration of amphetamine into the nucleus accumbens and prefrontal cortex 
(Hoebel et al., 1983; Phillips et al., 1981) cocaine into the prefrontal cortex 
(Goeders et al., 1983) and morphine into the ventral tegmental area, septum and 
nucleus accumbens (Bozarth and Wise, 1981), (see Figure 1.1 in Chapter 1). 
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"On-line" measurement of dopamine activation, quantified by 
electrophysiological, microdialysis or voltammetric techniques has also 
substantiated claims that mesolimbic and neostriatal dopamine projections serve as a 
"common neural currency" for rewards of most kinds sought by animals and 
humans (Wise 1978, 1982). By virtue of these techniques, it has been shown that 
dopamine activation is triggered by encounters with food, sexual partners, drugs of 
abuse, electrical brain stimulation at brain sites that support self-stimulation, and by 
the stimuli that have been paired with these incentives (Gilbert et al., 1995; Wilson 
etal., 1995; Fiorino et al., 1996; Schultz, 1996). 
Much of the causal evidence that dopamine systems mediate reward comes 
from studies of pharmacological blockade dopamine receptors or the ablation of 
dopaminergic pathways in animals (Wise, 1994). The inhibition of 
mesotelencephalic dopamine function, produced either by lesions or by 
pharmacological blockade, also inhibits the rewarding properties of a number of 
reinforcers. For example, 6-hydroxydopamine (6-OHDA) lesions of the nucleus 
accumbens and ventral tegmental area but not other brain loci, markedly inhibit self-
administration of cocaine. Traditional neuroleptic drugs or dopamine blockers such 
as pimozide, (Wise, 1972) acting at these brain sites produce similar results with 
various reinforcers including food and sexual activity. More recently, evidence has 
accumulated to suggest that a number of pharmacologically distinct dopaminergic 
drugs have similar effects (Sanger, 1996). 
To the degree that individual receptor subtypes can be separately 
manipulated by by selective drugs, D l , D2, D3 and D4 dopamine receptor subtypes 
have all been suggested to participate in at least some aspect of food, drug, or brain 
stimulation reward (Berridge and Robinson, 1998). Further, there has been much 
interest in the functional separation of the aforementioned dopamine projections in 
terms of the mediation of separable aspects of reward (Hitchcott and Phillips, 1997, 
1998; Berridge, 1996). These discoveries have added to the complexity of 
empirical questions which attempt to redefine the nature of the contribution of 
mesolimbic and mesostriatal dopamine systems to reward. Therefore, the role of 
dopamine in the reward process been gradually redefined through empirical 
endeavour and this has led to a reciprocal reconceptualisation of the nature of 
reward. It is no longer useful or correct to conceptualise reward as a single 
psychological process. For some, a more correct interpretation of reward would be 
"a constellation of multiple processes, many of which can be separately identified in 
behaviour, especially after the component processes are dissociated by brain 
manipulations" (Berridge and Robinson, 1998, p. 4). 
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There remains a great deal of interest in the involvement of brain dopamine 
systems in processing information related to rewards. The application of 
neurobiological tools to behavioural questions has produced a number of working 
models of the mechanisms mediating the rewarding and aversive (or "motivational") 
properties of stimuli. Such models have elucidated how rewards function in order 
to influence behaviour and vice versa. A brief overview of the basic functions of 
rewards is provided in Figure 2.2. (below). This will serve to give a flavour of the 
assumptions governing how "rewards" might be manipulated and operationalsied in 
an experimental context 
The aim of this chapter is to present a basic model of the role of dopamine in 
reward in the form of the anhedonia hypothesis (Wise, 1978, 1982). Support for 
this model will be provided followed by the discussion of lines of evidence which 
constitute challenges to this hypothesis. Some of these challenges have, by virtue 
of their empirical weight, metamorphosed into alternative theories of the role of 
dopamine in reward (i.e. Salamone, 1996; Robinson and Berridge, 1993). Thus, 
through the provision of a general, yet varied, theoretical background it will be 
possible to critically evaluate studies on dopamine receptor subtype involvement in 
several reward paradigms which manipulate conventional reinforcers as well their 
"neurochemical homologues" (Di Chiara, 1998, p.55 and also see General 
Discussion) such as drugs of abuse. Rnally,-this chapter will serve to furnish the 
reader with specific theoretical and practical details which are assumed and 
employed in food reward research. The final aim of this chapter is to highlight 
current scientific thinking on the role of dopamine receptor subtypes in ingestive 
behaviour, specifically their putative contributions to separable components of 
ingestive behaviour. 
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The eatere of rewards 
Three basic functions of reward:-
-rewards elicit approach and consummatory 
behaviour due to reward objects 
being labelled with appetitive value 
through i) innate mechanisms or 
ii) following learning. 
-rewards serve as goals of behaviour 
following associations between 
behavioural responses and outcomes 
-rewards increase the frequency and intensity 
of behaviour leading to such objects 
(i.e. learning) and they maintain learned 
-rewards serve as 'positive reinforcers' of 
behaviour in classical and instrumental 
conditioning procedures. 
-rewards induce subjective feelings of 
pleasure (hedonia) and positive 
emotional states. ^ 
Figure 2.1 The nature of rewards as defined by cognitive 
and biological needs: Adapted from text presented by 
Schultz et al. (1998). 
(Dickinson and Balleine, 1994). 1 
behaviour by preventing extinction. 
2 
3 
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2.2 Dopamine directly mediates reward: The anhedonia hypothesis 
Although many contemporary accounts of the neural substrate of reward and 
reinforcement postulate the involvement of several pathways in various aspects of 
the reinforcement process (Robbins and Everitt, 1987, 1996; Phillips et al., 1996; 
Harmer and Phillips, 1997; Berridge 1996), the idea of a general reinforcement 
mechanism or circuit subserving the behavioural effects of many different types of 
reinforcing stimuli (such as food, copulation and drugs of abuse) rests as the 
cardinal tenet in reward research. 
The "anhedonia hypothesis" (Wise, 1978, 1982) was originally advanced in 
the context of food reward. It held that dopamine receptor antagonists (neuroleptic 
drugs) which block dopamine receptors block the positive reinforcement and 
positive affect that is associated with rewarding events such as feeding. Empirical 
evidence burgeoned to include other reinforcers such as psychomotor stimulants 
(cocaine and amphetamine), opiates and rewarding intra-cranial self-stimulation and 
drugs of abuse (Wise, 1994). 
It was repeatedly reported by Wise and his colleagues that dopamine 
selective neuroleptics (such as the D2 antagonist pimozide) block or retard 
acquisition of food-rewarded operant habits and cause extinction of already learned 
operant habits despite continued food reward (Wise etal., 1978b). In behaviourist 
terms, when an operant habit undergoes extinction, initial responding is normal, but 
normal response rates are not maintained as they would be if the reward were given. 
In the neuroleptic treated rat, responding follows the same pattern (initially normal, 
then slowing, then fundamentally nil) despite the fact that the reward is still 
available to the animal. Wise and colleagues noted that behaviours induced by 
neuroleptic drugs were strikingly similar to the effects of normal instrumental 
extinction; a finding which was used to support Wise's original assertion. 
However, concerns about the possible motor effects of dopamine 
antagonists were voiced soon after Wise's original papers. Due to dopamine's 
ubiquitous role in behaviours such as locomotion it was difficult to exclude a 
"motor" explanation of these results. It was at this level that the hypothesis was 
most vigourously challenged (i.e. Mason et al., 1980; Salamone 1994,1997). 
The assumption was that dopamine blockers could be interfering with the ability to 
initiate the kinetic requirements necessary to access a rewarding stimulus (Wise, 
1994). The neuroleptic induction of "anergia" rather than "anhedonia" was implied 
(Mogenson, 1980; Salamone, 1992 ). 
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Features of the pattern of responding reflecting instrumental "extinction" 
were pivotal in debating the motor versus motivational hypotheses. For example, it 
seemed that Wise saw within-session decline as prima facie evidence that a motor 
deficit could not be in operation in the operant situation (Salamone, 1996). 
Salamone points to Wise's assertion that if one was to appeal to the motor 
hypothesis then, "....there should be no period within a pimozide test when 
response rates are normal" (Wise, 1982, p.78). Initial normality of responding, it 
seemed, precluded the need to attribute these response patterns to any aspect of 
motor function. However, there are those who see the similarities between 
neuroleptic-induced within session decline in responding and "extinction" as 
incorrect and superficial (Salamone, 1996). Therefore, a great deal of research 
effort was exerted upon addressing this conceptual problem, with most of the 
studies conducted within an operant paradigm. Although it would not be feasible to 
present all of the experimental evidence available in addressing this problem, some 
of the most informative operant studies are presented below. 
Dopamine receptor subtypes: Effects on operant responding 
- for food and water 
Since the original studies by Wise and colleagues, the availability of 
pharmacological compounds selective for specific receptor subtypes has helped to 
clarify the motor versus motivational debate to some extent. Fowler and colleagues 
examined the effects of neuroleptics such as haloperidol (a D2 antagonist) the 
microstructure of operant responding (i.e. on the duration of individual lever 
responses), and observed that pimozide increases (i.e. slows) lever press duration 
in a way that differs substantially from extinction (Fowler etal., 1986). They also 
noted that the D2 antagonist pimozide produces within session increases in the 
duration of lever press responses (Liao et al., 1990). Results such as these are 
difficult to explain by drawing a parallel with the effects of extinction. 
In a study by Fowler and Liou (1994) of the effects of dopamine antagonists 
on operant responding for food, an across session decrease was seen over several 
days of testing with the Dl-like antagonist SCH-23390 but not with the D2-like 
antagonist raclopride. A simple motor effect of these drugs would have been 
expected to produce a uniform decrease in responding within or across sessions. 
The authors, after extensive and detailed behavioural analysis suggest that the D l -
receptor antagonist had a greater effect on reward than the D-2 like receptor. The 
D2-like antagonist was seen to have a greater role in motor function. These results 
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echoed previous operant studies by McDougall and colleagues (1991, 1992). These 
studies required rat pups to run for a nipple attachment reward. Results from both 
studies showed that SCH 23390 but not the D2-like antagonist sulpiride produced 
an extinction like decrease in running speed, although sulpiride augmented the 
effects of SCH 23390 when they were coadministered. The authors conclude that 
both D l and D2 receptor are undoubtedly involved in reward-related learning. 
However, the differential effects of antagonists, when given alone, acting at their 
receptor subpopulations, suggest that D l receptor may be more importantly 
involved (McDougall et al., 1991,1992). 
These and other results (Salamone et al., 1987) present the possibility that it 
is the maintenance of movement that is affected by dopamine-related manipulations. 
Such authors see the effects of neuroleptic drugs or nucleus accumbens ablations as 
response maintenance deficits or progressive motor dysfunctions rather than 
impairments in emotional processes (Fowler, 1990). 
2.3 Nucleus accumbens dopamine as a "sensorimotor interface" 
Therefore, it is clear that in parallel with the early and the contemporary 
investigations into the true nature of neuroleptic-induced response deficits was an 
appreciation that it was the maintenance of movement that was primarily affected by 
manipulations of the dopamine system (Gaddy andNeill, 1977; Salamone, 1987). 
A large body of evidence indicated that low doses of dopamine antagonists, or 
depletions of brain dopamine do not impair fundamental aspects of food motivation 
such as chow consumption and simple instrumental responses for food, (Salamone, 
1992). 
\ A further finding served to test the original anhedonia hypothesis. In its 
original form this hypothesis had little to say about the specific brain loci which 
might be critical to the mediation of dopamine related reinforcement However, it 
gradually became apparent that the nucleus accumbens was the specific site at which 
natural and drug reinforcers preferentially activated dopamine systems (DiChiara 
and Imperato, 1986; Mark et al., 1991), undergo this brain site seemed to be 
where dopamine mediated reward. Moreover, it became apparent, through 
anatomical and behavioural investigation that this site may be a "nodal point" for the 
integration of information necessary for both motivational and motor control. 
Mogenson (1980), proposed that the nucleus accumbens represented a functional 
interface between the limbic system and the motor system, thereby providing a link 
between motor and motivational processes. 
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Since this original assertion (Mogenson, 1980), considerable evidence has 
accrued showing that nucleus accumbens dopamine is involved in the allocation of 
responses in relation to various reinforcers (for review, see Salamone, 1997). 
According to Salamone, nucleus accumbens dopamine participates in the function of 
enabling organisms to overcome "response costs" or obstacles, in order to obtain 
access to stimuli such as food. Therefore, unlike the original anhedonia hypothesis, 
nucleus accumbens dopamine is not seen as directly mediating food reinforcement, 
but instead is seen as a type of higher-order sensorimotor integrator that is involved 
in modulating response output in relation to motivational factors and response 
constraints, (Salamone, 1997 and see General Discussion). 
Responding for rewarding brain stimulation 
As mentioned above, the earliest suggestions that brain dopamine might play 
an important role in reward function came from studies of brain stimulation reward 
(Olds and Millner, 1954). Results from this paradigm were instrumental in teasing 
apart the motor and motivational strands of neuroleptic-induced response deficits. 
The curve shift paradigm 
Confirmation that neuroleptics attenuated the rewarding effects of brain-
stimulation came from the "curve-shift" paradigm of Edmonds and Gallistel (1974). 
This paradigm offers a dose-response analysis of brain stimulation reward 
(Liebman, 1983), with dose of stimulation manipulated through variations in the 
frequency, intensity or duration of the trains of rewarding stimulation pulses that the 
animal earns with each response (Wise, 1994). Using this methodology, it was 
possible to functionally uncouple the reward-attenuating and the performance-
impairing effects of neuroleptics (Gallistel, 1987). Teasing apart these confounds 
diminished confidence in purely "motor" interpretations of the effects of 
neuroleptics (Fibiger et al., 1976). 
In brief, low doses of dopamine antagonists cause parallel rightward shifts 
in the dose-response curve, increasing the amount of stimulation required for a 
given level of responding but not changing the maximum level of responding 
demonstrated when the animal is given maximal stimulation (Stellar et al., 1983). 
The fact that neuroleptic treatment can reduce the effectiveness of stimulation at 
doses that do not reduce the maximum response rate of the animals confirms for 
some that neuroleptics have a low-dose action above and beyond any performance-
impairing effects of these drugs (Wise, 1994). 
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High doses of neuroleptics shift the curve to the right but also shift it down, 
reducing the maximal response rate of the animal as well as increasing the 
stimulation required to produce responding at maximal rates (Gallistel and Davis, 
1983; Rompre and Wise, 1989; Stellar et al., 1983). A difference in curve-shift is 
seen after the administration of amphetamine. Alone, this drug causes parallel 
leftwards shifts and reverses rightwards shifts of the curve caused by dopamine 
antagonists (Gallistel and Freyd, 1987). That these shifts reflect independent 
mechanisms is seen to be confirmed when using a morphine pretreatment (Wise, 
1994). For example, morphine injections that shift the curve to the left reverse the 
rightward shift but fail to reverse the downward shift caused when high doses of 
neuroleptics are given (Rompre and Wise, 1989). 
Since dopamine receptor subtypes have been reclassified (Sokoloff, 1990) 
the effects of various dopamine receptor antagonists on reward have been assessed 
using brain stimulation as the rewarding stimulus. Hunt et al. (1994), showed that 
reward and performance effects could not be dissociated after the administration of 
the D2-like antagonist spiperone, but could be clearly uncoupled when animals had 
received the Dl-like antagonist SCH-23390. Again, as with the results from 
Fowler and Liou (1994) this data could reflect a more important role for Dl-like 
receptors in reward-related learning (Beningerand Miller, 1998). 
Accordingly, a suggestion was made that reward-related learning may 
consist of a dopamine signal at D l receptors (Beninger, 1992). A consequent 
prediction from this was that the administration of a D l agonist would mask the 
potential reward signal and impair reward-related learning. Ranaldi and Beninger 
(1994) gave systemic and intra-cerebral injections of the D2/D3 agonist quinpirole 
and the D l agonist A-77636 and found that both of these compounds, when 
injected systemically, reduced the rate-frequency functions to the left and reduced 
the threshold frequencies necessary to maintain responding for brain stimulation 
reward to the ventral tegmental area. Results after microinjection of these 
compounds were not clear cut but Ranaldi and Beninger concluded that the 
stimulation of D l or D2 receptors by dopaminergic agonists enhanced the rewarding 
effects of brain stimulation. 
Gilbert et al. (1995), in search of a role for the D3 autoreceptor in 
performance in this paradigm showed that systemically administered 7-OH-DPAT 
(0.01-0.3 mg/kg) dose-dependently reduced responding for electrical stimulation to 
the ventral tegmental area Voltammetry was used in order to measure dopamine 
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levels in the nucleus accumbens and the authors observed that 7-OH-DPAT reduced 
the size of the dopamine-generated voltammetric signal. This effect of the putative 
D3 receptor agonist was not reversed by the D2 autoreceptor antagonist sulpiride. 
Hence, Gilbert et al. (1995), discussed the possibility that 7-OH-DPAT reduces 
the release of dopamine in the nucleus accumbens at D3, but not at D2 autoreceptors 
and that it is by this mechanism that the rewarding effect of ventral tegmental area 
stimulation is reduced. However, most recently, Nakajima and Patterson (1997) 
found that while intracerebral injections of raclopride and haloperidol (D2 receptor 
antagonists) reduced the rewarding effect of brain stimulation, neither (+)-UH 232, 
(a D3 antagonist) nor clozapine (a D4 antagonist) influence the rewarding effect of 
such stimulation. 
Responding for drugs of abuse 
Drug self administration procedures typically involve the implantation of 
long-term jugular catheters into animals who are men trained to self-adminster 
stimulants intravenously in daily sessions. This model has a high degree of face 
and construct validity (DiCiano et al., 1998) hence, the model is an excellent animal 
model of drug use. 
Psychomotor stimulants 
When given to trained animals that have the opportunity for intravenous 
psychomotor stimulant (such as amphetamine and cocaine) self-administration, 
neuroleptics give rise to a condition in which there is an initial compensatory 
increase in drug taking. Then, if neuroleptic doses are high enough, there is 
extinction of the lever-pressing habit (Yokel and Wise, 1975). More concisely, 
drug-self administration in animals exhibits a characteristic inverted U-shape dose-
respose curve. Manipulations (such as neuroleptic treatment) that shift this curve to 
the left can be interpreted as increasing the reinforcing potency of the drug. This is 
usually manifested as a decrease in the frequency of stimulant self-injection. Since 
the animals respond more (not less) than usual following neuroleptic treatment, this 
can be construed as an effect of dopamine blockade on the reward value of the 
stimulant. Also, several dopamine agonists are self-administered in much the same 
way as psychomotor stimulants (Wise et al., 1976, 1990). These and other 
similar findings have led authors such as Wise, 1978; Wise and Rompre, 1989) to 
conclude that it is the ability of stimulants to activate the dopamine system that 
makes psychomotor stimulants habit-forming. 
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Further confirmation of a role for dopamine in the mediation of effects of 
psychomotor stimulants comes from lesion studies which have shown that cocaine 
self-administration in the rat depends upon an intact mesocorticolimbic dopamine 
system (Roberts etal., 1977). However, an important aside here is that a similar 
effect of these depletions on decreasing lever pressing for food reinforcement was 
not apparent (see General Discussion). 
In order to map out a role for dopamine receptor subtypes in the formation 
and maintenance of such habitual drug use, researchers such as Caine and Koob 
(1993), have used relatively selective ligands for the dopamine D3 receptor in order 
to assess their ability to modulate cocaine self-administration. They found that 
dopamine agonists had differential affinities for the dopamine D3 receptor and that 
these affinities correlated highly with the agonists' relative potencies in decreasing 
cocaine self-administration. 7-OH-DPAT and quinpirole potently decreased cocaine 
self-administration at doses that were not by themselves reinforcing. All of the 
agonists, when self-administered in combination with cocaine, reduced cocaine 
intake by producing an increase in the interval between injections without disrupting 
self-administration. This is interpreted as an enhancement of cocaine's reinforcing 
effects because an increase in the dose of cocaine produces the same effect, (Hubner 
and Koob, 1990). These results point to the .03 receptor as a useful target for 
pharmacotherapies of cocaine abuse (Caine and Koob, 1993). 
Refinements to the above study were carried out by the same authors. In a 
follow-up study, (Caine and Koob, 1995) tested the hypothesis that the 
administration of the D3 receptor agonist 7-OH-DPAT would shift the cocaine dose-
effect function to the left (i.e. enhancing the reinforcing properties of cocaine). 
They favoured this prediction over those which stated that 7-OH-DPAT was 
producing non-specific effects or was exclusively enhancing the rate decreasing 
effects of high doses cocaine. Employing a number of reinforcement schedules, 
Caine and Koob again found that 7-OH-DPAT decreased cocaine (0.25 
mg/infusion) self-administration by increasing the interval between reinforcers. In 
addition, pretreatments with subcutaneous 7-OH-DPAT not only decrease the self-
administration of cocaine, but also lowered the minimum effective dose of cocaine 
to maintain self-administration under fixed-ratio schedules. 
In order to elucidate the mechanism by which D3 receptor preferring 
agonists such as 7-OH-DPAT modulate cocaine reinforcement, Parsons et al., 
(1996) employed microdialysis in the nucleus accumbens to monitor dopamine 
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levels during the self-administration of cocaine and cocaine plus D3 receptor 
agonists. They discovered that both '7-OH-DPAT and quinelorane attenuated 
cocaine-induced elevations in nucleus accumbens dopamine concentrations at the 
same time that the reinforcing properties of cocaine were enhanced" (p. 1086). 
They postulate a post-synaptic nucleus accumbens receptor as the mechanism by 
which these D3 receptor agonists achieve their effects on nucleus accumbens 
dopamine levels. Sanger et al. (1996) used a wide range of dopaminergic drugs 
and measured their effects on operant responding in rats. Their aims were twofold: 
firstly, they investigated whether the potencies of dopamine agonists to decrease 
operant responding in rats would also correlate with published (i.e. Sautel et al., 
1995) D3 receptor functional potencies. Additionally, they studied the ability of 
three antipsychotic drugs (haloperidol, amisulpride and remoxipride), to antagonise 
the effects of 7-OH-DPAT on rates of operant responding. 
The potencies of the dopamine agonists to decrease operant responding 
correlated significantly with their published potencies to produce a functional D3 
receptor but not a functional D2 response (i.e. stimulation of mitogenesis in 
transfected cells). Low doses of the antipsychotic amisulpride (1.0 and 3.0 mg/kg) 
antagonised the rate-decreasing effects of 7-OH-DPAT. At these low doses 
amisulpride is thought to exert preferential activity at presynaptic dopamine 
receptors. Their results were consistent with the view that D3 receptors may play 
an important role in mediating the behavioural effects of dopamine agonists and that 
these receptors have a presynaptic location. 
Summary 
It is clear that there is a substantial amount of empirical support for the 
anhedonia hypothesis. This has not constrained the reconceptualisation of the 
functional role of dopamine in reward For example, the notion of nucleus 
accumbens dopamine as a sensorimotor interface can be seen to accomodate much 
of the data which originally bolstered the idea that dopamine directly mediated 
reward. 
The discovery of novel dopamine receptor subtypes and the 
acknowledgement of the neuroanatomical heterogeneity of dopamine projections 
points towards a further reinterpretation of the functional role of dopamine. It 
remains contentious, not least with respect to the D3 receptor, whether agonists 
which are selective for these receptors exert their effects on behaviour pre- or post-
synaptically. Moreover, it remains unclear which aspects or components of reward 
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or motor function are particularly associated with dopamine receptor subtype 
agonism or antagonism. The next section reviews further paradigms (i.e. 
conditioned place preference and conditioned place aversion) which have been used 
to address this issue. Technological advances have gone some way to clarifying 
this issue. The next section (Section 2.4) also discusses some of these 
methodologies, the employment of which have given rise to data which are not 
easily explained by the anhedonia hypothesis. 
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2.4 Problems for the anhedonia hypothesis: Involvement of 
dopamine in aversive and appetitive behaviours 
Originally, Wise postulated that neuroleptics "take the pleasure out of 
normally rewarding brain stimulation, take the euphoria out of normally rewarding 
amphetamine and take the 'goodness' out of normally rewarding food" (Wise, 
1982, p.263). Consequently, this hypothesis has had difficulty in accommodating 
results from studies which show that dopamine efflux (as measured by 
microdialysis) is elevated during aversive as well as appetitive conditions (for 
reviews see Blackburn, 1992; Salamone, 1994). Parallel to a corpus of empirical 
evidence showing that dopamine antagonists reliably reduce positively reinforced 
instrumental responding, runs a host of studies which reveal that neuroleptics also 
impair avoidance responding (Beninger etal., 1980; Blackburn and Phillips, 
1990). Dopamine antagonists impair place aversion conditioning as well as 
interfering with place preference (Di Scala and Sandner, 1989). Several other 
characteristic features of neuroleptic treatment, such as the within-session decline in 
instrumental responding, have also been demonstrated to occur with neuroleptic-
treated animals in avoidance tasks (Sanger et al., 1993). Again there are 
inconsistencies within the results. For example, there are those who have reported 
that there are no significant variations in striatal dopamine release in animals 
exposed to stimuli of either positive (appetitive) or negative (aversive) affective 
value (Mark et al., 1994). 
These findings have prompted a reorganisation of assumptions underlying 
the correct interpretation of dopaminergic involvement in the rewarding situation 
and has led to questions such as: Do responses to environmental stimuli concern 
specific motivational attributes or reflect more general stimulus salience? (Robinson 
andBerridge, 1993; Schultz, 1992). 
Nevertheless, other studies which measure on-line dopamine efflux or 
electrophysiological responses of dopaminergic neurons present evidence which is 
consistent with the anhedonia hypothesis. For example, Mirenowicz and Schultz 
(1996) compared dopamine impulse responses to motivationally opposing appetitive 
and aversive stimuli and found that these neurons "preferentially report 
environmental stimuli with appetitive rather than aversive motivational value", 
(p.449). Using microdialysis, Besson and Louilot (1997) have confirmed the 
capacity of dopaminergic neurons to code for affective directionality. Increases in 
striatal dopamine levels coincided with an attractive stimulus and decreases were 
observed on the presentation of an aversive stimulus. 
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Further evidence of a role for dopamine in associative processes comes from the 
place preference paradigm (see below for further details). This paradigm can reveal 
much about the possible subjective (both positive and negative) effects of agonists 
and antagonists which are selective for dopamine receptor subtypes. 
Dopamine receptor subtypes and Pavlovian conditioning 
Conditioned place preference and conditioned place aversion 
The place conditioning paradigm measures the incentive-motivational effects 
of stimuli that become associated with drug effects through classical conditioning 
(or stimulus-stimulus associations). The environment becomes a cue eliciting 
approach (i.e. conditioned place preference) or avoidance (i.e. conditioned place 
aversion) depending on whether the rewarding or aversive properties of the drug 
become associated with the environment to which the animals have become familiar. 
Drugs which are reported to exert their effects at the dopamine D3 receptor 
have been shown to produce both preference and aversion in this paradigm and the 
differential effects seem to be dependent on dose (Khroyan et al., 1997). For 
example, a low dose of 7-OH-DPAT (0.03 mg/kg) produces conditioned place 
aversion (Khroyan et al., 1995) whereas a higher dose (5 mg/kg) produces 
conditioned place preference (Mallet and Beninger, 1994; Kling-Petersen et al., 
1995). Another mixed D2/D3 agonist quinpirole, if given at a high dose (1.0 
mg/kg) also produces conditioned place preference (Hoffman and Beninger, 1988). 
This differential dose effect was further validated by Chaperon and Thiebot 
(1996) who suggest that the aversive state experienced by rats given low doses of 
7-OH-DPAT was probably accounted for by impaired dopamine transmission in 
mesolimbic dopamine pathways. This may be achieved through the preferential 
activation of inhibitory D3 postsynaptic receptors as has been suggested in the case 
of locomotor activity (Svensson et al., 1994). The emergence of conditioned place 
preference at higher doses of D3 receptor agonists might reflect the stimulation of 
postsynaptic D2 receptors. Therefore, Chaperon and Thiebot (1996) do not feel 
convinced that their results represent definite evidence of a preferential role for D3 
receptors in 7-OH-DPAT induced learning. 
Following the establishment of conditioned place preference with the D3 
receptor antagonist PNU 99194A (Kling-Petersen etal., 1994). Chaperon and 
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Thiebot, (1996) tried to replicate this effect with another selective D3 receptor 
antagonist, /- nafadotride. This compound did not produce conditioned place 
preference and was deemed devoid of intrinsic reinforcing properties, at least at the 
doses studied. However, in a narrow range of low doses, /- nafadotride revealed 
food-induced conditioned place preference. Similarly, Guyon et al. (1993) noted a 
potentiation of the food-induced conditioned place preference achieved by 
administering low doses of the mixed D2/D3 receptor antagonists sulpiride 
(4mg/kg); amisulpride (0.5,1 mg/kg) or pimozide (0.03; 0.06 mg/kg) before the 
food conditioning sessions. The positive effects of amisulpride were reversed by 
the dopamine Dl-like receptor SCH-23390 (0.01 mg/kg). These effects were 
interpreted by these authors as a pro-hedonic effect of low doses of some D2/D3 
receptor selective neuroleptics. 
The neurobiological substratum of such effects is more difficult to pin-point 
Both sets of authors who have identified a food-induced conditioned place 
preference with low doses of neuroleptics have invoked basal dopamine levels as an 
important connection to the observed food-induced conditioned place preferences. 
Since eating and/or the preparatory phase of appetitive behaviour have been shown 
to evoke the release of dopamine in mesolimbic structures (Phillips et al., 1991 and 
see Section 2.5) /- nafadotride may have favoured incentive learning only when 
basal dopamine function was high (i.e. when.food was present) but not under 
standard conditions. As doses increased, these "pro-appetitive" effects of l-
nafadotride were presumably cancelled out due to the blockade of post-synaptic D2 
receptors by the drug, as suggested by the hypoactivity and catalepsy that has been 
observed after high doses (Sautel et al., 1995; Chaperon and Thiebot, 1996). The 
results of Guyon et al. (1993) were originally attributed to a D2 autoreceptor 
blockade, however, the more recent results obtained by Chaperon and Thiebot 
(1996) although analogous to the earlier results, are interpreted in terms of the 
ability of the D3/D2 receptor antagonists to remove the inhibitory influence of a 
subset of "D2-like" receptors on reward related activity. These possibilities may 
only be confirmed or rejected when more selective D3 receptor ligands become 
available and are used in conjunction with appropriate methodologies. 
Therefore, it is suggested that low doses of D3 receptor agonists produce 
conditioned place aversion whereas high doses produce conditioned place 
preference. Khroyan et al. (1997) tested this general statement and used the 
selective D3 receptor agonists 7-OH-DPAT and PD 128907 in the place 
conditioning paradigm. Their hypothesis was not supported as only one dose of 
one of the agonists produced a conditioned place preference (PD 128907, 1mg/kg). 
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Khroyan et al. (1998) took advantage of the finding that low doses of the putative 
D3 receptor agonists such as 7-OH-DPAT produced a behavioural profile opposite 
to that produced by locomotor stimulants (i.e. low doses of 7-OH-DPAT produce 
conditioned place aversion compared to conditioned place preference produced by 
psychomotor stimulants). Therefore, they speculated that the investigation of 
interactions between low doses of 7-OH-DPAT and psychomotor stimulants could 
lead to important discoveries in the devlopment of treatments for psychomotor 
stimulant abuse. They determined that 7-OH-DPAT (0.1 mg/kg) when co-
administered with d-amphetamine attenuated the previously established d-
amphetamine conditioned place preference. They infer from these and other data 
that this dose of 7-OH-DPAT attenuates the reinforcing properties of d-
amphetamine and is consistent with a whole host of psychomotor stimulant self-
administration studies such as those of Caine and Koob (1993, 1995). 
There are futher instances of a dissociation of behaviours which can be seen 
as characteristic of low and high doses of 7-OH-DPAT. In a study by DeFonseca et 
al. (1995) 7-OH-DPAT did not produce a conditioned place preference at any of 
the doses tested (0.01-5 mg/kg). However, the higher doses (0.25 and 5 mg/kg 
prevented the acquisition of a morphine-induced place preference. The lower doses 
(such as 0.01 mg/kg) did not have an effect on the place preference with morphine. 
The authors again nominate 7-OH-DPAT as a possible pre-clinical candidate for the 
treatment of opiate dependence and craving and attribute the differential dose effects 
in this paradigm to an interaction of 7-OH-DPAT with pre and post-synaptic D3 
receptors. 
Conditioned taste aversion 
A further model with which to test the subjective effects of drugs is the 
conditioned taste aversion paradigm. This phenomenon is typically studied by 
allowing rats brief access to a novel taste solution and then administering an emetic 
agent such as lithium chloride. Consequently, previously poisoned rats consume 
less of the fluid relative to either their own baseline intake or relative to non-
poisoned rats. 
Although most studies employ peripheral emetics such as lithium chloride 
support a conditioned taste aversion it has been repeatedly demonstrated that drugs 
which act upon central dopamine systems also support this form of associative 
learning. For example, amphetamine (Cappell and LeBlanc, 1971) and cocaine 
(Foltinetal. 1981; Goudieetal., 1978) induce conditioned taste aversions. 
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However, original interpretations of the way in which drugs of abuse function as 
unconditioned stimuli in conditioned taste aversion have been extensively 
questioned (see Grigson, 1997). 
The behavioural and neural mechanisms of conditioned taste aversion have 
been further elucidated by using specific dopamine agonists and antagonists as the 
unconditioned stimuli. Conditioned taste aversions have been reported with the 
direct dopamine agonist apomorphine, the dopamine D l receptor agonist SKF 
38393 and the D2/D3 receptor agonist quinpirole (Asin and Montana, 1989; 
Hoffman and Beninger, 1988). Not only do dopamine receptor subtypes seem to 
have a role to play in the initial acquisition of a conditioned taste aversion but also, 
antagonists at these sites attenuate the acqusition of amphetamine-induced taste 
aversion (Lin et al., 1994). Recently, Bevins et al. (1996) examined 7-OH-
DPAT in this paradigm and found that this compound (0.1-10 mg/kg) produced a 
significant conditioned saccharin aversion suggesting a role for the D3 receptor in 
dopamine agonist induced conditioned taste aversions. They do, however, issue a 
caveat regarding the pharmacological specificity of such effects (see Section 7.4). 
The D3 receptor and stimulus-reward learninfi 
The D3 receptor has been selectively implicated in other forms of associative 
learning. In examining the role of the mesoamygdaloid dopamine projection in 
Pavlovian stimulus-reward learning, Hitchcott et al., (1997), investigated the 
effects of post-session intra-amygdala infused dopamine agonists SKF-38393 (Dl), 
quinpirole (D2/D3) and 7-OH-DPAT (D3/D2) on the acqusition of a discriminative 
approach response. Only 7-OH-DPAT enhanced selectively CS+ (initially neutral 
stimulus paired with a 10% sucrose reward) approach in a dose-dependent fashion. 
Therefore, the authors infer that the D3 receptor receptor subtype is involved in the 
modulation of stimulus-reward learning by the mesoamygdaloid dopamine 
projection. 
Summary 
The data discussed in this section highlight some of the conceptual problems 
for the anhedonia hypothesis which have been borne out of the application of 
particular methodologies such as microdialysis. More precisely, dopaminergic 
activation is obviously integral to both appetitive and aversive motivation. This 
section also further outlines a role for dopamine receptor subtypes in some of the 
associative processes necessary for the operation of reward. A particular role for 
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the D3 receptor has been postulated in the acquisition of stimulus-reward learning. 
Again, with regards to the D3 receptor, the differential dosage effects of D3 
receptor-preferring ligands on Pavlovian conditioning highlight the need for caution 
in interpretating data from these paradigms. The next section (Section 2.5) 
concentrates on the measurement of dopaminergic activity. In particular it discusses 
those aspects of motivated behaviour which have been thought to temporally covary 
with dopaminergic activity. Again, such evidence poses problems for theories 
which view dopamine as directly mediating reward. 
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2.5 Further problems for the anhedonia hypothesis: Does 
dopaminergic activity covary with the appetitive and/or the 
consummatory phase of behaviour? 
Many studies have shown that appetitive stimulus conditions can be 
accompanied by an increase in accumbens dopamine release as measured by "on-
line" techniques such as voltammetry, microdialysis or electrophysiology (Hoebel 
etal., 1983,1992; Hernandez etal., 1987; Schultz etal., 1993; Gratton, 1994; 
Mark et al., 1994). In vivo procedures such as brain microdialysis have provided 
unique opportunities to investigate regional changes in dopamine release in freely 
moving animals during feeding or the performance of food motivated tasks. 
Although it has been shown rewards can both incite and reinforce behaviour, it 
remains unclear which of these effects reflect increased dopamine transmission 
(Richardson and Gratton, 1996). 
There are many variables which influence electrochemical responses of 
dopamine neurones that are related to both the stimulus and the internal state of the 
animal. More concisely, the reward value associated with a stimulus is not a static, 
intrinsic property of that stimulus. Several microdialysis studies are testament to 
this assertion having manipulated the animals' motivational state in relation to 
appetitive stimuli such as food (Wilson et al., J995; Pothos et al., 1995) and 
sexually receptive partners (Fiorino et al., 1997)., Animals can assign different 
appetitive values to a stimulus as a function of their internal states at a) the time the 
stimulus is encountered, and b) as a function of their experience with the stimulus 
(Dickinson and Balleine, 1994). 
Therefore, it is not surprising that many findings are opposed to an 
assumption implicit to much of the conventional thinking on meso- nucleus 
accumbens dopamine function, that is, increased dopamine transmission covaries 
specifically with the behavioural reinforcing action of rewards (Wise et al., 1978; 
Wise etal., 1982; Koob, 1992). 
For example, there is considerable evidence to suggest that increases, 
specifically in nucleus accumbens dopamine transmission do not occur as a 
consequence of food consumption but rather occur during the anticipation of a meal, 
at which times the rat is engaged in preparatory feeding behaviours (Blackburn et 
al., 1989). Kiyatkin and Gratton (1994), reinforced the idea that dopamine 
transmission in the nucleus accumbens does not specifically covary with the 
consumption of food per se. In rats lever pressing for a food reward, nucleus 
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accumbens dopamine increased primarily in anticipation of earning food and that the 
immediate consequence of consuming food was a transient suppression of this 
increase, a result reminiscent of that of Salamone et al. (1994). More recently and 
in contrast with these results, Wilson et al., (1995) have found that consummatory 
rather than anticipatory aspects of feeding are most robustly associated with 
increases in nucleus accumbens dopamine release. To further complicate the issue, 
a number of studies show increases in nucleus accumbens dopamine efflux during 
appetitive and consummatory phases of male sexual behaviour (Damsma et al., 
1992; Fumeroetal., 1994; Masetal., 1995b). 
The "biphasic and time-locked" (Richardson and Gratton, 1996, p.8160) 
changes in nucleus accumbens dopamine transmission suggested by some of the 
microdialysis data are congruent with electrophysiological evidence that similar 
changes in ventral tegmental area dopamine cell activity are associated with food 
reinforcement (Schultz, 1986; Romo and Schultz, 1990; Schultz and Romo, 1990; 
Ljungberg et al., 1992; Schultz etal., 1993; Schultz et al., 1998) 
Studies into the temporal characteristics of dopaminergic activity have 
shown that not only does dopamine efflux increase when an animal is engaging in 
"rewarding" behaviour but also increases when presented with a neutral stimulus 
(CS) which has been repeatedly paired with the primary reward such as food (US). 
This anticipatory aspect of dopaminergic activity has been elegantly displayed by 
Schultz and colleagues (1986, 1996, 1997, 1998). When recording from midbrain 
dopaminergic neurones of monkeys, they discovered that dopamine signals 
observed in response to the (CS) also diminished after extensive training. 
Dopamine neurones seemed only to fire if the event was worse (decreased spike 
production) or better (increased spike production) than that predicted by the (CS). 
Midbrain dopamine neurones could therefore be seen as "error predictors" which 
coded for the discrepancy between what was anticipated and what was actually 
encountered. 
Dopamine neurons have therefore been seen to have a capacity to code for 
unpredictability or error. To test this prediction further, Fiorino et al. (1997) have 
measured dynamic changes in nucleus accumbens dopamine efflux during the 
appetitive and consummatory phases of copulation. Specifically, they have noted 
that, in behavioural terms, sexual satiety in male rats can be overcome if the 
original female is replaced with a novel and receptive alternative female. This is 
commonly known as the Coolidge Effect (Wilson et al., 1963). Therefore, in the 
light of the putative role of nucleus accumbens dopamine in the initiation and/or 
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maintenance of motivated behaviour, these researchers were interested in the 
dopaminergic correlates that may be associated with copulation, the apparent state of 
sexual satiation and the reinstatement of copulatory behaviour with the presentation 
of a novel female. They found that nucleus accumbens dopamine concentrations 
returned to baseline values at the onset of sexual satiety after having been enhanced 
by both the appetitive and consummatory phases of copulation. A novel receptive 
female was men put into close proximity to the male (behind a screen) which gave 
rise to a small increase in nucleus accumbens dopamine. This slight increase was 
interpreted by the authors as a potential spur to the reinstatement of sexual 
behaviour during which this slight signal was significantly augmented. Therefore, 
in this case, moderate dopamine activity coincides with the presentation of the novel 
female, only reaching significantly higher levels at the reinstatement of copulation 
and so the dynamics of dopamine activity may be more complicated than the 
dichotomy of "appetitive" and "consummatory" can reveal (see General 
Discussion). 
Effects of motivational manipulations on nucleus accumbens dopamine release 
-deprivation state 
As dopamine obviously has some role to play in motivation, and motivation 
is defined with reference to both the internal and the external context of the 
organism, it is logical mat motivational manipulations such as restricted eating and 
concomitant weight loss have been shown to have a selective effect on the 
neurochemistry of some critical brain structures involved in reinforcement Pothos 
et al., (1995) observed that in rats reduced 20-30% below normal weight, basal 
extracellular dopamine in the nucleus accumbens decreased by 50%. However, no 
such change was observed in dorsal striatum or medial prefrontal cortex which 
could suggest that the ventral tegmental area- nucleus accumbens pathway mediates 
some unique aspect of motivation as it relates to food restriction and weight loss. 
They infer that the selective underactivity of nucleus accumbens dopamine systems 
in response to feeding resrictions and weight loss could underlie the increase in 
food and drug intake observed in underweight animals (and humans) when they 
attempt to restore extracellular dopamine levels by natural or artificial means. 
A further example of manipulating levels of motivation is seen in work by 
Wilson et al. (1995). These researchers attempted to identify some of the 
dopaminergic correlates of motivated behaviour. Again, one of the variables which 
they manipulated was deprivation state. They discovered that the motivational state 
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of animals significantly influenced the magnitude of the neurochemical events 
associated with goal directed behaviours. The magnitude of increase during the 
consumption of a palatable meal was enhanced in rats which had been food-
deprived for 20hr at the time of testing. Studies such as this highlight the 
importance of manipulating relative and absolute levels of motivational status (see 
Chapter 7 and General Discussion). 
-incentive value 
Examples of manipulating the value of the stimulus (or stimulus properties) in 
anticipation of a selective effects on dopamine levels are extremely important in 
delineating the involvement of brain dopamine systems in processing information 
related to rewards. In a particularly relevant study, Martel and Fantino (1996) 
examined the effects of the ingestion of two foods varying in palatability on the 
activity of the mesolimbic dopamine system. Rats have previously been shown to 
exhibit a preference for short cakes (high palatability) over regular chow (low 
palatability) (Cabanac, 1983,1985). Therefore the study aimed to determine 
whether this preference was accompanied by an increase in extracellular levels of 
dopamine and its main metabolites (dihydroxyphenylacetic acid (DOPAC) and 
homovanillic acid (HVA) measured by microdialysis in the nucleus accumbens. 
During feeding, dopamine rose significantly with a greater rise for the highly 
palatable food than for the low palatability food. Levels of DOPAC and HVA only 
reached significance during the ingestion of the highly palatable food. Moreover, 
dopamine release during the ingestion of the highly palatable food peaked during the 
first 25 minutes of food supply. This is consistent with an influence of the 
orosensory properties of foods rather than their postingestive effects (Mark et al., 
1994; Schneider etal., 1986), and so, such neurochemical corellates of palatability 
manipulations could be extremely useful in redefining a role for dopamine in 
ingestive behaviour. 
Richardson and Gratton (1996) manipulated the value of the stimulus in an 
attempt to determine how the apparent suppression of nucleus accumbens dopamine 
transmission previously observed during food consumption (Kiyatkin and 
Richardson, 1994) was affected by changes in the stimulus conditions such as: the 
rate of milk delivery; the duration of milk presentation; temporal contiguity between 
the operant response and milk presentation and the reinforcement schedule. Rats 
were trained to respond on a fixed ratio (FR1) schedule for 0.2ml condensed milk 
delivered over 30 sec. During this delivery period there was an accompanying cue 
light. Consumption of the initial milk rewards within the first session of the first 
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test day caused dopamine signal increases in the nucleus accumbens as measured by 
voltammetry. On subsequent days the most pronounced initial signal increases 
coincided with the presentation of conditioned stimuli that marked the start of the 
test session. Responses to each reinforced lever-press were preceded by increases 
and were followed (during milk consumption) by decreases in dopamine signal. If 
milk delivery was delayed there was a corresponding delay in dopamine signal 
decreases; the timing of which was bound by the duration of milk consumption. If 
the rate of milk delivery was increased mere was a corresponding increase in the 
anticipatory dopamine signal. The authors take these results to be suggestive of an 
involvement of meso-nucleus accumbens dopamine neurons in coding for incentive 
rather than for the reinforcing properties of food. 
Again such an anticipatory role for dopamine further reinforces the 
hypothesis that the disruption of autoshaped behaviour and instrumental behaviour 
by dopamine receptor antagonists is attributable to interference with the response-
eliciting rather than the response-reinforcing properties of stimuli such as palatable 
food (Beninger, 1983). 
Caveat and summary: Beyond the striatum 
The data in this section go some way to identifying those aspects of internal 
and external states which may modify dopaminergic transmission. However, a 
further important consideration has to be outlined here. Not only are dopamine 
receptors pharmacologically diverse but the anatomical distribution of these 
receptors seem to have functional consequence in coding information concerning the 
nature of rewards. A very recent paper by Schultz and colleagues warns that target 
sites for electrophysiological measurement need to be chosen with care and in 
accordance with a very specific hypothesis. This is necessary when also 
acknowledging the considerable effects on dopamine activity that have been 
observed with changes in stimuli (both internal and external to the organism). 
Hence, after extensive experimentation, Schultz et al. (1998) have 
postulated that different brain structures process reward information in very 
different ways. They claim "dopamine neurons emit a reward teaching signal 
without indicating the specific reward, striatal neurons adapt expectation activity to 
new reward situations, and orbitofrontal neurons process the specific nature of 
rewards". (P. 421). Therefore, many properties of the experimental situation must 
be closely controlled in order to elucidate the correct role for this neurotransmitter in 
motivated behaviour. The specific type of stimulation of dopamine (for example 
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tonic or phasic) (see DiChiara, 1998), the motivational impact of the stimulus (in 
terms of novelty, unpredictability, its perception by a specific sensory modality, 
deprivation state of the organism) and the particular brain areas targeted for 
observation are crucial variables to consider when interpreting empirical evidence. 
The next section (Section 2.6) deals with a theory which has, among other things, 
taken heed of data which reflects the "anticipatory" nature of dopamine which has 
been outlined in this section. A specifically motivational role for dopamine is put 
forward which differs significantly from the original anhedonia hypothesis. 
Chapter 2 
2.6 Dopamine neurons code for generic motivational salience: 
Dopamine's role in incentive-sensitisation 
Motivation is the process by which stimuli predictive of rewards and 
punishers becomes capable of controlling behaviour. Therefore, much of the 
evidence already viewed in this chapter clearly calls for a specifically motivational 
role for dopamine. However, motivation as a process might be most correctly 
viewed as having two parts: an acquisition phase and an expression phase. 
According to Robinson and Berridge (1993), dopamine is exclusively involved in 
the latter phase. 
This association has been made in the light of many empirical studies which 
are-reviewed as part of their thesis which postulates that firstly, addictive drugs 
share the ability to enhance mesotelencephalic dopamine neurotransmission and 
secondly, one psychological function of mis neural system is to attribute "incentive 
salience" to the perception and mental representation of events associated with the 
activation of the system. Incentive salience is a psychological process that 
transforms the original perception of stimuli, investing them with importance, 
making them attractive "wanted" incentive stimuli. The repeated use of addictive 
drugs can sensitise this neural system to drugs and drug-associated stimuli 
(Robinson and Berridge, 1993). The sensitisation of dopamine systems is "gated 
by associative learning" hence it causes excessive incentive salience to be attributed 
to tiie act of drug taking and to stimuli associated with drug taking. 
Therefore, at least for these authors, dopamine neurons code for generic 
motivational salience, a postulation which encapsulates much, but not all of the data 
presented thus far. There are many studies, especially using in vivo monitoring 
techniques such as brain microdialysis, which have shown that dopaminergic 
neurons are sensitive to the affective or hedonic properties of the stimulus as well as 
other motivational variables. Although theoretical points are to be considered more 
thoroughly in the General Discussion of this thesis, it is worth reiterating that many 
studies in the previous section serve as direct criticisms of theories, such as that of 
Robinson and Berridge (1993) which propose that mesolimbic dopaminergic 
activity is, in effect, insulated from hedonic and/or motivational manipulations (see 
Section 2.5, Section 2.11 and General discussion). 
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Interim summary: Theorising a role for dopamine in food reward 
The anhedonia hypothesis has stimulated a massive amount of empirical 
research which in turn has formed the basis of several new models in which to 
interpret data on the the part dopamine has to play in reward. Empirical and 
conceptual problems for the anhedonia hypothesis or any model which postulates a 
"direct" role for dopamine in reward do not obviate a crucial role for dopamine in 
the acquisition and maintenance of motivated behaviour. Dopamine obviously has 
some part to play in the formation and maintenance of representations of Pavlovian 
and instrumental contingencies for a whole host of reinforcers. 
The most obvious shift in theory is contained in the idea that brain dopamine 
activity is not necessarily directly involved in the mediation of "hedonia" but that it 
has an anticipatory or incentive quality which may have little to do with the 
perception, evaluation or actions taken as a consequence of, the subjective feelings 
of "pleasure". 
What can be stated with security from the evidence presented up to this 
point, is that the process of reward is not a unitary and immutable phenomenon. 
The focus of this thesis is the way in which dopamine receptor subtypes might 
contribute to components of food reward which incorporates questions such as: 
What is the best way to measure food reward. Which critical brain structures/ 
, dopamine receptor subtypes underlie dissociable aspects of food reinforcement? To 
what extent and under which circumstances do motivational processes rely on the 
dynamic nature of the reward value associated with a stimulus? 
Therefore, in the following sections, the remit of the thesis is narrowed in 
order to attempt answers to these questions. Subsequent sections will serve to 
outline some of the common conceptions and methodologies employed in food 
reward research. It will also represent the forum for the presentation of empirical 
research in this area as well as new theories which attempt to account for such data. 
Firstly there will be a brief explanation of the variables which are 
manipulated and measured in assessing the neural bases of food reward. Following 
this will be an overview of the effects of dopamine agonists and antagonists on 
feeding behaviour including preliminary data on the effect of such compounds on 
the microstructure of feeding and non-feeding behaviour. As total intake has been 
the most commonly determined dependent variable in food reward research, this 
measure is discussed leading to the presentation of alternatives to this measure in the 
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form of alternative methodologies which attempt to isolate components of ingestive 
behaviour and study the effects of dopaminergic compounds on these components. 
Data collected from alternative methodologies has led to the emergence of new 
theories of the role of dopamine in food reward which will also be described. 
Finally, there will be a discussion of the importance and utility of the fine-grained 
analysis of feeding behaviour in the form of the microstructural analysis of licking 
behaviour. The effects of dopaminergic compounds as applied to licking 
microstructure will be discussed and will form the basis of the rationale for the 
experiments presented in this thesis. 
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2.7 Important concepts in the study of ingestive behaviour 
The discussion of dopamine's role in motivated behaviour at the beginning 
of this chapter serves to introduce both traditional and more contemporary concepts 
in reward research, as well as the specific role postulated for dopamine in those 
reward processes. Such discussion also highlights the need to explicate theoretical 
concepts such as reward and reinforcement in order to enhance their empirical 
utility. In much the same way, concepts central to feeding research are subject to 
scrutiny and need to be clarified here to be profitable in terms of understanding the 
later chapters. This is not a simple task since constructs which are central to 
research in this area, are hypothetical in that they cannot be directly observed. 
" Hence, concepts such as appetite, hunger, satiety and palatability are 
difficult to define and therefore not easily measurable (Blundell, 1979); this is 
especially the case in research using animals. Animal research into ingestive 
behaviour also cannot draw upon the evidence of subjective report of behavioural 
states which may be important in initiating or ceasing feeding (i.e. feelings of 
'Tullness" or "pleasantness"). Nevertheless, many drugs tested preclinically on 
animals have been reported to have effects such as "appetite suppressant" or 
"satiety-inducing" ; in short these compounds are generally seen to reduce or 
remove the motivation to eat. However, there is debate as to whether the cues 
which lead to the cessation or reduction of feeding are best described as "drive -
reducing" or are more correctly viewed as modulators of the value of incentive 
stimuli (Toates, 1986). Therefore the next section describes some of the minimal 
definitions or "skeletal properties of food reward" (Berridge, 1996) which have 
been necessary in order to make research into them productive. 
\ Dopamine agonist- and antagonist-induced decreases in food intake are often 
interpreted as a loss of "appetite." However, mis description does little to tell us 
why there has been such an apparent loss of appetite. A decrease in intake, drug 
induced or otherwise, could be reflecting one or more of several behavioural 
mechanisms which would be more or less obviously associated with a decrease in 
intake. Drug-induced decreases in feeding could reflect the promotion or cessation 
of central and/or peripheral satiety signals which mimic or block the inhibitory 
feedback signals produced by an accumulation of food in the gastrointestinal tract. 
Following drug administration, food may be also be underconsumed as a 
consequence of a perceived change in the palatability (i.e. taste, temperature, 
texture of food etc.). More generally, drugs could change feeding patterns by 
means of either a motoric deficit or the induction of stereotyped behaviour which 
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interferes with the actual act of feeding. One of the properties of a drug which 
apparently affects appetite may be to induce emesis or some other type of illness. 
Therefore, it is clear that the behavioural expressions of anorexia (or the antecedents 
thereof) are not always equivalent It is not surprising then that the validity of 
empirical testing in feeding research has come under close scrutiny. 
Many theories and empirical studies have relied on constructs such as 
hunger and satiety in trying to define the neural bases of the control of ingestion. 
Early theories conceived of hunger as "drive" which was reduced on presentation of 
"reward" in the form of food (i.e. Hull, 1943). Animals were often assumed to 
cease feeding as a consequence of a reduction of drive, possibly resulting in a state 
of satisfaction or fullness. Without subscribing to anthropomorphic definitions, at 
the most basic level, satiation might be described as being stimulated by ingested 
food resulting in an inhibition of feeding. As such, this process is an example of a 
negative-feedback action which is necessary for central neural integration (Smith, 
1998). Nevertheless, definitions of satiety have ranged from those based on 
subjective feelings correlated with the tendency to eat or not, to those which have a 
grounding in an assumed internal or physiological state to those based on some 
consequence of ingestive behaviour (i.e. the amount of food consumed or the 
induction of a characteristic behavioural satiety sequence after feeding (Davis, 
1998). 
Some researchers have attempted to define the integration of the incentive 
properties (i.e. palatability factors) of food as well as accounting for physiological 
state (i.e. satiety factors). Cabanac (1990) encapsulates this interdependence of the 
two types of information in the concept of alliesthesia which is described as a 
change in pleasantness of a constant physical stimulus as a consequence of a change 
in physiological state. This definition incorporates much of what may now be said 
of the construct of palatability. 
Palatability can be described as the hedonic component of food reward 
(Berridge, 1996). Defined in this way, palatability, does not merely substitute for 
aspects of the orosensory stimulus properties of food (i.e. taste, smell, flavour, 
texture and temperature) (Rogers, 1990). Rather, it results from a central 
integrative process that can incorporate aspects not only of the orosensory stimuli 
but also of the physiological state and of the animal's associative history (Grill and 
Berridge, 1985; Berridge, 1996). This type of definition of palatability supercedes 
definitions which were based on stimulus properties of tastants. These invariant 
properties of tastants (i.e. sucrose) were seen to lead to a predictable response in 
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consumers (i.e. increase in concentration led to increase in consumption). 
However, it was soon realised that responses to prototypical tastants were 
not necessarily "stimulus bound". For example, the behavioural response to a 
sucrose solution depends at least in part on the physiological state of the animal and 
or the associative cues previously paired with the solution. Therefore, a definition 
of palatability evolved in appreciation of these factors. Models of the control of 
ingestion (i.e. Davis and Levine, 1977) incorporated a formalised definition of 
palatability in terms of the ability of palatability factors to exert excitatory control 
over feeding behaviour. These positive factors are seen by the authors to be 
countered by the inhibitory effects of food which has already been consumed (i.e. 
satiety signals) (for more detail see section 2.12). More formalised definitions offer 
the possibility of experimentally manipulating palatability factors, especially of 
prototypical tastants, as behavioural reactions to these tastants, all else being equal, 
have been shown to be relatively stable across several test situations. 
Despite Ihe obvious complexity of a construct such as palatability, there 
have been many attempts to operationalise this and other constructs central to 
feeding research. The following section (2.8) presents some of the experiments on 
dopamine receptor subtype agonists and antagonists on feeding and other 
behaviours that have been carried out in recent years. It provides a general 
background to those studies presented later in Chapter 2 which have specifically 
predicted dopamine receptor subtype involvement in components of ingestive 
behaviour. These latter type of experiments necessitate the operationalisation of 
constructs such as satiety and palatability and will therefore be described in detail in 
Sections 2.10-2.12). 
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2.8 The effects of dopamine receptor subtype selective compounds 
on feeding and other behaviours in the rat 
It is well established that both dopamine agonists and antagonists reduce 
feeding. What is less well established is the way in which these compounds 
achieve these effects. As has already been mentioned in Chapters 1 and 2, dopamine 
has long been considered important in the regulation of motor behaviour, and so 
changes in motor control may be responsible for observed decreases in feeding. The 
motor systems involved in stereotyped and normal motoric behaviour may be 
separate from those required for normal ingestive behaviour. Alternatively, 
dopamine receptor stimulation or blockade may induce behaviours, such as 
stereotypy, which impede the execution of actions which are necessary for normal 
feeding (Terry, 1996). 
If drug-induced changes in feeding behaviour are accompanied by the 
emergence of competing motor behaviours, it is difficult to ascribe a role for 
dopamine in food reward per se; hence, there is a need for a fine-grained analysis 
to the study of dopaminergic involvement in feeding and other behaviours which 
may be occurring between or instead of feeding. The following part of the 
Introduction will serve to provide some general information on the relative 
contribution of dopamine receptor subtypes to feeding in general and also to certain 
parameters of feeding as assessed by the microstructural analysis of ingestive 
behaviour (see also section 2.10 and 2.12). 
2.8.1 Dopamine Dl-like preferring compounds 
Dopamine D l agonists 
Using non-deprived rats given access to a palatable wet mash diet, Gilbert 
and Cooper (1985) were the first to report that the D l type agonist SKF 38393 
produced a dose-dependent reduction in food intake. A decremental effect of SKF 
38393 (4h after administration) was also shown in rats who were free-feeding 
(Martin-Iverson and Dourish 1988; Cooper and Al-Naser, 1993). This result was 
repeated in food-deprived rats and further confirmed by others (Zarrindast et al., 
1991; Terry and Katz, 1992,1994). SKF 38393 is a benzazepine compound with 
only partial agonist efficacy in the adenylyl cyclase assay of D l - type agonist 
efficacy (e.g. O'Boyle et al., 1989). Other benzazepines with differing efficacies 
also reduce food intake dose-dependently, such as SKF 75670 in non-deprived rats 
eating palatable mash (Rusk and Cooper, 1989 a), and both SKF 77434 and SKF 
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82958 in food deprived rats (Terry and Katz, 1992). Other Dl type agonists, 
although structurally dissimilar to the prototypical agonists such as SKF 38393 are 
also known to reduce feeding. The agonist A-77636 reduces intake in free feeding 
rats while and A-68930 a similar agonist decreases intake in food-deprived rats (Ai-
Naser and Cooper, 1994). 
Dopamine D l antagonists 
The Dl-type prototypical antagonist SCH-23390 reduced food intake in 
both food deprived (Gilbert and Cooper, 1985; Zarrindast et al, 1991; Terry and 
Katz, 1992) and free-feeding animals (Clifton et al., 1991; Naruse et al., 1991). 
An early study on the effects of a D l antagonist on food intake (Koechling et al., 
1988) showed that across a series of discrete meal segments, SCH-23390 increased 
the latency to eat and reduced the speed of eating. 
Central mechanism of a dopamine Dl-like effects on feeding? 
Dopamine D l agonists 
There are studies which have attempted to establish central rather than 
peripheral sites as the basis of the effects of D l agonists on ingestive behaviour. 
Dopamine Dl agonists which are peripherally rather than centrally active, such as 
SKF 82526 fail to reduce intake (Rusk and Cooper, 1989a). Somewhat 
counterintuitively, intracranial infusions of D l agonists do not produce reductions 
in food intake. When SKF 38393 was infused into the nucleus accumbens there 
was no apparent associated anorectic effect (Phillips et al, 1995). Another brain 
area which has been shown to be important in feeding is the ventrolateral striatum 
(Inoue et al., 1992). When CY-208-243 was delivered to this brain site a reduction 
in feeding was not observed (Inoue et al., 1995). Therefore, it seems the brain sites 
critical to the action of D l agonists remain to be mapped. 
Dopamine Dl antagonists 
When administered centrally, D l antagonists have much the same effect on 
intake as systemic administration of the same drug. For instance, Inoue et al., 
(1995) found that in the absence of an hypophagic effect SCH-23390 severely 
disrupted water intake. The basis of this selective effect is unclear but may be 
related to the deprivation state of the animals used in the study. 
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Effects of Dl-like preferring compounds on the microstructure of ineestive 
behaviour 
Microstructural analysis of feeding and other behaviours offers a valuable 
insight into the mechanism by which drugs reduce intake. The theoretical 
assumptions underlying the use of this type of methodology will be discussed in 
detail in Section 2.10 and 2.12. For the purposes of this section of the thesis there 
will be a brief description of the studies which have found that dopamine receptor 
stimulation and blockade may affect particular parameters of feeding behaviour. 
Dopamine D l agonists 
The microstructural analysis of the effects of the D l agonist SKF 38393 on 
feeding and other behaviours showed this compound to share a behavioural profile 
(at least to some extent) with the non-selective agonists. For instance there was a 
significant reduction in time spent eating, but in the case of SKF 38393 this seemed 
directly attributable to a marked reduction in the frequency of bouts. The local rate 
of eating also declined, and was accompanied by a compensatory increase in the 
mean bout duration of the feeding bouts. Few other Dl agonists have been 
compared to the prototypical agonist SKF 38393 in the microstructural paradigm. 
However, Al-Naser and Cooper (1994) used this methodology to show that in 
common with the prototype, the D l agonist A-68930 produced a reduction in 
intake which was accompanied by a dose-dependent decline in the total time spent 
feeding, and this decline in turn was primarily a product of a reduction in the 
number of meals consumed. 
There were other common effects of SKF 38393 and A-68930 on 
microstructural parameters, for instance, eating rate decreased with dose while 
mean meal duration increased. Terry (1996) notes that, taken at face value, this 
commonality of results within the same class of compound could lead one to believe 
that there was a common mechanism underlying the actions of D l agonists on 
feeding; namely a specific effect on the number of feeding bouts. Terry also notes 
that, interestingly, an effect on this parameter is also associated with reduced food 
intake as a consequence of pre-satiation (Cooper and Francis, 1993). This could be 
an indication that D l agonists induce satiety. Further support for this idea comes 
from sham-feeding studies where some of these agonists (namely SKF 38393 and 
CY 208-243) effectively and dose-dependently reduced intake even in fistulated rats 
(see Section 2.10 on sham-feeding). 
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One way of further examining this assertion is to compare the D-1 agonists 
on their ability to produce competing behaviours in the feeding test situation. In the 
case of A-68930, there was significant enhancement of grooming at doses below 
the anorectic threshold dose (Cooper et al., 1990) which could have contributed to 
the reduction in meal frequency. The same authors observed an anorectic effect of 
SKF 38393 in the absence of competing motor effects. These differences in 
behavioural effects between the two Dl agonists can be explained in terms of their 
possible pharmacological characteristics but further research will need to be 
conducted to discern this. 
Dopamine Dl antagonists 
The anorectic effects of D l antagonists have not yet been studied as 
thoroughly as those of other dopaminergic agents especially in terms of the 
microstructural variables that contribute to their effects. In terms of the ability of 
Dopamine D l antagonists to produce competing motor responses, there is some 
evidence to suggest that certain doses of D l antagonists can affect non-feeding 
behaviours without incurring a significant decrease in food intake. D l receptor 
blockade has long been associated with the induction of stereotyped motor 
behaviour. In the case of SCH-23390 the systemic dose range which commonly 
reduces food intake (>0.01 mg/kg subcutaneously; >0.03 mg/kg intraperitoneally) 
(Terry, 1996) are those that are often associated with significant disruption of motor 
behaviour. Examples of this are the potentiation of the dorsal immobility response 
(Meyer et al., 1992); reduced locomotor activity (Meyer et al., 1993); and 
catalepsy (Morelli and DiChiara, 1985). 
\ It is important therefore, to seek out a measure of behavioural specificity of 
the effects of such Dl-type antagonists. Genn, (1994, unpublished dissertation 
B.Sc. dissertation report) showed that the D l - agonist SCH-39166 (0.03-0.3 
mg/kg i.p.) significantly reduced motor behaviours such as locomotion, rearing and 
grooming but did not significantly decrease total intake of a sweetened mash. There 
was however a significant decrease in the number of meals consumed which was a 
product of a dose-dependent increase in the mean duration of feeding bouts. 
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Pharmacological specificity of Dl-like effects on feeding: Blocking studies 
Characterising the behavioural effects of D l agonists on feeding has been 
made more difficult as attempts to demonstrate the receptor specificity of these 
behavioural effects are both few and inconclusive. Most researchers have chosen to 
demonstrate receptor-specific antagonism. Terry and Katz (1992) attempted to 
block the anorectic effects of SKF 38393 by pretreating food-deprived animals with 
the Dl antagonist SCH-23390. The antagonist failed to attenuate the anorectic 
effects of SKF 38393 but partially attenuated the reduction in feeding produced by 
another D l agonist, namely SKF 77434. Conversely, SCH-23390 fully blocked 
the effects of the D l agonist SKF 82958. These results call into question the 
prototypicality of compounds such as the Dl agonist SKF 38393 and have 
important implications for the interpretation of results which attribute reductions in 
feeding to the stimulation of D l receptors (Terry, 1996). 
Further obstacles to interpretation come from findings which imply that non-
dopaminergic receptors could contribute to the anorectic effects of the prototypical 
Dl agonists (see also General Discussion). For instance, Zarrindast et al (1991) 
showed that the anorectic effect of SKF 38393 could be reversed by the non-
specific 5-HT antagonist metergoline, a result which has been replicated in an food-
rewarded operant paradigm (Terry and Katz, 1993). These studies follow findings 
which show the D l agonist SKF 38393 to be partial agonists at the 5-HT2C 
receptor (Briggs et al, 1991). This complicates interpretation in that agonists acting 
on the 5-HT2C receptor are themselves anorectic agents (Kenneth and Curzon, 
1988,1991). It may also go some way to explaining the inability of SCH-23390 to 
attenuate the effects of SKF38393 as these two compounds could be having an 
additive effect at a common serotonergic site (Terry, 1996). 
This problem was partially overcome by using the D l antagonist SCH-
39166 to attenuate the anorectic effects of SKF 38393. This antagonist has 
negligible affinity for the 5HT2 C receptor (Taylor et al., 1991). and so one might 
expect that it would be more efficacious in antagonising the effects of such a 
prototypical agonist such as SKF 38393 (Terry and Katz, 1994). However, the 
expected enhanced antagonism of SKF 38393 by SCH-39166 was not borne out of 
this study. More recently (Terry and Katz, 1994) have demonstrated the generality 
of the antagonist effect of SCH-39166 by showing that this compound inhibits 
deprivation induced food intake dose-dependently. Given the negligible affinity of 
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SCH-39166 at 5HT2 C receptors, this finding points towards Dl-blockade as 
sufficient to reduce food intake. 
2.8.2 Dopamine D2-like preferring compounds 
Dopamine D2 agonists 
Early reports of a role for the D2 receptor in feeding used D2- receptor 
agonists such as N-0437 (Rusk and Cooper, 1988) and RU 24213 (Martin-Iverson 
and Dourish, 1988). Both of these compounds produced significant reductions in 
palatable mash intake in non-deprived animals and N-0437 produced a comparable 
effect when powdered laboratory chow was used 
Contrary to these initial results, Martin-Iverson and Dourish (1988) found 
that food-intake was enhanced in free-feeding rats as a function of dose of PHNO, a 
D-2-type agonist This effect could be attenuated by pretreartment with haloperidol, 
a D2 antagonist This effect was found to be specific to a particular set of stimuli, 
namely laboratory food pellets as if the accessible diet was changed to sweetened 
milk or liquid chow, this effect was reversed producing the initially established 
hypophagia in response to a D2 agonist. The authors explained this discrepancy 
observed with solid pellets to the stimulation of chewing behaviour. As the effect 
was observed over a wide dose range it is unlikely that it could be attributed to the 
stimulation of D2 autoreceptors (see Chapter 1). 
Nevertheless, the interaction of D2 agonists at autoreceptors to produce 
effects on feeding has become an interesting research area. However, studies 
which hypothesised this type of interaction have produced mixed results. For 
instance, there is some evidence to suggest that low doses of D2 agonists may act 
centrally upon autoreceptors to increase feeding (Morley et al., 1982). Opposition 
to this view comes from studies using systemic doses of the D2 agonist lisuride 
which purportedly act upon autoreceptors. In an early investigation, (Carruba et 
al., 1980) found that lisuride produced a hypophagic effect However, in 
accordance with the possibility that dopamine D2 agonist might stimulate feeding at 
low doses (by autoreceptor activation) and inhibit feeding at higher doses (by 
postsynaptic receptor activation), Clifton et al., 1989, showed that N-0437 
produced this type of biphasic dose-effect function in free-feeding rats. Ferrari et 
al.(1992a, 1992b) further scrutinised the effects of autoreceptor selective doses of 
D2 agonists. The agonist B-HT 920 decreased the latency to initiate feeding and 
increased food intake over a 6-h period in food-deprived rats. Two other D2 
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agonists (lisuride and CQ 32-084) were tested within two different feeding 
paradigms (a modified X-maze and home-cage). The biphasic effects on feeding 
associated with differential receptor stimulation were apparent only in the stressful 
situation (i.e. hyperphagia at low doses of the D2 agonists when not in home cage). 
Ferrari et al., (1992b) suggest that this may reflect an anxiolytic action of D2 
autoreceptor activation, rather than a specific interaction with mechanisms regulating 
food intake (see Chapter 7). 
Systemic administration of quinpirole (mixed D2-D3 agonist with a similar 
profile of selectivity to 7-OH-DPAT Levesqueetal., 1992) routinely inhibits food 
intake Zarrindast et al., 1991; Cooper and Al-Naser, 1993) and D2 agonist 
induced hyperphagia has not been reported elsewhere. The issue of presynaptic 
versus postsynaptic effects of dopaminergic compounds has already been reviewed 
in relation to locomotor behaviour in Chapter 1. However, these differential dose 
effects obviously have a bearing on feeding behaviour. A reconceptualisation of 
these effects might emerge from developments in dopamine receptor classification 
and the suggestion that certain behavioural effects previously attributed to D2 or D3 
autoreceptor binding might instead be due to drug action at postsynaptic receptor 
subpdpulations of the D3 receptor subtype (Waters et al., 1993). 
D2- antagonists 
Despite the widespread use of the D2 antagonist pimozide to demonstrate a 
reduction in food reward (i.e. a reduction in free-feeding,Wise and Colle, (1984) a 
reduction in feeding induced by deprivation; Wise and Raptis, (1986); feeding 
provoked by electrical stimulation of the lateral hypothalamus, Streather and 
Bozarth, (1987) and normal and sham intake of both saccharin and saccharin-
sucrose solutions (Xenakis and Sclafani, 1981; Geary and Smith, 1985), there are 
many reports of failure to inhibit feeding by D2 antagonists leading to debate as to 
whether D2 antagonists can be said to consistently modify food intake (see 
Blackburn, 1992 and Chapter 2). 
For example, an early study by Heffner et al., (1977) showed that while 
spiperone had a deleterious effect on food intake, another D2 antagonist, 
haloperidol, did not. Many others have reported no effect (see Blackburn et al., 
1992 and Cooper et al., unpublished results). Nevertheless, Rusk and Cooper 
(1994) demonstrated that a high dose of the D2 antagonist YM 09151-2 (0. lmg/kg, 
i.p.) served to decrease consumption of palatable wet mash and also reduced 
deprivation induced feeding. A lower dose (0.01 mg/kg, i.p.) had the opposite 
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effect in food-deprived rats. A similar low-dose enhancement of feeding was not 
apparent after the administration of pimozide in this particular study but had 
previously been reported by Lawson et al. (1984). There are, however, a 
substantial number of reports of this low-dose effect of D2 antagonists such as 
spiperone (Cooper and Sweeney, 1980) and haloperidol (Hobbs et al., 1994). 
Central mechanism of D-2 like effects on feeding? 
Dopamine D2 agonists 
Intraventricular bromocriptine, a D2 agonist, can stimulate feeding at low 
doses which supports the idea that D2 agonists acting on autoreceptors can increase 
intake. Also, infusion of quinpirole (mixed D2-D3 agonist) (Levesque et al. 1992) 
into the ventrolateral striatum has been shown to produce hyperphagia (Inoue et al., 
1995). However, infusion of quinpirole into the nucleus accumbens is without 
effect (Phillips et al., 1995). These dissociable results highlight a possible site for 
the hyperphagic effect induced by D2 agonists. 
Dopamine D3 agonists 
There is only one study which specifically examines the effects of a D3 
receptor agonist on feeding behaviour. Intake of a preferred 3% sucrose solution 
was significantly reduced by intra-accumbens infusions of the D3 receptor subtype-
selective agonist 7-OH-DPAT (Gilbert and Cooper, 1995). Despite implications of 
an involvement of this particular receptor in reward (see Chapter 2), without further 
study, it is difficult to conclude that this receptor has a more or less important role to 
play in the reduction of intake when compared to other dopamine receptor subtypes. 
D2 antagonists 
Parada et al. (1988), have used sulpiride to investigate the neural bases of 
feeding behaviour induced by D2-antagonism. Injected into the lateral 
hypothalamus, sulpiride increased food intake. Other brain sites have also been 
identified in the mediation of D2-antagonist effects on feeding. Bakshi and Kelley 
(1991) showed that when the D2 antagonist haloperidol was injected into a number 
of striatal regions, there was a resultant dose-dependent increase in feeding duration 
without a significant increase in total intake (nucleus accumbens) or a reduction in 
feeding duration (ventrolateral striatum). These anorectic effects which occur as a 
73 
Chapter 2 
result of direct injection of a D2 agonist into the latter brain site have since been 
confirmed by Inoue et al., (1995). 
Effects of D2-like preferring compounds on the microstructure of ingestive 
behaviour 
Dopamine D2 agonists 
Rusk and Cooper (1989b) have provided a microstructural analysis of 
ingestive behaviour after the administration of the D2 type agonist, N-0437. 
Despite early reports of hyperphagia in response to low doses of this agonist 
(Martin-Iverson and Dourish, 1988), the application of the microstructural approach 
revealed that N-0437 dose-dependently reduced food intake over a wide dose range 
(0.3-3.0 mg/kg). This drug effect on total intake seemed to be achieved primarily 
by a reduction in the local rate of eating without affecting the time-course of 
feeding. There was no effect of N-0437 on the total feeding duration nor on the 
frequency of feeding bouts. With regards the induction of non-feeding behaviours, 
N-0437 at the anorectic doses of 1.0 and 3.0 mg/kg significantly reduced the 
frequency of grooming whilst increasing sniffing behaviour. Locomotor activity 
was not affected. These same anorectic doses also increased the total duration of 
oral behaviours. This dose-dependent decrease in oral and other non-feeding 
behaviours are difficult to fully reconcile with the accompanying changes in feeding 
parameters. 
More work is needed in this area as the only other report on the the 
microstructure of feeding in response to a D2 agonist (i.e. quinpirole) is by Al-
Naser (1993). Results from this study revealed that quinpirole reduced intake in 
much the same way as N-0437 by decreasing the local rate of eating, suggesting a 
common mechanism of action. This result is in contrast to that of Clifton et al. 
(1989) who found a biphasic effect of N-0437 without the significant reduction in 
local rate of eating (although it was slightly reduced). 
Dopamine D2 antagonists 
Bakshi and Kelley (1991) used microstructural analysis of feeding 
responses after the central administration of the D-2 type antagonist haloperidol. 
Their main findings were dissociable effects on feeding parameters which were 
dependent on the site of injection (see also central mechanisms). With regards 
feeding enhancement, injection into the nucleus accumbens increased the mean 
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duration of feeding, rather than increasing feeding bout frequency. Central 
administration of haloperidol did not have a decremental effect on eating rate, 
although systemic injection of haloperidol has been shown to reduce feeding 
through alterations in this parameter accompanied by a decline in feeding duration 
(Salamone, 1988; Salamone et al., 1990). 
Thus it seems that D2 agonists and antagonist reliably produce a decrease in 
the rate of eating regardless of the overall effect on intake (i.e. stimulation or 
inhibition). Terry et al. (unpublished results) observed that, after the administration 
of raclopride, feeding behaviours were affected in a biphasic manner. Eating rate 
did not change as a function of the dose of raclopride. Total duration of feeding 
decreased and latency to engage in feeding behaviour increased significantly as a 
function of increasing doses of raclopride. Latency seemed most profoundly 
affected by the highest dose of raclopride (1.0 mg/kg, i.p.). This effect, along with 
a reduction in the number of feeding bouts, seemed responsible for the high dose 
hypophagia which was observed. The low-dose hyperphagic effect of raclopride is 
the product of a combination of slight increases in both number of feeding bouts 
and mean bout duration. This enhancement occurs in the absence of competing 
behavioural responses, whereas the high-dose hypophagia was accompanied by 
disruption to non-feeding behaviours. Therefore, although this study shows that 
changes in eating rate are not necessarily characteristic of D2 antagonism, it is 
difficult to assume behavioural specificity of the D2 antagonist hypophagia. 
Dopamine D3 antagonists 
There is only one report of an effect of a specific D3 receptor antagonist on 
feeding. This finding was part of an "ethogram" collated by Clifford and 
Waddington (1998) in an attempt to further characterise the novel compound PNU-
99194A. Eating counts were increased at 15-45 mg/kg PNU-99194A. However 
since microstructural parameters were not measured, it is difficult to propose a 
mechanism by which this compound achieved such an effect from this study alone. 
Pharmacological specificity of D2-like effects on feeding: Blocking studies 
As is the case for D- l type agonists, the dependent variable in studies of D-2 
type agonist -antagonist interaction studies has been the measure of total intake. 
However, receptor specificity of the anorectic effects of D2 agonists has been 
successfully demonstrated. Rusk and Cooper (1988) showed that pretreatment with 
the D2 antagonist YM 09151-2 abolished the decremental effect of N-0437 on 
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palatable mash consumption. Ladurelle and colleagues (1991) also showed reversal 
of the anorectic effects of RU 24926 by sulpiride in food-deprived mice. However, 
there are some anomolous results. For example, Zarrindast et al. (1991) found that 
whereas the anorectic effects of quinpirole could be reversed by pretreating animals 
with either sulpiride or pimozide, only pimozide was capable of reversing the 
decremental effects on feeding of another D2 agonist, bromocriptine. Specificity at 
other receptor subtypes remains possible as explanation of conflicting results. 
Summary 
There are obviously several inconsistencies in the evidence from studies 
which have tried to discover the relative contributions of dopamine receptor 
subtypes to ingestive behaviour. Such discordant evidence could be due to 
procedural differences (i.e. deprivation status, scheduling of food, type of diet and 
drug and test history, Terry, 1996), questionable pharmacological specificity of the 
dopaminergic compounds used, and most certainly differential effects of the doses 
used. In the light of such incomplete characterisation of dopaminergic drug effects 
on feeding, and also in the light of the reclassification of dopamine receptor 
subtypes, it is difficult to pull out dissociable receptor subtype contributions to the 
control of ingestive behaviour. 
Nevertheless, in reviewing the literature, some authors have concluded that 
there may be some definable differences between those drugs which act at putative 
D2 receptors and those which act at D l receptors. For example, much of the above 
evidence gave rise to the observation, that D l agonist and antagonist effects on 
ingestive behaviour very often occur in conjunction with competing motor 
behaviours. However, both agonists and antagonists in this class seem to produce 
a decremental effect on meal frequency, Terry (1996). The biphasic dose effects of 
both D2 agonists and antagonists render conclusions about the behavioural role of 
this receptor subtype difficult. While there is some evidence that low doses of this 
class of drug enhance intake and that high doses depress intake, this effect does not 
always occur. D2 preferring compounds have also been reported to primarily affect 
eating rate, but again, this effect does not always become manifest (Terry, 1996). 
In a general sense, the disparity of the results presented above provide the 
perfect impetus for any study which seeks to tease out behavioural similarities and 
differences within and between pharmacological classes of dopamine receptors. 
The following section considers some of the methodologies which have been used 
in an attempt to further isolate specific effects of dopamine agonists and antagonists 
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on feeding behaviour. It also evaluates the utility of total intake measures in 
answering such questions. Further sections provide alternatives to total intake 
measures and the theoretical assumptions underlying the choice of optional 
dependent variables. 
Chapter 2 
2.9 Total intake measures for liquid diets 
Total intake measures are quick, efficient and cost effective approximations 
of an animals responsiveness to a given food or fluid (Grill, 1987) and the common 
use of this dependent measure is testament to these assertions. However, this 
measure is of limited value to those interested in the study of ingestive behaviour as 
it is a composite standard which reflects a variety of behavioural acts that occur 
during a time when an animal is feeding or drinking (Davis and Levine, 1977). 
Nevertheless, much of the evidence from studies of the neural bases of the control 
of feeding and drinking have used this measures. Therefore, it would seem 
sensible to outline some methods of procuring total intake measures and the effects 
of pharmacological manipulations on these dependent variables. 
-two-bottle intake tests 
In this test situation, animals are presented in their home cages with a choice 
between water and a taste solution, hence the common reference to this method as a 
preference test Food is available ad libitum and test duration usually varies from 
24-48hr. Over successive days the concentration of the taste stimulus is varied 
usually in an ascending fashion. The results are typically expressed as the ratio of 
taste to total fluid (water plus taste solution) intake as a function of the taste stimulus 
concentration. Control for bottle position is necessary as the preference may reflect 
this variable rather than solution choice. 
-one-bottle intake tests 
This test situation is usually short in duration (e.g. 15-30 min) and water is 
unavailable during this period. The taste solution presented to animals in their home 
cage is their sole fluid source. Interpretation of data from this situation is more 
difficult than data from a preference test, as in the absence of a water intake 
measurement it is difficult to exclude changes in physiological state and 
environmental fluctuations as explanations for changes in fluid consumption. To 
avoid this potential problem, water trials are often interspersed between other taste 
stimulus trials during the course of the experiment to provide a comparison. When 
this control has been implemented the data from one and two- bottled tests is found 
to be comparable (Grill etal., 1987). 
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Effects of dopaminergic agonists and antagonists in fluid intake tests 
Towell et al. (1987), were among the first to report that the D2-type 
antagonist pimozide reduced the preference for sucrose over water, without altering 
total fluid intake. Using the single choice test, this antagonist was shown to 
selectively reduce intake at low sucrose concentrations, while sparing the intake of 
equal or higher volumes at higher concentrations. This finding confirmed the 
results of Bailey et al. (1986), who showed that pimozide supressed operant 
responding maintained by weak sucrose concentrations but that this finding did not 
hold when the stimulus was a higher sucrose concentration. It was difficult to 
explain such results in terms of a motoric deficit and so Muscat and Willner (1989) 
went on to further investigate the effects of Dl-type and D2-type receptor blockade 
on sucrose consumption and preference. 
In general, these authors concluded that antagonising either subtype of 
dopamine receptor appeared to be similar to those of reducing the concentration of 
sucrose. Both sulpiride (D2-type receptor antagonist) and SCH-23390 (Dl-type 
receptor antagonist) decreased sucrose intake in single bottle tests when sucrose 
concentration was weak but neither drug had any effect when the sucrose 
concentration was made stronger. By manipulating drive or motivational level (i.e. 
reducing drive by using non-deprived animalsX the effects were reversed for the 
single bottle test In the two-bottle test, both drugs reduced preference for the 
weakest sucrose concentration but increased preference for the strongest 
concentration. 
Therefore, it seemed that although neuroleptics usually suppress reinforced 
behaviour, if very sweet rewards are used, it is possible to demonstrate the opposite 
effect, an increase in performance following neuroleptic treatment (Phillips et al., 
1991a). Studies of operant responding raise the possibility that the direction in 
which neuroleptics change responding may be dependent on the magnitude of 
reward available. In the light of such results, Phillips et al. (1991c) employed non-
operant tests of sucrose solutions consumption and preference after the 
adminstration of the D2-type antagonist raclopride. These studies set out to 
determine the bases of the behavioural generality of the paradoxical effect of 
neuroleptics on behaviour maintained by a very sweet reward. A further line of 
investigation assessed the behavioural mechanism by which very sweet rewards 
alone suppress performance. Many authors attribute this finding to the highly 
satiating nature of high carbohydrate solutions, (Davis, 1977). Phillips et al. 
(1991c) examined the time course by which raclopride enhances intake of very 
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sweet solutions, to re-evaluate the potential contribution of satiety to the 
suppression of intake. Two further possibilities were also considered within the 
study; that very sweet solutions alone may have aversive effects and that raclopride 
may produce an anti-aversive effect in the face of the negative hedonic impact of 
those very sweet solutions. More concisely, Phillips et al. (1991c) wanted to 
elucidate the effect of choice upon preference and the overall (and within-session) 
effects of raclopride on these parameters. 
Previously, Phillips et al. (1991a) reported that raclopride reduced intake of 
concentrations from the ascending limb and increased intake of concentrations from 
the descending limb of the concentration-intake curve (i.e. the concentration-intake 
function is shifted to the right). Further testing of these hypotheses involved the 
comparison of the effects of raclopride in two separate experimental paradigms. 
Animals were presented with either, 0.7,7 or 34% sucrose solutions, each coupled 
with the presentation of water as an alternative (two-bottled test). In another 
experiment, separate groups were allowed access to all three of the above 
concentrations concurrently (three-bottle test). 
In the two-bottled test, presentation of sucrose solutions yielded an inverted 
U-shaped concentration-intake function (similarly low intake measures for the high 
and low concentrations with highest intake measures in response to the intermediate 
sucrose concentration). However, the high sucrose concentration was preferred in 
the three-bottle test Therefore, when comparing preference data from one two and 
three-bottle tests, it is difficult to attribute the suppressed intake measures on the 
descending limb of the single-bottle concentration-intake curve to the aversive 
properties of very sweet solutions. In both tests raclopride (100-400u,g/kg) 
reduced intake of the intermediate sucrose concentration but increased the intake of 
the high sucrose concentration. These effects were apparent very early in the test 
session (within the first 5-min). Therefore, the potential "satiety" explanation 
seems unlikely. 
In the two-bottle test, intake of the intermediate concentration showed both 
effects: an immediate decrease and a later increase. In the three-bottle test, sucrose-
naive animals showed a gradual onset of preference for the high sucrose 
concentration. Immediate enhancements of intake by raclopride required three 
sessions of exposure. The authors suggest that both preference for sweeter 
solutions and concomitant concentration-dependent enhancements of intake induced 
by raclopride are acquired over time and involve some form of learning (also see 
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Pecina and Berridge, 1998, in Chapter 4). Raclopride also did not alter the 
consumption of a 0.001% solution of quinine. It was hypothesised that if the 
effects of raclopride upon reactivity were non-specific , then the drug might be 
expected to ameliorate the impact of quinine and increase the volume of quinine-
adulterated water ingested. Raclopride had no effect on quinine or water intake but 
reduced the intake of the 0.7% sucrose solution in the same animals. This 
effectively negated the suggestion that the efficacy of raclopride may exend to a 
blunting of the direct impact of an aversive stimulus such as quinine. Although the 
exact mechanisms by which changes in responding to varying rewards are not yet 
clear, there are obviously many alternative aspects to the reward-dependent 
suppression or facilitation of consummatory behaviour by neuroleptics such as 
raclopride. 
Using a very similar set of paradigms, Muscat et al. (1991) tested the 
hypothesis that the stimulation of high-concentration sucrose solution intake after 
the administration of raclopride could be dependent on calorie content of the 
solution used rather than its perceived sweetness. They found results which at face 
value could be in support of such an hypothesis. For example, in two-bottle tests 
sucrose and the non-nutritive sweetener saccharin produced comparable inverted U-
shaped concentration-intake functions. The lack of effect of raclopride at the 
highest saccharin concentration, in contrast tothe stimulation of intake observed at 
the highest sucrose concentration, is compatible with the hypothesis that the 
stimulation of sucrose intake is related to calorie content. 
On further examination, the three-bottle test revealed that the highest 
concentrations of sucrose (34%) and saccharin (0.8%) differed in a way which was 
not related to caloric value but may rather be related to potential aversive properties 
of saccharin at high concentrations. Evidence for this comes from data which 
reflects differences between the preference and intake measures. For instance, in 
the case of sucrose, intermediate concentration solutions support the highest intake 
whilst high concentration solutions are shown to be preferred. This contrasts with 
the effects of saccharin solutions where the intermediate concentration solution not 
only supports the greatest intake but is also preferred in the three bottled test 
Calorie content was further excluded as an explanatory variable by rendering 
the high concentration sucrose solution aversive after the addition of the high 
concentration saccharin solution. Intake of this cocktail was not increased by 
raclopride despite its isocaloric relationship with the high concentration sucrose 
solution. 
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A possible change in palatability after the administration of raclopride 
becomes favourable after the exclusion of a postingestional explanation. If calories 
are to be effective they first have to be absorbed. The stimulatory effects of 
raclopride in these experiments were apparent within the first 5-min of the test and 
did not increase thereafter (Phillips et al., 1991a; Phillips et al., 1991C, Muscat et 
al., 1991). 
Muscat et al. (1991), summarise by noting that the anomaly at the high 
concentration sucrose solution arises because at high concentrations there is a 
disjunction between reward and consumption: relative to 7% sucrose, 34% sucrose 
is preferred (three-bottle test) but underconsumed (two-bottle test). The 
consequence of this is that at high sucrose concentrations, the "quantity consumed 
is not monotonically related to reward", (pp. 213). In fact sucrose concentration 
seems to increase with reward (as measured by preference) while consumption 
decreases . These authors attempt to resolve the paradox by speculating that a 
decrease in reward might be reflected in an increase in consumption as is observed 
following the administration of several dopamine receptor antagonists. 
There is a caveat to the above corpus of results. Cooper et al. have 
conducted many studies in which they tested the ability of dopamine antagonists to 
differentially affect various sucrose rewards. Although this work is largely 
unpublished, the general findings should be stated here. They found that dopamine 
antagonists decreased sucrose solution intake irrespective of sucrose concentration 
(1-30%). The studies by Willner, Muscat and Phillips above show that differential 
effects of dopamine antagonists may depend upon the value of the reinforcer, and 
the extent to which a motoric interpretation is favoured is often based upon the 
occurrence of such a differential effect. What should not be underemphasised is 
that this differential effect of dopamine antagonism does not always occur. 
Central effects of raclopride? 
Within their experimental design, Muscat et al. (1991), accommodated an 
hypothesis related to the pharmacological specificity of the effects produced by 
raclopride. In order to ensure that the stimulant effect of raclopride on consumption 
of 34% sucrose was centrally mediated, these researchers also tested the effects of 
domperidone (a D2-type antagonist that does not cross the blood brain barrier). 
Results showed that raclopride exerts its effects centrally rather than peripherally. 
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These authors followed results from Phillips et al., (1991b). Phillips and 
colleagues used intracerebral injections of the D2 antagonist sulpiride to investigate 
the neuroanatomical substrate of neuroleptic induced changes in sucrose intake. As 
with systemic raclopride, administration of the D2-type antagonist sulpiride to the 
nucleus accumbens or the anterodorsal striatum reduced intake of a sucrose solution 
from the ascending limb of the concentration-intake curve, but increased intake of 
7% and 34% sucrose solutions. The only effect of sulpiride infusion into the 
basolateral amygdala was to increase intake of 34% sucrose. 
Drug free preference tests 
Hsaio and Smith (1995) tested the prediction of decreased preference in a 
different way. Using a two-bottle test, rats were tested for 5-min. The stimuli used 
were either a grape or an orange flavour mixed with 10% sucrose, these flavours 
were non-caloric and were equally preferred in an initial preference test. Conditions 
were then switched to a one-bottle test where animals had the chance to sample one 
of the flavoured sucrose solutions after pretreatment with raclopride (400u.g/kg). 
Raclopride decreased 1-bottle intake by 55% under these conditions. On alternate 
test days, rats ingested the other flavoured 10% sucrose solution after vehicle 
injection. The volume ingested after vehicle injection was yoked to the volume 
ingested after raclopride treatment in the preceding test. Making the volumes equal 
insured that any change in preference was not due to different amounts of 
orosensory stimulation by sucrose. Rats were tested twice after raclopride treatment 
and twice after vehicle treatment 24-hr after the last one-bottle test with raclopride 
pretreatment, rats were given a 2-bottle preference test for 5-min in the absence of 
drug pretreatment. In this test they had access to both flavours which had 
previously been associated with either vehicle or raclopride pretreatment. 
Rats showed a significantly decreased preference for the flavour that had 
been paired with the raclopride pretreatment The same reliable result was obtained 
after three repetitions of the protocol. The decrease preference was obviously not a 
direct effect of the drug, rather, it depended on prior experience of the drug-flavour 
pairing. (Smith, 1996) notes that this was not a result that could be explained in 
terms of a conditioned taste aversion as there was no progressive decrease of 1-
bottle intakes across the sequence of raclopride treatments. 
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Summary 
Inasmuch as decreases in total intake measures reflect a decrease in the 
efficacy of a reinforcer to maintain responding, both dopamine Dl and D2 
antagonists clearly reduce reward. This decrease in responding is very often seen in 
the absence of a motoric deficit Effects of dopamine antagonists on ingestive 
behaviour may vary as a consequence of reinforcer value but these results have not 
been observed universally (Cooper et al. unpublished results). 
Total intake measure, although informative to a certain extent, are of limited 
use if the aim of an experiment is to elucidate a role for dopamine receptor subtypes 
in separable components of ingestive behaviour. The following section (Section 
2.10) offers alternatives to total intake measures and the findings produced through 
the use of these optional methodologies. Findings using more refined technologies 
to examine ingestive behaviour have led to novel theories on the role of dopamine in 
food reward. These will be outlined in Section 2.11. 
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2.10 Alternatives to total intake measures 
Meal pattern analysis 
If the aim of a study is to describe and quantify the various types of 
behaviour that occur during a time when an animal is primarily engaged in ingesting 
food or fluid, it is necessary to adopt at least two strategies. The first is to 
catalogue all behaviours that an animal engages in during the test situation, the 
second, to determine which behaviours belong together as a functional unit (Smith, 
1996). One paradigm which engages such strategies is that of meal pattern analysis 
which constitutes the observation and analysis of temporal patterns of feeding, 
typically over 24hr. 
Theoretical assumptions underlying the temporal pattern of feeding 
drinking 
The collection and analysis of temporal patterns of feeding and drinking 
relies heavily upon theoretical assumptions about the nature of the act of ingestion. 
Clifton (1987) outlines these assumptions clearly and so provides a theoretical 
background to a number of the experimental goals adopted by researchers into the 
temporal patterns which are integral to feeding. 
Among the alternatives to measuring total intake, there are two types of 
analysis which are widely used for temporal patterns of ingestion. The first is 
simply to divide the time over which the recording was made into one or more 
intervals and calculate the number of items eaten, or time spent eating or drinking, 
in each of these intervals (Clifton, 1987). The second is to acknowledge that the 
behaviour is organised into a number of episodes or bouts. In the case of feeding 
these episodes are usually referred to as meals. With both these types of analysis 
there are assumptions as to the nature of the periods of non-ingestion. One of these 
assumptions rests on the fact that the non-ingestive periods must fall into two 
classes. These are short intervals between acts that do not characterise the end of a 
bout and there are long intervals that lie between bouts (Clifton, 1987). 
Before proceeding with further analyses, a decision must be made as to the 
criterion which will separate these two classes of interval in an efficient way. 
Crucial to such a choice is a model of the expected distribution for the between act 
intervals. Traditionally, there was an assumption that two overlapping normal 
distributions might be expected (Baker, 1953). If these assumptions are formalised 
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this renders such a result unlikely as it requires complex changes in the probability 
of a fresh event with time since the last event (Clifton, 1987). The very simplest 
assumption would be that the time intervals between acts have a constant probability 
of ending. This assumption can be most easily tested by plotting the distribution of 
the interval data in the form of a survivorship curve (Slater, 1974). If the Y axis is 
logarithmic, then provided that a single negative exponential distribution fits the data 
the plot should be a straight line. However, this is not the case. The distribution 
has a typical "broken stick" shape which suggested that it might be better fitted by 
two overlapping negative exponential distributions (Clifton, 1987). One of these 
has a high probability generating the majority of short intervals and the second with 
a low probability generating the majority of long intervals. 
As the two distributions overlap it would be impossible to achieve a perfect 
criterion, therefore, this type of analysis may not proceed without a choice of 
criterion that would best separate the two distributions. Slater, (1974) suggests 
that the best choice of criterion might be just to the right of the most obvious break 
in the survivorship function (see also Morris and Cooper, 1993). Misassignment 
seems to be unavoidable if the criterion chosen is too short (i.e. within-bout 
intervals are apportioned to the between-bout class). The number of 
misassignments increases rapidly as a shorter criterion is is taken but increases only 
slowly with a longer criterion. Therefore, care should be taken in deciding this 
separating criterion as the results of misassignment could have important 
consequences for interpretation (also see Section 2.12). 
Once a suitable criterion has been chosen it is possible to produce a 
sequence of appropriately defined meals and intervals between them and then go on 
to calculate meal size, duration and intermeal interval. It is then feasible to ask 
specific questions as to the influence of pharmacological manipulations on these 
parameters thereby deconstructing the concept of ingestion and further elucidating 
neurotransmitter substrates which might underlie specific alterations in specified 
parameters. 
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The effect of dopamine agonists and antagonists on meal 
patterning 
D l type agonists 
Clifton and Cooper (unpublished results in Cooper and Al-Naser, 1993) 
described the effects of the enanliomer of SKF 38393 (fl(+)SKF 38393) on meal 
patterns at the onset of the night phase of the diurnal light cycle. This compound 
increased the latency to eat, with experimental animals taking approximately fours 
times as long as controls to begin earing. (7?(+)SKF 38393) reduced the average 
meal size without affecting the frequency of eating bouts and this hypophagic effect 
lasted 2-3 hours. Meal patterns were also analysed in free-feeding rats after the 
administration of the Dl-like agonist A-77636. In common with (i?(+)SKF 38393) 
the anorectic effect of A-77636 seemed to be achieved by reducing the size of meals 
but the effect on meal bout frequency was quite different; A-77636 produced a 
slight increase in number of meals. This result brings the generality of the 
behavioural effects of Dl-like agonists into question. To determine whether these 
differences are based on the compounds' respective pharmacological action, or 
could be better explained in terms of discrepant methodologies, needs further 
research. ^ 
Dl-type antagonists 
There have been few studies on the effects of D l antagonists on the 
temporal patterns of feeding. By using meal pattern analysis Clifton et al. (1991) 
reported that SCH-23390 produced a small reduction in the number of meals 
consumed and in the feeding rate during a meal. There was no effect on meal size 
but there was a selective effect on water intake. This effect was substantially greater 
than the effect of SCH-23390 on food intake. Further support for this Dl-type 
agonist effect on intake comes from a more recent study by Clifton (1995). 
Findings from this study show that SCH-39166 produces no anorectic effect at 
doses which severely disrupt water intake. 
D2-type agonists 
Again using a meal pattern analysis, Clifton et al., (1989) obtained a 
biphasic dose-response profile for the effects of N-0437 on feeding. At 0.3 mg/kg 
i.p. food intake was enhanced whereas 1.0 and 3.0 (mg/kg i.p.) significantly 
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reduced intake. Meal size was most profoundly decreased although meal duration 
increased at the lowest dose. These results reflect other observations of low dose 
hyperphagia induce by D2 agonists in other feeding paradigms (see Section 2.8). 
D2-type antagonists 
Clifton et al. (1991) used several D2-type antagonists to show that in 
general, mean meal bout duration, in addition to meal size increased after the 
administration of YM 09151-2, remoxipride and raclopride. This effect was 
significant for all but raclopride. However, in the short term, both raclopride and 
remoxipride increased food intake. Notwithstanding such differences, all the re -
type antagonists significantly slowed eating rate. Haloperidol has been shown to 
produce concordant results (Clifton, 1995). This result contrasts with the central 
administration paradigm in that eating rate was not affected by striatal infusion of 
haloperidol (Bakshi and Kelley, 1991). 
These results have specific clinical significance as obesity is associated with 
typical neuroleptics when used as treatment for schizophrenia (Stanton, 1995). 
Atypical neuroleptics, such as clozapine and olanzapine, are preferred for clinical 
use owing to their negligible cataleptic effects. Unlike classical neuroleptics, these 
atypical neuroleptics do not exert their effects exclusively through their action at D2 
receptors. When effects on meal patterning were compared, classical, but not 
atypical neuroleptics enhanced meal-size in free-feeding rats (Lee and Clifton, 
1998). Such dissociations have been attributed to actions of atypical neuroleptics at 
alternative dopamine receptor subtype populations (Sanger et al., 1993). 
Central mechanisms of effects of dopaminergic compounds on meal patterning? 
As mentioned above, Bakshi and Kelley (1991) saw no effect on feeding 
rate over a 30 min test session after infusion of the D2 antagonist haloperidol into 
three striatal subregjons, one of which was the nucleus accumbens. Clifton and 
Somerville (1994) examined the effects of electrolytic lesions of the nucleus 
accumbens which had no obvious effect on body weight or on the short term intake 
of solid food, sucrose and salt solutions. However, when recording of feeding and 
drinking was extended to 24hr periods, it became apparent that lesioned animals 
took many more meals of shorter duration and yet feeding rate within meals was not 
affected. These data highlights the importance of duration of test when trying to 
elucidate the neural mechanisms that underly the short- and long-term temporal 
structure of motivated behaviour. 
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Isolating components of ingestive behaviour 
-test duration 
There is a problem of interpretation in the study of ingestive behaviour 
which is most apparent (but by no means exclusive to) those studies using volume 
of intake as their dependent variable. Inherent in the design of such tests as the one 
and two bottle intake tests, is the need for a relatively long test duration (Grill et al., 
1987). Tests of relatively long duration usually give rise to a greater cumulative 
intake, which in turn is likely to limit fluid intake. These effects, which appear over 
time, are no longer directly attributable to the effects of taste as they eminate from 
outside the oral cavity and are attributed to what are collectively named postingestive 
stimuli. Therefore, no matter how carefully the parameter of taste has been 
systematically varied, for instance by increasing sucrose concentration, there 
remains the probability that nongustatory (i.e. postingestive) factors also contribute 
to the results from these tests. More concisely, taste is but one of the dimensions 
along which solutions vary. Other dimensions are those such as caloric value or 
osmotic and mechanical impact 
An example of this can be seen in a study by Spector and Smith (1984) 
which shows that, over 24hr, rats' daily total intake of a sucrose solution increases 
with concentration up to a peak value at about 0.3M at which point the relationship 
between concentration and intake essentially reverses producing decreases in intake 
following further increases in sucrose concentration. They attribute this inverted U 
shape dose-response curve to the influence of postingestive stimuli. The prior 
dietary experience of the animal along with its motivational state can also influence 
the results from such tests (Davis and Levine, 1977). 
One way to reduce postingestive stimuli is to reduce the duration of the 
intake tests (Grill and Berridge, 1985) therefore more effectively minimising the 
effects of such stimuli and consequently increasing the interpretive strength of the 
test with respect to taste (Grill et al., 1987). An example of the effects of sucrose 
concentration on intake in a short term test comes from Davis (1973). In contrast to 
the relationsnip between sucrose concentration and intake in the longer test of 
Spector and Smith, Davis (1973) revealed that if the test session is very brief (i.e. < 
60 sees) total sucrose intake is a monotonically rising function of sucrose 
concentration. The same seems to be true of data collected during early portions of 
longer term drinking tests (i.e. Sclafani and Xenekis, 1987). 
89 
Chapter 2 
However, reducing test duration is not the only method which has been 
adopted in trying to isolate variables which may control ingestion. The following 
section will discuss conceptual considerations and empirical data which has been 
collected using in response to the identification of confounds in food reward 
research. 
The sham-feeding preparation 
The effects of dopamine agonists and antagonist on sham-intake 
The advantage of sham-feeding is that it eliminates or minimises the post-
ingestive satiating effects of sucrose and other stimuli. Therefore, the confound of 
the post-ingestive satiating effects of food interacting with dopamine antagonists 
that has been observed in some of the early lever-pressing and free-feeding 
experiments is effectively eliminated. When post-ingestive or satiating effects were 
abolished through gastric fistulation, sham feeding also eliminated the decrease in 
intake observed with sucrose solutions more concentrated than 10% (Mook, 1963; 
Sclafani and Nissenbaum, 1985; Weingarten and Watson, 1982). Thus, when rats 
sham-fed sucrose, there was a sigmoid-shaped relationship between sucrose 
concentration and 30-min intake (Bernz et al., 1983; Joyneretal., 1985). 
Furthermore, most concentrations elicited intake throughout the test session; thus 
any termination of intake within a test becomes significant (Smith, 1996). For these 
reasons, sham-feeding of sucrose is a sensitive assay for evaluating the 
hypothesised effect of dopamine antagonists to decrease the response-maintaining 
effect of food on ingestion. Hence, the application of this paradigm to drug studies 
can reveal much as to the neural controls of ingestion. 
Dopamine D l agonists 
There is only one sham-feeding study which makes use of D l agonists in 
order to examine their effects on the control of ingestion. It shows that SKF 38393 
inhibits sucrose sham-feeding in gastric Fistulated rats (Cooper et al, 1993), as does 
the ergoline D l agonist CY 208-243. 
Dopamine D l antagonists 
Schneider et al (1988) demonstrated that the Dl antagonist SCH-23390 
inhibited sucrose sham feeding although its effects on corn-oil sham feeding were 
much weaker (Weatherford et al 1990). In this experiment no dose of SCH-23390 
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that did not produce obvious motor impairment, decreased the sham intake of 100% 
corn oil. These authors use another macronulrient solution in order to extrapolate 
their previous findings for sucrose. They allowed their sham-prepared animals 
access to corn oil as well as sucrose and discuss their results in terms of dopamine 
receptor subtype contributions to the mediation of the positive reinforcing effects of 
the orosensory stimulation produced by these different stimuli. They found that the 
inhibitory potency of SCH-23390 is inversely related to the hedonic potency of 
100% corn oil and 6 and 10% sucrose as measured by 2-bottle prefernce tests. 
Dopamine D2 agonists 
Despite reducing intake in real feeding situations, the D2-type agonist N-
0437 does not terminate sucrose sham-feeding, even though it reduces sucrose 
intake by non-fistulated rats (Cooper etal., 1989). Rusk and Cooper (1989b) 
suggest that N-0437 may only reduce intake in the presence of normal satiety cues. 
This profile of results in the sham-feeding preparation is in stark contrast to the 
actions of D l type agonists in this preparation which produce strong dose-
dependent reductions in intake (Cooper et al., 1993). 
Dopamine D2 antagonists 
Pimozide has been shown to reduce sham-feeding of both saccharin and 
saccharin-sucrose solutions (Geary and Smith, 1985). Schneider et al. (1986) 
linked the inhibitory potencies of four D2-type antagonists to their binding potencies 
at central D2 receptors. Central mediation of effects on sham-feeding have been 
verified by the administration of domperidone. This D2-type antagonist is excluded 
form the central nervous system and fails to reproduce the effects on feeding seen 
after the administration of pimozide (Duong and Weingarten, 1993). Along with a 
Dl-type antagonist Weatherford et al., (1990) compared a the effects of a D2-
antagonist raclopride on the sham feeding of sucrose and corn oil. Raclopride 
unlike SCH- 23390 did not only produce a decrease in sham-feeding which was 
secondary to a noticeable motoric deficit but did so at doses which did not produce 
motoric effects. They are conservative in their interpretation of these effects as they 
did not completely control for differences in the absolute hedonic potencies of the 
stimuli used. Therefore it is difficult to reinforce any discrete functional 
dissociations which may exist for D-l-type and D2-type in food reward 
(Waddington, 1989). 
91 
Chapter 2 
Roitman et al. (1997) determined that dopamine D2 antagonists haloperidol 
and raclopride also suppressed sham-drinking of NaCl solutions in the rat Sodium 
ingestion in rats depleted of Na is a strong motivated behaviour that is enhanced 
further when depleted rats are sham-drinking. This suppression of sham drinking 
by D2-like antagonists was observed in the absence of any effect on real drinking of 
NaCI solutions. This led the authors to the conjecture that the positive motivating 
properties of NaCl stimulation in depleted, sham-drinking rats are mediated by 
central D2 receptors. 
Oral Infusion Methods 
When compared to intake tests, the benefits of the use of oral infusion 
methods lie in their brevity, and their elimination of the problem of stimulus 
sampling (e.g. when using an aversive taste stimulus). With such brief and direct 
methods there is no need to ensure stimulus sampling in the form of water 
deprivation or training with highly preferred taste stimuli (Grill et al., 1987). 
Rather, responses to a wide variety of tastants can be measured immediately (within 
seconds) without the need for animals to voluntarily initiate contact with the tastant. 
As well as ensuring stimulus sampling, this advantage is most apparent when 
assessing the role of taste in the ingestive behavior for a variety of neurological 
preparations that do not eat or drink (e.g. aphagic, adipsic, neonatal) (Grill and 
Berridge, 1985). Other impediments to eating and drinking, such as a loss or lack 
of motor control after the administration of certain drugs, do not pose 
insurmountable problems for this method. Hence, this method would be most seem 
to be most useful in assessing the effects of dopaminergic compounds on initial 
hedonic responses to tastants. 
Intraoral intake tests 
In intraoral intake tests animals are fitted with an intraoral cannula, the 
intraoral end of which is placed just rostral to the first maxillary molar (Grill and 
Norgren, 1978 a,b). Tubing is led out subcutaneously to the skull and secured to a 
short piece of stainless steel tubing and anchored to the skull with dental acrylic 
(Grill, 1987). In this test, the surgery and habituation procedures used are the same 
as those for the taste reactivity test (for full details see Grill and Norgren, 1978a). 
On test days, the stimulus filled tubing is attatched to the rat's intraoral 
cannula and the rat is then placed in the test chamber. The delivery of the stimulus 
into the rat's mouth is controlled by an infusion pump and enters at a constant rate 
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(usually 0.5 to 1.0 ml/min). This rate of delivery was chosen as it was seen to be 
within the rat's capability to keep up with the accumulation of fluid in the oral cavity 
(Grill and Norgren, 1978 a,b). The test continues as long as the rat ingests the fluid 
stimulus. When fluid is seen to be expelled from the rat's mouth the pump is turned 
off. After a 30-sec pause the pump is turned back on. After this off-period the test 
only continues until two successive rejections of the stimulus occur. The volume 
ingested is computed by multiplying the infusion rate by the duration of ingestion. 
Again, as with the taste reactivity test, stimulus sampling is insured. In contrast to 
the taste reactivity test the oral infusion can be lengthy as the duration of the test is 
governed by the animal. This test procedure also makes use of a criterion for the 
temiination of ingestion. Therefore, it is possible to measure total intraoral intake 
but due to the potentially longer duration, interpretive caution is needed due to the 
possibility of the influence of postingestive signals (Grill, 1987). 
Recently, analogies have been made between intraoral infusion methods and 
spout-licking (Kaplan et al., 1995; Grill et al., 1996) inasmuch as rhythmic oral 
motor responses observed during intraoral infusions are organised in a burst/pause 
pattern and are emitted in the same frequency range and serve the function of 
intraoral transport of fluid into position for swallowing. This analogy indicates that 
there is potential value in analysing temporal patterns for various applications of the 
taste reactivity and intra-oral infusion paradigms. 
The effects of dopaminergic compounds on intraoral intake tests 
There are few studies which attempt to outline a role for dopamine receptor 
subtypes in the control of ingestion via an intraoral catheter. This is surprising as 
this paradigm eliminates the approach phase integral to the normal feeding situation, 
in favour of targeting consumption as the important dependent measurement. As 
has been mentioned, effects of dopaminergic compounds on feeding have often 
been interpreted as primarily motoric and so this method should be viewed as a 
highly appropriate paradigm in which to observe such effects. 
, Tyrka, Gayle and Smith (1992) compared the effects of raclopride on 
measures of independent ingestion (II) and also when animals were receiving 
sucrose via an oral catheter (OC). Pretreatment with raclopride resulted in 
decreased intake in the (II) tests but not in (OC) tests in rat pups. The authors 
conclude that this difference is due to raclopride decreasing the sensory control by 
sucrose of the appetitive behaviours required to maintain ingestion of sucrose 
during the (II) tests. As this function is effectively bypassed in the (OC) paradigm, 
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there is no reason to expect a decrease in intake after the administration of 
raclopride. Therefore, D2 receptor may be more involved in the appetitive phase of 
ingestion than the consummatory phase. 
The work above was conducted with rat pups in an effort to uncover some 
of the dopaminergic influences on unconditioned responding for sucrose. Any 
differences after dopaminergic drug treatment of rats without prior experience of test 
conditions or stimuli cannot be explained in terms of incentive motivation or any 
other forms of learning about sucrose reinforcement (Tyrka and Smith, 1993). 
In a further study, Tyrka and Smith (1993) compared the Dl-like antagonist 
SCH-23390 and the D2-like antagonist raclopride in the (OC) test They discovered 
thatSCH-23390 but not raclopride decreased intake of intraorally infuse 10% 
sucrose in adult rats. Tyrka and Smith infer from these, and oilier results that D l 
but not D2 receptors are necessary components of the neural network that processes 
the unconditioned gustatory stimulus of 10% sucrose into mouthing and 
swallowing movements that maintain ingestion. 
The taste reactivity test 
The taste reactivity test (Grill and Norgren, 1978), as its name implies, 
measures the initial oral motor behaviours resulting from the oral infusion of 
tastants. Brief oral infusions of taste stimuli elicit a number of discrete oral 
responses which can be easily identified and quantified and whose magnitude and 
distribution are taken to reflect differences in the discriminability and palatability of 
various taste stimuli. There are nine behaviours in the lexicon of taste reactivity 
responses which are categorised as either "ingestive" or "aversive" and are 
characterised by the removal (aversive) or acceptance (ingestive) of the taste 
stimulus from the oral cavity (see Grill and Berridge, 1985). 
The effects of dopaminergic compounds on the taste reactivity test 
The taste reactivity test has been used in conjunction with the administration 
of drugs which affect ingestive behaviour. As has been stated, drugs may achieve 
their anorectic effects by many central and peripheral mechanisms, therefore results 
from this paradigm can offer insight into whether a compound is changing the initial 
hedonic evaluation or palatability of a tastant. Many of the original conceptions of 
the role of dopamine in reward referred to the necessity of the integrity of 
dopaminergic systems for positive hedonic evaluation to take place. Since then, 
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dopamine has also been implicated in responding to aversive stimuli (see Section 
2.4). The suggestion that blocking dopamine reduces the subjective enjoyment of 
food reward would appear on the surface to be amenable to test with the taste 
reactivity paradigm. However, many taste reactivity studies have lead to the 
absolution of dopamine in the process of attributing relative reward values to 
positive (Treit and Berridge, 1989; 1990) and negative hedonic stimuli (Pecina and 
Berridge, 1998) and indeed is seen by some to play a separate role from systems 
which effectively mediate hedonic evaluation (see Section 2.11). For example, 
Berridge et al., (1989) found no evidence that sweet solutions became less 
palatable or mat bitter solutions became more aversive in animals with extensive 
damage to their brain dopamine systems, achieved by lesioning the nigrostriatal 
dopamine system with 6-OHDA. Even when dopamine was depleted by over 95% 
after combined lesions of the neostriatum and accumbens there did not appear to be 
any shift in the hedonic or aversive reaction patterns (Berridge and Robinson, in 
press, reported by Pecina and Berridge, 1998). Concordant with these findings are 
those of Treit and Berridge, (1990). They discovered that haloperidol pretreatment 
failed to reduce hedonic reactions or increase aversive reactions to a 1-min infusion 
of sucrose or quinine. 
In contrast, Leeb et al., (1991) found decreased sensitivity to sucrose in 
the same paradigm using pimozide (the D2-type antagonist) treated rats. These 
animals showed progressively less appetitive or ingestive tongue movements and 
progressively more neutral mouth movements both within (an extinction-like effect) 
and across (an apparent decrease in resistance to extinction) daily test sessions. 
Conversely, from the same research group, Parker and Lopez (1990) reported that 
pimozide enhanced aversive reactions to to a 2-min infusion of concentrated quinine 
solution. Combined, these results suggest that pimozide serves to makes palatable 
tastes less pleasant and to make noxious tastes more unpleasant 
More recently and consistent with their previous reports, Pecina and 
Berridge (1997) reported that they could discern sensorimotor effects of pimozide 
on taste reactivity but not for a hedonic shift in palatatrility. These conclusions were 
bolstered by the observation that changes in reactivity patterns induced by pimozide 
did not appear until several minutes after oral infusion began. They explain the 
previous discrepant results from the Parker laboratory on differences in procedural 
factors. It has been due to these and related results that have led Berridge (1996) to 
conclude that dopamine systems do not mediate hedonic or aversive palatability and 
that dopamine suppression does not produce a condition of anhedonia. 
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2.11 New conceptions of the role of dopamine in food reward 
Brain substrates of wanting and liking 
In terms of food reward Berridge (1996) has gone further to propose 
separable neural substrates of components of food reward. These components 
represent distinguishable psychological functions which have heretofore been 
masked by the umbrella construct of food reward. Reward can be separated into 
"liking" (pleasure/palatability) and "wanting" (appetite/incentive motivation). 
Berridge believes these can be manipulated and measured separately. Liking and 
Wanting seem to have separable neural substrates. Mediation of "wanting" related 
to food reward has been attributed to mesotelencephalic dopamine systems and 
divisions of the nucleus accumbens and the amygdala. These systems and 
structures are not construed as critical to the mediation of liking related to food 
reward (Berridge, 1996). Although elegant, this theory derives much of its data 
from a single paradigm; The taste reactivity Paradigm (Grill and Norgren, 1978) 
which allows the study of initial affective or hedonic reactions to food. However, 
the theory does not fully acknowledge the advances in pharmacological techniques 
which have disclosed evidence as to the functional and neuroanatomical 
heterogeneity of dopamine receptor subtypes (see Chapters 4, 5 and General 
Discussion). 
No role for dopamine in the ascription of relative reward? 
The contrast effect paradigm 
As has been made clear throughout the introduction, animals can assign 
different appetitive values to a stimulus as a function of their internal states at a) 
the time the stimulus is encountered and b) as a function of their experience with the 
stimulus (Dickinson and Balleine, 1994). An example of this point can be taken 
from the food reward literature where a given concentration of sucrose solution may 
lead to, an exaggerated increase or decrease in licking behaviour, depending upon 
the relative concentration of a previously presented sucrose solution. This 
exaggeration in responding is referred to as a contrast effect (Flaherty et al., 1982 
and see Chapter 7). Incentive relativity or contrast effects may occur in many 
different paradigms and take several forms (see Flaherty, 1996). 
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Most pertinent to the theme of the thesis is the phenomenon of successive 
contrast which can be either negative or positive. In the case of negative contrast, 
this phenomenon is expressed behaviourally as a decrement in goal-directed 
behaviour (i.e. licking or runway behaviour) in response to a reward downshift, 
when compared to unshifted controls. Such a decrement in behaviour is often 
accompanied by increases in activity and indicators of a stress reponse (i.e. 
corticosterone, see Flaherty, 1986). Although this phenomenon appears simple, it 
is more correctly viewed as a chain of consequential psychological processes, such 
that, in the first place, a sensory detection of reward change is necessary followed 
by the evaluative comparison of the current reward with the memory of past 
rewards. At the next stage, a search for the missing reward is employed if the new 
reward is valued less than the previous one. This stage is followed by a 
stress/emotional response if the original reward is not obtained and eventually, 
recovery from contrast ensues (Flaherty, 1996). Selective drugs may selectively 
affect a link in this chain and a role for dopamine cannot easily be ignored due to the 
apparent plurality of participation of this neurotransmitter in aspects of reward and 
reinforcement. 
Therefore, it is surprising that in the few studies which have attempted to 
influence contrast effects by blocking dopaminergic neurones with dopamine 
antagonists results have been negative, (Flaherty et al., 1992) and authors such as 
Flaherty have concluded that dopamine receptor blockers may affect the absolute but 
not the relative value of sucrose (but see Kentridge and Aggleton, 1993; Phillips 
and LePiane, 1986; Royall and Klemm, 1981 and Chapter 7). 
Summary 
^ It seems from the evidence above that there remain unanswered questions, at 
least with regard to the dopaminergic mediation of relative reward. Both Berridge 
and Flaherty see little noteworthy evidence to suggest that dopaminergic substrates 
are involved in the hedonic evaluation of stimuli but this is not a rigid conclusion as 
the work of Parker et al., (1990) illustrates. What gives a certain flexibility to the 
debaters an appreciation of the functional significance of the differences between 
dopamine receptor subtype populations in terms of anatomy, distribution and 
location. Flaherty, (1992), used antagonist compounds which were non-selective 
for dopamine receptor subtypes, hence, there is far more scope within such a 
paradigm to investigate the contribution of distinct receptor subtype populations to 
the mediation of incentive relativity. 
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2.12 Licking Microstructure: Models, methodology and applications 
It is clear from the preceding sections of this Chapter that it has become 
possible to go beyond total intake as the basic metric in food reward research. By 
virtue of the many technological and methodological advances in this area, it is now 
feasible to examine the components of ingestive behaviours of animals at a very 
detailed level. Collectively, these techniques are called the microstructural analysis 
of ingestive behaviour. In the case of licking behaviour the data recorded are the 
onset times of each lick made by the rat during the test session. These data are 
obtained from an electronic lickometer which connects to a computer interface 
where the data are collected during the test session and are stored for later analysis. 
For many years it has been appreciated that licking behaviour of rats 
ingesting a liquid diet consists of a series of rapidly occuring rhythmic tongue 
movements at a rate of 6-7 licks per second (Stellar and Hill, 1952). These licks 
occur in bursts and clusters of bursts (Davis and Levine, 1977; Davis, 1989), (see 
Figure 2.2) The size of bursts of licking was originally construed as number of 
licks that occur before a pause greater than 250msec occurs. The distribution of 
interlude intervals which fall into this range (constituting the within burst i l i 
distribution) are fairly invariable with a small standard deviation and have led 
researchers to conclude that this reflects the operation of a motor pattern generator 
which may be found in the hypoglossal nucleus (Wiesenfield et al 1977). The size 
of these bursts are typically 3- over 100 licks (Davis, 1989). 
These bursts of licking are separated by two types of pause each with its 
own characteristic frequency distribution and descriptive statistics (also see Section 
2.10). The first type is brief, generating an ILI in the range of 250-500 msec. 
These ILIs have a symmetrical distribution, with an average of about 330 msec and 
are collectively named interburst intervals (IBIs) (Davis and Levine, 1977; Davis, 
1989). Bursts which are separated by these types of pauses are combined by 
adding them together. Consequently, these groups of barely separated bursts may 
be called clusters. The second, longer types of pause separate these clusters and so 
are called (ICIs). These pauses are characterised by a skewed frequency 
distribution, ranging from 500msec to lOOsecs or more, with about half of them in 
the range of 0.5 to about 3 sec, (Davis and Levine, 1977; Davis, 1989). 
Lick data are assembled into bouts depending on the assumptions 
underlying the definition of a bout In early work, Davis and Levine, (1977) 
grouped licks into bursts (separating ILIs, </=250 ms) and clusters of bursts 
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(separating ILIs, </=500 ms) for the purposes of analysis. However, when the 
model was extended the primacy and utility of clusters in assessing palatability was 
highlighted (Davis and Smith, 1992). In the Experiments in this thesis we have 
chosen a value between the range of these ILI's as work from Morris and Cooper, 
(1993) has shown that an upper ILi specification of 400 ms as this interval was just 
longer than the break point in a log survivor plot of ILIs. 
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Figure 2.2 A schematic illustration of the temporal pattern of licking by a rat ingesting a 
liquid diet The vertical lines represent individual licks and the intervals between them are 
interlude intervals (ILIs). The horizontal lines define graphically the terminology used within 
this paradigm. 
Bursts are runs of licks separated by ILIs</= 250ms, Clusters are runs of licks separated by 
ILIs</= 500ms, Interburst intervals (IBIs) are the intervals between bursts (ILIs > 251ms and 
</=500ms), and Intercluster intervals are the intervals between clusters (ILIs > 500ms). 
Adapted from Davis and Levine, (1977) 
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A model for the control of ingestion: Predictions and validations 
In some cases the development of techniques which analyse ingestive 
behaviour at this level have been heavily influenced by models of the control of 
ingestive behaviour. One such model is that of Davis and Levine (1977) and has 
been developed more recently to accommodate a considerable corpus of empirical 
results on licking behaviour in several experimental contexts (Davis and Smith, 
1992). 
1) Predictions 
It has been demonstrated repeatedly that taste, postingestive feedback, 
physiological state and prior experience interact to influence the amount consumed 
during a meal. What remains unclear is the extent to which these variables exert 
their influence during a meal. Also, what are the neural mechanisms underlying the 
modulatory effects of these variables? Davis and Levine (1977) formalised these 
questions and devised a predictive model of the control of ingestion of 
carbohydrates under real-feeding conditions. Results from their studies into the 
control of ingestive behaviour highlight at least two variables which are important to 
such control. One variable is the orosensory information which is proposed have a 
stimulatory effect on ingestion while the otherjs post-ingestive information which 
counteracts this stimulation and reduces intake. The model makes appropriate 
predictions about how manipulation of these two variables should affect the rate of 
ingestion. 
The first prediction is that the initial rate of ingestion of a solution reflects 
the hedonic evaluation or palatability of that stimulus. Secondly, the model predicts 
that the rate of decline of licking over a period of time is a result of the development 
of a negative feedback signal arising from the postingestional cosequences of 
feeding. In an extension of their work, Davis and Smith (1992), have suggested 
that microstructural analysis of licking behaviour in rats may also provide relevant 
information concerning the precise role of orosensory and post-ingestive factors in 
influencing ingestive behaviour. 
Rate measurements 
However, before discussing these results it is necessary to clarify some of 
the major constructs of such models, such as the measurement of "rate". Many of 
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the references to licking or drinking rate are defined in part by the duration of tests 
used. 
The first type of measure is rate of consumption within a bout or the local 
rate of eating/drinking/licking. As has already been mentioned, the consummatory 
behaviour within these licking bouts is quite stereotyped A corollary of this is that 
the temporal separation of the onset of consecutive licks (or interiick interval), is 
relatively constant also. Hence, the local lick rate for each licking bout (which is the 
reciprocal of the interiick interval) is also relatively constant. In short-term 
experiments, local lick rate dose not seem to be influenced by the chemical nature of 
the stimulus fluid nor the physiological state of the animal (Davis, 1973). Even 
highly preferred mixtures (i.e. 3% glucose and 0.125% saccharin, for which it has 
been observed that, some rats drink amounts equal to their body weight during a 
24hr period) does not alter average interiick interval as compared to water (Smith et 
al., 1980). 
The second is the change in rate of licking over the test session (overall lick 
rate). This parameter can be influenced by the animal's physiological state (i.e. 
water deprivation) (Davis, 1973) and also by the chemical nature of the stimulus. 
Davis (1973) observed that overall licking rate increased monotonically with 
concentration when animals had access to sucrose, glucose and fructose solutions 
during 30s fluid presentations. If cumulative licking curves are derived, obtained by 
cumulating the number of licks in each successive minute during the test, they may 
be fitted by the least squares method to an exponential function. This provides an 
estimate of the initial rate of licking and of the rate of decline in the rate of licking 
(Breslin et al., 1996). This measure is often used in longer term tests as it offers 
the possibility of studying the interaction between orosensory stimulation and post-
ingesttve negative feedback which naturally occur during free-feeding situations. 
2) Validations 
In terms of validating the predictions for lick rate, there have been numerous 
experiments which have shown that initial lick rate increases as a function of 
increasing carbohydrate concentration (Davis, 1973; Davis and Smith, 1988). 
Conversely, an aversive stimulus such as quinine produces decreases in the initial 
lick rate, (Davis and Levine, 1977, Spector and St John, 1998). 
The prediction for the decline of lick rate as a consequence of post-ingestive 
negative feedback signals has also been validated. By adding mannitol to the test 
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solution, the experimenter effectively slows the rate of clearance of ingested 
substances from the stomach. This is a result of the slow absorption of mannitol 
from the intestine and so creates a "false satiety" situation. Following from the 
prediction, mannitol has a selective effect on the decline of the rate of licking within 
the test session whilst having no effect on the initial rate of licking (Davis and 
Levine, 1977; Davis, Smith and Kung, 1995). 
Other microstructural variables have been shown to reflect separable 
components and therefore have been incorporated into the model. For example, 
bout size (the number of consecutive licks before the criterion pause) has been 
suggested to reflect stimulus palatability (Davis and Smith, 1992; Davis and Perez, 
1993). This is necessarily seen in the measurement of mean bout duration as a 
function of increasing sucrose concentration (Davis and Smith, 1992). This 
contrasts with the relationship between the much used measure of total intake and 
concentration which varies non-monotonically according to an inverted u-shaped 
function. This function is thought to reflect the accumulation of ingested material in 
the gastrointestinal tract (Spector and Smith, 1984). Spector and St. John (1998) 
have shown that when quinine was the stimulus, the substantial decrease in intake 
was entirely a function of a decrease in lick volume and bout size. Contrary to the 
intake-suppressing effects of quinine, pause duration decreased and bout number 
increased. Therefore, it seems that a number of parameters can be usefully 
examined in the extraction of information concerning variables affecting intake. 
The generality of any principles derived from microstructural analyses of 
ingestive behaviour will ultimately depend on the number of different experimental 
contexts in which the licking data are collected. The more the predictions of a 
model are tested (using different macronutrient solutions) the more support may be 
mustered for the underlying theoretical assumptions. Therefore, there have been 
several experiments Which have attempted to investigate whether the principles of 
the Davis and Levine model apply when the test stimulus is not a prototypical test 
solution such as sucrose. 
, For example, Davis, (1996), compared the results of a microstructural 
analysis when the test stimulus was Polycose (a complex mixture of mono-, di- and 
polysaccharides) to other mono- and disaccharides (such as sucrose). Both initial 
rate of licking and bout size were increasing linear functions of the concentration of 
Polycose. Similar results have been found with a fat emulsion, Intralipid (Higgs 
and Cooper, 1996) and the non-sweet tasting polysaccharide Maltodextrin (Higgs 
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and Cooper, 1998). However, Davis (1995) failed to find a similar result with 
increasing concentrations of corn oil. 
Breslin et al. (1996) used the non-nutritive sweetener, saccharin, to 
determine whether orosensory stimulation contributed to the magnitude of the 
negative feedback signal during ingestion. Saccharin concentration was varied and 
each concentration was added to a standard 0.2M glucose solution. Initial rate of 
licking increased monotonically over the saccharin concentration range while 
estimates of the rate of decline of the rate of licking ramained constant over the test 
session. They concluded that there was no evidence for a orosensory contribution 
to the decline in the rate of licking. This further validates the discretion of the two 
separate variables, orosensory stimulation and post-ingestive inhibition, which are 
thought to exert control over feeding. 
Microstructural analysis of drug effects on licking behaviour 
The analysis of the temporal distribution of rhythmic tongue movements 
provides a behavioural description of the activity of the motor system which 
controls the ingestion of liquids. Variations in the characteristics of this distribution 
induced by experimental manipulations, such^s drug treatment, provide a way of 
analysing how the drug influences the physiological and neurophysiological 
mechanisms that control this motor system (Davis, 1989; Davis and Smith, 1992; 
Asin et al., 1992). Therefore, not only does that model presented above make 
strong predictions about the variables which might control ingestive responses, but 
it can also elucidate more about possible motor disruptions thought to be induced by 
certain drug treatments. 
Several drug studies have shown that there may be neural substrates which 
are particularly responsible for aspects of the control of ingestion. For example, 
drug effects on sham-feeding led to speculation that CCK and bombesin may be 
involved in the post-ingestive satiating effects of foods (Gibbs, Geary and Smith, 
1993; Smith and Gibbs; 1992). This prediction was validated by microstructural 
analysis (Stratford, Gibbs and Smith, 1995) which revealed that Bombesin and/ or 
gastrin releasing peptide decreased intake by decreasing the rate of decay of 
lickingand decreasing the number of bouts without changing the initial rate of 
licking or the size of the bouts. In accordance with the hypothesis that drugs which 
act at benzodiazepine receptors achieve their appetite stimulant effects through an 
enhancement of palatability (Berridge and Pecina, 1995; Cooper and Higgs, 1996), 
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Higgs and Cooper, (1997) have shown that drugs which act as agonists at 
benzodiazepine receptors actually increase initial rate of licking and also increase 
mean bout duration in a fashion similar to that observed with increasing 
concentration. 
Effects of dopaminergic drugs on the microstructure of licking behaviour Can we 
exclude a motor deficit for licking? 
There are few studies which have employed the microstructural 
methodology to study the effects of dopamine receptor subtype blockade or 
stimulation on components of ingestive behaviour. The first, (Schneider et al., 
1990), used raclopride a dopamine D2 antagonist to investigate whether decreases 
in intake of sucrose solutions and water in sham-feeding tests could be ascribed to: 
i) a decrease in the positive reinforcing effect of sucrose or ii) to an impairment of 
licking movements. Raclopride-treated sham-feeding rats decrease their intake of 
sucrose solutions in the same manner as animals given a sucrose solution of 
reduced concentration. Schneider et al. (1990) point to their measures of average 
interlick interval (hence intrabout lick rate) in both groups: they interpret this 
measure as a reflection of motor capability and have clearly shown that average 
interlick interval is perfectly normal in both the neuroleptic-treated and reduced 
concentrations conditions. Indeed, Davis andJSmith (1992) validated this measure 
by manipulating the accessibility of the spout and found that when an animal had to 
extend its tongue further to make contact with the tube there was a negative 
relationship with the intrabout lick rate. 
The results of Schneider et al., (1990) are echoed in the work of 
Weatherford et al. (1990). These authors failed to find a difference in intrabout lick 
rate in neuroleptic-treated and normal rats. Therefore, motor deficit for licking does 
not seem to be "sufficient to explain the observed patterns of deteriorating 
commerce with rewarding stimuli", (Wise, 1994, pp.250). This work also reflects 
results from a number of tests on free feeding which suggest that neuroleptics have 
effects on the drinking of sweet solutions that parallel the effects of reward-dilution 
(Bailey et.aL, 1986; Geary and Smith, 1985; Schneider etal., 1986 a,b; 
Weatherford et al., 1990; Xenakis and Sclafani, 1981,1982). 
As has already been mentioned, the specification of a motor deficit in 
response to neuroleptics relies heavily on the doses used: high doses of dopamine 
antagonists are capable of causing significant motor deficits. There are however, 
paradigms which have revealed that the threshold doses for "reward" deficits seem 
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to be well below those for motor deficits. One such method; Reward summation 
function analysis was adapted from the curve shift paradigm of Edmonds and 
Gallistel (1974; see Chapter 2). In common with the curve shift paradigm, changes 
of the reinforcer response function on the horizontal axis are considered reward 
effects and changes on the vertical axis are considered motor effects. They 
observed that the D2-type antagonist pimozide reduced the reward value of sucrose 
without impairing response capacity (Bailey et al., 1986). 
Nevertheless, a study by Asin et al. (1992) showed that the catecholamine 
agonists amphetamine and phenylpropanoline reduced intake primarily by reducing 
the number of bouts without affecting their size "suggesting a fractionation of the 
normal pattern of ingestion" (Asin et al., 1992, pp. 415). Therefore, the results 
did not represent an effect on the palatability of solutions per se. These researchers 
relied upon motor hypothesis to explain their results. 
Among the many experiments which have tried to dissociate dopamine's 
involvement in motor versus motivational aspects of behaviour are those which 
have equated the response deficits apparent in operant situations (forelimb response 
force and duration) with those which are specific for licking (tongue extensions and 
lick durations). Original studies by Gramling and Fowler, (1984) showed a deficit 
in orolingual competence which was expressed^ the inability of animals to reach 
fluid cups with their tongues after neuroleptic treatment. Rather than significantly 
slowing lick rate, neuroleptics influenced animals' licking behaviour so that they 
appeared only to make contact with the sucrose on approximately every other lick. 
Drugs can now be studied in a task emphasising the fine motor details of 
rats' tongue movements during licking behaviour. Rats are allowed to lap drops of 
tap water from a force sensing disk. From this behaviour, at least four variables 
were derived: peak-force of tongue strikes; duration of tongue contact, number of 
separate tongue contacts in 2 min and the rhythm of the lapping behaviour as 
quantified by Fourier analysis (Fowler and Mortell, 1992). 
^ Using this lingual motor task, Fowler et al. (1986, 1989, 1990) showed 
that subcataleptic doses of D2-like antagonist haloperidol produced disruption of 
forelimb response force and duration in an operant task while, at the same doses, 
decreasing number of licks, force of tongue protrusion and lick duration while 
increasing average interlick interval. 
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Davis and Smith (1992) have showed showed clearly that the mechanisms 
that control the cycles of extension and retraction of the tongue is influenced by 
sensory feedback and that these mechanisms can be influenced by experimental 
manipulations such as varying the accessibility of the drinking spout. In the same 
way, Fowler and Mortell (1992) note that while lick force was modulated by water 
drop delivery, this effect was not influenced by haloperidol and therefore suggests 
that there was no interference of the drug on sensory regulation of licking. 
Studying a number of atypical neuroleptics, compounds which have been 
praised for their lack of encumbant extrapyramidal side effects, Fowler and 
colleagues have been able to compare the effects of these clinically efficacious 
compounds to the more traditional neuroleptics such as haloperidol. Lick rhythm 
was^ the dependent variable that most clearly distingushed haloperidol from 
clozapine (Fowler and Das, 1994): haloperidol had little effect on lick rhythm 
whilst clozapine reduced lick-rhythm in a dose-dependent manner (Das and Fowler, 
1995). Also, within-session decrements in behaviour previously reported for 
haloperidol in the lick task were not produced by either clozapine or olanzapine (Das 
and Fowler, 1996) further driving the conceptual wedge between typical and 
atypical antipsychotics. 
Summary 
It is clear from the literature that it is both conceptually and empirically 
important to investigate the neural substrate for dopamine agonist and antagonist-
induced changes in feeding behaviour. Evidence from many feeding paradigms; not 
least the microstructural methodology and taste reactivity test have been 
inconclusive. This is especially apparent in terms of a precise role for dopamine in 
motivational rather than exclusively motor apsects of behaviour. A specific role for 
dopamine receptor subtypes in licking behaviour has not yet been well established. 
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2.13 Aims of the thesis 
As has been made clear throughout the introduction, both dopamine agonists 
and antagonists reduce the ingestion of several foods. What remains unclear is the 
specific way in which such compounds achieve these effects. The primary aims of 
this thesis are to compare a selection of drugs selective for dopamine receptor 
subtypes (both within and between pharmacological "super-families") on their 
ability to affect feeding parameters. By coupling pharmacological manipulation 
with the examination of licking behaviour at a very detailed level, it is possible to 
uncover some of the bases of the neural controls of ingestive behaviour. Further, 
extant models of the control of ingestion offer the possibilty of formulating 
hypotheses as to the effects of dopamine agonists and antagonists on particular 
licking parameters. Microstructural analysis of licking can therefore provide 
detailed information as to the components of ingestive behaviour which may be 
affected by these dopaminergic compounds. 
The experiments reported in Chapter 4 (Experiments 1,2 and 3) used 
microstructural analysis to examine whether a putative dopamine D3 receptor 
agonist, 7-OH-DPAT , a mixed D2/D3 receptor agonist, quinpirole and a D2 
receptor antagonist, raclopride would differ injterms of the behavioural expression 
of anorexia in a 20-min test session. A further aim of the studies in Chapter 1 was 
to clarify whether these decreases in ingestive responses were due to decreases in 
licking parameters which most robustly reflect hedonic evaluation or palatability 
(i.e. mean bout duration and initial rate of licking). 
Chapter 5 (Experiments 4,5 and 6) formed a set of follow-up experiments 
to Chapter 1. The main aims of this set of experiments were firstly, to further 
compare a D l antagonist (SCH- 23390) to the D3 receptor agonist 7-OH-DPAT and 
the D2 receptor antagonist raclopride in the microstructural paradigm using brief 
contact tests. The test session was shortened in order to increase its interpretive 
strength with regards to palatability. Secondly, an additional tastant was used in the 
form of Intralipid in order to further generalise the principles of the control of 
ingestion (Davis and Levine, 1977) to other macronutrient solutions. Finally, 
motoric effects of the compounds used in these experiments were considered and 
measures were taken in order to assess these (i.e. average interlick interval and 
intrabout lick rate). 
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The sixth chapter comprises a set of experiments (Experiments 7,8 and 9) 
which aimed to test the pharmacological specificity of the effects of the D3 receptor 
agonist 7-OH-DPAT on licking parameters using microstructural analysis. In 
experiment 7, two doses of the selective D3 receptor agonist PNU 99194A were 
used, and in Experiment 8, low doses of the benzamide derivative amisulpride, 
were used to attempt to abolish the effects of 7-OH-DPAT on licking parameters. 
The results of Experiment 8 suggested a hyperphagic effect of higher doses of 
amisulpride. Therefore, a longer test (20-min) was used to test this prediction in 
drug-naive rats. 
Chapter 7 contains one experiment (Experiment 9), the aims of which are 
related to the results from several preceding chapters (Experiments 1,4,7 and 8). 
The D3 receptor agonist 7-OH-DPAT seemed to be decreasing mean bout duration 
in both experimental contexts (short and long test sessions). This result can be 
interpreted as an effect of this compound on the palatability of solutions available to 
the animal. Therefore, 7-OH-DPAT may be seen to be affecting the initial hedonic 
evaluation of the stimulus. Hence, a contrast effect paradigm was used in order to 
further assess the ability of 7-OH-DPAT to affect the ascription of relative rather 
than absolute reinforcer value to a stimulus. 
The general aims of this thesis are to father outline a role for dopamine 
receptor subtypes in the mediation of ingestive behaviour and to present new 
evidence concerning the behavioural effects of the D3 receptor agonist 7-OH-DPAT 
in comparison to more traditional dopamine receptor agonists and antagonists. 
Further, the empirical evidence gathered for mis thesis will be discussed in the light 
of contemporary theory in food reward research in order to assess the theoretical 
contribution of the experiments presented herein. 
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Chapter 3: General methods 
3.1 Animals 
The animals used in all of the experiments were adult male hooded Lister 
rats supplied by Charles River (Margate, UK). The body weights of animals at the 
time of testing were in the range 350-500g. Laboratory food pellets (SDS RMI (E), 
Essex,U.K.) were available for all animals on an ad libitum schedule, unless 
otherwise stated in particular experimental procedures. They also had access to 
water at all times. Animals were housed in pairs in plastic and metal cages and 
were tested in the experimental apparatus described below, to which they had been 
familiarised. Animals were maintained on a 12h light 12h dark cycle with tights on 
at 08.00h. Testing always took place between 09.00h and 18.00h (light phase). 
All experiments were carried out in the Life Sciences Support Unit, Durham 
University. 
Caveat 
The experiments contained in Chapters 4,5 and 6 employ experimental 
designs which necessitate the re-use of animals for different drug doses 
(Experiments 1-6) or for different drugs (Experiments 7-9). This practice represents 
a conventional compromise in the field of behavioural pharmacology, whereby it is 
not unusual to re-use animals when training of animals is time-consuming and/or if 
the number of animals needed to avoid repeated drug administration becomes 
prohibitively great. The re-use of animals involves leaving a minimum period of 48 
hr to allow the drug to be "washed-out" of the animal. However, the use of a 
wash-out period does not exclude the possibility of the development of tolerance or 
sensitisation to the drug. However, there is no evidence from this laboratory or 
from Professor Cooper's laboratory in Birmingham that baseline ingestive 
behaviour is altered and/or that drug-induced responses are diminished or enhanced 
by repeated drug treatments or repeated presentations of stimuli such as sucrose. 
3.2 Drugs: Preparation and administration 
Dopamine receptor agonists 
(+-)7-OH-DPAT (7-hydroxy-2-(di-n -propylamino)tetralin) (Research 
Biochemicals International, UK and Sigma-Aldrich Co. Ltd, U.K.). 7-OH-DPAT 
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is a mixed dopamine D2/D3 receptor agonist which was dissolved in saline and 
injected (i.p.) 20 minutes before the start of testing. Details of preparation and 
administration, as well as an injection-test period of 20 minutes were chosen as 
previous work has shown this to be adequate time for a drug effect on intake to 
become apparent (Sokoloff, 1990; Sanger et al., 1993). 
(-)-Quinpirole HC1 (LY 171555) (Research Biochemicals International, 
UK) Quinpirole is also a mixed dopamine D2/D3 receptor agonist which was 
dissolved in distilled water and injected (s.c.) 20 min before the start of testing. 
Doses of quinpirole, injection-test times and route of administration were chosen 
based on previous feeding studies with this compound (Zarrindast et al., 1991; 
Cooper and Al-Naser, 1993). 
Dopamine receptor antagonists 
S(-)-Raclopride L-tartrate (Research Biochemicals International, UK). 
Raclopride is a dopamine D2 receptor antagonist which was dissolved in saline and 
injected (i.p.) 20 minutes before the start of testing. Doses of raclopride and 
injection-test time as well as route of administration were chosen on the basis of 
previous feeding studies (Phillips et al., 1991_a, b) and from results from 
Professor Cooper's Birmingham laboratory. 
R(+)-SCH-23390 ([R]-7-cMoro-8-hydroxy-23A5-tetrahydro-3-methyl-l-
phenyl-lH-3-benzazepine) (Research Biochemicals International, UK). SCH 
23390 is a dopamine D l receptor antagonist which was dissolved in sterile water 
and was injected (i.p.) 30 minutes before the start of testing. Injection-test time and 
route of administration were chosen on the basis of those used in previous studies 
(i.e. Gilbert and Cooper, 1985; Terry and Katz, 1992). Doses were chosen on the 
basis of previous studies on feeding and pilot studies conducted in our own 
laboratory. 
, PNU99194A (5,6^dimethoxy-2-(dipropulamine)indian-hydrochloride), 
was a gift from Dr. K. Svensson (Gothenburg, Sweden). PNU 99194A is a D3 
receptor antagonist which was dissolved in saline and injected (i.p.) 30 minutes 
before the start of testing. Injection-test times were chosen as these had previously 
been shown to be adequate for a behavioural response to take effect (Waters et al., 
1993). Choice of doses was limited as only a small amount of the drug was made 
available to our laboratory. 
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Amisulpride is a benzamide derivative and was a gift of Dr. David Sanger 
(Synthelabo, France). Amisulpride is a mixed dopamine D2/D3 receptor antagonist 
which was dissolved in ionised water with two drops of Tween (B.D.H Chemicals 
Ltd., Poole, UK) to aid suspension. This suspension was injected (i.p.) 60 
minutes before the start of testing. Doses of amisulpride were chosen on the basis 
of its ability to block 7-OH-DPAT in an operant paradigm (Sanger et al., 1997). 
The route of administration and injection-test period was taken from those reported 
by Sanger etal., (1997). 
In all cases, the injection volume was 1 ml/kg. 
" - It is of critical importance to note that the timing of drug injection-test is not 
an arbitrary matter, as the peak effect of a drug treatment can differ significantly 
depending on many physiological and pharmacological factors. Drug pretreatment 
times for the experiments presented in this thesis have been chosen on the basis of 
work from Professor Cooper's laboratory in Birmingham and also from reports 
cited above, wherein the time course of the behavioural effect of drugs used has 
previously been identified. These issues of the time course of drug actions are of 
particular importance when criterion test periods have theoretical implications (e.g. 
1 min and 20 min licking tests- see Chapter 2)_and therefore have a bearing on the 
interpretation of results. 
3.3 Test Apparatus and Data Collection 
\ In order to analyse licking behaviour, rats were trained to lick for fluids and 
the licks were individually logged and successive inter-lick intervals calculated 
There were two types of test which differ in their duration and the apparatus used: 
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Figure 3.1 The MS80 lickometer 
The brief contact tests (i.e. tests of 1-3 minutes) were carried out using the 
MS80 multistation lick analysis system (Dilog Instruments, Talahassee, Florida). 
Animals were placed in a perspex chamber which was approximately 16 cm wide, 
30 cm long and 20 cm tall. A perspex lid with four small ventilation holes secured 
the chamber. The floor was a stainless steel grid made up of thin metal bars spaced 
1 cm apart. An opening in the centre of the front face of the chamber allowed 
animals access to a drinking spout which was located 85mm from the grid floor of 
the chamber. The drinking spout was located 3mm behind the wall so that licking 
from the spout required a tongue protrusion through another small aperture. A 
motorised shutter could impede access, allowing drinking from the spout to be 
carefully controlled. This was to ensure the exclusive measurement of licks rather 
than contacts with the spout from paws or snout Bottles containing test fluids were 
mounted on a motorised metal platform allowing the experimenter to determine 
whether the platform should move backward or forward. This allowed any bottle to 
be positioned in front of the drinking slot for a time allotted by the experimenter and 
controlled by the computer via a reversible motor. The experimenter could also 
manipulate the order and duration of presentations as well as the interpresentation 
intervals. 
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The lickometer was connected to an amplifier that passed less than 60 nA 
through the rat when tongue contact was made with the drinking spout. This 
current was fed to a computer which stored the time of each lick to the nearest 
millisecond. Data from brief contact sessions were initially collated using the (MS 
80) (John D. Davis, Nyack, NY, U.S.A.) data collection program and analysis of 
the lick time data was performed using Dilog software (Ross Henderson, Dilog 
Instruments; Talahassee, FL, U.S.A., 1994) followed by further processing using 
a Microsoft Excel spreadsheet. 
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Figure 3.2 The contact 108 lickometer 
Tests of longer duration (i.e. 10-20 minutest took place in the Contact 108 
lickometer apparatus (John D. Davis, Nyack, NY, U.S.A.). As this piece of 
apparatus had eight testing stations or lickometer boxes it was possible to test up to 
8 animals simultaneously. The eight test chambers were modified home cages (i.e. 
plastic and metal cages) fitted at the front of the cage with a small aperture through 
which the animal had to protrude its tongue in order to access the drinking spout 
Stainless steel drinking spouts were attatched to plastic calibrated tubes (50ml) 
through rubber bungs. These tubes containing test solutions were put in place by 
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the experimenter at the beginning of each test session rather than using computer 
controlled presentation. Again, each tongue contact with the spout completed a 
circuit and was recorded as a lick to the nearest millisecond. 
Data recorded from the Contact 108 apparatus were first collated by the ILI8 
(John D. Davis, Nyack, NY, U.S.A.) data collection program. Licking rate data 
was analysed by a collection of programs (Quicklick, John D. Davis, Nyack, 
NY,1990), or Dilog software (Ross Henderson, Dilog Instruments; Talahassee, 
FL, U.S.A., 1994) followed by further processing using a Microsoft Excel 
spreadsheet program. The creation of these programs was based on observations 
and assumptions about the nature of the licking behaviour of the rat ingesting a 
liquid diet (see Davis and Smith, 1992). Further analysis was performed using the 
Feed6 analysis program (David Barton, 1996) and a Microsoft Excel spreadsheet 
program. 
3.4 Test fluids 
Sucrose solutions 
Sucrose solutions (granulated cane sugar, Tate and Lyle, London, U.K.) of 
varying concentrations (ranging between 1% and 32%) were made up 
weight/volume each day using tap water (during both training and testing). 
Intralipid emulsions 
Intralipid (Pharmacia; Milton Keynes, U.K.) was in the form of a 
commercially prepared 20% emulsion. This emulsion consists of fractionated soya 
bean qil, fractionated egg phospholipids, and glycerol. For a 20% solution it has a 
caloric value of 200 kcal per 100 ml. Several concentrations of Intralipid were made 
up by dilution with tap water (during both training and testing). 
3.5 Experimental design and statistical analysis 
Details of further statistical analysis and individual experimental designs are 
described in the Method sections of appropriate experimental Chapters, (i.e. 
Sections 4.2, 5.2, 6.2 and 7.2). 
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Chapter 4: Microstroctoral analysis of drinking for 
sucrose after the administration of 7-OH-DPAT, quinpirole 
and raclopride 
4.1 Introduction 
Results from preference tests have suggested that D-2 type antagonists such 
as pimozide reduce intake of sucrose solutions by decreasing the reinforcing 
potency of the solution without producing a motoric deficit (Bailey et al., 1986; 
Towell, 1987). However, alternative methodologies such as taste reactivity studies 
have revealed that the profile of initial responses to hedonic and aversive stimuli 
remain unchanged after the administration of several dopaminergic compounds 
(Treit and Berridge, 1990). In the light of such inconsistencies, considerable effort 
has been directed towards formulating hypotheses to explain neuroleptic-induced 
decreases in ingestion. In response to criticisms of total intake measures, many 
researchers have analysed the effects of dopaminergic drugs on components of 
ingestive behaviour. 
For example, it has been shown that dopamine receptor agonists and 
antagonists of the D-l and the D-2-type, reduce the ingestion of sweet solutions in 
gastric-fistulated rats (See Chapter 2). Therefore, it is inferred that the inhibition of 
sham intake is not due to the ability of dopamine receptor antagonists to increase the 
post-ingestive, negative feedback of the sucrose solutions. One hypothesis offers 
the possibility that dopaminergic compounds decrease the hedonic value or 
palatability of the stimulus (Smith, 1996). Another is that dopaminergic drugs 
induce motoric deficits which interfere with the ability to approach and/or consume 
accessible food sources (Salamone, 1992, 1994). 
An appropriate model with which to test these hypotheses is the taste 
reactivity paradigm (see Chapter 2). Taste reactivity studies purport to measure the 
initial affective reactions to tastants (i.e. their palatability) while circumscribing the 
problems of possible motor deficits which may be preventing animals from 
approaching a drinking spout Within this paradigm, a number of dopamine 
antagonist have been tested but results from such studies are far from consistent 
For example, Berridge et al. (1989) found no evidence that sweet solutions became 
less palatable or that bitter solutions became more aversive in animals with extensive 
damage to their brain dopamine systems, achieved by lesioning the nigrostriatal 
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dopamine system with 6-OHDA. Even when dopamine was depleted by over 95% 
after combined lesions of the neostriatum and accumbens there did not appear to be 
any shift in the hedonic or aversive reaction patterns (Berridge and Robinson, in 
press, reported by Pecina and Berridge, 1997). Drugs which block dopamine 
receptors produced a similar result. Treit and Berridge (1990) discovered that 
haloperidol pretreatment failed to reduce hedonic reactions or increase aversive 
reactions to a 1-min infusion of sucrose or quinine. 
In contrast, Leeb et al. (1991) found decreased sensitivity to sucrose in the 
same paradigm using pimozide (the D2-type antagonist) treated rats. Parker and 
Lopez (1990) reported that pimozide enhanced aversive reactions to a 2-min 
infusion of concentrated quinine solution. Combined, these results suggest that 
pimozide serves to makes palatable tastes less pleasant and to make noxious tastes 
more unpleasant. More recently and consistent with their previous reports, Pecina 
and Berridge (1997) reported that they could discern sensorimotor effects of 
pimozide on taste reactivity but they did not detect a hedonic shift in palatability.In 
the light of the conflicting results from taste reactivity studies, it is still unclear 
whether dopamine receptor subtypes have a specific contribution to make to the 
mediation of palatability. 
Alternative methodologies may be employed in order to assess the 
palatability of tastants. It is clear fom the Chapter, 2 that analysis of the rate and 
microstructure of ingestive behaviour may provide accurate "on-line" information 
concerning the factors responsible for controlling food and fluid intake (Davis and 
Levine, 1977; Davis and Smith, 1992). For example, manipulating concentration 
of ingested fluids produces quite specific effects on the rate and microstructure of 
licking for carbohydrates. The initial rate of licking and mean bout duration have 
been shown to vary monotonically with increasing concentration of carbohydrates 
(Davis et al., 1973; Davis and Levine, 1977; Davis and Smith, 1992), while the 
rate of decline of licking over the test session is thought to provide an estimate of 
the increasing influence of inhibitory post-ingestive behaviour (Davis et al., 1975; 
Davis and Levine, 1977). Therefore, microstructural analysis provides a 
comprehensive framework in which to study the effects of pharmacological 
compounds on several aspects of ingestive behaviour. 
There are few studies which have applied these microstructural techniques to 
the study of the effects of dopamine agonists and antagonists on the control of 
ingestive behaviour. There are some reports on the microstructure of feeding in 
response to a D2 agonist (i.e. quinpirole). A study by Al-Naser, (1993) revealed 
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that quinpirole reduced intake in much the same way as another D2 receptor agonist 
N-0437 by decreasing the local rate of eating which indicated a common 
mechanism of action for the two compounds. This result is, however, in contrast to 
that of Clifton et al. (1989) who found a biphasic effect of N-0437 without the 
significant reduction in local rate of eating (although eating rate was slightly 
reduced). 
Analysing the microstructure of licking, Asin et al. (1992) showed that the 
catecholamine agonists amphetamine and phenylpropanoline reduced intake 
primarily by reducing the number of bouts without affecting their size "suggesting a 
fractionation of the normal pattern of ingestion" (Asin et al., 1992, pp. 415). This 
investigation did not reveal an effect of dopaminergic drugs on the palatability of 
solutions per se. These researchers evinced a motor hypothesis in explaining their 
results and the similarities that were found between the effects of the two 
catecholaminergic drugs on licking behaviour were taken to reflect a common 
neurotransmitter mechanism. 
Employing the sham-feeding preparation and a more specific D2-type 
antagonist, Schneider et al. (1990) showed that when the intake of a 10% sucrose 
solution was reduced by pretreatment with raclopride to the intake of a 5% sucrose 
solution (without raclopride treatment) microslructural licking patterns and the rate 
of ticking observed under the two conditions were not significantly different 
Therefore, the behavioural effects of raclopride were equated with the effects 
produced by a sucrose solution of a lower concentration. Further confirmation of a 
reduction in hedonic potency comes from the analysis of microstructural variables 
such as mean bout duration. Raclopride and dilution of a sucrose solution by 50% 
produced comparable decreases in mean bout duration which can be interpreted as a 
decrease in palatability. A deficit in oromotor movements was excluded through 
analysis of licking rate under the two conditions. 
The results from Asin and Schneider go some way to highlighting the 
different behavioural effects on the same dependent variable which may be 
attributed to the mode of action of the drugs used. Thus, these studies highlight the 
importance of testing compounds which are selective for pharmacologically and 
neuroanatomically discrete dopamine receptor populations within the same 
paradigm. As the number of dopamine receptor subtypes has recently burgeoned 
(Sokoloff et al., 1990) and compounds which are specific for these subtypes have 
developed, it is possible to examine the contribution of these "new" receptor 
subtypes to the decrease in intake after the administration of both dopamine agonists 
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and antagonists. For example, much of what is known about the functional 
specificity of the D3 receptor has come from behavioural studies using 7-OH-
DPAT. Indeed, it is with this compound that the D3 receptor has become implicated 
in the control of ingestive responses (Gilbert and Cooper, 1995). 
However, there is much debate as to whether 7-OH-DPAT is acting at post-
synaptic D2 receptors, D3 autoreceptors or post-synaptic D3 receptors (see 
Chapters 1 and 2). Quinpirole, although traditionally labelled as being a D2 
selective agonist has recently been described as having affinity for the D3 receptor 
(Sokoloff et al., 1992). Therefore, one of the aims of this study was to determine 
whether the behavioural expression of the anorexia induced by dopamine based 
anorectics was the same or different depending upon the receptors they purport to 
stimulate (i.e. within the D2 family). Although raclopride has been studied using 
microstructural analysis (Schneider et al., 1990), the effects of quinpirole and 7-
OH-DPAT on ingestive responses have not been examined in such detail. 
Nevertheless, these compounds have been shown to decrease ingestive behaviour. 
(Inoueetal., 1992, Gilbert and Cooper, 1995). 
The aim of this study was to examine the similarity of effect on licking 
responses within this class of dopamine selective drugs. The prediction was that 
changes in microstructural variables induced by 7-OH-DPAT would be more 
similar to those induced by quinpirole than those induced by raclopride in this 
paradigm due to their similar modes of action (i.e. putative autoreceptor agonists vs. 
postsynaptic antagonist). The experiments reported in Chapter 1 are original 
studies of the effects of 7-OH-DPAT and quinpirole on licking microstructure 
(Experiments 1 and 2). The effects of raclopride on licking microstructure has 
already been conducted in other laboratories (Schneider et al., 1992) but is included 
in this chapter to serve as a comparison (Experiment 3). 
Due to the conflicting evidence from taste reactivity studies, an integral 
purpose of the study was to examine microstructural variables in order to clarify 
whether observed changes after dopaminergic drug administration reflected 
variation in those parameters which most robustly reflect palatability (initial rate of 
licking and mean bout duration), a change in the rate of decay of licking (reflecting 
satiation) or a fractionation of the normal ingestive response (as reflected in the 
number of bouts). 
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4.2 Method 
4.2.1 Animals 
Seventy two non-deprived adult male hooded Lister rats weighing 350-400g 
at the time of testing were used. They were housed and maintained as described in 
Chapter 3. These animals constituted three groups of 24 subjects per experiment: 
differing in the type of drug treatment which was administered before testing (i.e. 7-
OH-DPAT, quinpirole or raclopride). 
4.2.2 Drugs 
In Experiment 1,7-OH-DPAT (Research Biochemicals International, UK), 
was dissolved in saline and injected i.p., 20 min before testing. Doses of 7-OH-
DPAT were 0.1,0.3 and 1 mg/kg or its vehicle. For the purposes of Experiment 2, 
quinpirole (Research Biochemicals International, UK) was dissolved in distilled 
water and injected s.c, 20 min before the start of testing at doses of 0.03, 0.1 and 
0.3mg/kg or vehicle. In experiment 3, raclopride (Research Biochemicals 
International, UK), was dissolved in saline and injected i.p., 20 min before testing 
at doses of 0.03, 0.1 and 0.3mg/kg or vehicle. Al l details of drug preparation and 
administration for each drug can be found in Chapter 3. 
4.2.3 Test Fluids 
The three test solutions were 1,3 or 10% sucrose solutions made up as 
described in Chapter 3. Groups were trained and tested on one of the sucrose 
solutions. 
4.2.4 Apparatus 
Testing was carried out using the 108 multistation lickometer described in 
detail in Chapter 3. 
120 
Chapter 4 
4.2.5 Procedure 
Training 
Each group of twenty four animals used in each of the first three 
experiments were randomly allocated to groups of eight. The allocation was based 
on the concentration of sucrose to which the group had access during training and 
testing (i.e. either 1,3 or 10% sucrose). Each group was familiarised with the test 
apparatus and solutions for approximately 10 days or until baseline drinking levels 
were stable. Training consisted of 20-min access to the sucrose solution at the same 
time on each training day. Two days prior to testing animals received a sham 
injection of vehicle in order to familiarise them with the injection procedure. 
Testing 
Experiment 1: Microstructural analysis of drinking for sucrose after the 
administration of7-OH-DPAT: Analyses of licking during a 20-min session and 
during first minute of 20-min session. 
Following training, either 7-OH-DPAT (0.1, 0.3 and 1.0 mg/kg) or vehicle 
was administered i.p., 20-min before the rats were placed in the lickometer boxes 
where they had access to either 1, 3 or 10% sucrose solutions. Sucrose solutions 
were presented for a total test duration of 20-min. The study employed a mixed 
design with fluid concentration as the between-subjects variable and drug dose as 
the within-subjects variable. Injections were counterbalanced using a Latin Square 
design and there was a 48h time lapse between injections to avoid carry-over 
effects. 
Experiment 2: Microstructural analysis of drinking for sucrose after the 
administration ofquinpirole : Analyses of licking during a 20-min session and 
during first minute of 20-min session. 
Following training, either quinpirole in doses of 0.03, 0.1 and 0.3 mg/kg or 
vehicle was administered s.c, 20-min before the rats were placed in the lickometer 
boxes where they had access to either 1,3 or 10% sucrose solutions for a total of 
20-min. The design of the study and the injection procedures are as described for 
Experiment 1. 
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Experiment 3: Microstructural analysis of drinking for sucrose after the 
administration ofraclopride: Analyses of licking during a 20-min session and 
during first minute of 20-min session. 
Following training, either raclopride in doses of 0.03, 0.1 and 0.3 mg/kg or 
vehicle was administered i.p., 20-min before the rats were placed in the lickometer 
boxes where they had access to either 1,3 or 10% sucrose solutions for a total of 
20-min. The design of the study and the injection procedures are as described for 
Experiments 1 and 2. 
4.2.6 Design and statistical analysis 
Initial analysis of the lick time data was carried out using programs as 
outlined in Chapter 3. In Experiments 1,2 and 3 the change in lick rate across the 
session was also calculated and an exponential decay function of the form y = Ae (" 
B t ) was fitted by a least squares method to the rate of licking data from each 
experiment This was done using the Sigma Plot graphics programme (Jandel 
Corp. Rafael, CA, 1986). Other measures derived from the raw data included total 
intake (ml) and a number of microstructural variables: Number of licks, mean bout 
duration (s) and number of bouts. 
Experiments 1,2 and 3 each employed a mixed design with fluid 
concentration as the between-subjects variable and drug dose as the within-subjects 
variable. Therefore, intake measures and microstructural variables from each 
experiment were analysed using a two-way ANOVA with a between-subjects factor 
of concentration and a within-factor of drug dose. I f there was a statistical main 
effect of drug dose in the absence of a significant interaction between drug dose and 
fluid concentration, post hoc comparisons to determine any significant differences 
between doses and vehicle controls were made using Dunnet's t-test for each 
concentration. Statistical tests were performed using Super Anova and Statview 
SE+graphics (Abacus Concepts Increase., Berkeley, CA). A result was considered 
statistically significant i f p<0.05. 
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4.3 Results 
Experiment 1: Microstructural analysis of drinking for sucrose after the 
administration of7-OH-DPAT: Analyses of licking during a 20-min session 
and during first minute of 20-min session. 
a) for ful l 20 min test session 
Total intake 
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Figure 4.1 Intake of 1,3 and 10% sucrose in a 20-min test as a function of 
dose 7-OH-DPAT (0.1-1.0 mg/kg) + S.E.M. Asterisk indicates significantly 
different from vehicle control group * px 0.05; Plus indicates significantly 
different from vehicle control group + p< 0.01 (Dunnett's t-test). 
Figure 4.1 shows the mean intake of sucrose solutions as a function of 
drug dose. The volume consumed decreased significantly with drug dose 
giving a main effect of dose 7-OH-DPAT: (F 3 2 1 = 16.96, p<0.0001). There 
was also a significant effect of sucrose concentration: (F 2 2 1 = 3.91, p<0.05). 
However, there was not a significant interaction between drug dose and sucrose 
concentration: (F 6 a =1.62, n.s.). Post hoc tests revealed that the 0.1 mg/kg 
dose of 7-OH-DPAT significantly decreased intake of the 1% solution alone 
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whilst the supression of intake produced by the 0.3 mg/kg of 7-OH-DPAT was 
significantly different from control in groups drinking the 1 or 3% solutions. At 
the highest dose (1.0 mg/kg), 7-OH-DPAT significantly decreased intake of all 
sucrose solutions when compared to the control group. 
Rate of I ickinp 
350 
300 h 
8. 
o 
250 -
200 -
10 15 
time (min) 
Figure 4.2 The effect of dose 7-OH-DPAT (mg/kg) on the rate of licking 
(licks per min) for a 10% sucrose solution for a) vehicle and b) high dose 
conditions. The lines represent the least squares f i t of the function y=Ae (-Bt) to 
the data. Open circles (O) indicate the vehicle condition (0.0 mg/kg 7-OH-
DPAT) while open squares ( D ) indicate the high dose condition (1.0 mg/kg 7-
OH-DPAT). 
The effect of the highest dose 7-OH-DPAT (1.0 mg/kg) on the rate of 
licking (licks per minute) at one minute intervals can be seen in Figure 4.2. The 
rate of licking in the vehicle condition is compared to that of the high dose 
condition (1.0 mg/kg). An exponential decay function (y=Ae (-Bt)) was fitted to 
the data. The parameters derived from the curve fitting process are shown in 
Table 4.1. A Spearman correlation between the actual data and predicted data 
revealed that this exponential decay function provided a good description of the 
data (see Table 4.1). At the 1.0 mg/kg dose, 7-OH-DPAT profoundly affected 
the initial rate of licking (A), reducing the licks per minute by over 50%. In 
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contrast, 7-OH-DPAT had little effect on the rate constant (B) serving only to 
decrease it slightly. 
Table 4.1 Parameter estimates and standard errors for the least squares fit to 
the rate of licking of the function y=Ae (^t) . 
7-OH-DPAT sucrose A B r 
Dose 
(mg/kg) 
concentration 
(%) 
0 10 
estimate 374.52 0.14 0.955 
S.E. 18.52 0.01 
1 10 
estimate 142.13 0.12 0.904 
S.E. 13.94 0.012 
Parameters A and B refer to the intercept and rate constant respectively, r is the 
correlation coefficient resulting from the correlation of the actual and predicted 
values (Spearman correlation coefficient). 
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Microstructural Analysis 
Number of licks 
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Figure 4.3 a) Number of licks collapsed across sucrose concentration in a 
20-min test as a function of dose 7-OH-DPAT (0.1-1 mg/kg) + S.EM, 
b) Number of licks collapsed across doses 7-OH-DPAT in a 20-min test as a 
function of sucrose concentration (%) + S.E.M. 
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Figure 4.4 Number of licks for 1,3 and 10% sucrose in a 20-min test as a 
function of dose 7-OH-DPAT (0.1-1.0 mg/kg) + S.E.M. Asterisk indicates 
significantly different from vehicle control group * p< 0.05; Plus indicates 
significantly different from vehicle control group + p< 0.01 (Dunnett's t-test). 
There was a main effect of drug dose on total number of licks: (F 3 2 1 = 
12.04, p<0.0001) and also a main effect of concentration: (F 2 2 1 = 12.38, 
p<0.0005) (see Figures 4.3 a) and b) respectively). There was no significant 
interaction between dose and concentration: (F 6 6 3 = 1.75, n.s.). 7-OH-DPAT 
affected the total number of licks in response to differing sucrose solutions in 
much the same way as it affected total intake. As with mean intake, post hoc 
tests showed responses to the 1% solution to be most sensitive to drug treatment 
with all doses differing significantly from vehicle control. Only the medium 
dose of 7-OH-DPAT (0.3 mg/kg) affected those animals drinking the 3% 
solution compared to controls, while both medium (0.3 mg/kg) and high (1.0 
mg/kg) doses of 7-OH-DPAT differed significantly from control in those 
drinking the 10% solution. 
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Figure 4.5 Mean bout duration of licking for 1,3 and 10% sucrose in a 20-
min test as a function of dose 7-OH-DPAT (0.1-1.0 mg/kg) + S.E.M. Asterisk 
indicates significantly different from vehicle control group * p< 0.05; Plus 
indicates significantly different from vehicle control group + p< 0.01 (Dunnetfs 
t-test). 
Figure 4.5 shows that mean bout duration was significantly shortened as 
a function of drug dose. There was a main effect of drug dose: (F 3 2 1 = 22.57, 
p<0.0001) but not of concentration: (F 2 2 1 = 1.86, n.s.). There was no 
significant interaction between drug dose and sucrose concentration: (F 6 & = 
0.98, n.s.). Post-hoc tests showed that all doses of 7-OH-DPAT produced 
changes in mean bout duration that differed significantly from the vehicle 
control group when animals were drinking the 10% solution. For the 3% 
solution, significant differences from control are seen at the 0.3 and 1.0 mg/kg 
doses and for the 1% solution, the 0.1 and 1.0 mg/kg doses differ significantly 
from control. 
128 
Chapter 4 
Number of bouts 
200 
150 
i3 
E3 \% 
i | I 
rani 
• 100 3% 
T • 1 0 % 
T T 
1 
1 1 0 
00 0.1 03 1.0 
Dose 7-OH-DPAT (mg/kg) 
Figure 4.6 Mean licking bout frequency for 1,3 and 10% sucrose in a 20-
min test as a function of dose 7-OH-DPAT (0.1-1.0 mg/kg) + S.E.M. Asterisk 
indicates significantly different from vehicle control group * p< 0.05; Plus 
indicates significantly different from vehicle control group + p< 0.01 (Dunnett's 
t-test). 
As figure 4.6 shows, bout frequency generally increased as a function 
of dose of 7-OH-DPAT. There was a significant incremental effect of drug on 
mean bout frequency: (F 3 2 1 = 3.33, p<0.005) and also an effect of 
concentration following a similar pattern (F 2 2 1 = 4.73, p<0.005). Again, 
these two variables did not interact significantly: (F 6 & =1.02, n.s.). Only 
the highest dose of 7-OH-DPAT (1.0 mg/kg) produced a result which differed 
significantly from control and this was only in the case of the 3% group. 
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b) Microstructural analysis of data from the 1st nun of a 20-min test session 
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Figure 4.7 Number of licks for 1, 3 and 10% sucrose in the first minute of a 
20-min test as a function of dose 7-OH-DPAT (0.1-1.0 mg/kg) + S.E.M. 
Asterisk indicates significantly different from vehicle control group * p< 0.05; 
Plus indicates significantly different from vehicle control group + p< 0.01 
(Dunnett's t-test). 
Figure 4.7 shows that during the first minute of a 20-min test, the 
effects of 7-OH-DPAT on the number of licks produced are more clear cut than 
the effects of the drug over the full 20-min. In this portion of the test there is a 
monotonia relationship between drug dose and number of licks: (F 3 2 1 = 19.42, 
rxO.0001). There is also an overall effect of concentration: (F 2 2 , = 12.241, 
p<0.0005). There were no significant drug-concentration interactions: (F 6 M -
0.127, n.s.) In general, the 1.0 (mg/kg) dose of 7-OH-DPAT seems to be the 
most effective in decreasing number of licks at this stage of the test However, 
the 0.3 (mg/kg) dose has an early effect on all but one of the concentration 
groups (i.e. 1% and 3%). 
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Mean bout duration 
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Figure 4.8 Mean bout duration of licking for 1,3 and 10% sucrose in the 
first minute of a 20-min test as a function of dose 7-OH-DPAT (0.1-1.0 mg/kg) 
+ S.E.M. Asterisk indicates significantly different from vehicle control group * 
p< 0.05; Plus indicates significantly different from vehicle control group + p< 
0.01 (Dunnett'st-test). 
Mean bout duration is also decreased significantly in the 1st min of the 
20-min test There remains a significant drug effect ( F 3 2 , = 19.06, p<0.0001) 
yet as is true of the 20-min data, there is no main effect of concentration: (F 2 
2 1 = 1.633, n.s.) or any significant drug-concentration interactions: (F 6 a -
0.14, n.s.). The 0.3 and 1.0 mg/kg doses of 7-OH-DPAT shorten licking mean 
bout duration significantly compared to controls at all concentrations. This 
differs slightly from the mean bout duration measures over 20-mins. Post-hoc 
tests show the 0.1 (mg/kg) dose of 7-OH-DPAT differs significantly from 
controls when data from the whole test session is analysed (see Figure 4.8). 
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Figure 4.9 Mean bout frequency of licking for 1, 3 and 10% sucrose in the 
first minute of a 20-min test as a function of dose 7-OH-DPAT (0.1-1.0 mg/kg) 
+ S.E.M. 
Figure 4.9 shows that in the 1st min of the 20-min test session there was 
no main effect of drug on mean bout frequency: (F 3 2 1 = 1.46, n.s.). 
However, there was an effect of concentration: ( F i 2 1 = 7.02, jxO.005). There 
was no significant interaction of dose-concentration: (F 6 M = .611, n.s.). 
132 
Chapter 4 
Experiment 2: Microstructural analysis of drinking for sucrose after the 
administration ofquinpirole : Analyses of licking during a 20-min session and 
during first minute of 20-min session. 
a) for full 20 min test session 
Total intake 
15 
T 
1 
10 
E3 i% T T + 1 
a • : iji r; + ! : 
! L : 1 0 % ij j; 
: 
}':': 
I I 
1 r o r 
0.00 0.03 0.10 0.30 
Dose quinpirole (mg/kg) 
Figure 4.10 Intake of 1,3 and 10% sucrose in a 20-min test as a function of 
dose quinpirole (0.03-0.3 mg/kg) + S.E.M. Asterisk indicates significantly 
different from vehicle control group * p< 0.05; Plus indicates significantly different 
from vehicle control group + p< 0.01 (Dunnett's t-test). 
Figure 4.10 shows that mean intake sharply decreases as a function of 
increasing dose of quinpirole. Measures of intake are similar at the medium dose 
(0.1 mg/kg) and the high dose (0.3 mg/kg) of quinpirole. There is a significant 
main effect of drug dose: (F 3 2 1 = 22.734, p<0.0001) and of sucrose concentration 
(F 2 2 1 = 6.082, p<0.05). There was no significant drug-concentration interaction: 
(F 6 6 3 = 0.441, n.s.). The results of post hoc tests showed all doses to be 
significantly different from vehicle control groups at each sucrose concentration. 
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Figure 4.11 The effect of dose quinpirole (mg/kg) on the rate of licking (licks per 
min) for a 10% sucrose solution for a) vehicle and b) high dose conditions. The 
lines represent the least squares f i t of the function y=Ae (-Bt) to the data Open 
circles (O) indicate the vehicle condition (0.0 mg/kg quinpirole) while open squares 
( • ) indicate the high dose condition (0.3 mg/kg quinpirole). 
The effect of quinpirole on the rate of licking (licks per minute) at one 
minute intervals can be seen in figure 4.11. The rate of licking in the vehicle 
condition is compared to that of the high dose condition (0.3 mg/kg). An 
exponential decay function (y=Ae (-Bt)) was again fitted to the data. The parameters 
derived from the curve fitting process are shown in table 4.2. A Spearman 
correlation between the actual data and predicted data revealed that this exponential 
decay function provided a good description of the data (see table 4.2). At the 0.3 
mg/kg dose, quinpirole roughly halved the initial rate of licking (A). In contrast, as 
was found with the high dose (1.0 mg/kg) of 7-OH-DPAT, quinpirole (0.3 mg/kg) 
had little effect on the rate constant (B) producing a marginal attenuation of this 
parameter. 
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Table 4.2 Parameter estimates and standard errors for the least squares fit to the 
rate of licking of the function y=Ae (-Bt). 
quinpirole concentration A B r 
Dose 
(mg/kg) 
sucrose 
(%) 
0 10 
estimate 211.40 0.11 0.886 
S.E. 21.0 0.02 
0.3 10 
estimate 104.10 0.08 0.891 
S.E. 9.483 0.01 
Parameters A and B refer to the intercept and rate constant respectively, r is the 
correlation coefficient resulting from the correlation of the actual and predicted 
values (Spearman correlation coefficient). 
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Miqpstractural Analysis 
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Figure 4.12 Number of licks for 1,3 and 10% sucrose in a 20-min test as a 
function of dose quinpirole (0.03-0.3 mg/kg) + S.E.M. Asterisk indicates 
significantly different from vehicle control group * p< 0.05; Plus indicates 
significantly different from vehicle control group + p< 0.01 (Dunnett's t-test). 
The number of licks after the administration of quinpirole decreased 
significantly giving a main effect of drug dose: (F 3 2 1 = 9.270, p<0.0001). There 
was also a main effect of concentration, in that it increased number of licks 
monotonically: (F 2 2 1 = 25.104, p<0.0001). There was no interaction between 
drug dose and concentration: (F 6 a = 0.171, n.s.). Post hoc means comparisons 
highlighted significant differences between all doses and vehicle control for those 
drinking 1% or 10% sucrose. Number of licks for those drinking 3% sucrose were 
only significantly different from vehicle at the 0.1 (mg/kg) dose of quinpirole (see 
Figure 4.12). 
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Figure 4.13 Mean bout duration of licking for 1,3 and 10% sucrose in a 20-min 
test as a function of dose quinpirole (0.03-0.3 mg/kg)+ S.E.M. Asterisk indicates 
significantly different from vehicle control group * p< 0.05; Plus indicates 
significantly different from vehicle control group + p< 0.01 (Dunnett's t-test). 
Figure 4.13 reveals mat mean bout duration became shorter as the dose of 
quinpirole increased. This was found to be a highly significant main effect of drug: 
(F 3 2 1 = 27.074, p<0.0001). Concentration served to significantly increase mean 
bout duration: (F x 2 , = 5.779, p<0.01). There was no significant interaction 
between drug dose and concentration (F 6 a = 0.826, n.s.). Differences between 
dose groups and vehicle control groups were significant at each dose for each 
concentration. 
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Figure 4.14 Mean licking bout frequency for 1, 3 and 10% sucrose in a 20-min 
test as a function of dose quinpirole (0.03-0.3) + S.E.M. Asterisk indicates 
significantly different from vehicle control group * p< 0.05; Plus indicates 
significantly different from vehicle control group + p< 0.01 (Dunnett's t-test). 
Figure 4.14 highlights that in the case of bout frequency, there was no 
significant main effect of drug: (F 3 2 1 = 1.684, n.s.). Therefore, post hoc tests 
were not conducted. Concentration significantly affected the number of bouts: (F 2 
2 1 = 12.878, rxO.OOl) but there was no significant drug-concentration interaction: 
( F 6 i 6 3 = .468, n.s.). 
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b) Microstructural analysis of data from the 1st min of a 20-min test session 
Number of licks 
200T 1 
I 
150 
11 
m i% 
100 1-, • .r; T I n 10% 
50 
L T 1 
T f 0 1 ( 
0.00 0.03 0.10 0.30 
Dose quinpirole (mg/kg) 
Figure 4.15 Number of licks for 1,3 and 10% sucrose in the first minute of a 
20-min test as a function of dose quinpirole (0.03-0.3 mg/kg) + S.E.M. Asterisk 
indicates significantly different from vehicle control group * p< 0.05; Plus indicates 
significantly different from vehicle control group + px 0.01 (Dunnett's t-test). 
In the first minute of the 20-min test session number of licks decreased as a 
function of dose of quinpirole (see Figure. 4.15). This drug effect was statistically 
significant (F 3 2 1 = 28.156, p<0.0001). Concentration also significantly affected 
the number of licks at this early stage of the test (F x 2 1 = 3.679, p<0.05). 
However, the drug-concentration interaction did not reach statistical significance: (F 
6 = .846, n.s.). Following the significant main effect of drug, post hoc tests 
showed that the 0.1 and 0.3 (mg/kg) doses of quinpirole were significantly different 
from controls at all concentations. However, the low dose of quinpirole (0.03 
mg/kg) was only different to controls in the group drinking 1% sucrose. 
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Figure 4.16 Mean bout duration of licking for 1,3 and 10% sucrose from the 
first minute of a 20-min test as a function of dose quinpirole (0.03-0.3 mg/kg) + 
S.E.M. Asterisk indicates significantly different from vehicle control group * p< 
0.05; Plus indicates significantly different from vehicle control group + p< 0.01 
(Dunnett's t-test). 
Figure 4.16 reveals that drug dose also produced a significant decremental 
effect on the mean bout duration during the first minute of the 20-min test (F 3 2 1 = 
24.523, rxO.0001). The main effect of concentration during this first minute did 
not reach statistical significance: (F 2 2 1 = 1.874, n.s.); nor was there a significant 
drug-concentration interaction: (F 6 & = 1.021, n.s.). Post hoc test showed that all 
doses were significantly different from controls at all levels of concentration with 
the exception of those animals in the 10% group which had received the low dose 
(0.03 mg/kg) of quinpirole. 
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Figure 4.17 Mean bout frequency of licking for 1,3 and 10% sucrose in the 
first minute of a 20-min test as a function of dose quinpirole (0.1-1.0 mg/kg) + 
S.E.M. Asterisk indicates significantly different from vehicle control group 
* p< 0.05. 
While mean bout frequency increased significantly as a function of drug 
dose over the 20-min test session, the opposite occurs within the first minute of the 
same test session (see figures 4.14 and 4.17). Figure 4.17 shows that mean bout 
frequency tended to decrease with increasing dose of quinpirole. This was found to 
be a significant main effect of drug dose: (F 3 2 1 = 5.914, p<0.005). Concentration 
had a similar and significant main effect on mean bout frequency when measured 
over 20 mins and also in the first minute of the test 
During the first minute, concentration served to significantly increase the 
number of bouts: (F 2 2 1 = 3.615, p<0.05). Again, there was no significant 
interaction of drug and concentration: (F 6 ^ = 0.887, n.s.). Post hoc tests point to 
the higher doses as significantly different from vehicle controls (i.e. 0.1 and 0.3 
mg/kg) for the 1% sucrose group; the 0.3 (mg/kg) is the only dose which is 
significantly different from vehicle in those drinking the 10% solution and in the 3% 
group, doses of quinpirole failed to significantly differ from vehicle controls. 
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Experiment 3: Microstructural analysis of drinking for sucrose after the 
administration of raclopride: Analyses of licking during a 20-min session and 
during first minute of 20-min session. 
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Figure 4.18 Intake of 1, 3 and 10% sucrose in a 20-min test as a function of 
dose raclopride (0.03-0.3 mg/kg) + S.E.M. 
Figure 4.18 shows that intake decreased only slightly in the 3 and 10% 
sucrose groups and more noticably in the 1% group as a function of dose. Across 
concentrations the main effect of drug was not significant: (F 3 2 , = 1.291, n.s.). 
The main effect of concentration on mean intake was highly significant (F 2 2 1 = 
25.716, p<0.0001). The drug-concentration interaction was non-significant: (F 6 
= 0.23, n.s.). 
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Figure 4.19 The effect of dose raclopride (mg/kg) on the rate of licking (licks per 
min) for a 10% sucrose solution for a) vehicle and b) high dose conditions. The 
lines represent the least squares fit of the function y=Ae (-Bt) to the data. Open 
circles (O) indicate the vehicle condition (0.0 mg/kg raclopride ) while open squares 
(D) indicate the high dose condition (0.3 mg/kg raclopride). 
The effect of raclopride on the rate of licking (licks per minute) at one 
minute intervals can be seen in figure 4.19. The rate of licking in the vehicle 
condition is compared to that of the high dose condition (0.3 mg/kg). An 
exponential decay function (y=Ae (-Bt)) was again fitted to the data. The parameters 
derived from the curve fitting process are shown in Table 4.3. A Spearman 
correlation between the actual data and predicted data revealed that this exponential 
decay function provided a good description of the data (see table 4.3). At the 0.3 
mg/kg dose, raclopride decreased the initial rate of licking (A). This decrease was 
not as extreme as that produced by the highest doses of 7-OH-DPAT (1.0 mg/kg) 
or quinpirole (0.3 mg/kg). Raclopride (0.3 mg/kg) had little effect on the rate 
constant (B) producing a marginal attenuation of this parameter. In this way 
raclopride produced similar effects to 7-OH-DPAT and quinpirole (see results: 
Experiments 1 and 2). 
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Table 4.3 Parameter estimates and standard errors for the least squares fit to the 
rate of licking of the function y=Ae ( Bt). 
raclopride sucrose A B r 
Dose 
(mg/kg) 
concentration 
(%) 
0 10 
estimate 242.63 0.10 0.889 
S.E. 23.01 0.02 
0.3 10 
estimate 168.77 0.08 0.915 
S.E. 12.13 0.01 
Parameters A and B refer to the intercept and rate constant respectively, r is the 
correlation coefficient resulting from the correlation of the actual and predicted 
values (Spearman correlation coefficient). 
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Figure 4.20 Number of licks for 1,3 and 10% sucrose in a 20-min test as a 
function of dose raclopride (0.03-0.3 mg/kg) + S.E.M. 
Figure 4.20 shows a similar decremental pattern to figure 4.18 with those in 
the 1% sucrose group licking less than animals in the 3 or 10% groups. Again, the 
main effect of drug on number of licks was not significant' (F 3 2 1 = 2.109, n.s.) 
and the main effect of concentration was highly significant (F 2 2 1 = 25.744, 
rxO.0001). There was no significant drug-concentration interaction: (F ^  & = 
0.289, n.s.). 
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Figure 4.21 Mean bout duration of licking for 1,3 and 10% sucrose in a 20-min 
test as a function of dose raclopride (0.03-0.3 mg/kg)+ S.EM. Asterisk indicates 
significantly different from vehicle control group * p< 0.05; Plus indicates 
significantly different from vehicle control group + p< 0.01 (Dunnett's t-test). 
Figure 4.21 shows an overall decrease in mean bout duration with 
increasing doses of raclopride. At the highest dose (0.3 mg/kg) mean bout duration 
is approximately halved compared to vehicle. For this parameter there was a 
signifi^irtfmain effect of drug: (F 3 2 1 - 16.467, rxO.0001) but no significant main 
effect of concentration: (F 2 2 , = 1.663, n.s.). Neither was there a significant drug-
concentration interaction: (F 6 M = 1.06, n.s.). Post hoc tests revealed mat the 
highest dose of raclopride (0.3 mg/kg), significantly attenuated mean bout duration 
when compared to vehicle control group. This was the case for each sucrose 
concentration group. 
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Figure 4.22 Mean licking bout frequency for 1, 3 and 10% sucrose in a 20-min 
test as a function of dose raclopride (0.03-0.3) + S.E.M. Asterisk indicates 
significantly different from vehicle control group * px 0.05; Plus indicates 
significantly different from vehicle control group + p< 0.01 (Dunnett's t-test). 
Number of bouts generally increased as a function of dose of raclopride 
(see figure 4.22). However, those animals drinking 1% sucrose did not increase 
their mean bout frequency to the same extent as animals in the 3 or the 10% groups. 
For this parameter there was a significant main effect of drug: (F 3 2 1 = 8.674, 
p<0.0001); concentration: (F % 2 , = 20.58, p<0.0001) and a significant drug-
concentration interaction: (F 6 a = 16.467, p<0.05). Post hoc tests showed the 
highest dose of raclopride (0.3 mg/kg) to be significantly different from vehicle 
controls for those animals drinking 3 or 10% sucrose. 
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h\ Microstmctural analysis of data from the 1st min of a 20-min test session 
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Figure 4.23 Number of licks for 1,3 and 10% sucrose in the first minute of a 
20-min test as a function of dose raclopride (0.03-0.3 mg/kg) + S.E.M. Asterisk 
indicates significantly different from vehicle control group * p< 0.05 (Dunnett's t-
test). 
The decrease in the number of licks as a function of drug dose (see Figure 
4.23) was only statistically significant at the highest dose of raclopride (0.3 mg/kg) 
where number of licks were reduced by approximately 40%. This main effect of 
drug was statistically significant (F 3 2 1 = 4.539, p<0.05); as was the main effect 
of concentration: (F 2 2 , = 4.948, p<0.05). However, there was no interaction 
between drug dose and sucrose concentration: (F 6 a = 0.339, n.s.). Post hoc tests 
snowed that during the first minute of the 20 min test session, the reduction in 
number of licks was most evident at the highest dose of raclopride (0.3 mg/kg) in 
the 3 and 10% sucrose groups. 
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Figure 4.24 Mean bout duration of licking for 1,3 and 10% sucrose in the first 
minute of a 20-min test as a function of dose raclopride (0.03-0.3 mg/kg) + S.E.M. 
Asterisk indicates significantly different from vehicle control group * p< 0.05 
(Dunnett's t-test). 
Consistent with the mean bout duration data from the full 20-min session, 
mean bout duration in the first minute was generally reduced by over 50% (see 
figure 4.24). The effects of drug dose on this parameter were significant (F 3 2 , = 
6.188, p<0.005). However, there was no significant main effect of concentration: 
(F 2 2 1 = 1.362, n.s.) nor was there a significant drug-concentration interaction: (F 
6 6 3 = 0.306, n.s.). The highest dose of raclopride (0.3 mg/kg) was most effective 
at reducing the mean bout duration at this early stage of the test After a post hoc 
test the effects of this dose were shown to be significantly different from vehicle 
controls in the 1% and 10% sucrose groups. 
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Figure 4.25 Mean bout frequency of licking for 1,3 and 10% sucrose in the 
first minute of a 20-min test as a function of dose raclopride (0.03-0.3 mg/kg) + 
S.E.M. 
Figure 4.25 shows that for the first minute of the 20-min test session there 
was no significant main effect of drug dose on mean bout frequency: (F 3 2 1 = .092, 
n.s.). Concentration did show a main effect : ( F U 1 = 4.977, p<0.05), however 
this relationship was non-monotonic. There was no significant drug-concentration 
interaction: ( F 6 a = 0.477, n.s.). 
150 
Chapter 4 
Summary 
Table 4.4 Drug effects on microstructural parameters when measured in the first 
minute of a 20-min test session and when measured over full 20-min of the test 
session. 
Data taken from: 
20-min 1-min 
7-OH Quin Rac 7-OH Quin Rac 
Number of 
licks 
Mean bout 
duration (s) 
Number of 
bouts 
n=24 per drug group 
= significant decrease (p<0.05) 
= n.s. effect of drug dose 
= significant increase (p<0.05) 
7-OH = 7-OH-DPAT (0.1-1.0 mg/kg) 
Quin = quinpirole (0.03 - 0.3 mg/kg) 
Rac = raclopride (0.03 - 0.3 mg/kg) 
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4.4 Discussion 
Over the 20 minute test session, the three dopaminergic compounds did not 
reduce total intake to the same degree. Most profound decrements were found with 
increasing doses of 7-OH-DPAT which approximately halved the amount ingested 
at its highest dose. Quinpirole halved the volume of intake at both the medium and 
high doses (0.1 and 0.3 mg/kg) while raclopride did not significantly reduce intake 
overall (although a decreasing trend is evident for animals drinking 1% sucrose). 
These results suggest that these compounds may not be acting at the same receptor 
populations to achieve their differential effects on ingestive behaviour. 
The pattern of results for total intake was reflected in the drug effects on 
total number of licks. When we examined the effects of the three drugs at the 
various level of sucrose concentration, differences emerged. The difference in 
number of licks between the vehicle and high dose conditions vary as a 
consequence of the value of the test solution (i.e. % sucrose), so that for 7-OH-
DPAT there are differences between the percentage reduction between 1%, 3% and 
10%. In the case of quinpirole number of licks are approximately halved at all 
concentrations and raclopride reduces the number of licks by 50% only at the 1% 
sucrose concentration, relatively sparing the intake of both the 3 and 10% solutions. 
Towell, (1987) observed, in accordance with Jhe present results from raclopride, 
that in a one-bottle test, pimozide (a D2 antagonist) selectively reduced intake at low 
sucrose concentrations while sparing the intake of equal or higher volumes at higher 
concentrations. 
The results from the administration of raclopride are reminiscent of studies 
by Phillips et al. (1991, a,b) who found that the extent to which the D2-receptor 
antagonist suppressed operant responding maintained by sucrose reinforcement was 
inversely related to the concentration of sucrose used. Indeed, facilitation of 
rewarded performance by pimozide (Phillips et al., 1991a) and raclopride (Phillips 
et al., 1991b) was observed when the stimulus was a high sucrose reward, even 
though the same compounds have been repeatedly shown to decrease the 
consumption of lower concentrations of sucrose (i.e. 1% and 10%) in several 
experimental situations (Phillips et al., 1991b). 
The differential effects of a D2-antagonist (in the present experiment, 
raclopride) seem to be dependent upon the concentration of sucrose reward (Phillips 
etal., 1991b). The results from the present experiment suggest that it may not be 
the interaction between dopamine blockade and the absolute value of the reinforcer 
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that maintains or disrupts ingestive behaviour. For instance, in the present 
experiment responding (i.e. licking) for 3 and 10% solutions was spared relative to 
the amount ingested of the 1% solution. These findings also highlight the 
importance of considering the animal's prior experience with alternative values of 
reinforcer when interpreting drug effects on either conditioned or unconditioned 
responding (i.e. see Dickinson and Balleine, 1994 and General Discussion). 
Nevertheless there is evidence to the contrary. Cooper et al. have conducted many 
studies in which they tested the ability of dopamine antagonists to differentially 
affect various sucrose rewards. Although this work is largely unpublished, the 
general findings should be stated here. They found that dopamine antagonists such 
as raclopride and pimozide decreased sucrose solution intake irrespective of sucrose 
concentration (1-30%). 
It is implied by the drug effects on the number of licks that the behavioural 
expression of the anorexia induced by these compounds differ significantly. As 
was mentioned in Chapter 2, the size of licking bouts reflect the persistance of the 
motor system which controls the tongue activity. Larger bouts reflect longer runs 
of uninterrupted licking and this variable has been reported to be directionally 
proportional to the concentration of the sucrose solution used as a tastant (Davis 
1989; Schneider etal., 1990; Davis and Smith, 1992), and thus has been 
considered as a measure of palatability of the diet As mean bout duration decreased 
significantly for all the compounds tested (over both the full 20-min session and the 
first minute of the test) this may be interpreted as an ability of each of these 
compounds, despite their pharmacological similarities and differences, to reduce the 
palatability of available sucrose solutions. For none of the drugs at any point of the 
test session could the decreases in number of licks observed be attributed to a 
decrease in the number of bouts (see Table 4.4). Therefore, the theoretical 
possibility that ingestion decreased as a result of a decrease in the number of bouts 
can be discounted. 
Again, in the case of all three compounds, the reductions in ingestive 
responses were greater in the first minute than over the full twenty minute session. 
This was the case even for raclopride which had showed no significant effect on 
intake (or, consequently, number of licks) over the 20-min session This implies 
that these dopaminergic compounds are having their effects at the beginning of a 
meal. Changes in concentration in all three experiments were robustly reflected in 
the monotonic relationship between increasing concentration and increasing number 
of licks. This relationship seemed to be dependent on an increase in mean bout 
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duration rather than an increase in the mean bout frequency of licking. Therefore, 
such early effects on parameters thought to reflect hedonic evaluation suggest that 
these compounds are having an effect on palatability. 
Further evidence to support the idea of dopaminergic involvement in early 
meal events comes from the exponential curve fits fitted to the licks per min data. In 
the case of 7-OH-DPAT the initial rate of licking (the intercept A) was severely 
dampened by the highest dose of 7-OH-DPAT (1.0 mg/kg) (over halved), while in 
the case of quinpirole the initial rate of licking was reduced by 50% (0.3 mg/kg). 
The estimate of A for raclopride at the highest dose (0.3 mg/kg) was almost double 
the estimate provided for the vehicle condition lick rate. Estimates of B (rate of 
decay of licking) were almost unaffected by each of these drugs. The decrease in 
the initial rate of licking found here after drug administration, is consistent with an 
inhibitory effect of dopamine receptor antagonism (or autoreceptor agonism) on the 
sensory/hedonic effect of sucrose, while the failure of the drugs to change the rate 
of decay of intake is evidence against the compounds decreasing intake by impairing 
ingestive movements necessary for sustained feeding (Davis and Levine, 1977). 
This profile of reduced initial rate of ingestion produced by dopamine receptor 
antagonists without a substantial change in the rate of decay of responding is 
equivalent to the profile of responding observed when sucrose solutions are 
devalued by dilution (Davis and Smith, 1988^1992). 
The results of Pecina and Berridge (1997) are useful in interpreting the 
present data. These authors identified certain characteristics of the data which led 
them to their interpretation of the results, one of which is the timing of the drug-
induced effect. Conventional manipulators of hedonic or aversive taste palatability 
such as (hunger/satiety, aversion conditioning, brain lesions, opioid or 
benzodiazepine agents) typically produce taste reactivity patterns that can be detected 
in the first seconds or minute of a taste infusion (Berridge et al., 1996). In the 
hands of Pecina and Berridge, pimozide produced effects which only emerged 
gradually over successive minutes as the oral infusion was continued and that 
sometimes grew in strength as trials were repeated. They see these delayed effects 
as argument against an immediate and direct change in taste palatability in favour of 
the interpretation that the rats cannot maintain high response rates after an initial 
burst of of taste reactivity components. 
Another feature of responding which Pecina and Berridge see as suggestive 
of impairment of sensorimotor function is the lack of selectivity of the drug effect 
(Pecina et al., 1997). They observed that behavioural suppression associated with 
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pimozide applied to hedonic, aversive and neutral categories of taste reactivity and 
to general activity. These authors see the results with pimozide as congruent with 
the "anergia" hypothesis advanced by Salamone and colleagues (McCullough and 
Salamone, 1992, Salamone, 1994; Salamone etal., 1990, Salamone et al., 1994) 
(see Chapter 2). 
Therefore, the results of the present experiment could also be explained 
within this theoretical framework as reductions in mean bout duration over the 20-
min test session were less profound than those data collected from the first minute 
of the test which could be construed as reflecting a gradual motor dysfuntion 
(Salamone, 1992,1994) but could also reflect the induction of a post-ingestive 
negative feedback signal (Davis and Levine, 1977). Observations on the number of 
bouts, however, go some way to countering a motoric interpretation as bouts 
increased rather than decreased over the test session when animals were injected 
with raclopride or 7-OH-DPAT. This final observation is in contrast to the selective 
decrease in bouts after dopamine blockade found by both Asin et al. (1992) and 
Pecina and Berridge (1997). 
The findings above are consistent with hypothesis which states that D2 
antagonists such as pimozide reduce intake by decreasing the reinforcing potency of 
the sucrose solution without producing a motoric deficit (Towell, 1987; Bailey et 
al., 1986; Schneider etal., 1990). In this respect, the compounds used are similar 
to each other. However, because of the paucity of data on the effects of selective 
D3 receptor ligands on feeding, on the basis of these experiments alone it is difficult 
to tease out an effect on feeding parameters rather than idiosyncratic effects of the 
D3 receptor agonists used. In general, the dependent variables measured in this set 
of experiments (Experiments 1-3) reflect that the initial hedonic evaluation of 
tastants is impaired due to dopamine blockade. 
The effects of quinpirole and 7-OH-DPAT have not, to date, been analysed 
at the level of individual licks. Both of these drugs seem to decrease ingestion by 
reducing those parameters which are thought to reflect palatability. This constitutes 
further confirmation of a role of D3 and D2 receptors in food reward. It is difficult 
to completely discount a motoric impairment induced by these pharmacological 
manipulations on the strength of these measures alone. Measures such as intrabout 
lick rate and latency could further illuminate possible motoric effects of these 
compounds. Therefore, Experiments 4, 5 and 6 aim to further investigate a motoric 
as well as a hedonic component to the effects of dopamine receptor subtype ligands 
on licking behaviour. 
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Chapter SrMicrostrectural analysis using a brief contact 
test: The effects of 7-OH-DPAT, raclopride and SCH 
23390 on drinking for sucrose and Intralipid 
5.1 Introduction 
Results from Experiments 1,2 and 3 showed that the putative D3 receptor 
agonist, 7-OH-DPAT, the D2 receptor antagonist raclopride and the mixed D2/D3 
receptor agonist quinpirole reduced the intake of sucrose solutions. Each of these 
compounds reduced the number of licks by decreasing the mean bout duration 
rather than the number of bouts. These reductions were most apparent in the first 
minute of the test sessions. Examination of the overall lick rate revealed that initial 
rate of licking was affected by these compounds rather than the rate of decay of 
licking over the test session. Taken together, these results imply that 7-OH-DPAT, 
raclopride and quinpirole reduced licking responses by reducing the palatability of 
the sucrose solutions rather than promoting satiety signals. An increase in number 
of bouts after the administration of 7-OH-DPAT, quinpirole (albeit non-significantly 
in the case of quinpirole) and raclopride in Chapter 4 represents preliminary 
evidence against the induction of a motoric deficit by these compounds. 
As was mentioned in Chapter 2, a shorter test session helps to eliminate 
post-ingestive negative feedback and so gives the test more interpretive strength 
with regards the assessment of drug effects on palatability. Therefore, the set of 
experiments in this Chapter (Experiments 4,5 and 6) used a 60 sec presentation of 
tastants in order to further eliminate these post-ingestive stimuli. However, there 
are mechanisms, other than those which are involved in the mediation of palatability 
and/or, satiety, by which a reduction in intake may be realised. For example, drugs 
may affect some activational mechanism necessary to induce feeding. Therefore, 
along with microstructural variables, Experiments 4,5 and 6 also measured the 
latency to begin drinking in the brief contact test 
A further possibility which was not fully resolved in Chapter 4 is that the 
decrease in the number of licks after the administration of dopaminergic antagonists 
(or putative dopamine autoreceptor agonists) could be partially due to a decrease in 
the rate of licking within a bout reflecting a motor impairment Previously, 
Gramling and Fowler (1984) observed that neuroleptic treatment led to a decrease in 
lick frequency. On further analysis this result was attributed to an abnormal pattern 
of tongue protrusions aimed at the licking spout. Orolingual motor competence was 
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therefore said to be impaired by the neuroleptic treatment (but see General 
Discussion). 
Nevertheless, Schneider et al. (1990) found that the D2 receptor antagonist 
raclopride did not affect the motor capability of rats as reflected by their interlick 
intervals. The administration of neuroleptics has been shown to affect intervals 
between bouts and the number of licks within a bout without affecting the rate of 
licking within a bout (Schneider etal., 1990; Weatherford etal., 1990). These 
results suggest neuroleptic treated animals were capable of making the rapid motoric 
responses necessary to sustain normal licking behaviour. 
Due to this conflict in results, it is important that more investigation is 
directed towards the important distinction between the motor system which controls 
refined alterations in tongue protrusions (the actual act of licking) from that system 
which orchestrates licking behaviour into bouts of licking (Davis, 1989; Schneider 
et al., 1990). Specifically, the experiments in this Chapter serve to highlight such a 
distinction by testing three drugs which purportedly act at separable dopamine 
receptor subtypes using a microstructural analysis of licking behaviour in a brief 
contact test. In these shortened tests, microstructural measurements have been 
extended to include measures which may reflect a type of motoric impairment (i.e. 
latency, intrabout lick rate and average interlick interval). 
The drugs used in Experiments 4 and 5 (7-OH-DPAT and raclopride) have 
already been used in conjunction with a microstructural analysis in Chapter 4 over a 
20 min test session. The use of a shorter test session for Experiments 4, 5 and 6 
along with the measurement of variables which further reflect motor competence 
will help to resolve questions regarding motoric effects of such drugs, which were 
only partially answered in Chapter 4. Experiment 6 uses a D l receptor antagonist 
(SCH 23390) which works at post-synaptic receptors, to further broaden the 
comparison of the contribution of dopamine receptor subtypes to changes in licking 
microstructure. 
More recent work has shown that SCH-23390 reduces food intake in both 
food deprived (Gilbert and Cooper, 1985; Zarrindast et al, 1991; Terry and Katz, 
1992) and free-feeding animals (Clifton et al, 1991; Naruse et al, 1991). 
Further, it is fairly well established that the importance of differences between D l 
and D2 receptor antagonists lies in the possibility that D l antagonists may have 
lower extrapyramidal side effect liability (Coffin et al., 1989; Fowler and Liou, 
1994). Due to its limbic selectivity, the same characteristic has been inferred for the 
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D3 receptor agonist 7-OH-DPAT (Sokoloff, 1990). However, an early study on the 
effects of a Dl-type antagonist on food intake (Koechling et al., 1988) showed that 
across a series of discrete meal segments, SCH-23390 increased the latency to eat 
and reduced the speed of eating which may reflect a motoric effect of the drug. 
Therefore, it is unclear whether Dl-like antagonists produce more of a motoric 
deficit than D2 receptor antagonists, thus, a further aim of this set of experiments 
was to examine in detail any changes in orolingual motor competence after the 
administration of SCH-23390 and to compare the results with lick data collected 
after the administration of raclopride and 7-OH-DPAT. 
Chapter 2 also shows that the model for the control of ingestion formulated 
by Davis and Levine (1977) can incorporate lick data which has been collected in 
response to a variety of different macronutrient solutions. For example, Davis, 
(1996), compared the results of a microstructural analysis when the test stimulus 
was Polycose (a complex mixture of mono-, di- and polysaccharides) to other 
mono- and disaccharides (such as sucrose). Both initial rate of licking and bout size 
were increasing linear functions of the concentration of Polycose (Davis, 1996). 
This finding has been further confirmed by Higgs and Cooper, (1998). Similar 
results have been found with a fat emulsion, Intralipid (Higgs and Cooper, 1996). 
However, Davis (1995) failed to find a similar result with increasing concentrations 
of corn oil. Therefore, the final aim of this set of experiments was to attempt to 
replicate the effects of Intralipid concentration on mean bout duration, and to 
compare any concentration effects with those of sucrose solutions. At 
the same time, the effects of the dopaminergic agonist and antagonists on the two 
types of macronutrient fluid ingestion were investigated. 
158 
Chapters 
5.2 Method 
5.2.1 Animals 
Sixty non-deprived adult male hooded Lister rats (n=20 per Experiment 4, 5 
and 6), weighing 350-400g at the time of testing were used. They were housed and 
maintained as described in Chapter 3. 
5.2.2 Drugs 
In Experiment 4,7-OH-DPAT (Research Biochemicals International, U.K.) 
was dissolved in saline and injected i.p. 20 minutes before testing. Doses of 7-OH-
DPAT were 0.1,0.3 and 1 mg/kg or its vehicle. For the purposes of Experiment 5, 
raclopride (Research Biochemicals International, UK) was dissolved in distilled 
water and injected i.p. 20 mins before the start of testing at doses of 0.03; 0.1 and 
0.3mg/kg or vehicle. In Experiment 6, SCH- 23390 (Research Biochemicals 
International, UK) was dissolved in sterile water and injected i.p. 20-min before 
testing at doses of 0.01,0.03 and 0.1 mg/kg or vehicle. All details of drug 
preparation and administration for each drug can be found in Chapter 3. 
5.2.3 Test Fluids 
The two types of test fluid were sucrose solutions or Intralipid emulsions 
made up as described in Chapter 3. In each experiment (4,5 and 6), 10 animals 
were trained and tested on 1,3 and 10% sucrose while the remaining 10 animals 
had access to 1,3 and 10% Intralipid. During both training and testing animals had 
experience of all concentrations of the fluid. 
5.2.4 Apparatus 
Testing was carried out using the MS80 lickometer described in detail in 
Chapter 3. 
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5.2.5 Procedure 
Training 
20 animals were assigned to each of Experiments 6,7 and 8. These 
experiments differed in the type of drug treatment which was administered before 
testing (i.e. 7-OH-DPAT, raclopride or SCH 23390). The 20 animals in each 
experiment constituted 2 groups of 10 randomly assigned members. This split was 
based on the type of test solution they were to have access to during training and 
testing (i.e. sucrose solution or Intralipid emulsion). Each group was familiarised 
with the test apparatus and solutions for approximately 10 days or until baseline 
drinking levels were stable. Training consisted of 1 min access to each 
concentration of the test fluid (1,3 and 10% sucrose solution or 1,3 and 10% 
Intralipid emulsion) at the same time on each training day. Two days prior to 
testing animals received a sham injection of vehicle in order to familiarise them with 
the injection procedure. 
Testing 
Experiment 4: Early effects of 7-OH-DPAT on the microstructure of licking: a brief 
contact test. 
Following training, 7-OH-DPAT (0.1,0.3 and 1.0 mg/kg) or vehicle was 
administered i.p., 20-min before animals were placed in the lickometer chamber 
where they were presented with 1,3 and 10% sucrose for 1 min per concentration, 
with an inter-presentation interval of 10s. The study employed a repeated measures 
design with all animals having access to all concentrations of their allotted test fluid 
after all doses of drug. Injections were counterbalanced using a Latin Square 
design as were the presentations of concentrations of test fluid. There was a 48h 
time lapse between injections to avoid carry-over effects. 
Experiment 5: Early effects of raclopride on the microstructure of licking: a brief 
contact test. 
* Following training, raclopride was administered i.p. (0.03, 0.1 and 0.3 
mg/kg) or vehicle. Presentation of test fluids, the design of the study and the 
injection procedures are as described for Experiment 4. 
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Experiment 6: Early effects of SCH-23390 on the microstructure of licking: a brief 
contact test. 
Following training, SCH-23390 (0.01, 0.03 and 0.1 mg/kg) or vehicle 
was administered i.p. Presentation of test fluids, the design of the study and the 
injection procedures are as described for Experiment 5. The data from one animal 
in Experiment 6 (sucrose group) was excluded due to a swollen leg on the third 
injection day. 
5.2.6 Design and statistical analysis 
Initial analysis of the lick time data was carried out using the programs 
outlined in Chapter 3. Measures derived from the raw data included latency to 
engage in drinking (time from shutter opening to first lick) and a number of 
microstructural variables: number of licks, mean bout duration (s), number of 
bouts, intrabout lick rate (licks/s within bouts), and interlick interval (msec). 
Data from Experiments 4,5 and 6 were analysed using a two-way repeated 
measures ANOVA with drug dose and fluid concentration as factors. Where there 
was a significant main effect of drug but no significant interaction between drug 
dose and fluid concentration post hoc tests were employed. To do this, the main 
effect of drug was collapsed across concentration and Dunnett's t-test was used to 
determine any significant differences between animals who had received drug doses 
and vehicle controls. Statistical tests were performed using Super Anova and 
Statview SE+graphics (Abacus Concepts Inc., Berkeley, CA). A result was 
considered statistically significant if p<0.05). 
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5.3 Results 
To avoid confusion and redundancy in the results section, the means and 
standard errors measured from Experiments 4,5 and 6 are presented firstly in 
tabulated form without statistical information followed by graphs of the results from 
each parameter accompanied by statistical information. 
Experiment 4: Early effects of7-OH-DPAT on the microstructure of ticking: a 
brief contact test. 
A brief contact licking test involves the presentation of differing 
concentrations of selected fluids for 60 seconds. Below are the licking parameters 
measured after the administration of 7-OH-DPAT. The parameters measured were 
number of licks, mean bout duration, number of bouts, intrabout lick rate (and 
average interlick interval) as well as latency. Animals licking for all concentrations 
of Intralipid emulsions or sucrose solutions are represented in Table 5.1. 
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Table 5.1 The average (+ S.E.M.) of the feeding parameters at each dose of 7-
OH-DPAT and at each sucrose / Intralipid concentration (1,3 and 10%). 
Dose 7-OH-DPAT (mg/kg) 
0.0 0.1 0.3 1.0 0.0 0.1 0.3 1.0 
Sucrose Intralipid 
Latency 
(s) 
Fluid (%) 
1 5.5 2.9 5.0 27.3 21.7 26.6 25.1 44.9 
(1-5) (1.2) (3.3) (7.2) (7.2) (8.8) (6.1) (6.6) 
3 10.0 3.3 3.8 21.5 25.6 19.4 22.4 42.4 
(5.7) (1.4) (1.1) (7.3) (7.3) (7.6) (8.2) (6.5) 
10 7.2 7.9 8.7 18.8 12.2 8.8 17.3 31.1 
(4.9) (2.6) (3.4) (7.4) (5.1) (2.8) (6.1) (8.0) 
Number of 
licks 
Fluid (%) 
1 84.7 66.6 67.1 43.5 93.0 60.3 67.1 9.3 
(27.2) (18.9) (23.4) (17.3) (27.3) (25.8) (19.3) (5.2) 
3 159.4 196.4 127.2 88.5 119.4 123.4 77.4 18.0 
(26.2) (24.9) (30.6) (26.1) (40.9) (37.6) (34.0) (6.7) 
10 332.6 316.6 241.6 159.9 258.0 247.7 248.8 81.7 
(9.1) (19.3) (23.6) (27.6) (36.4) (21.5) (31.0) (25.1) 
Mean bout 
duration 
(s) 
Fluid (%) 
1 1.0 1.4 1.4 0.9 1.9 1.2 1.8 0.5 
(0.2) (0.2) (0.4) (0.3) (0.3) (0.4) (0.5) (0.2) 
3 1.9 2.3 2.2 1.4 1.9 1.8 1.3 1.1 
(0.3) (0.2) (0.3) (0.3) (0.5) (0.4) (0.5) (0.4) 
10 3.1 3.3 2.7 1.7 3.9 3.1 3.6 1.7 
(0.2) (0.3) (0.2) (0.2) (0.6) (0.3) (0.6) (0.7) 
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(Table 5.1 continued) 
Number of 
bouts 
Fluid (%) 
1 7.6 6.0 5.5 5.1 6.1 4.4 4.0 1.7 
(1.9) (1.2) (1.1) (1.2) (1.6) (1.9) (0.8) (0.9) 
3 10.1 12.1 8.3 9.6 6.4 7.3 4.7 1.9 
(1.3) (1.5) (1.4) (1.7) (2.1) (1.5) (2.0) (0.5) 
10 15.1 14.6 14.8 17.2 10.0 12.5 10.0 7.5 
(0.7) (1.0) (0.6) (2.6) (1-5) (0.9) (1.5) (2.3) 
Intrabout 
lick rate 
(lieks/s) 
Fluid (%) 
1 7.3 6.7 6.0 4.4 6.5 4.8 5.5 2.2 
(0.2) (0.1) (0.3) (0.7) (0.7) (1.1) (0.9) (0.8) 
3 6.3 6.6 6.0 4.6 5.8 6.0 4.7 2.8 
(0.7) (0.1) (0.2) (0.6) (0.9) (0-7) (1.1) (0.8) 
10 6.9 6.7 5.7 4.5 6.9 6.4 6.2 3.4 
(0.01) (0.1) (0.2) (0.5) (0.2) (0.1) (0.2) (0.8) 
Interliek 
interval 
(msec) 
Fluid (%) 
1 140.1 157.1 165.5 177.7 143.9 127.6 141.8 178.6 
(4.3) (5.8) (15.6) (7.9) (4.2) (11.1) (5.6) (22.8) 
3 142.1 154.4 169.3 198.9 137.1 155.3 128.3 200.1 
(2.1) (3.2) (4.7) (7.9) (5.2) (7.7) (11.8) (9.8) 
10 145.0 150.9 176.7 201.8 147.3 159.4 163.6 190.5 
(1.8) (2.6) (5.1) (6.9) (4.1) (3.4) (4.6) (12.7) 
n= 10 animals per test fluid group 
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Figure 5.1 Latency to start drinking sucrose and Intralipid in a brief contact test 
as a function of increasing dose of 7-OH-DPAT (0.1-1.0 mg/kg) + S.E.M. Plus 
indicates significantly different from vehicle +p<0.01. 
Figure 5.1 shows that the latency to begin drinking increased significantly 
with drug dose giving a main effect of dose 7-OH-DPAT: (F 3 „ = 7.092, 
p<0.05). However, there was no significant effect of sucrose concentration: (F 2 
1 8 = 0.069, n.s.) on latency. There was not a significant interaction between drug 
dose and sucrose concentration: (F 6 M =1.090, n.s.). Post-hoc tests revealed that 
the 0.1 mg/kg dose of 7-OH-DPAT significantly increased latency. This effect of 
drug seemed to be most profound within the group drinking 1% sucrose where the 
increase in latency in the high dose group (0.1 mg/kg) was almost five times that of 
the vehicle controls. 
In the case of Intralipid, there was also an incremental main effect of dose 7-
OH-DPAT (F 3 2 7 = 4.781, p<0.05) but no effect of concentration: (F 2 , g= 3.079, 
n.s.) although latency tended to decrease with increasing concentration. Again, the 
interaction between drug dose and concentration was non significant: (F 6 M 
=0.253, n.s.). Post hoc tests revealed that the 1.0 mg/kg dose of 7-OH-DPAT 
significantly increased latency when compared to vehicle controls. 
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Microstructural analysis 
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Figure 5.2 Number of licks for sucrose and Intralipid drinking in a brief contact 
test as a function of increasing dose of 7-OH-DPAT (0.1-1.0 mg/kg) + S.E.M. 
Plus indicates significantly different from vehicle +p<0.01. 
Table 5.2 Main effect of fluid concentration on total number of licks . 
Mean number of licks * S.E.M. 
Fluid (%) 1 3 10 
Sucrose 68.5±10.8 142.9±14.5 262.7±14.9 
Intralipid 57.4±11.3 84.6±17.1 209.1±18.3 
n=10 animals per test fluid group 
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Figure 5.3 Total number of licks for 1,3 and 10% sucrose as a function of dose 
7-OH-DPAT (0.1-1.0 mg/kg) + S.E.M. 
Number of licks for sucrose were approximately halved after the 
administration of the highest dose (1.0 mg/kg) of 7-OH-DPAT but the relationship 
between drug dose and number of licks was only monotonic in the case of those 
animals drinking 10% sucrose. Nevertheless, there was a significant main effect of 
dose 7-OH-DPAT: (F 3 2 7 = 6.672, p<0.05) and a highly significant main effect of 
concentration: (F % 1 8= 113.430, p<0.0001). There was also a significant 
interaction between drug dose and concentration: (F 6 M = 2.840, p<0.05). Post 
hoc tests were not conducted owing to the significant interaction. 
The number of licks for Intralipid were also decreased significantly as a 
function of drug dose: ( F 3 „ = 9.459, p<0.01). These decreases seen after the 
high dose were more profound than those observed for sucrose. For instance, 
when animals were drinking 1 and 3% Intralipid, the mean number of licks after the 
highest dose of 7-OH-DPAT were approximately 10% of those observed in the 
vehicle control group, while those drinking 10%, under the same drug condition 
showed a decrease in the number of licks of approximately 60%. Increasing 
concentration gave rise to a significant increase in the number of licks: (F 2 l g = 
21.444, p<0.0001). In this case there was no significant interaction of drug dose 
and concentration: (F 6 „ = 1.725, n.s.). Post hoc tests revealed that, as with 
sucrose, at the highest dose (1.0 mg/kg) of 7-OH-DPAT there was a significant 
difference in number of licks as compared to vehicle controls (see Figure 53). 
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Figure 5.4 Mean bout duration for sucrose and Intralipid drinking in a brief 
contact test as a function of increasing dose of 7-OH-DPAT (0.1-1.0 mg/kg)+ 
S.E.M. Asterisk indicates significantly different from vehicle *p<0.05; Plus 
indicates significantly different from vehicle +p<0.01. 
Table 5.3 Main effect of fluid concentration on mean bout duration. 
Mean bout duration * S.E.M. 
Fluid (%) 1 3 10 
Sucrose 1.2±0.1 2.0±0.2 2.7±0.2 
Intralipid 1.3±0.2 1.5±0.2 3.1±0.3 
n=10 animals per test fluid group 
Figure 5.4 reveals that mean bout duration of licking for sucrose decreased 
significantly as a function of dose 7-OH-DPAT : (F 3 2 7 = 4.512, p<0.05). These 
decremental effects were most noticeable in those drinking 10% sucrose, where 
mean bout duration was shortened by approximately 45%. There was a highly 
significant effect of concentration on mean bout duration; as concentration 
increased so did mean bout duration and this relationship was monotonic: (F 2 , 8 = 
21.444, p<0.0001), (see Table 5.3). There was no significant interaction between 
drug and concentration: (F 6 M = 1.910, n.s.). Post hoc tests showed that at the 
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highest dose of 7-OH-DPAT (0.1 mg/kg) mean bout duration was significantly 
shorter than the mean bout duration measured for the vehicle controls. 
As is clear from Figure 5.4, the mean bout duration for drinking of 
Intralipid was reduced non-monotonically as a function of dose 7-OH-DPAT: (F 3 
2 7 = 4.044, rx0.05). In mis case the most profound drug effects were observed 
within the 1% Intralipid group where mean bout duration was shortened by 
approximately 70% at the highest dose of 7-OH-DPAT (1.0 mg/kg) as compared to 
the vehicle control group. Increasing concentration led to a significant and 
monotonic increase in mean bout duration: (F 2 1 (p 12.844, p<0.01). There was 
no significant interaction between drug dose and Intralipid concentration in the case 
of mean bout duration: (F 6 M = 1.085, n.s.), (see Table 5.3). Post hoc tests 
showed that compared to vehicle controls, the highest dose of 7-OH-DPAT (1.0 
mg/kg) significantly reduced mean bout duration. 
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Figure 5.5 Mean number of bouts for sucrose and Intralipid drinking in a brief 
contact test as a function of increasing dose of 7-OH-DPAT (0.1-1.0 mg/kg)+ 
S.E.M. Asterisk indicates significantly different from vehicle *p<0.05. 
Tabic 5.4 Main effect of fluid concentration on mean number of bouts . 
Mean number of bouts * S.E.M. 
Fluid (%) 1 3 10 
Sucrose 6.1±0.7 10.0±0.8 15.4±0.2 
Intralipid 4.1±0.7 5.1±0.9 10.0±0.9 
n=10 animals per test fluid group 
There was no overall drug effect on mean bout frequency for those animals 
drinking sucrose: (F 3 n = 0.543, n.s.). Number of bouts tended to decrease in the 
1% and 3% drinkers but were slightly increased in the 10% sucrose group (see 
Figure 5.5). In contrast, there was a highly significant main effect of concentration 
on mean bout frequency: (F 2 I 8 = 12.844, p<0.01); whereby increasing 
concentration led to more bouts. There was no significant interaction of drug dose 
and concentration: (F 6 „ = 0.995, n.s.). 
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Figure 5.5 also shows that for those animals drinking Intralipid, there was a 
significant but non-monotonic decrease in mean bout frequency as a function of 
drug dose: (F 3 2 7 = 2.965, jx0.05). Similar to sucrose, increasing Intralipid 
concentrations gave rise to a significant increase in bouts: (F 2 l g = 13.784, 
p<0.01), (see table 5.4); however, there was no significant interaction between 
drug dose and Intralipid concentration: (F 6 , 5 4 = 0.540, n.s.). The highest dose of 
7-OH-DPAT (0.1 mg/kg) was shown to be significantly different from vehicle 
controls in a post hoc test. 
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Figure 5.6 Intrabout lick rate for sucrose and Intralipid drinking in a brief contact 
test as a function of increasing dose of 7-OH-DPAT (0.1-1.0 mg/kg)+ S.EM. 
Plus indicates significantly different from vehicle +p<0.01. 
As can be seen in Figure 5.6, intrabout licking rate for sucrose decreased as 
a function of drug dose. Therefore, there was a significant and monotonia effect of 
dose 7-OH-DPAT on intrabout lick rate: (F 3 2 7 = 22.650, p<0.0001). 
Concentration did little to affect intrabout lick rate and so the effect of this variable 
was non-significant (F 2 l g = 0.507, n.s.). Nor was there a significant interaction 
between drug dose and sucrose concentration for this parameter: (F 6 M = 0.507, 
n.s.). The highest dose of 7-OH-DPAT (1.0 mg/kg) was shown to be significantly 
different from vehicle controls in a post hoc test 
Animals drinking Intralipid were affected similarly to those drinking sucrose 
within this feeding parameter. Intrabout licking rate for Intralipid decreased as a 
function of drug dose leading to a significant and monotonia effect of dose 7-OH-
DPAT on intrabout lick rate: (F 3 „ = 19.374, p<0.0001). Concentration had a 
marginal effect on intrabout lick rate increasing it slightly but non-signilleantly in 
those animals drinking 10% Intralipid: (F 2 , 8= 1.996, n.s.). There was no 
significant interaction between drug dose and Intralipid concentration for intrabout 
lick rate: (F 6 « = 0.415, n.s.). Again the highest dose of 7-OH-DPAT (1.0 mg/kg) 
was shown to be significantly different from vehicle controls in a post hoc test. 
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Figure 5.7 Average interlick interval for sucrose and Intralipid drinking in a brief 
contact test as a function of increasing dose of 7-OH-DPAT (0.1-1.0 mg/kg)+ 
S.E.M. Plus indicates significantly different from vehicle +p<0.01. 
The average interlick interval for sucrose increased as a function of dose 7-
OH-DPAT. This main effect was significant: (F 3 2 7 = 18.703, p<0.0001). 
Concentration did not significantly affect average interlick interval: (F x l g = 3.446, 
n.s.), nor was there any significant interaction between drug dose and sucrose 
concentration: (F 6 M - 1.450, n.s.). Both medium (0.3 mg/kg) and high (1.0 
mg/kg) doses of 7-OH-DPAT were shown to be significantly different from vehicle 
controls in a post hoc test (see Figure 5.7). 
Again, the changes in average interlick interval induced by 7-OH-DPAT 
were similar for animals drinking sucrose and Intralipid. The average interlick 
interval for Intralipid increased as a function of dose 7-OH-DPAT but non-
monotonically. This main effect was significant (F 3 2 7 = 12.378, p<0.0001). 
Concentration, however significantly and monotonically increased average interlick 
interval for those drinking Intralipid: (F 2 I 8 = 4.199, p<0.05). As with sucrose, 
there was no significant interaction between drug dose and Intralipid concentration 
in this parameter (F 6> M = 1.546, n.s.). Only the highest dose of 7-OH-DPAT (1.0 
mg/kg) was shown to be significantly different from vehicle controls in a post hoc 
test (see Figure 5.7). 
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Experiment 5: Early effects of raclopride on the microstructure of licking: a brief 
contact test. 
A brief contact licking test involves the presentation of differing 
concentrations of selected fluids for 60 seconds. Below are the licking parameters 
measured after the administration of raclopride. A brief contact licking test involves 
the presentation of differing concentrations of selected fluids for 60 seconds. 
Below are the licking parameters measured after the administration of raclopride . 
The parameters measured were number of licks, mean bout duration, number of 
bouts, intrabout lick rate (and average interiick interval) as well as latency. Animals 
licking for all concentrations of Intralipid emulsions or sucrose solutions are 
represented in Table 5.5. 
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Table 5.5 The average (+ S.E.M.) of the feeding parameters at each dose of 
raclopride and at each sucrose / Intralipid concentration (1,3 and 10%). 
Dose raclopride (mg/kg) 
0.0 0.03 0.1 0.3 0.0 0.03 0.1 0.3 
Sucrose Intralipid 
Latency 
(s) 
Fluid (%) 
1 10.2 8.7 11.8 9.7 17.4 17.7 12.3 23.4 
(5.6) (5.8) (3.1) (3.5) (7.3) (6.1) (4.6) (8-1) 
3 11.4 6.5 14.1 11.5 11.6 24.0 29.6 25.1 
(5.7) (2.1) (6.0) (5.8) (5.8) (8.2) (7.6) (7.8) 
10 3.0 9.4 7.5 9.8 15.1 17.3 20.2 15.9 
(0.9) (5.9) (5.8) (5.1) (6.2) (7.5) (5.8) (7.5) 
Number of 
licks 
Fluid (%) 
1 96.6 54.4 86.1 27.9 77.1 48.7 93.3 18.0 
(16.1) (16.9) (23.6) (10.3) (28.2) (16.8) (31.7) (10.2) 
3 189.5 167.5 192.2 94.8 122.5 103.3 75.1 34.7 
(35.3) (30.2) (23.7) (24.7) (35.1) (32.2) (37.2) (16.4) 
10 312.6 312.7 300.4 234.8 190.0 245.9 183.0 146.4 
(36.2) (36.5) (35.9) (30.4) (48.8) (41.6) (41.8) (38.1) 
Mean bout 
duration 
(s) 
Fluid (%) 
1 2.5 1.3 2.1 0.8 2.2 1.4 1.8 0.6 
(0.5) (0.4) (0.4) (0.2) (0.6) (0.3) (0.3) (0.1) 
3 3.1 2.6 2.7 1.7 2.8 3.0 1.3 0.7 
(0.7) (0.3) (0.5) (0.4) (0.6) (0.5) (0.3) (0.2) 
10 7.5 6.1 4.8 3.3 1.9 3.2 2.9 1.6 
(2.7) (1.8) (1.3) (0.6) (0.4) (0.3) (0.4) (0.1) 
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(Table 5.5 continued) 
Number of 
bouts 
Fluid (%) 
1 5.3 4.3 5.3 3.4 3.1 4.2 5.6 2.4 
(1.0) (0.7) (1.0) (0.9) (0.8) (1.2) (1.7) (1.1) 
3 8.9 8.8 10.8 6.2 6.3 4.8 5.0 3.4 
(1.7) (1.2) (2.2) (1.4) (1.7) (1.8) (2.1) (1.3) 
10 10.0 9.7 11.3 12.1 9.1 11.1 10.6 10.0 
(2.3) (1.8) (2.1) (1.9) (2.5) (2.0) (2.8) (2.4) 
Intrabout 
lick rate 
(licks/s) 
Fluid (%) 
1 6.2 6.4 6.7 6.5 5.1 5.0 6.0 4.5 
(0.7) (0.8) (0.1) (0.4) (1.2) (1.1) (0.8) (1.3) 
3 5.9 6.9 5.9 5.1 5.4 4.1 4.2 5.0 
(0.7) (0.1) (0.6) (0.8) (0.9) (1.1) (1.1) (1-1) 
10 6.8 5.9 6.0 6.7 5.3 5.2 5.2 4.7 
(0.2) (0.6) (0.6) (0.2) (0.9) (0.9) (0.9) (1.0) 
Interlick 
interval 
(msec) 
Fluid (%) 
1 131.6 130.3 154.4 163.8 105.4 105.0 144.2 86.7 
(14.9) (15.2) (4.4) (13.2) (23.1) (23.5) (21.4) (22.8) 
3 149.9 145.9 139.5 129.8 123.1 89.8 90.4 102.1 
(4.0) (2.7) (15.9) (22.4) (21.6) (24.6) (25.4) (9.8) 
10 134.7 137.3 135.7 152.5 121.4 123.0 125.5 108.3 
(15.1) (15.4) (15.2) (3.9) (20.4) (20.6) (22.9) (23.9) 
n= 10 animals per test fluid group 
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Latency 
Latency to drink sucrose did not change significantly with increasing doses 
of raclopride: (F 3 2 7 = 0.112, n.s.). Sucrose concentration did not significantly 
affect latency to start drinking: (F 2 l g = 1.492, n.s.) and there was no significant 
interaction between drug dose and sucrose concentration: (F 6 54 =0.719, n.s.). 
Intralipid drinkers were slower to approach the spout to drink as a function 
of dose raclopride and this relationship between dose and latency was monontonic. 
However, the result did not reach statistical significance: (F 3 „ = 0.387, n.s.). 
Neither did Intralipid concentration significantly affect the latency to begin drinking 
Intralipid: (F 2 l g = 0.912, n.s.). Again, as for sucrose, there was no significant 
interaction between drug dose and Intralipid concentration: (F 6 M =0.700, n.s.), 
(see Table 5.5). 
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Figure 5.8 Number of licks for sucrose and intralipid drinking in a brief contact 
test as a function of increasing dose of raclopride (0.03-0.3 mg/kg) + S.E.M. 
Asterisk indicates significantly different from vehicle *p<0.05; Plus indicates 
significantly different from vehicle +p<0.01. 
Table 5.6 Main effect of fluid concentration on total number of licks. 
Mean number of licks * S.E.M. 
Fluid (%) 1 3 10 
Sucrose 66.3±9.4 161.0±15.2 290.1±17.6 
Intralipid 59.2±12.2 83.9±15.9 191.3±21.3 
n=10 animals per test fluid group 
Figure 5.8 shows that number of licks were reduced as a function of dose of 
raclopride. This result was statistically significant: (F 3 „ = 3.041, p<0.05). There 
was also a highly significant effect of sucrose concentration on the number of licks: 
(F 2 l g = 181.408, rxO.0001) and the relationship between concentration and 
number of licks was monotonia (see Table 5.6). However, there was no significant 
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interaction between drug dose and sucrose concentration: (F 6 M =0.442, n.s.). 
Post hoc tests revealed that the highest dose of raclopride (0.3 rag/kg) was 
significantly different to vehicle controls. 
The number of licks for Intralipid were also reduced as a function of dose of 
raclopride. Unlike those for sucrose, number of licks for Intralipid were not 
decreased significantly: (F 3 2 7 = 1.499, n.s.). As was the case for sucrose, 
concentration had a marked incremental effect on the number of licks for Intralipid: 
(F 2 l f p 19.794, p<0.0001), (see Table 5.6). Again, there was no significant 
interaction between drug dose and Intralipid concentration: (F 6 ^ =0.967, n.s.). 
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Figure 5.9 Mean bout duration for sucrose and intralipid drinking in a brief 
contact test as a function of increasing dose of raclopride (0.03-03 mg/kg) + 
S.E.M. 
Table 5.7 Main effect of fluid concentration on mean bout duration . 
Mean bout duration * S.E.M. 
Fluid (%) 1 3 10 
Sucrose 1.7±0.2 2.5±0.3 5.4±0.9 
Intralipid 1.5±0.2 2.0±0.3 2.4±0.2 
n=10 animals per test fluid group 
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Figure 5.10 Mean bout duration of licking for 1,3 and 10% Intralipid as a 
function of dose 7-OH-DPAT (0.1-1.0 mg/kg) + S.E.M. 
Mean bout duration of licking for sucrose was reduced overall by raclopride 
(see Figure 5.9). The reduction in mean bout duration by raclopride was non-
significant: (F 3 2 7 = 1.635, n.s.). Changes in mean bout duration as a function of 
dose of raclopride were not uniform across all sucrose concentrations; mean bout 
duration was most noticeably attenuated when animals were drinking 10% sucrose 
solutions. There was a highly significant main effect of sucrose concentration on 
mean bout duration: (F ^  1 8 = 29.167, p<0.0001), (see Table 5.7); this was 
demonstrated as a linear increase in mean bout length as concentration increased. 
There was no significant interaction between drug dose and sucrose concentration: 
(F 6 5 4 =0.520, n.s.). 
Figure 5.9 also shows that mean bout duration of licking for Intralipid was 
shortened overall as a function of dose of raclopride. Although this decrease was 
not linear, the main effect of drug was statistically significant (F 3 2 7 = 7.789, 
pcO.Ol). Increasing Intralipid concentration led to an increase in mean bout 
duration which was also significant: (F 2 1 8 = 10.041, p<0.01), (see Table 5.7). 
Unlike sucrose, there was a significant interaction between drug dose and Intralipid 
concentration: ( F 6 M =3.397, p<0.001). 
181 
Chapters 
Number of bouts 
Table 5.8 Main effect of fluid concentration on mean number of bouts. 
Mean number of bouts * S.E.M. 
Fluid (%) 1 3 10 
Sucrose 4.6±0.5 8.7±0.8 10.8±0.9 
Intralipid 3.8±0.6 4.9±0.9 10.2±1.2 
n=10 animals per test fluid group 
Although there was no significant overall main effect of drug on mean bout 
frequency: (F 3 2 7 = 0.391, n.s.), the number of bouts were reduced by raclopride 
when animals were drinking 1 and 3% sucrose but were increased when these 
animals were drinking 10% sucrose. Increasing concentration of sucrose led to a 
monotonic increase in bouts that was statistically significant (F x l g = 31.557, 
p<0.0001), (see Table 5.8). There was however, no significant interaction between 
drug dose and sucrose concentration: (F 6 ^ =1.419, n.s.). 
A similar pattern of results was observed in animals licking for Intralipid. 
There was no main effect of drug on mean bout frequency: (F 3 2 7 = 0.287, n.s.). 
Again, for Intralipid, the number of bouts were reduced by raclopride when 
animals were drinking 1 and 3% Intralipid but were increased when these animals 
were drinking 10% Intralipid. As concentration of Intralipid increased so did the 
number of bouts and this effect of concentration was significant (F 2 l g = 32.623, 
p<0.0001), (see Table 5.8). There was no significant interaction between drug 
dose and Intralipid concentration: (F 6 „ =0.396, n.s.). 
Intrabout lick rate 
Licks within a bout for sucrose were not significantly affected by either 
drug: (F 3 2 7 = 0.111, n.s.) or sucrose concentration: (F 2 1 8 = 0.787, n.s.). Nor 
was there a significant interaction between drug dose and sucrose concentration: (F 
6 54 =1.960, n.s.). 
In the case of Intralipid, the results are very similar to those of sucrose. 
There was no significant main effect of drug: (F 3 2 7 = 0.088, n.s.) or Intralipid 
concentration: (F x 1 8 = 0.518, n.s.). There was no significant interaction between 
drug dose and Intralipid concentration: (F 6 ^ =0.575, n.s.). 
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Average interiick interval 
The average interiick interval for sucrose increased slightly as a function of 
dose raclopride. This effect was non-significant: (F 3 2 7 = 0.267, n.s.). 
Concentration had no effect average interiick interval: (F 2 ig= 0.438, n.s.), nor 
was there any significant interaction between drug dose and sucrose concentration: 
( F 6 S 4 = 1.629, n.s.). 
The average interiick interval for Intralipid decreased as a function of 
raclopride but non-monotonically. This effect was non-significant (F 3 2 7 = 0.214, 
n.s.). Concentration, increased average interiick interval for those drinking 
Intralipid but this relationship was non monotonic and the result was non-
significant (F 2 1 8= 0.982, n.s.). As with sucrose, there was no significant 
interaction between drug dose and Intralipid concentration for this parameter (F 6 M 
= 1.256, n.s.). 
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Experiment 6: Early effects of SCH 23390 on the microstructure of licking: a brief 
contact test. 
A brief contact licking test involves the presentation of differing 
concentrations of selected fluids for 60 seconds. Below are the licking parameters 
measured after the administration of SCH-23390. A brief contact licking test 
involves the presentation of differing concentrations of selected fluids for 60 
seconds. Below are the licking parameters measured after the administration of 
SCH-23390. The parameters measured were number of licks, mean bout duration, 
number of bouts, intrabout lick rate (and average interlick interval) as well as 
latency. Animals licking for all concentrations of Intralipid emulsions or sucrose 
solutions are represented in Table 5.9. 
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Table 5.9 The average (+ S.E.M.) of the feeding parameters at each dose of 
SCH-23390 and at each sucrose / Intralipid concentration (1,3 and 10%). 
Dose SCH-23390 (mg/kg) 
0.0 0.01 0.03 0.1 0.0 0.01 0.03 0.1 
Sucrose Intralipid 
Latency 
(s) 
Fluid (%) 
1 2.6 3.7 6.1 32.8 8.7 15.2 3.8 54.3 
(0.7) (2.1) (2.1) (10.1) (4.2) (6.4) (1.2) (5.7) 
3 1.9 6.2 10.7 29.6 5.5 16.3 31.6 37.8 
(0.6) (3.9) (6.6) (9.2) (1.6) (6.8) (8.5) (7.9) 
10 2.8 13.6 14.2 11.5 10.3 28.2 12.8 40.9 
(1.4) (7.0) (7.3) (7.0) (4.1) (8.0) (5.5) (7-5) 
Number of 
licks 
Fluid (%) 
1 183.6 130.0 193.4 46.6 206.8 94.1 207.1 2.7 
(43.5) (28.7) (36.6) (24.4) (32.4) (25.1) (31.8) (2.7) 
3 278.5 285.7 236.7 138.6 226.9 226.6 84.3 81.1 
(20.6) (36.5) (45.6) (49.3) (37.9) (31.8) (33.9) (37.1) 
10 341.7 242.6 290.1 244.0 308.7 244.8 244.8 74.9 
(9.0) (46.6) (36.6) (46.0) (15.9) (44.4) (42.7) (34.8) 
Mean bout 
duration 
(s) 
Fluid (%) 
1 3.4 2.1 3.4 0.8 3.0 1.6 4.0 0.08 
(0.8) (0.4) (0.6) (0.3) (0.5) (0.3) (1.2) (0.08) 
3 3.2 6.3 5.8 3.6 3.4 3.1 1.5 1.4 
(0.3) (1.3) (3.0) (2.1) (0.9) (0.7) (0.6) (0.6) 
10 6.6 7.2 7.2 12.5 3.6 4.5 4.0 1.1 
(1.0) (2.9) (1.9) (6.3) (0.9) (1.4) (10) (0.4) 
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(Table 5.9 continued) 
Number of 
bouts 
Fluid (%) 
1 7.5 
(0.9) 
8.5 
(1.1) 
8.5 
(1.4) 
3.8 
(1.7) 
10.5 
(1.8) 
7.1 
(1.9) 
10.6 
(1.9) 
0.5 
(0.5) 
3 13.4 
(1.3) 
11.0 
(1.7) 
9.3 
(1.8) 
5.7 
(1.9) 
11.0 
(1.9) 
12.0 
(2.0) 
5.4 
(2.2) 
4.7 
(2.2) 
10 
Intrabout 
lick rate 
(licks/s) 
9.1 
(0.9) 
9.2 
(1.8) 
7.6 
(1.6) 
5.5 
(1.9) 
16.1 
(1.8) 
8.5 
(1.8) 
9.6 
(2.1) 
5.4 
(2.7) 
Fluid (%) 
1 6.5 
(0.2) 
6.3 
(0.2) 
5.6 
(0.4) 
3.1 
(1.0) 
6.7 
(0.2) 
6.0 
(0.7) 
6.1 
(0.2) 
0.6 
(0.6) 
3 6.3 
(0.1) 
5.9 
(0.07) 
5.5 
(0.7) 
3.6 
(0.9) 
6.8 
(0.2) 
5.6 
(0.6) 
3.8 
(1.0) 
3.1 
(1.0) 
10 6.3 
(0.08) 
5.3 
(0.7) 
5.3 
(0.7) 
4.8 
(0.6) 
6.5 
(0.1) 
5.0 
(0.8) 
6.2 
(0.9) 
4.0 
(1.1) 
Inteiiick 
interval 
(msec) 
Fluid (%) 
1 160.2 
(7.8) 
162.8 
(5.1) 
190.3 
(21.0) 
108.4 
(36.6) 
151.1 
(5.1) 
137.4 
(15.9) 
165.4 
(3.9) 
18.1 
(18.1) 
3 161.4 
(3.7) 
170.2 
(2.1) 
145.9 
(18.6) 
125.7 
(31.8) 
149.3 
(4-0) 
145.9 
(16.5) 
104.1 
(24.1) 
96.3 
(26.6) 
10 159.9 
(2.1) 
149.7 
(18.9) 
150.1 
(21.0) 
165.7 
(21.6) 
155.1 
(2.6) 
129.2 
(21.7) 
130.3 
(21.9) 
79.5 
(26.9) 
n= 9 animals per group (Sucrose) 
n= 10 animals per group (Intralipid) 
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Figure 5.11 Latency to drink sucrose and Intralipad in a brief contact test as a 
function of increasing dose of SCH-23390 (0.01-0.1 mg/kg) + S.EM. 
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Figure 5.12 Latency to drink 1,3 and 10% sucrose as a function of dose SCH-23390 
(0.01-0.1 mg/kg) + S.E.M. 
187 
Chapter 5 
1% 
3% 
10% 
0.00 0.01 0.03 0.10 
Dose Sch 23390 (mg/kg) 
Figure 5.13 Latency to drink 1, 3 and 10% Intralipid as a function of dose SCH-
23390 (0.01-0.1 mg/kg) + S.E.M. 
Figure 5.11 illustrates that latency to start drinking sucrose was increased as a result 
of increasing doses of SCH-23390. This result was statistically significant: (F 3 M = 
4.922, p<0.01) and the relationship between drug dose and latency was monotonia This 
effect of drug on latency was most prominent in animals drinking 1% sucrose, where at 
the highest dose (0.1 mg/kg) SCH-23390 produced latencies which were ten times those 
of animals who had been treated with vehicle (see Figure 5.12). There was no effect of 
sucrose concentration on the latency to start drinking: (F 2 1 6 = 0.064, n.s.) and there was 
a significant interaction between drug dose and sucrose concentration: (F 6 ^ = 2.957, 
p<0.05.). 
Similarly, as dose SCH-23390 increased so did latency to start drinking Intralipid 
(see Figure 5.11). This led to a significant main effect of drug: (F 3 2 7 = 4.992, p<0.01). 
Intralipid concentration had a negligible effect on latency and so this result was non-
significant (F ^  1 8 = 0.279, n.s.). Again, a highly significant interaction was found 
between drug dose and Intralipid concentration: (F 6 54 = 5.694, p<0.0001), (see Figure 
5.13). 
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Figure 5.14 Number of licks for sucrose and Intralipid in a brief contact test as a 
function of increasing dose Sch-23390 (0.01-0.1 mg/kg) + S.E.M. Plus indicates 
significantly different from vehicle +p<0.01. 
Table 5.10 Main effect of fluid concentration on total number of licks. 
Mean number of licks * S.E.M. 
Fluid (%) 1 3 10 
Sucrose 138.4±19.1 234.9±21.4 279.6±19.3 
Intralipid 127.7±18.5 154.7±20.5 218.3±22.3 
n= 9 animals per group (Sucrose) 
n= 10 animals per group (Intralipid) 
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Figure 5.15 Total number of licks for 1,3 and 10% Intralipid as a function of 
dose SCH 23390 (0.01-0.1 mg/kg) + S.E.M. 
Figure 5.14 reveals mat number of licks for sucrose were decreased as a function of 
dose SCH-23390. There was a significant main effect of drug dose on number of licks: 
(F 3 M = 3.993, px0.05). Conversely, as sucrose concentration increased so did the 
number of licks (see Table 5.10). This effect of concentration was highly significant (F 2 
1 6 = 36.067, fxO.0001). Drug dose and sucrose concentration did not interact 
significantiy: (F 6 ^ = 1.362, n.s.). Only the highest dose of SCH-23390 (0.1 mg/kg) 
was shown to have significantly different effects to vehicle controls. 
The number of licks for Intralipid decreased overall after the administration of SCH-
23390 (see Figure 5.14). This led to a highly significant main effect of drug: (F 3 2 7 
=14.561, rx0.05). Table 5.10 shows that number of licks increased as a function of 
Intralipid concentration. This led to a significant main effect of mis variable: (F z , 8 = 
10.929, p<0.01). There was also a significant interaction between drug dose and Intralipid 
concentration: (F 6 M = 4.082, p<0.01) (see Figure 5.15). 
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Figure 5.16 Mean bout duration for sucrose and intralipid drinking in a brief 
contact test as a function of increasing dose SCH-23390 (0.01-0.1 mg/kg) + 
S.E.M. Plus indicates significantly different from vehicle +p<0.01. 
Table 5.11 Main effect of fluid concentration on mean bout duration . 
Mean bout duration * S.E.M. 
Fluid (%) 1 3 10 
Sucrose 2.5±0.3 4.8±1.0 8.4±1.8 
Intralipid 2.2±0.4 2.3±0.3 3.3±0.5 
n= 9 animals per group (Sucrose) 
n=10 animals per group (Intralipid) 
Results displayed in Figure 5.16 reveal that there was no significant effect of drug 
on the mean bout duration of animals drinking sucrose: (F 3 M =0.112, n.s.). Increasing 
concentration also augmented the length of bouts in a monotonic fashion and this result 
was significant: (F 2 1 6 = 10.929, p<0.05), (see Table 5.11). There was no significant 
interaction between drug dose and sucrose concentration: (F 6 ^ = 1.524, n.s.). 
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In the case of Intralipid, mean bout duration did decrease as a function of drug dose 
and this effect was significant: (F 3 2 7 =4.943, p<0.01). Length of bouts increased 
significantly as a function of Intralipid concentration: (F 2 , 8 = 4.817, p<0.05), (see Table 
5.11). As with sucrose, there was no significant interaction between drug dose and 
Intralipid concentration: (F 6 M = 1.934, n.s.). Post hoc tests revealed that at the highest 
dose (0.1 mg/kg) SCH-23390 reduced the length of bouts when compared to vehicle 
controls. 
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Figure 5.17 Number of bouts of sucrose and Intralipid drinking in a brief 
contact test as a function of increasing dose SCH-23390 (0.01-0.1 mg/kg) + 
S.E.M. Plus indicates significantly different from vehicle +p<0.01. 
Table 5.12 Main effect of fluid concentration on mean number of bouts . 
Mean number of bouts * S.E.M. 
Fluid (%) 1 3 10 
Sucrose 7.1±0.7 9.9±1.0 8.1±0.8 
Intralipid 2.2±0.4 2.3±0.4 3.3±0.5 
n= 9 animals per group (Sucrose) 
n= 10 animals per group (Intralipid) 
193 
Chapters 
20 
T 
15 
T a • T T • 10 
T 
I; 
• 
!!! 
r 0 
El i % 
H 3% 
10% 
0.00 0.01 0.03 0.10 
Dose Sch-23390 (mg/kg) 
Figure 5.18 Number of bouts of licking for 1,3 and 10% Intralipid as a 
function of dose SCH 23390 (0.01-0.1 mg/kg) + S.E.M. 
Figure 5.17 illustrates that mean bout frequency for sucrose decreased dose-
dependently as a function of increasing dose of SCH-23390 and this result was 
significant (F 3 M =4.116, p<0.05). As sucrose concentration increased so did the 
number of bouts, however the relationship was non-monotonic (see table 5.12). This 
result was significant: (F 2 1 6 = 5.827, p<0.05). There was no significant interaction 
between drug dose and sucrose concentration: (F 6 ^ = 0.992, n.s.). Post hoc tests 
showed that the highest dose of SCH-23390 (0.1 mg/kg) was significantly different to 
vehicle controls (results not shown). 
Mean bout frequency for Intralipid decreased dose-dependently as a function of 
increasing dose of SCH-23390 and this result was highly significant: (F 3 „ =8.183, 
p<0.001). The mean bout frequency for Intralipid increased monotonically as a function 
of concentration (see Table 5.12) but this result was not significant: (F 2 , 8 = 2.825, n.s.). 
In the case of Intralipid there was a significant interaction between drug dose and Intralipid 
concentration: (F 6 < „ = 3.163, n.s.), (see Figure 5.18). 
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Figure 5.19 Intrabout lick rate for sucrose and Intralipid drinking in a brief contact test 
as a function of increasing dose SCH-23390 (0.01-0.1 mg/kg) + S.E.M. Plus indicates 
significantly different from vehicle +p<0.01. 
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Figure 5.20 Intrabout lick rate for 1,3 and 10% Intralipid drinking as a function 
of dose SCH 23390 (0.01-0.1 mg/kg) + S.E.M. 
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The rate of licking within a bout for sucrose decreased monotonically as the dose 
SCH-23390 increased (see Figure 5.19). This result was significant: (F 3 M =5.013, 
fxO.Ol) Drug dose had the most profound effect when animals were licking for 1% 
sucrose, (results not shown). The concentration of sucrose had no effect on this 
parameter. (F 2 l 6 = 0.081, n.s.), nor was there a significant interaction between drug dose 
and sucrose concentration: (F 6 4 8 = 2.161, n.s.). The highest dose of SCH-23390 (0.1 
mg/kg) reduced intrabout lick rate significantly when compared to vehicle controls in a 
post hoc test (results not shown). 
Intrabout lick rate for Intralipid also decreased as a function of dose SCH-23390 
with the most dramatic reductions occurring when animals were drinking 1% Intralipid 
and had received the highest drug dose (see Figure 5.20). This result was highly 
significant (F 3 2 7 =11.925, p<0.0001). As with sucrose, intrabout lick rate was hardly 
affected by Intralipid concentration despite a slight increase in rate in response to 10% 
Intralipid. This result was non-significant: (F 6 ^ =1.808, n.s.). Unlike sucrose, there 
was a significant interaction between drug dose and Intralipid concentration: (F 6 M = 
4.373, p<0.01). 
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Figure 5.21 Average interlick interval for sucrose and Intralipid drinking in a brief 
contact test as a function of increasing dose SCH-23390 (0.01-0.1 mg/kg) + S.E.M. 
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Figure 5.22 Average interlick interval for 1,3 and 10% Intralipid drinking as a 
function of dose SCH 23390 (0.01-0.1 mg/kg) + S.E.M. 
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Figure 5.21 shows that the main effect of drug failed to reach statistical 
significance: (F 3 M = 1.420, n.s.). Concentration did not significantly affect 
average interlick interval: (F 2 1 6 = 0.1, n.s.), nor was there any significant 
interaction between drug dose and sucrose concentration: (F 6 4 8 = 1.461, n.s.). 
The changes in average interlick interval induced by SCH-23390 for 
Intralipid were dose-dependent This main effect was significant (F 3 2 7 = 8.846, 
rxO.001). Intralipid concentration, however, did not affect average interiick 
interval (F 2 1 ^= 0.190, n.s.). Unlike sucrose, there was a significant interaction 
between drug dose and Intralipid concentration for this parameter (F 6 M = 4.699, 
rxO.001), (see Figure 5.22). 
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Summary 
Table 5.13 Effects of concentration on latency and microstructural parameters of 
licking for sucrose solutions or Intralipid emulsions in a brief contact test. 
Test Fluid 
Sucrose Inlraiipid 
1% 3% 10% 1% 3% 10% 
Latency ,_, 
Number of licks 
ft ft ft ft 
Mean bout 
duration (s) 
ft ft ft ft ft 
Number of bouts 
ft ft ft ft 
Intrabout lick rate 
(licks/s) 
Average interiick 
interval (ms) 
ft 
CZJ = 
n=10 per drug group per dose* 
*n=9 for SCH-23390/Sucrose 
= significant decrease (p<0.05) 
= n.s. effect of concentration 
ft = significant increase (p<0.05) 
7-OH = 7-OH-DPAT (0.1-1.0 mg/kg) 
Rac = raclopride (0.03 - 0.3 mg/kg) 
SCH = SCH 23390 (0.01 - 0.1 mg/kg) 
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Table 5.14 Drug effects on latency and microstructural parameters of licking for 
sucrose solutions or Intralipid emulsions in a brief contact test. 
T e s t Fluid 
Sucrose Intralipid 
7-OH Rac SCH 7-OH Rac SCH 
Latency 
ft = 
Number of licks 
Mean bout 
duration (s) 
Number of bouts E Z 3 
Intrabout lick rate 
(licks/s) 
Average interlick 
interval (ms) =» 
n=10 per drug group per dose* 
*n=9 for SCH 23390/Sucrose 
4 - significant decrease (p<0.05) 
= n.s. effect of drug dose 
= significant increase (p<0.05) 
7-OH = 7-OH-DPAT (0.1-1.0 mg/kg) 
Rac = raclopride (0.03 - 0.3 mg/kg) 
SCH = SCH 23390 (0.01 - 0.1 mg/kg) 
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5.4 Discussion 
By shortening the test period to eliminate post-ingestive stimuli, it becomes 
possible to isolate the effects of drags on the initial hedonic evaluation of the 
consumed fluid. It was predicted that increasing concentration of sucrose and 
Intralipid using a brief contact test would result in an increase in the mean bout 
duration of licking for either test fluid. As is clear from table 5.13, the effects of 
fluid concentration for sucrose and Intralipid on microstructural parameters were 
extremely similar, echoing the results of Higgs and Cooper (1996). Increasing 
concentrations of either sucrose or Intralipid gave rise to an increase in the number 
of licks, an increase in mean bout duration and an increase in the number of bouts. 
Neither latency nor intrabout lick rate were affected by the concentration of 
the test fluid. The consistent observation that concentration has little or no effect on 
either intrabout lick rate and/or average interlick interval allows us to infer that any 
changes in these parameters are due to changes that are not related to the palatability 
of the diet. However, in Experiment 4, animals licking for Intralipid showed an 
increase in average interlick interval without an incumbent decrease in the reciprocal 
of this measure, intrabout lick rate. The effect of concentration on average interlick 
interval in Experiment 4 was monotonic yet small. In addition, this effect did not 
appear for either test fluid in Experiments 5 or 6. Therefore, this result does not 
seriously question the validity of the above interpretation of this measure (i.e. that 
intrabout lick rate is insulated from changes in concentration). Nevertheless, it has 
been suggested that when more viscous solutions are used there can be a 
concomitant increase in average interlick interval (Davis, 1996). Taken together, 
these results represent further confirmation of the model for the control of ingestion 
of Davis and Levine (1977). 
The drug effects on microstructural parameters are less clear cut 
Previously, in Chapter 1 it was found that dopaminergic drugs could affect those 
licking parameters which most robustly reflected palatability (i.e. initial rate of 
licking and mean bout duration). One of the aims of Experiments 4,5 and 6 was to 
examine further the specificity of the effects of dopaminergic compounds on licking 
behaviour. For example, Davis and Smith (1992) showed that by making the 
drinking spout gradually more inaccessible to animals (so that they had to 
effectively "reach" for the spout) led to a gradual decrease in intrabout lick rate. 
Intrabout lick rate seems to measure motoric competence, and therefore any change 
in ingestion due to changes in intrabout lick rate (in the absence of any significant 
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decrease in mean bout duration) might indicate a motoric explanation to account for 
decreased ingestion. 
In the case of sucrose ingestion, only 7-OH-DPAT decreased mean bout 
duration significantly, probably due to the highest dose (1.0 mg/kg). This 
compound also decreased intrabout lick rate by increasing the length of the average 
interlick interval. Latency was also increased by 7-OH-DPAT, again probably due 
to the highest dose. Latency is often seen as a measure of motor competence as 
increases in latency suggest difficulty in approaching the drinking spout (Smith, 
1996). Hence, drug effects on this measure could reflect the operation (or not as 
the case may be) of a mechanism which is necessary to induce feeding. Therefore, 
7-OH-DPAT, at the doses used, seems to affect those parameters which best reflect 
both palatability and also the motoric competence necessary to execute approach. 
In the case of raclopride the number of licks for sucrose decreased 
significantly, as a result of small changes in several parameters. Statistical tests did 
not identify any specific way in which this decrease in the number of licks was 
achieved (i.e. through a decrease in mean bout duration or a decrease in intrabout 
lick rate). It may be inferred that raclopride produces a non-specific decrease in 
ingestion in this brief-contact test situation. SCH- 23390 increased the latency to 
lick and also decreased the intrabout lick rate and number of bouts without 
selectively affecting the mean bout duration. This profile is most probably 
characteristic of a motoric deficit. The decremental effect on number of bouts is 
suggestive of a fragmentation of normal feeding (Asin et al., 1992), as was the 
effect of SCH- 23390 on intrabout lick rate. 
In the case of Intralipid ingestion, 7-OH-DPAT decreased the number of 
licks by increasing the latency to lick, shortened the bout length, decreased the 
number of bouts and decreased the intrabout lick rate by lengthening average 
interlick interval. Drug effects of SCH- 23390 and 7-OH-DPAT on licking for 
Intralipid were similar. The only parameter to be significantly affected in animals 
that received raclopride was mean bout duration which was significantly reduced, 
but not sufficiently to produce a significant decrease in number of licks. Therefore, 
there seems to be compensation for the decreases in mean bout duration by means 
of an increase in number of bouts (probably induced by the 0.03 and 0.1 dose of 
raclopride; see Figure 5.10) as this compound had very little effect on intrabout lick 
rate (see table 5.5). 
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In summary, the drug effects on licking microstructure show that there are 
differential effects on licking parameters dependent upon the dopamine receptor 
subtypes at which they exert their effects. From the overall results it seems mat the 
ingestion of Intralipid may be slightly more sensitive to dopaminergic drug effects 
than that of sucrose. Moreover, the difference in behavioural effects go some way 
to 
distinguishing neuroleptic-induced motoric and non-motoric effects on licking 
microstructure. It was predicted in the introduction that a D l antagonist and a 
putative D3 receptor agonist might be less likely to induce motoric effects than a D2 
receptor antagonist owing to the brain areas at which these drugs are purportedly 
acting (Coffin et al., 1989; Fowler and Liou, 1994). However, the opposite 
seems to be so, at least at the doses used in Experiments 4, 5 and 6. Thus, this 
hypothesis was not supported by the results from the brief contact tests used here. 
The motoric deficits induced by SCH-23390 and 7-OH-DPAT are more consistent 
with the results of Fowler and Liou (1994) than those of Schneider et al. (1990). 
This conclusion is bolstered by results from a pilot study carried out in our 
laboratory (results not included here). 7-OH-DPAT (0.1-1.0 mg/kg) was shown to 
reduce locomotion and rearing dose-dependently. 
Nevertheless, the increases in latency and the decreases in intrabout lick rate 
induced by both SCH-23390 and 7-OH-DPAX do not preclude effects of these 
drugs on the palatability of the test fluids. As measured by mean bout duration, 7-
OH-DPAT and SCH-23390 also decreased the palatability of sucrose solutions and 
Intralipid emulsions. Therefore, these compounds could be having early meal 
effects which are at once motoric and also related to the hedonic evaluation of the 
tastant, a view which is at odds with those studies which emphasise only motoric 
effects of dopaminergic compounds in a brief contact test (Pecina and Berridge, 
1997, see Chapter 1). In general, the results from the brief contact tests 
(Experiments 4, 5 and 6) do not present a strong argument for a specific effect of 
these dopaminergic compounds on palatability. 
Very recently, results have come to light which further implicate the D l 
receptor in the mediation of orolingual/orophyrangeal motor control. Jia et al., 
(1998) observed that SCH- 23390 inhibits the swallowing reflex in guinea pigs 
which necessarily affected their drinking behaviour. This could account for the 
decrease in intrabout lick rate observed after SCH-23390 administration in 
Experiment 6. However, as is applicable to all the Experiments presented up to this 
point, caution must be used in ascribing particular behavioural roles to discrete 
receptor subtypes when the pharmacological specificity of compounds is 
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questionable. For example, SCH-23390, although often viewed as a prototypical 
Dl antagonist, has been shown, under certain conditions, to exert dopamine Dl 
agonist like effects. Chapter 1 has already discussed the debatable affinities 
reported for the dopamine D3 receptor. Therefore, the next chapter contains 
experiments which attempt to elucidate further the pharmacological specificity of 
behavioural effects induced by putative D3 receptor agonists such as 7-OH-DPAT. 
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Chapter 6: Attempts to block the effects of 7-OH-DPAT on 
licking microstructure using the dopamine D3 receptor 
antagonist PNU-99194A or the mixed dopamine D3/D2 
antagonist amisulpride 
6.1 Introduction 
In an attempt to further outline a behavioural profile for D3 receptors, 
several D3 receptor antagonists have been developed and investigated preclinically 
(see Table 1.3, Chapter 1). For the purposes of the experiments in this Chapter, 
two D3 receptor antagonists were chosen in an endeavour to block the effects of 7-
OH-DPAT on licking responses which have already been established in Chapters 1 
and 2. Integral to the design of Experiments 7 and 8 were conditions where the 
effects of D3 receptor antagonists alone and in combination on licking 
microstructure could be assessed. 
The first antagonist chosen was PNU-99194A and this compound was used 
in Experiment 7. There are several reports of the behavioural effects of this 
antagonist alone and in combination with putative D3 receptor agonists such as 7-
OH-DPAT. Originally, PNU-99194A was identified and shown to have 25-fold 
selectivity for D3 receptor sites over D2 receptor sites and to induce behavioural 
stimulation in the absence of any concomitant change in dopamine release, 
consistent with blockade of postsynaptic D3 receptors (Waters et al., 1993). 
Further, PNU-99194A along with other D3 receptor-preferring antagonists, 
produce mild locomotor activation and have also been shown to establish a 
conditioned place preference in rats (Svensson etal., 1986,1993; Waters etal., 
1993; Mallet and Beninger, 1994; Kling-Petersen et al., 1995 a, b). 
Drug discrimination procedures have often been employed to classify novel 
substances such as PNU-99194A and to examine the neural mechanisms involved 
in the discriminative stimulus effects (or subjective effects) of such drugs. These 
methods have revealed that PNU-99194A, despite its locomotor activating effects, 
does not have discriminative stimulus effects similar to those of the psychomotor 
stimulants (Baker et al., 1997). 
Clifford and Waddington (1998) recently found the behavioural effects of 
PNU-99194A to be much broader than just stimulation of locomotion. They 
produced an "ethogram" which highlighted the behavioural effects of PNU-99194A 
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as inducing non-stereotyped sniffing, locomotion and some rearing, with both non-
consummatory chewing and eating of faecal pellets and cage bedding. Eating was 
induced by PNU-99194A only at high doses of this compound (15 and 45 mg/kg) 
which renders the pharmacological specificity of this effect debatable. 
Therefore, one of the aims of Experiment 7 was to further characterise 
PNU-99194A in terms of its low dose effects on feeding behaviour. In the light of 
results from other reward paradigms such as conditioned place preference it might 
be expected that PNU-99194A would have an effect on componenents of food 
reward. A brief contact test was employed to assess the effects of this D3 receptor 
antagonist on licking parameters. As 7-OH-DPAT has been shown, in previous 
chapters, to reliably reduce number of licks by means of decreasing mean bout 
duration of licking for tastants it was predicted that PNU-99194A would increase 
these salient parameters. 
Despite its well documented status as a D3 receptor antagonist, PNU-
99194A has only once been used in an attempt to abolish the behavioural effects of 
the putative D3 receptor agonist, 7-OH-DPAT. Using the discriminative stimulus 
method, Baker et al., (1998) conclude that PNU-99194A fails to block 7-OH-
DPAT substitution for d-amphetamine or cocaine. Therefore, a further aim of 
Chapter 7 was to attempt to block the previously established effects of 7-OH-DPAT 
on licking microstructure. 
Experiments 8 and 9 used another antagonist for the D3/D2 receptor, the 
atypical benzamide antipsychotic, amisulpride. Clinically, atypical neuroleptics are 
defined as drugs that are active in the treatment of schizophrenia but have a lesser 
propensity to induce extrapyramidal side effects than conventional neuroleptics (see 
Chapter 1). Within session response decrements which have been taken as 
characteristic of classical neuroleptics such as haloperidol and pimozide are not 
evident for a number of atypical neuroleptics (Sanger and Perrault, 1995). As these 
atypical compounds are claimed to produce fewer motor side effects than more 
traditional neuroleptics, this result confirms the view that within-session response 
decrements are probably the result of motor impairments. 
Amisulpride also differs from most other antipsychotic drugs in showing 
similar affinities for D2 and D3 receptors (Schoemaker et al., 1997). In vivo, in 
rats, amisulpride blocks preferentially D2 and D3 receptors in limbic structures in 
comparison with its ability to block receptors found in the striatum (Schoemaker et 
al., 1997). Therefore, amisulpride has a combination of at least three 
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neurochemical properties which make it unique in the class of neuroleptics. The 
properties are a selectivity for D3 receptors (and to a slightly lesser extent D2 
receptors) (Schoemaker et al., 1997), limbic selectivity and preferential affinity at 
low doses for presynaptic dopamine autoreceptors (Scatton et al., 1997). 
For example, in rats, amisulpride preferentially inhibits effects produced by 
low doses of apomorphine (hypomotility and yawning) related to the stimulation of 
presynaptic D2/D3 autoreceptors (0.1 and 0.3 mg/kg). In contrast to this, at higher 
doses (i.e. 30 mg/kg) amisulpride antagonised apomorphine induced hypermotility, 
a postsynaptic dopamine receptor-mediated effect (Sanger etal., 1996). In 
addition, amisulpride does not induce catalepsy even at very high doses (i.e. 100 
mg/kg) (Millan et al., 1995) but there is one report that it may induce catalepsy in 
mice at high doses (Navarro et al., 1997). 
As is mentioned above, amisulpride, has been found (at low doses) to 
selectively antagonise the effects of dopamine agonists mediated by autoreceptors 
(Storey et al., 1995; Perrault et al., 1997). It has been shown that the rate 
decreasing effects of 7-OH-DPAT on operant responding can be antagonised by 
low doses (1 and 3 mg/kg) of amisulpride. As these doses of amisulpride have 
been shown to exert preferential activity at presynaptic dopamine receptors it is 
assumed that the rate-decreasing effects of 7-QH-DPAT are a result of this 
compound acting at presynaptic sites. This is further confirmed by the study of 
Gilbert et al. (1995). Their experiments were designed to test further the idea that 
7-OH-DPAT had its effects at Dopamine autoreceptors to reduce intracranial 
dopamine levels and to reduce a behaviour that was dopamine-dependent (electrical 
stimulation to the ventral tegmental area). They found that 7-OH-DPAT quickly and 
dose-dependently reduced responding for brain stimulation reward delivered to this 
brain area 
It has also been shown that low doses of amisulpride (0.5 and 1 mg/kg) can 
also potentiate a food-induced conditioned place preference (Guyon et al., 1993). 
This effect is described as reflecting a "pro-hedonic" property of amisulpride which 
has a neural basis in the potentiation of the release of dopamine (which is 
unconditionally evoked by food but see Chapter 1 etc.), through a selective 
blockade of the release modulating D2-autoreceptors. This contrasts with the usual 
effect of neuroleptics to reduce food-induced conditioned place preference (see 
Chapter 2). 
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These results (i.e. prohedonic or hyperphagic effects) are not always found 
to be expressed in the same way for the classical and the atypical antipsychotics. 
For example, increase in meal size observed after the administration of classical 
neuroleptics (Clifton et al., 1991; Clifton, 1995) is absent in the case of the 
atypical neuroleptics (Clifton and Lee, 1998). Classical neuroleptics, when 
administered chronically, produce weight gain and often obesity (Stanton, 1995). 
In an animal model of neuroleptic induced obesity (female rats treated chronically 
with the atypical antipsychotic sulpiride for 21 days) it was found that weight gain 
was associated with accompanying hyperphagia which can be prevented in rats by 
the application of food restriction (Baptista et al., 1998). Therefore it is the 
induction of hyperphagia rather than metabolic changes (i.e. in adipose tissue) 
which seems to lead to neuroleptic induced obesity. 
Therefore, the aims of the present experiments were to discover whether 
low doses of amisulpride, purportedly working at pre-synaptic D3 receptors, could 
abolish the effects of 7-OH-DPAT on selected feeding parameters (Experiment 8), 
which have been reliably demonstrated to be decrease by this drug in Chapters 4 
and 5. Also, we tested whether the putative D3 receptor antagonist PNU-99194A 
could reverse the effects of 7-OH-DPAT on licking responses (Experiment 7). 
Integral to the design of these experiments were conditions where the effects of 
these antagonists alone on feeding could be assessed. Therefore, these antagonist 
were examined as to their effects on feeding behaviour and to further test the idea 
that admininstration of atypical antipsychotics could induce a "pro-hedonic" or 
hyperphagic response reflected in an increase in mean bout duration. Results from 
Experiment 8 suggested a "pro-hedonic" effect of higher doses of amisulpride 
which was further explored in a longer microstructural test in drug-naive animals 
(Experiment 9). 
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6.2 Method 
6.2.1 Animals 
Forty-eight non-deprived adult male hooded Lister rats weighing 350-450g 
at the time of testing were used (n=20 per Experiment 6 and 7, and n=8 in 
Experiment 9). They were housed and maintained as described in Chapter 3. 
6.2.2 Drugs 
In Experiment 7, PNU-99194A (gift from Dr. K Svensson, Gothenberg, 
Sweden) was dissolved in saline and administered in doses of 5.0 and 10.0 mg/kg, 
i.p. 30 min before testing. 7-OH-DPAT (Research Biochemicals International, 
U.K.) was prepared for injection by dissolving it in saline at a dose of 0.3 mg/kg 
and was then injected i.p. 20 min before testing. This dose of 7-OH-DPAT was 
chosen as it had been shown to reliably decrease parameters of feeding in 
Experiments 1 and 4. 
In Experiment 8, amisulpride (Synthelabo, France) at doses of 1.0,3.0, 
10.0, 20.0 and 30.0 mg/kg was ultrasonically dispersed with ionised water and two 
drops of Tween 80 (see Chapter 3). This suspension was administered i.p., lh 
before testing. 7-OH-DPAT (0.3 mg/kg) was prepared for injection by dissolving it 
in saline. This solution was then injected i.p. 20 min before testing. Only two of 
the pretreatment doses of amisulpride (1.0 and 3.0 mg/kg) were administered with 
7-OH-DPAT (0.3 mg/kg) over the first four test days. Increasing doses of 
amisulpride (10.0,20.0 and 30.0 mg/kg) were co-administered with 7-OH-DPAT 
in three further four-day test periods. 
For the purposes of Experiment 9, one pretreatment dose of amisulpride 
(20.0 mg/kg) was used which was chosen due to its ability to block some of the 
effects of 7-OH-DPAT (0.3 mg/kg) in Experiment 8. Other details of amisulpride 
and 7-OH-DPAT preparation and administration are described for Experiment 8. 
All details of drug preparation and administration for each drug can be found 
in Chapter 3. 
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6.2.3 Test Fluids 
The sucrose solutions were made up as described in Chapter 3. In 
Experiments 7 and 8, ten animals were trained and tested on 1, 3 and 10% sucrose 
solutions. During both training and testing animals had experience of all 
concentrations of the fluid. In Experiment 9, only one concentration of sucrose 
solution was used (10%). 
6.2.4 Apparatus 
Testing in Experiments 7 and 8 was carried out using the MS80 multistation 
lickometer described in detail in Chapter 3. In Experiment 9, testing was carried out 
using the 108 multistation lickometer also described in Chapter 3. 
6.2.5 Procedure 
Experiment 7: Interactions between the D3 receptor antagonist PNU-91994A and 
the D3 receptor agonist 7-OH-DPAT determined by microstructural analysis of a 
brief contact test. 
Training 
Twenty rats were well familiarised with the test apparatus and experimental 
procedure. This involved placing each rat in the test chamber where they had access 
to a range of sucrose solutions (1,3 and 10%) in a random order. Each 
concentration was presented for 60s and a 5s interval intervened btween subsequent 
presentations. This procedure continued at the same time each day until steady 
baselines of licking were observed (approximately 7-10 days). Two days prior to 
testing each rat received a sham injection of saline to familiarise it with the injection 
procedure. 
Testing 
Following this familiarisation period rats received i.p. injections of the 
antagonist/agonist combinations. A repeated measures design was used in which 
animals had injections of vehicle/vehicle; vehicle/0.3 mg/kg 7-OH-DPAT; 
vehicle/5.0 mg/kg PNU 91994A; vehicle/10.0 mg/kg PNU 91994A; 5.0 mg/kg 
PNU 91994A/0.3 mg/kg 7-OH-DPAT; 10.0 mg/kg PNU 91994A/0.3 mg/kg 7-
OH-DPAT. After injections of drugs, the rats were then placed in the lickometer 
210 
Chapter 6 
chamber where they had access to all concentrations of sucrose (1,3 and 10%). 
Each concentration was presented for a total duration of 60s (with an 
interpresentauon interval of 10s) and the order of these presentations were 
randomised across test days. Injections were counterbalanced across animals and a 
period of at least 48h was allowed to elapse between each series of injections to 
ensure dispersal of drugs. 
Experiment 8: Interactions between the D3 receptor antagonist amisulpride and the 
D3 receptor agonist 7-OH-DPAT determined by microstructural analysis of a brief 
contact test. 
Training 
Training procedures for Experiment 8 were the same as those described for 
Experiment 7. 
Testing 
Following the familiarisation period the rats received i.p. injections of 
drugs. Again, a repeated-measures design was used in which rats had injections of 
antagonist/agonist combinations. Combinations were as follows: vehicle/vehicle; 
vehicle/0.3 mg/kg 7-OH-DPAT; vehicle/1.0 mg/kg amisulpride; vehicle/3.0 mg/kg 
amisulpride; 1.0 mg/kg amisulpride/0.3 mg/kg 7-OH-DPAT; 3.0 mg/kg 
amisulpride/0.3 mg/kg 7-OH-DPAT. After injections of drugs, the rats were then 
placed in the lickometer chamber where they had access to all concentrations of 
sucrose (1,3 and 10%). As for Experiment 7, each concentration was presented 
for a total duration of 60s and the order of these presentations were randomised 
across test days. Injections were counterbalanced across animals and a period of at 
least 48h was allowed to elapse between each series of injections to ensure dispersal 
of drugs. 
Following preliminary data analysis it was decided that higher doses of 
amisulpride should be used in an effort to reverse the effects of 0.3 mg/kg 7-OH-
DPAT. Therefore, three more doses of amisulpride were co-administered with 0.3 
mg/kg 7-OH-DPAT in three subsequent sets of four injection test days. These 
subsequent tests were procedurally equivalent to the first, differing only in the 
doses of amisulpride used (see above). The first subsequent test used injection 
combinations as follows: vehicle/vehicle; vehicle/10.0 mg/kg amisulpride; 10.0 
mg/kg amisulpride/0.3 mg/kg 7-OH-DPAT. In the second subsequent test rats 
were administered with vehicle/vehicle; vehicle/20.0 mg/kg amisulpride; 20.0 
mg/kg amisulpride/0.3 mg/kg 7-OH-DPAT. Over the final four test days animals 
were injected with vehicle/vehicle; vehicle/30.0 mg/kg amisulpride; 30.0 mg/kg 
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amisulpride/0.3 mg/kg 7-OH-DPAT. A wash-out period of lweek was allowed 
between each series of injections as all drug tests were conducted using the same 
animals. 
Experiment 9: Microstructural analysis of drinking for 10% sucrose after the 
administration of amisulpride : Analyses of licking during a 20-min session and 
during first minute of 20-min session. 
Training 
A group of 10 drug-naive rats was familiarised with the test apparatus and a 
10% sucrose solution for approximately 10 days or until baseline drinking levels 
were stable. Training consisted of 20 mins access to the sucrose solution at the 
same time on each training day. Two days prior to testing animals received a sham 
injection of vehicle in order to familiarise them with the injection procedure. 
Testing 
Data from Experiment 8 suggested that at a dose of 20.0 mg/kg, amisulpride 
bagan to reverse many of the effects of 0.3 mg/kg 7-OH-DPAT on feeding 
parameters. Alone this dose of amisulpride seemed to produce a pro-hedonic effect 
(see Results for experiment 8). Therefore, the 20,0 mg/kg dose of amisulpride was 
administered alone and compared to vehicle. A repeated-measures design was used 
where animals had injections of either 20.0 mg/kg amisulpride or saline on two test 
days. After injection of drugs, the rats were placed in the lickometer boxes where 
they had access to a 10% sucrose solution for a duration of 20min. Injections were 
counterbalanced across rats and a period of 48h elapsed between each series of 
injections to ensure dispersal of drugs. 
6.2.6 Design and statistical analysis 
, For Experiments 7 and 8, initial analysis of the lick time data was carried out 
using programs as outlined in Chapter 3. For Experiment 9, analysis of the lick 
time data was conducted using the feed 6 programme described in Chapter 3. For 
Experiments 7 and 8, measures derived from the raw data included a number of 
microstructural variables: number of licks, mean bout duration (s), number of 
bouts, intrabout lick rate (licks/s within bouts) and average interlick interval (ms). 
The measure of total intake (ml) was taken and analysed for Experiment 9 as were 
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the microstructural variables of number of licks, mean bout duration and number of 
bouts. 
Data from Experiments 7 and 8 were analysed using a two-way repeated-
measures ANOVA with drug dose and fluid concentration as factors. Where there 
was a significant main effect of drug post hoc tests were employed. To do this, the 
main effect of drug was collapsed across concentration and Dunnett's t-test was 
used to determine any significant differences between animals which had received 
drug doses and vehicle controls. As the agonist 7-OH-DPAT had a decremental 
effect on feeding parameters and the antagonist amisulpride seemed to have 
incremental effects on feeding parameters, a two-way repeated measures ANOVA 
revealed little as to where the significance of the differential drug effect might lie. 
Therefore, post hoc tests were used even in the presence of a significant 
interaction between drug dose and fluid concentration as a means of separating out 
the total main effect of drug. All combinations were compared to a control in the 
post hoc tests but the control used depended on the type of antagonist /agonist 
combination to which it was to be compared. Thus in Experiments 7 and 8, the 
antagonist/agonist combinations were compared to vehicle/agonist combination, 
whereas the vehicle/antagonist combinations were compared to the vehicle/vehicle 
combination. In this way, it was possible to check whether i) the antagonist alone 
was having a significantly different effect when compared to vehicle/vehicle and ii) 
the antagonist was reversing the effects of the agonist as revealed by comparing 
antagonist/agonist combinations to vehicle/agonist 
For Experiment 9, both intake measures and microstructural variables such 
as number of licks, mean bout duration and number of bouts, were analysed using a 
one-way within-subjects ANOVA with drug dose as a factor. 
All statistical tests were performed using Super Anova and Statview 
SE+graphics (Abacus Concepts Inc., Berkeley, CA). For Experiments 7,8 and 9 a 
result was considered statistically significant if p<0.05. 
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6.3 Results 
Experiment 7: Interactions between the D3 receptor antagonist PNU 91994A and 
the D3 receptor agonist 7-OH-DPAT determined by microstructural analysis of a 
brief contact test. 
Number of licks 
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Dose PNU-99194A / 7-OH-DPAT (mg/kg) 
Figure 6.1 The effect of PNU-99194A (5.0 and 10.0 mg/kg) and 7-OH-DPAT 
(0.3 mg/kg) on the number of licks for sucrose in a brief contact test + S.E.M. 
Table 6.1 Main effect of sucrose concentration total number of licks 
Number of licks * S.E.M. 
Sucrose (%) 
1 3 10 
63.7±9.0 148.1±10.4 284.0±9.7 
n=10 animals per concentration 
7-OH-DPAT alone (0.3 mg/kg) decreased the total number of licks for 
sucrose, by approximately one third, in a brief contact test (see Figure 6.1). A one-
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way repeated measures ANOVA showed that for the total number of licks there was 
a significant main effect of the agonist 7-OH-DPAT (F 9 , 9 = 12.794, p<0.01). A 
two-way repeated measures ANOVA revealed a main effect of drug (F s 4 S = 4.479, 
rxO.Ol) and a main effect of concentration (F 2 1 8 = 116.676, p<0.0001) on the 
number of licks (see Table 6.1). There was also a significant interaction between 
the effects of drug and concentration (F 1 0 9 0 = 3.052, p<0.01). 
Post-hoc analyses showed that neither of the doses of PNU-99194A alone 
were significantly different from vehicle/vehicle condition and that pretreatment with 
PNU-99194A did not significantly attenuate the effects of 7-OH-DPAT when 
compared to the vehicle/7-OH-DPAT condition. 
Mean bout duration 
a 
I 
I 
s 
2 
I 
| f | i H 
mm 
««« 
P 
t f f • ! 
I.! I 
vehicleyvehicle 
vehicle/agonist 
antagonist/vehicle 
|:iliii;l antagonist/agonist 
::::::::::::::::; 
0/0 0/0.3 5.0/0 10.0/0 5.0/0.3 
Dose PNU-99194A / 7-OH-DPAT (rag/kg) 
10.0/03 
Figure 6.2 The effect of PNU-99194A (5.0 and 10.0 mg/kg) and 7-OH-DPAT 
(0.3 mg/kg) on mean bout duration of licking for sucrose in a brief contact test + 
S.E.M. 
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Table 6.2 Main effect of sucrose concentration on mean bout duration (s) . 
Mean bout duration * S.E.M. 
Sucrose (%) 
1 3 10 
1.5±0.2 2 .3±0 .2 4 .3±0 .4 
n=10 animals per concentration 
7-OH-DPAT alone (0.3 mg/kg) decreased the mean bout duration of licking 
for sucrose, approximately halving bout duration in a brief contact test (see Figure 
6.2). A one-way repeated measures A N O V A showed that for mean bout duration 
there was a significant main effect of the agonist 7-OH-DPAT (F 9 1 9 = 8.606, 
p<0.05). A two-way repeated measures A N O V A revealed a main effect of drug (F 
s 4 S = 3.368, p<0.05) and a main effect o f concentration (F 2 1 8 = 20.778, 
p<0.0001) on mean bout duration (see Table 6.2). As concentration increased so 
did mean bout duration. There was also a significant interaction between the effects 
of drug and concentration (F , 0 w = 3.092, p<0.01). 
Post-hoc analyses showed that neither of the doses of PNU-99194A alone 
were significantly different f rom vehicle/vehicle condition and that pretreatment with 
PNU-99194A did not significantly attenuate the effects o f 7-OH-DPAT when 
compared to the vehicle/7-OH-DPAT condition. 
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Figure 6.3 The effect of PNU-99194A (5.0 and 10.0 mg/kg) and 7-OH-DPAT 
(0.3 mg/kg) on bout frequency of licking for sucrose in a brief contact test + 
S.E.M. 
Table 6.3 Main effect of sucrose concentration on number of bouts . 
Number of bouts * S.E.M. 
Sucrose (%) 
1 3 10 
5 .6±0 .5 10.2±0.7 14 .0±0 .8 
n=10 animals per concentration 
Number of bouts were increased after the administration of 7-OH-DPAT 
(0.3 mg/kg) by approximately 25% (see Figure 6.3). A one-way repeated measures 
A N O V A showed that for mean bout frequency there was a significant main effect of 
the agonist 7-OH-DPAT (F 9 1 9 = 6.661, p<0.05). A two-way repeated measures 
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A N O V A revealed a main effect of drug ( F 5 4 S = 4.995, p<0.001). Table 6.3 
shows that as concentration increased so did mean bout frequency. This was 
realised as a main effect of concentration (F 2 1 8 = 27.352, pxO.0001). There was 
no significant interaction between the effects of drug and concentration (F 1 0 9 0 = 
1.758, n.s.). 
Post-hoc analyses showed that neither of the doses of PNU-99194A alone 
were significantly different f rom vehicle/vehicle condition and that pretreatment with 
PNU-99194A did not significantly attenuate the effects of 7-OH-DPAT when 
compared to the vehicle/7-OH-DPAT condition. 
Intrabout lick rate 
M 
*«« 
i l l k 
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antagonist/agonist 
0/0 0/0.3 5.0/0 10.0/0 5.0/0.3 10.0/0.3 
Dose PNU-99194A / 7-OH-DPAT (mg/kg) 
Figure 6.4 The effect of PNU-99194A (5.0 and 10.0 mg/kg) and 7-OH-DPAT 
(0.3 mg/kg) on intrabout lick rate for sucrose in a brief contact test + S.E.M. 
Asterisk indicates significantly different f rom vehicle / vehicle condition, *p< 0.05. 
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Table 6.4 Main effect of sucrose concentration on intrabout lick rate (lick/s) . 
Intrabout lick rate * S.E.M. 
Sucrose (%) 
1 3 10 
6.3+0.2 6.1 ±0 .1 6 .0±0.1 
n=10 animals per concentration 
Intrabout lick rate was attenuated by 7-OH-DPAT (0.3 mg/kg) alone by 
approximately 2 licks/s (see Figure 6.4). A one-way repeated measures A N O V A 
showed that for intrabout lick rate there was a significant main effect of the agonist 
7-OH-DPAT (F 9 1 9 = 85.239, p<0.0001). A two-way repeated measures 
A N O V A revealed a main effect of drug (F s 4 S = 36.388, p<0.0001) and a main 
effect of concentration (F 2 1 8 = 6.26, p<0.01) on licks within a bout. Table 6.4 
shows that as concentration increased intrabout lick rate decreased. There was a 
significant interaction between the effects of drug and concentration (F 1 0 9 0 = 
2.247, p<0.05). 
Post-hoc analyses showed that the lowest dose of PNU-99194A alone (5.0 
mg.kg) was significantly different from vehicle/ vehicle condition, (p<0.05). A t 
this dose of PNU-99194A (5.0 mg.kg) animals licked faster within bouts than 
those animals who had received vehicle/vehicle doses. However, neither of the 
pretreatment doses o f PNU-99194A were significantly different f rom the vehicle/7-
OH-DPAT condition. 
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Average interlick interval 
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Figure 6.5 The effect of PNU-99194A (5.0 and 10.0 mg/kg) and 7-OH-DPAT 
(0.3 mg/kg) on average interlick interval for sucrose in a brief contact test + S.E.M. 
Average interlick interval was lengthened by almost 50 ms after the 
administration of 7-OH-DPAT (0.3 mg/kg) alone (see Figure 6.5). A one-way 
repeated measures A N O V A showed that for average interlick interval there was a 
significant main effect of the agonist 7-OH-DPAT (F 9 1 9 = 34.424, p<0.005). A 
two-way repeated measures A N O V A revealed a main effect of drug (F 5 4 5 = 
22.392, p<0.0001) but no main effect of concentration (F 2 1 8 = 2.264, n.s.) 
average interlick interval. There was no significant interaction between the effects 
of drug and concentration (F 1 0 ^ = 1.111, n.s.). 
Post-hoc analyses showed that neither of the doses of PNU-99194A alone 
were significantly different f rom vehicle/vehicle group and that neither of the 
pretreatment doses PNU-99194A were significantly different f rom the vehicle/7-
OH-DPAT group. 
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Experiment 8: Interactions between the D3 receptor antagonist atnisulpride and the 
D3 receptor agonist 7-OH-DPAT determined by microstructural analysis of a brief 
contact test. 
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Fig 6.6 The effects of a) amisulpride (1.0, 3.0, 10.0, 20.0, 30.0 mg/kg) and b) 
7-OH-DPAT (0.3 mg/kg) + amisulpride on total number of licks in a brief contact 
test + S.E.M. In a) asterisk indicates significantly different f rom vehicle / vehicle, 
*p<0.05. I n b ) Plus indicates significantly different f rom vehicle/7-OH-DPAT; 
+p<0.01. 
221 
Chapter 6 
Table 6.5 Main effect of sucrose concentration on total number of licks . 
Mean number of licks * S.E.M. 
Sucrose (%) 
1 3 10 
97 .0±9 .4 192.0±9.6 303 .6±5 .7 
n=10 animals per concentration 
7-OH-DPAT succeeded in decreasing number of licks by approximately one 
third, when compared to vehicle controls. A one-way repeated measures A N O V A 
showed this result to be significant: (F 9 1 9 = 8.509, p<0.05). A two-way repeated 
measures A N O V A showed that there was a significant main effect of drug dose: (F 
n 9 9
 = H-510, p<0.0001) and also of sucrose concentration: (F 2 l g = 166.698, 
p<0.0001). As concentration increased so did number of licks (see Table 6.5). 
There was also a significant interaction between drug dose and concentration: (F 2 2 
1 9 8 = 4.479, p<0.01). Number of licks increased monotonically as a function o f 
amisulpride alone (1.0-30.0 mg/kg). Figure 6.6 shows that the highest dose of 
amisulpride alone (30.0 mg/kg) was significantly different f rom the vehicle/vehicle 
condition in a post hoc test (p<0.05). 
In terms of agonist/antagonist interactions, pretreatment with some of the 
doses of amisulpride abolished the effect of 7-OH-DPAT (0.3 mg/kg) on number of 
licks. The elimination of the effects of 7-OH-DPAT began with the 10.0 mg/kg 
pretreatment dose of amisulpride and the effects of 7-OH-DPAT were fu l ly 
abolished by the 10.0 and 20.0 mg/kg doses. In a post hoc test these three 
pretreatment doses (10.0,20.0 and 30.0 mg/kg) were shown to be significantly 
different f rom the vehicle/7-OH-DPAT condition (p<0.01). 
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Mean bout duration 
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Figure 6.7 The effects of a) amisulpride (1.0, 3.0, 10.0, 20.0, 30.0 mg/kg) and 
b) 7-OH-DPAT (0.3 mg/kg) + amisulpride on mean bout duration of licking in a 
brief contact test + S.E.M. In a) asterisk indicates significantly different f rom 
vehicle / vehicle, *p<0.05. In b) Plus indicates significantly different f rom vehicle 
/7 -OH-DPAT; +p<0.01. 
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Table 6.6 Main effect of sucrose concentration on mean bout duration (s) . 
Mean bout duration * S.E.M. 
Sucrose (%) 
1 3 10 
1.8+0.2 3 .0±0.3 5 .3±0 .5 
n=10 animals per concentration 
7-OH-DPAT succeeded in approximately halving mean bout duration, when 
compared to vehicle controls. A one-way repeated measures A N O V A showed this 
result to be significant: (F 9 1 9 = 11.426, p<0.01). A two-way repeated measures 
A N O V A showed that there was a significant main effect of drug dose: (F n 9 9 = 
5.523, p<0.0001) and also of sucrose concentration: (F 2 1 8 = 22.409, p<0.0001) 
(see Table 6.6). There was also a significant interaction between drug dose and 
concentration: ( F 1 2 , 9 8 = 1.626, p<0.05). Mean bout duration increased as a 
function of amisulpride alone (1.0-30.0 mg/kg). The highest dose of amisulpride 
alone (30.0 mg/kg) was significantly different f rom the vehicle/vehicle condition in 
a post hoc test (p<0.05) (see Figure 6.7 a). 
The decremental effect of 7-OH-DPAT (0.3 mg/kg) on mean bout duration 
began to be attenuted by pre treatment with 10.0 mg/kg amisulpride and was fu l ly 
abolished by 20.0 and 30.0 mg/kg. Not only did the highest dose of amisulpride 
abolish the decremental effects of 7-OH-DPAT (0.3 mg/kg) on mean bout duration, 
but this dose (30.0 mg/kg) increased mean bout duration over and above measures 
of mean bout duration for vehicle/vehicle controls. Pretreatment with the highest 
dose of amisulpride (30.0 mg/kg) was shown to be significantly different f rom the 
vehicle/7-OH-DPAT condition (p<0.01). 
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Number of bouts 
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Figure 6.8 The effects of a) amisulpride (1.0, 3.0, 10.0, 20.0, 30.0 mg/kg) and 
b) 7-OH-DPAT (0.3 mg/kg) + amisulpride on number of bouts of licking in a brief 
contact test + S.E.M. In b) Asterisk indicates significantly different f rom vehicle / 
7-OH-DPAT; *p<0.05. 
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Table 6.7 Main effect of sucrose concentration on number of bouts . 
Number of bouts ± S.E.M. 
Sucrose (%) 
1 3 10 
6.7+0.4 11 .4±0.5 13 .8±0.6 
n=10 animals per concentration 
7-OH-DPAT increased bout frequency by approximately 50%, when 
compared to vehicle controls. A one-way repeated measures A N O V A showed this 
result to be significant: (F 9 1 9 = 10.496, p<0.05). A two-way repeated measures 
A N O V A showed that there was a significant main effect of drug dose: (F n m -
4.190, p<0.0001) and also of sucrose concentration: (F 2 1 8 = 40.114, p<0.0001). 
As concentration increased so did number of bouts (see Table 6.7). There was also 
a significant interaction between drug dose and concentration: (F 22_ I 9 8 = 3.126, 
p<0.01). Number of bouts increased at the 10.0 mg/kg dose of amisulpride alone 
but higher and lower doses of amisulpride did little to change this parameter. None 
of the doses of amisulpride were significantly different from the vehicle/vehicle 
condition in a post hoc test. 
In terms o f agonist/antagonist interactions, pretreatment with doses of 
amisulpride partially attenuated the incremental effects of 7-OH-DPAT (0.3 mg/kg) 
on mean bout frequency. The highest dose of amisulpride almost abolished the 
effect of 7-OH-DPAT and this was shown to be significant in a post hoc test when 
compared to vehicle/7-OH-DPAT condition (p<0.05). (see Figure 6.8 b). 
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Figure 6.9 The effects of a) amisulpride (1.0, 3.0, 10.0, 20.0, 30.0 mg/kg) and 
b) 7-OH-DPAT (0.3 mg/kg) + amisulpride on intrabout lick rate in a brief contact 
test + S.E.M. In a) Plus indicates significantly different from vehicle / vehicle; 
+p<0.01. In b) asterisk indicates significantly different f rom vehicle / 7-OH-
DPAT; *p<0.05; Plus indicates significantly different f rom vehicle / 7-OH-DPAT; 
+p<0.01. 
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Table 6.8 Main effect of sucrose concentration on intrabout lick rate (l ick/s) . 
Intrabout lick rate ± S.E.M. 
Sucrose (%) 
1 3 10 
6 .4±0 .09 6 .3±0 .07 6 .0±0 .05 
n=10 animals per concentration 
7-OH-DPAT succeeded in decreasing intrabout lick rate by approximately 2 
licks/s when compared to vehicle controls. A one-way repeated measures A N O V A 
showed this result to be significant: (F 9 1 9 = 313.061, p<0.0001). A two-way 
repeated measures A N O V A showed that there was a significant main effect of drug 
dose: (F n ^ = 30.430, p<0.0001) and also of sucrose concentration: (F 2 l g = 
5.906, p<0.05). As concentration increased intrabout lick rate decreased, (see 
Table 6.8). There was also a significant interaction between drug dose and 
concentration: (F 2 2 1 9 8 = 1.768, p<0.05). Intrabout lick rate decreased as a 
function o f amisulpride alone (1.0-30.0 mg/kg). Three doses o f amisulpride alone 
(10.0, 20.0 and 30.0 mg/kg) were significantly different f rom the vehicle/vehicle 
condition in a post hoc test (p<0.01) (see Figure 6.9 a). 
The decremental effect of 7-OH-DPAT (0.3 mg/kg) on intrabout lick rate 
was partially abolished by all pretreatment doses of amisulpride (1.0-30.0 mg/kg). 
Howerer, this abolition was not dose-dependent A post hoc test showed that all 
pretreatment doses o f amisulpride were significantly different when compared to the 
vehicle/7-OH-DPAT condition (p<0.01; p<0.05 for 10.0 mg/kg). 
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Figure 6.10 The effects of a) amisulpride (1.0, 3.0, 10.0, 20.0, 30.0 mg/kg) 
and b) 7-OH-DPAT (0.3 mg/kg) + amisulpride on average interlick interval in a 
brief contact test + S.E.M. In b) Plus indicates significantly different f rom vehicle / 
7-OH-DPAT; +p<0.01. 
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7-OH-DPAT succeeded in increasing average interlick interval by 
approximately 50 ms, when compared to vehicle controls. A one-way repeated 
measures A N O V A showed this result to be significant: (F 9 1 9 = 264.022, 
p<0.0001). A two-way repeated measures A N O V A showed that there was a 
significant main effect of drug dose: (F n ^ = 23.250, p<0.0001). Average 
interlick interval did not vary with concentration, therefore there was no main effect 
of concentration on this parameter (F 2 1 8 = 1.894, n.s.). Nor was there a 
significant interaction between drug dose and concentration: (F 2 2 1 9 g = 1.071, 
n.s.). 
Average interlick interval only increased slightly as a function of the higher 
doses of amisulpride alone (10.0-30.0 mg/kg). Of these doses, none were found to 
be significantly different from vehicle/vehicle condition in a post hoc test (Figure 
6.10 a). The incremental effect of 7-OH-DPAT (0.3 mg/kg) on average interlick 
interval was partially abolished by all pretreatment doses of amisulpride (1.0-30.0 
mg/kg) but this effect was non-monotonic. A post hoc test showed that all 
pretreatment doses of amisulpride were significantly different when compared to the 
vehicle/7-OH-DPAT condition (p<0.01). 
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Experiment 9: Microstructural analysis of drinking for 10% sucrose after the 
administration of amisulpride : Analyses of licking during a 20-min session and 
during first minute of 20-min session. 
The effects of one dose of amisulpride on total intake and licking 
microstructure was compared to the effects of vehicle in a 20 min test session. 
a) for f u l l 20 min test session 
Table 6.9 Average (± S.E.M.) measures of total intake and microstructural 
licking parameters in a 20-min test session 
Dose amisulpride (mg/kg) 
0.0 20.0 
Amount intake 
(ml) 
Number of 
licks 
Mean bout 
duration (s) 
Number of 
bouts 
18 .6±0.9 
2069.5+103.6 
3.6+.0.4 
96 .0±9 .2 
19.0+1.2 
1786.1±53.2 
3.4±0.5 
96.2±14.7 
n= 8 animals per drug dose 
Intake 
Over a 20 min test session, amisulpride (20.0 mg/kg) did not affect total 
amount intake. Animals who received vehicle drank almost the same as those 
receiving the dose of amisulpride. There was no significant main effect of drug on 
this parameter. (F j 7 = 0.051, n.s.). 
Microstructural analysis 
Number of licks 
Number of licks were decreased after the administration of amisulpride 
(20.0 mg/kg). This result reached statistical significance: (F t 7 = 7.5, p<0.05). 
Mean bout duration 
Mean bout duration also decreased after the dose of amisulpride (20.0 
mg/kg). This result was slight and non-significant: (F , 7 = 0.774, n.s.). 
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Number of bouts 
Number of bouts were very similar whether animals had amisulpride (20.0 
mg/kg) or vehicle. Therefore there was no main effect of drug on bout frequency: 
( F 1 7 = 0.48, n.s.). 
b) for the first min of a 20 min test session 
Microstructural analysis 
Number of licks 
J2 
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Figure 6.11 The effect of amisulpride (20.0 mg/kg) on the number of licks for 
10% sucrose in the first min of a 20 min test session. 
Illustrated in Figure 6.11 are data from the first min of a 20 min test session, 
where there was no effect of amisulpride (20.0 mg/kg) on the total number of licks. 
Therefore there was no significant main effect of drug on number of licks: ( F , 7 = 
0.001, n.s.). 
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Mean bout duration 
•a 
1 
Dose amisulpride (mg/kg) 
Figure 6.12 The effect of amisulpride (20.0 mg/kg) on the mean bout duration 
of licking for 10% sucrose in the first min of a 20 min test session. 
Figure 6.12 shows that mean bout duration increased by approximately 4 
seconds after the administration of amisulpride (20.0 mg/kg). However, this result 
did not reach statistical significance: (F , 7 = 3.436, n.s.). 
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Figure 6.13 The effect of amisulpride (20.0 mg/kg) on number of bouts of 
licking for 10% sucrose in the first min of a 20 min test session. 
From Figure 6.13 it is clear that there was a decremental effect of 
amisulpride (20.0 mg/kg) on mean bout frequency, the drug almost halved the 
number of bouts compared to the vehicle condition. This was shown to be a 
statistically significant main effect (F , 7 = 5.723, p<0.05). 
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6.4 Discussion 
In Experiment 7, there was a clear effect of 7-OH-DPAT to reduce the 
number of licks by shortening the mean bout duration. Bout frequency was 
increased by 7-OH-DPAT which further argues against a motoric impairment 
induced by this dose of 7-OH-DPAT. However, 7-OH-DPAT also significantly 
decreased intrabout lick rate which points towards some kind of orolingual motor 
deficit Increasing sucrose concentration in Experiment 7 increases the number of 
licks, the mean bout durations and the number of bouts as has been determined in 
previous chapters. However, as concentration increased so did intrabout lick rate 
which, as was mentioned in Chapter 5, could be a result of the increasing viscosity 
of the higher sucrose concentrations rather than changes in palatability of the test 
fluid. Neither of the doses of PNU-99194A alone were significantly different from 
vehicle/vehicle conditions for number of licks, mean bout duration or mean bout 
frequency. However, at the 5.0 mg/kg dose, PNU-99194A did significantly 
increase intrabout lick rate which is in accordance with the previously reported 
stimulant effects of PNU-99194A (Waters et al., 1993). 
In terms of the ability of PNU-99194A to attenuate or abolish the effects of 
7-OH-DPAT on licking parameters it seemed that the lower dose of 5.0 mg/kg was 
most effective at eliminating 7-OH-DPAT's effects, although even at this dose the 
attenuation of 7-OH-DPAT's effects was not significant when compared to the 
vehicle/agonist condition in a post hoc test For none of the parameters did PNU-
99194A pretreatment produce effects that were easily distinguishable from 7-OH-
DPAT when the agonist was co-administered with the antagonist Therefore, it is 
reasonable to conclude that at the doses employed, PNU-99194A did not block the 
effects of 7-OH-DPAT in this test 
These results are generally consistent with the findings of Baker et al. 
(1998), who showed that PNU-99194A was unable to block 7-OH-DPAT 
substitution for D-amphetamine or cocaine in the drug discrimination paradigm. 
This result led these authors to question the pharmacological specificity of PNU-
99194A. In a further experiment they confirmed this suspicion. By comparing the 
discriminative cue produced by PNU-99194A to several other dopamine agonists 
and antagonists they discovered that the subjective cue produced by PNU-99194A 
is probably based on D l receptor antagonism (Franklin et al., 1998). Therefore, i f 
PNU-99194A exerts its effects through D l receptors it would not be surprising that 
this compound was unable to reverse the effects of 7-OH-DPAT in Experiment 7. 
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Alternatively, and most likely, the doses of PNU-99194A employed in 
Experiment 7 were too low to be effective. Support for this idea comes from the 
study by Clifford and Waddington (1998). Using doses comparable to the present 
experiment ( 5 and 10 mg/kg) PNU-99194A, the only behavioural count to decrease 
significantly was that of grooming. At 15mg/kg there was a significant increase in 
eating counts which were augmented further when the dose was raised to 45 mg/kg 
and therefore, the doses used in mis experiment were probably too low to counter 
the significant decremental effects of 7-OH-DPAT on feeding parameters. 
Therefore, it is difficult to infer any common site of action of the two drugs (PNU-
99194A and 7-OH-DPAT) from this experiment. Further experiments which assess 
higher doses of the antagonist on licking parameters, in conjunction with the 
assessment of other behavioural measures, need to be carried out. In combination 
with such studies, research is needed into the concentrations of such novel 
compounds that are selective for the D3 receptor. This information is not yet 
available but bears important implications for the interpretation of results from 
behavioural studies which use systemic routes of administration of novel drug 
compounds. 
Again, in Experiment 8, main effects of concentration were observed. As 
concentration increased so did the number of licks, mean bout duration and the 
number of bouts. Increasing concentration led to a significant decrease in intrabout 
lick rate which probably reflected the increasing viscosity of the sucrose solutions. 
7-OH-DPAT, on the other hand, decreased number of licks and mean bout duration 
significantly. It also increased mean bout frequency, decreased intrabout lick rate 
and increased average interlick interval significantly. These effects were 
differentially attenuated by doses of amisulpride. 
The hypothesis tested in Fjtperiment 8 was that low doses of amisulpride 
presumably act presynaptically and could block the effects of 7-OH-DPAT on 
licking parameters. This would have been consistent with the work by Sanger et al. 
(1996), who found that these low doses of amisulpride were sufficient to reverse 
the cueing and the rate-decreasing effects of 7-OH-DPAT on operant responding for 
food. Only at 10,20 and 30 mg/kg did amisulpide reverse the effects of 7-OH-
DPAT on number of licks. Therefore, the hypothesis was not confirmed. At 20 
and 30 mg/kg, respectively, amisulpride reinstated mean bout duration to levels 
comparable to and greater than those observed in the vehicle condition. Number of 
bouts were increased by 7-OH-DPAT and were decreased by the pretreatinent with 
amisulpride at 30 mg/kg. None of the doses of amisulpride totally abolished the 
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effects of 7-OH-DPAT on intrabout lick rate or average interlick interval. For these 
latter parameters, both low and high doses of amisulpride produced similar effects. 
This further suggests that the ability of amisulpride to affect components of food 
reward is separate from the ability of this drug to affect motor competence per 
significant effect 
However, there is a fundemental pharmacological issue which constraints 
the extent to which the action of amisulpride, in this case, can be described as 
antagonising the effects of 7-OH-DPAT. As is evident from the results, higher 
doses of amisulpride have a behavioural effect which is opposite to that of 7-OH-
DPAT. Therefore, interactions between these two compounds is unlikely to 
represent a straightforward pharmacological antagonism. Further work on the 
pharmacological effects of a broad dose range of these two compounds in 
combination would help to solve this problem. 
In Experiment 8, amisulpride alone had a dose-dependent incremental effect 
on number of licks and managed to increase significantly the number of licks at the 
highest dose (30 mg/kg). However, at doses which purportedly act at autoreceptors 
(1 and 3 mg/kg) there was a slight decrease in number of licks as compared to 
vehicle controls. This pattern was reflected also in the measures of mean bout 
duration. It therefore seems that at the higher-doses, where mean bout duration was 
almost doubled by amisulpride, this compound increased ingestion by enhancing 
the palatability of the sucrose solution in a brief contact test This may partially 
explain the induction of a food induced conditioned place preference by Guyon et 
al. (1993) in that as the stimulus originally paired with salient features of the 
environment food had inflated hedonic value which served to cement the 
associations necessary to establish a conditioned place preference. This is further 
supported by the non-monotonic relationship between dose of amisulpride and 
number of bouts. Amisulpride decreased the number of bouts at all doses (non-
significantly), apart from lOmg/kg which slightly increased mean bout frequency. 
Small doses (1 and 3 mg/kg) of amisulpride did not affect intrabout lick rate 
or the reciprocal of this (average interlick interval) at all. At the largest doses (10, 
20 and 30 mg/kg) although amisulpride decreased licking within a bout significantly 
at these doses the effect was small. Therefore, it seems that this drug did not have 
any severe deleterious effects on the motor competence necessary for sustained 
licking responses. This is consistent with those reports which have observed a lack 
of catalepsy with amisulpride even with large doses (Millan et al., 1995). 
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Taken together, although it is usually said that large doses (>30.0 mg/kg) 
of amisulpride act at postsynaptic receptors, it is not clear whether the doses of 
amisulpride used in these experiments are selective for postsynaptic D2 receptors. 
Hence, a strong conclusion for the mode of action of 7-OH-DPAT cannot be 
drawn. What these results seem to suggest is that 7-OH-DPAT does not 
necessarily, or exclusively, exert its effects through autoreceptors of the D2 or the 
D3 type as low doses of amisulpride which preferentially act at these autoreceptor 
sites do not abolish the robust effects of 7-OH-DPAT on feeding parameters. A 
caveat is necessary at this level of explanation as the effects of amisulpride used 
may not be accurately reflected in this test situation. The same animals were used to 
test, at first the low doses but consequently the 3 higher doses of this drug. 
Therefore, what might be occurring is a tolerance to these higher doses of 
amisulpride. Although a wash out period of 1 week was used between injection 
cycles this possibility cannot be discounted in interpreting these results. 
To partially circumvent this problem, we consequently tested the prediction 
that a dose of amisulpride which had been shown to effectively abolish the effects 
of 7-OH-DPAT on an important parameter such as mean bout duration in drug-
experienced animals, would also induce a hyperphagic (i.e an increase in intake) 
effect in drug naive animals. I f effects such as those reported by Guyon et al. 
(1993) are literally "pro-hedonic", then hyperphagia might be expected to be 
expressed as an increase in mean bout duration most prominently at the beginning 
of a test session. 
In Experiment 9, a 20-min test session was used. The amount ingested of a 
10% sucrose solution was not affected by a 20 mg/kg dose of amisulpride. Rather 
than being increased, the number of licks decreased with this dose of amisulpride 
but this significant decrease was not observed for mean bout duration. Again, the 
effect of amisulpride (20 mg/kg) on number of bouts was negligible. Contrary to 
measures taken over 20-min, results from the first minute of the test session 
highlight differential effects of amisulpride which are only evident at the beginning 
of the meal. 
The number of licks after the administration of either vehicle or amisulpride 
were the same in the first minute. However, when looking at initial licking 
responses (within the first minute of the test) it was observed that amisulpride 
increased mean bout duration by a considerable amount (4s) which resulted in a 
significant reduction in bouts. Despite the considerable augmentation of bout length 
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after amisulpride in the first minute, this result is non-significant. Therefore, it is 
difficult to claim that amisulpride seems to be increasing the initial hedonic value of 
the sucrose solution as reflected in an increase in mean bout duration in this case. 
This study, however, further validates the idea that it is not due to a tolerance to 
amisulpride that we get the abolition of effects of 7-OH-DPAT in several 
parameters. It also highlights the fact that short tests or analysis of results from the 
beginning of a test are of great interpretive strength i f one is concerned with initial 
hedonic reactions to tastants. 
In summary, the results of Experiments 8 and 9 suggest that amisulpride 
affected feeding parameters which reflect palatability but these effects are only 
apparent when a test of short duration is used. The action of amisulpride alone 
suggests a specific action of this drug to enhance palatability. However, this occurs 
in the main when high doses of the drug are used and so cannot be definitely 
attributed to an antagonist action at D3 receptor autoreceptors. Furthermore, the 
results from Experiment 7 did not yield concrete conclusions as to the behavioural 
effects of PNU-99194A, owing to the small doses of the drug which were used. 
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Chapter 7: The effects of the putative D3 receptor agonist 
7-OH-DPAT on successive negative contrast 
7.1 Introduction 
When an animal experiences one reward followed by a second reward of a 
different value (reward shift), "contrast" is said to occur i f the animal exhibits an 
exaggerated response on presentation of the second reward (Dunham, 1968), (see 
Chapter 2). One example of a contrast effect can be observed in the licking 
behaviour of rats as licking behaviour is not always determined by a given 
concentration of sucrose alone, but often reflects an animal's prior experience with 
alternative concentrations of sucrose solutions (Flaherty, 1982). Thus, a given 
concentration of a sucrose solution may lead to an exaggerated increase or decrease 
in licking behaviour, depending on the relative concentration of the solution 
presented previously. I f rats are trained in brief daily sessions to lick for a low 
concentration sucrose solution and are then shifted to a higher concentration there is 
an increase in the number of licks generated by these animals compared to animals 
who have had access to the higher concentration alone (Flaherty, 1982). This effect 
is known as a successive positive contrast. Alternatively, a successive negative 
contrast effect occurs when rats, previously given brief daily access to a high 
concentration of sucrose, are shifted to a low concentration. Under these 
circumstances, licking for the low concentration is suppressed relative to that 
generated by rats having experienced only the low concentration of sucrose. 
I f brain mechanisms exist which permit the comparison of rewards (i.e. 
behaviour is activated based on the relative value as well as the absolute value of 
rewards) then there is reason to assume that there are brain neurotransmitter systems 
which underlie the capacity to compare rewards (Flaherty, 1996). Therefore, the 
pharmacological bases of positive and negative contrast effects have been 
investigated by studying the effect of several classes of drugs on the development 
and maintenance of successive contrast. However, many of these studies have 
concentrated only on successive negative contrast. 
* In Chapter 2, evidence was reviewed which indicated that neuroleptics 
disrupt reinforced operant and consummatory behaviour - an outcome which has 
often been interpreted in terms of an "anhedonic effect" (Wise, 1978,1982). 
However, conclusions based on parallels drawn between the effects of neuroleptics 
on reinforced behaviour and the withdrawal and/or reduction of reinforcement, 
remain debatable (see General Introduction and General Discussion). The majority 
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of studies of the effects of dopamine blockade on consummatory behaviour have 
been concerned with the behavioural effects associated with the absolute value of a 
reinforcer. Many of the studies which have tried to establish a role for 
dopaminergic receptor sites in the mediation of relative reward have found that 
drugs which act at these receptor sites are largely ineffective in modulating 
consummatory contrast Flaherty and colleagues have conducted many studies 
examining drug effects on the behavioural effects of reward comparison which 
constitute a contrast effect Briefly, they achieve this by administering drugs to 
animals a sub-group of which are "shifted" (i.e. 32-4% sucrose) and a subgroup 
which are unshifted (i.e. 4-4% sucrose). Drugs are administered to some drug dose 
subgroups on the first day of the shift Animals which do not receive drug on mis 
day receive a dose on the second post-shift day. The rationale behind using a 
second post-shift day comes from drug studies on negative contrast which show 
that animals must have some experience with the post-shift solution before the drug 
becomes effective on contrast (Flaherty et al., 1986). The differential 
effectiveness of the drug early and late in the post-shift period has several possible 
explanations and is, as yet an incompletely understood phenomenon. 
Since much of the literature has suggested that dopaminergic transmission 
mediates several aspects of reward (Wise, 1978,1982; Flaherty et al., 1991b) 
have investigated the possibility that dopaminergic antagonists influence contrast. 
However, preliminary studies using a limited number of dopamine blockers have 
had negative results. For example, the neuroleptic chlorpromazine did not affect 
contrast when administered on either the first or the second post-shift day (Flaherty 
et al., 1992). The more specific dopamine antagonist haloperidol, was also 
without effect on contrast when administered on the second post-shift day. This 
drug produced a dose-dependent decrease in consumption of the post-shift sucrose 
solution which was proportional in both shifted and unshifted rats. This result 
further suggested that haloperidol does not seem to affect the relative reward value 
of sucrose; rather, this drug may affect the absolute reward value of sucrose and/or 
have sedating or motor-impairing effects (Flaherty etal., 1992). Yet, i t is 
important to note that drugs which act more selectively at specific dopamine receptor 
subtypes have not been thoroughly studied in this paradigm. I t is difficult to 
eliminate a role for dopamine in the mediation of relative reward i f these more 
extensive pharmacological studies are not carried out 
In addition, despite the results discussed above, there is some evidence to 
support the idea that dopamine is involved in the mediation of relative reward. By 
manipulating the more traditional contrast procedure, it has been shown that 
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blockade, and release from dopamine blockade may produce contrast (Kentridge 
and Aggleton, 1993; Phillips and LePiane, 1986; Royall and Klemm, 1981). 
The study by Kentridge and Aggleton (1993) used animals trained on a variable 
interval schedule. The magnitude of reinforcement used in each test session 
alternated daily between one and four 45-mg food pellets and this variation in 
magnitude was signalled by lights in the operant chamber. One group of rats were 
injected with a low dose of the dopamine blocker cis(Z)-flupentixol before testing, 
while another group received saline before the test session. A second phase saw the 
drug conditions reversed. The change in drug conditions between phases produced 
both positive and negative successive contrast effects, consistent with the 
hypothesis that dopamine blockade attenuated the hedonic impact of reinforcement 
Using this novel experimental situation the authors propose a role for dopamine in 
the ascription of relative reward value to the stimulus (Kentridge and Aggleton, 
1993). 
It should also be noted that studies on contrast effects typically use outcome 
measures in the form of total licks or total intake. The emphasis on these total 
session variables is widespread within the literature, despite the established value of 
microstructural analysis in elucidating processes which may govern consummatory 
behaviour (Davis and Levine, 1977). There has been only one attempt to identify 
the patterns of licking behaviour associated with negative contrast (Grigson et al., 
1993). Grigson and her colleagues identified patterns of licking behaviour which 
constituted a contrast effect in bom deprived and free-feeding rats. Temporal 
analysis of the licking behaviour of deprived animals revealed that the contrast effect 
was, in the main, accomplished through a decrease in bout size and an increase in 
the number of bouts initiated. 
\ An innovative way of further assessing the contribution of dopamine 
receptor subtypes to the control of ingestive behaviour would be to combine the 
temporal analysis of licking behaviour as a consequence of a reward down-shift 
with the administration of a selective pharmacological treatment The aims of the 
present experiment were to adopt the microstructural analysis of successive negative 
contrast already assessed by Grigson et al. (1993) and also to examine the effect of 
the putative dopamine D3 receptor agonist, 7-OH-DPAT, on consummatory 
contrast The dopamine D3 receptor has been implicated in a number of aspects of 
rewarded behaviour (see Chapter 2) including ingestive behaviour. Experiments 1, 
3,7 and 8 show that when using both 20 and 1 min presentations, 7-OH-DPAT 
decreases ingestive behaviour by reducing mean bout duration . This change in 
bout duration may be interpreted as a decrease in palatability (Davis and Smith, 
242 
Chapter 7 
1992), as this parameter varies monotonically with an increase in sucrose 
concentration. 
Therefore, it is suggested that 7-OH-DPAT may have an impact on the initial 
hedonic evaluation of the test solution. I f the behavioural expression of 
consummatory negative contrast relies, at least in part, on the hedonic evaluation of 
the stimulus, 7-OH-DPAT should affect the consummatory negative contrast which 
occurs as a consequence of reward downshift The aim of the experiment was to 
test this prediction. 
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7.2 Method 
7.2.1 Animals 
Eighty-four adult male hooded Lister rats weighing 250-350g at the time of 
testing were used. They were housed and maintained as described in Chapter 3. 
Animals were food-deprived to approximately 80% of their free-feeding body 
weights and maintained at that level by once per day feeding. This level of 
deprivation was chosen in order that the experiment was comparable to that of 
Flaherty et al. (1992). Water was continuously available throughout the 
experiment 
7.2.2 Drugs 
7-OH-DPAT (Research Biochemicals International, U.K.) was dissolved in 
saline and injected i.p. 20 minutes before testing. Doses of 7-OH-DPAT were 0.1, 
0.3 and 1 mg/kg or its vehicle. An injection-test period of 20-min was used as 
previous work has shown this to be adequate time for a drug effect on intake to 
become apparent (see Experiments 1 and 4). 
7.2.3 Test Fluids 
The two test solutions were either 4% or 32% sucrose solutions and were 
made up as described in Chapter 3. Access to the two solutions during training or 
testing depended on whether animals had been assigned to either the shifted or 
unshifted group (see Section 7.2.5). 
7.2.4^ Apparatus 
Testing was carried out using the 108 multistation lickometer described in 
detail in Chapter 3. 
7.2.5 Procedure 
The rats were randomly assigned to 14 groups, 7 of which received 4% 
sucrose throughout the experiment (unshifted group) and 7 of which received 32% 
sucrose for the first 8 days of the experiment and then were shifted to 4% for the 
remaining 2 days (shifted group). Access was given to the sucrose solutions for 10 
min at the same time each day. When animals were well familiarised with the test 
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apparatus and solutions they received a sham injection of saline to familiarise them 
with the injection procedure (day 7) .The seven subgroups of each shift condition 
differed in drug treatment One subgroup was injected with isotonic saline on each 
of the first 2 post-shift days. The remaining six groups in each shift condition 
received injections of 0.1, 0.3 or 1.0 mg/kg 7-OH-DPAT on either the first or the 
second post-shift day. I f an animal was not injected with drug on either of the post-
shift days, they were injected with saline. Drugs were administered 20-min before 
each test session. 
7.2.6 Design and statistical analysis 
Initial analysis of the lick time data was carried out using programs as 
outlined in Chapter 3. Measures derived from the raw data included a number of 
microstructural variables: number of licks, mean bout duration (s) and number of 
bouts as these parameters have been shown to be sensitive to the effects of sucrose 
concentration and to the effects of 7-OH-DPAT treatments, (see Experiments 1 and 
4). 
Data were separated depending on whether they had been collected from the 
first min of the test session or whether it was taken over the full 10-min of the test 
session. This decision was made on the basis of previous observations concerning 
the interpretive strength of the test time (see Chapter 2). This applied to all analyses. 
Statistical tests were performed using Super Anova and Statview SE+graphics 
(Abacus Concepts Increase., Berkeley, CA). A result was considered statistically 
significant i f p<0.05. 
7.2.6.1 Terminal pre-shift period 
Pre-shift measures were derived by averaging penultimate and preceding 
pre-shift day measures for each animal in each shift group. Effects of sucrose 
concentration (32 or 4%) before reward shift and before drug testing were 
compared using a one-way between-subjects ANOVA. 
7.2.6.2 Negative contrast effects 
Traditionally, a consummatory contrast effect post-shift is measured and 
analysed relative to the unshifted controls. For example, animals shifted to a lower 
sucrose concentration show suppressed licking relative to unshifted controls 
(Grigson et al., 1993, and see Introduction, Section 7.1). This conception of a 
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negative contrast effect assumes that in the pre-shift period, animals licking for a 
high sucrose solution will lick more than those licking for a lower solution. The 
effects of sucrose solutions were inversely related to the level of intake observed in 
the present experiment Therefore, due to these unexpected baseline levels of 
drinking as reflected in terminal pre-shift measures (see Section 7.3) it was decided 
that a contrast effect was seen to be established i f the pre-shift means of shifted 
animals were significantly greater than post-shift means for the same animals. This 
was achieved by employing a one-way within subjects ANOVA to analyse data 
from the shifted group. 
7.2.6.2 Drug effects on negative contrast 
^ On each of the first 2 post-shift days, the data for the groups that received 
the drug injection on that day were compared to that of one of the saline control 
groups injected on the same day. The saline control group used was chosen at 
random from the 4 control groups available for analysis on each post-shift day. The 
groups that received the drug injection on the alternative day were analysed 
separately. The effects of 7-OH-PAT on negative contrast were analysed using a 
two-way between subjects ANOVA with shift condition and dose of 7-OH-DPAT 
as factors. I f there was a reliable dose effect on any of the microstructural variables 
which did not coincide with a significant interaction between dose and shift 
condition, post hoc tests were used to examine at which dose the drug effect had 
become effective. These were applied to each shift condition separately. 
The drug effectiveness ratio (DER) (Flaherty, 1991b) was also computed 
for each level of the drug investigated (0.1, 0.3 and 3.0 mg/kg 7-OH-DPAT). The 
larger the ratio, the greater the effect on consummatory contrast Below is the 
method by which it is computed: 
[P (unshifted vehicle)] - [P (shifted vehicle)] 
DER = 
[P (unshifted drug)] - [P (shifted drug)] 
The greater the effect of the drug in reducing contrast, the larger the DER 
(Flaherty, 1991b, 1996). 
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The computation of this ratio serves two purposes: firstly, it discounts pre-
shift differences in lick frequency (in this case licks/min) by examining post-shift 
data in terms of proportions (P) of terminal pre-shift values. Thus, (P) may be 
derived by dividing (terminal pre-shift lick frequency) / (first post-shift day lick 
frequency plus terminal pre-shift lick frequency). 
Secondly, the effectiveness of the drug is then examined by obtaining a ratio 
of the difference between vehicle-injected shifted and unshifted animals and drug-
injected shifted and unshifted animals. 
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7.3 Results 
Terminal preshift period 
a) data f rom the fu l l 10 min test session 
Terminal pre-shift measures were calculated as described in section 7.2. 
Table 7.1 shows the effects of sucrose concentration (32 or 4%) on the 
microstructural variables in this phase o f the experiment. 
Table 7 .1 Effects of sucrose concentration on average (±S.E.M.) 
parameters of licking over a 10-min test session. 
Sucrose concentration 
32% 4% 
Number o f licks 589 .4±24 .9 1038.3±44.1 
Mean bout duration (s) 2 .962±0 .1 4.4+0.2 
Number of bouts 28 .2±1 .3 3 4 . 3 ± 1 . 8 
n= 42 per concentration group 
Those animals drinking 32% sucrose licked approximately half as much as 
those that had access to 4% sucrose (see Table 7.1). The latter group were licking 
for longer within a bout and also initiated a higher number of bouts within the 10-
min test session. Therefore, a one-way between subjects A N O V A showed that 
there was a main effect of sucrose concentration on number of licks: (F t 8 2 = 
74.408, p<0.0001); mean bout duration: ( F 1 8 2 = 32.472, p<0.0001) and mean 
bout frequency: (F ,. m - 7.158, p<0.05). 
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b) in the first min o f the 10-min test session 
Table 7.2 Effects of sucrose concentration on average (±S.E.M.) parameters of 
licking in the first min of a 10-min test session. 
Sucrose concentration 
32% 4% 
Number of licks 119.0±11.672 167.6±6.5 
Mean bout duration (s) 2 .5±0 .2 4 .5±0 .2 
Number o f bouts 6 .5±0 .7 5 .5±0.3 
n= 42 per concentration group 
In the first minute of the 10-min test session the effects of sucrose 
concentration were less profound than the effects on microstructural variables over 
the f u l l 10-min test session (see Tables 7.2 and 7.1 respectively). Number of licks 
and mean bout duration were greater for the group drinking 4% sucrose than for 
those drinking 32% sucrose and these results reached statistical significance. There 
was a main effect of sucrose concentration on number of licks: (F h 8 2 = 13.209, 
p<0.0005) and on mean bout duration: (F h 8 2 = 53.207, p<0.0001). 
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Negative contrast effects 
Usually, a contrast effect post-shift is measured and analysed relative to the 
unshifted controls (see Section 7.2). However, due to unexpected baseline levels 
of drinking as reflected in terminal pre-shift measures (see above) a contrast effect 
was seen to be established i f the pre-shift means of shifted animals were 
significantly greater than post-shift means. This was achieved by employing a one-
way within subjects A N O V A to analyse data f rom the shifted group. 
a) data f rom the f u l l 10 min test session 
Number of licks 
1250 
1000 -
c/5 
3 750-
500-
250-
pre 
post 
shifted (32-4%) unshifted (4-4%) 
Shift condition 
Figure 7.1 Average (+S.E.M) number of licks for sucrose in a 10-min licking 
test pre- and post-shift as a function of shift condition (32^t%) or (4-4%) on the 
first post-shift day. 
In the post-shift period, half the animals (n=42) were shifted f rom 32-4% 
sucrose (shifted) while the other half continued to have access to a 4% sucrose 
solution (unshifted). Shifted animals generated fewer licks (approximately 250 
licks) in the post-shift period relative to the pre-shift period whereas unshifted 
animals did not show such a profound difference despite a slight drop in the number 
of licks in the post-shift period (approximately 75 licks) (see Rgure 7.1). A one-
way within subjects A N O V A revealed that number of licks within the shifted group 
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was significantly affected by shift period (pre- and post-): ( F , 4 6 = 15.358, 
p<0.0005). 
Mean bout duration 
in 
l 3 pre 03 
• post 
: 
(1 
shifted (32-4%) unshifted (4-4%) 
Shift condition 
Figure 7.2 Mean (+S.E.M) bout duration of licking for sucrose in a 10-min 
licking test pre- and post-shift as a function of shift condition (32-4%) or (4-4%) on 
the first post-shift day. 
Figure 7.2 shows that shifted animals licked with shorter mean bout 
durations in the post-shift period relative to the pre-shift period. This difference of 
almost 1.5 s was significant (F , 4 6 = 58.207, p<0.0001). Unshifted animals did 
not show such a profound decrease despite a slight reduction in mean bout duration 
of approximately 0.5s in the post-shift period. 
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Number of bouts 
Number of bouts increased marginally in the unshifted group in the post-
shift period. The number of bouts initiated by shifted animals were almost 
equivalent in the pre- and post- shift periods. Therefore, over the fu l l 10-min 
session, there was no effect of shift on mean bout frequency. A one-way within 
subjects A N O V A on pre- and post- shift measures f rom the shifted group confirmed 
this observation: (F , ^ = 3.194, n.s.). These results are not shown graphically. 
b) in the first min of a 10-min test session 
Number of licks 
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ISO 
T CO 
E3 pre 
100 • 2 post 
50 ijiiiii-i 
: : : : : : : : 
: : : : ; : : : 
• • • • • • • 
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0 
shifted (32-4%) unshifted (4-4%) 
Shift condition 
Figure 7.3 Average (+S.E.M) number of bouts of licking for sucrose in the first 
min of a 10-min licking test pre- and post-shift as a function of shift condition (32-
4%) or (4-4%) on the first post-shift day. 
Consistent with results over the fu l l 10-min session, shifted animals 
generated fewer licks in the post-shift period relative to the pre-shift period whereas 
unshifted animals did not show such a profound difference despite a slight 
reduction in the number of licks in the post-shift period (see Figure 7.3). 
However, discordant with results collected over 10-min, the effect of devaluing 
sucrose to 4% did not produce a significant decrease in number of licks within the 
shifted group: ( F , ^ = 0.691, n.s.). 
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Mean bout duration 
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Figure 7.4 Mean (+S.E.M) bout duration of licking for sucrose in a 10-min 
licking test pre- and post-shift as a function of shift condition (32-4%) or (4-4%) on 
the first post-shift day. 
Unlike measures of mean bout duration over the fu l l 10-min test session, 
mean bout duration in the first min decreased to a similar extent in the post shift 
period irrespective of shift condition (see Figure 7.4). Within the shifted group, a 
one-way within subjects A N O V A showed that this decrease in mean bout duration 
did not reach statistical significance ( F , ^ = 1.672, n.s.). 
Number of bouts 
Measures f rom the first minute showed that mean bout frequency decreased 
slightly in the post-shift period for shifted animals but remained almost the same for 
unshifted animals. Consequently, within the shift group there was no main effect 
of shift on the number of bouts: ( F , < 4 6 = 0.691, n.s.). These results are not shown 
graphically. 
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Summary 
Table 7.3 The occurrence (+) or absence (-) of contrast in licking 
parameters shifted rats: data f rom the first min of a 10-min test 
session and f rom the fu l l 10-min test session 
Data collected from: 
First min Full 10-min 
Number of licks . + 
Mean bout duration (s) . + 
Number of bouts 
n=42 in the shifted group 
From the microstructural data i t is clear that negative contrast effects were 
most apparent when data was analysed f rom the f u l l 10-min session. These effects 
could be seen in measures of number of licks and mean bout duration but not i n 
number of bouts. 
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Drug effects on negative contrast 
In the third phase of the experiment, only one of the vehicle conditions (of 
four possible vehicle conditions per day / per group) was included in the analysis 
(see Section 7.2). A two-way between-subjects A N O V A was used to test for the 
main effects of the drug and shift conditions and for any interaction between the 
two. 
a) over the f u l l 10-min test session 
Table 7.4 The average (± S .E .M.) of feeding parameters at each dose of 7-OH-
DPAT collapsed over shift condition in a 10-min licking test on the first and second 
post-shift days. 
Dose 7-OH-DPAT (mg/kg) 
0.0 0.1 0.3 1.0 
Post-shift day 
1 
Number of 
licks 
598 .4±76 .1 536.5+54.0 409 .0±79 .7 394.1+43.8 
2 725 .1±71 .8 540.0+104.3 496 .8±76 .0 494.5+114.3 
1 
Mean bout 
duration (s) 
2 .5±0 .3 2 .2±0 .2 1.2±0.1 1.1+0.1 
2 3 .2±0 .2 2 .3±0 .3 1.5±0.2 1.1+0.1 
1 
Number of 
bouts 
32 .8±3 .0 37 .8±2 .9 53.5+9.9 58 .9±5 .8 
2 30 .8±2 .2 24.3+3.6 54 .6±6 .7 4 4 . 9 ± 1 1 . 5 
n= 6 per dose group per day within each shift condition 
Table 7.4 shows that both the number of licks and mean bout duration were 
dose-dependently decreased by 7-OH-DPAT on both the first and the second post-
shift days. Number o f bouts showed a dose-dependent increase on the first post-
shift day but on the second post-shift day number of bouts did not increase in a 
dose-dependent manner. A two-way between-subjects A N O V A revealed that for 
number of licks there was a significant main effect of dose on post-shift day 1: (F l 
4 0 = 5.394, p<0.005) but not on post-shift day 2: (F , ^ = 2.774, n.s.). There was 
a main effect of dose on mean bout duration on post-shift day 1: (F j ^ = 18.317, 
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jxO.OOOl) and a significant and dose-dependent decrease was also revealed on 
post-shift day 2: ( F 1 ^ = 19.858, p<0.0001). The dose-dependent increase in 
number of bouts on post-shift day 1 was statistically significant: ( F , ^ = 6.030, 
p<0.005). There was also a main effect of dose on number of bouts on post-shift 
day 2: (F1 4 6 = 3.957, p<0.05). 
Table 7.5 The average (+ S.E.M.) of the feeding parameters in shifted and 
unshifted groups collapsed over dose conditions in a 10-min licking test on the first 
and second post-shift days. 
Sucrose condition 
Shifted (32-4%) Unshifted (4-4%) 
Post-shift 
day 
1 
Number of 
licks 
325.3+32.4 643.7+38.0 
2 341 .3±37 .6 786.9+58.2 
1 
Mean bout 
duration (s) 
1.3±0.07 2 .2±0 .2 
2 1.6±0.1 2 .4±0 .2 
1 
Number of 
bouts 
36.8+3.2 54.6+5.3 
2 32.8+3.6 4 4 . 5 ± 6 . 5 
n=24 per shift group 
Table 7.5 shows the overall effect of shift on the parameters o f licking. 
Shifted animals emitted approximately half the number of licks of unshifted animals 
on both the first and the second post-shift days. Unshifted animals engaged in 
longer bouts than shifted animals on days 1 and 2 and also initiated more bouts than 
the shifted animals on both post-shift days. 
A two-way between subjects A N O V A revealed that for number of licks 
there was a significant main effect of shift on post-shift day 1: (F , ^ = 55.514, 
p<0.0001) and on post-shift day 2: (F 4 0 = 46.069, p<0.0001). There was a 
similar result, in that mean bout duration also decreased on post-shift day 1: (F i 4 0 
= 31.519, p<0.0001) and 2: (F u 4 0 = 17.508, p<0.0005). The increase in mean 
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bout frequency on day 1 was statistically significant: (F r < 4 0 = 12.392, p<0.005). 
However, there was no main effect of shift on number of bouts on post-shift day 2: 
( F 1 4 6 = 2.931, n.s.). 
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Number of licks 
a) Post-shift day 1 
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1000 
1 
T 1 750 
l 
500 III ! • T I 
^ I 
: 
250 
0 
shifted (32-4%) 
unshifted (4-4%) 
0.0 0.1 0.3 1.0 
Dose 7-OH-DPAT (mg/kg) 
Figure 7.5 Average (+ S.E.M.) number of licks for sucrose over 10 min during 
the post-shift period as a function of drug condition in shifted (32-4%) and 
unshifted (4-4%) rats, a) Post-shift day 1- Plus indicates significantly different 
f rom vehicle +p<0.01; b) Post-shift day 2- Asterisk indicates significantly different 
from vehicle *p<0.05; Plus indicates significantly different f rom vehicle +p<0.01. 
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For number of licks, there was no significant interaction between shift and 
drug dose on the first: (F 3 ^ = 2.257, n.s.), or the second post-shift day: (F 3 ^ 
= 2.774, n.s.). In the absence of significant interactions, post-hoc tests revealed 
that within the unshifted group number of licks were decreased significantly by the 
medium and high doses of 7-OH-DPAT (0.3 and 1.0 mg/kg) on post-shift day 1 
when compared to vehicle controls (p<0.01). On post-shift day 2 a post hoc test 
showed that the number of licks emitted by unshifted animals was significantly 
decreased by the 0.3 mg/kg dose o f 7-OH-DPAT, (p<0.01). 
In the shifted group, post hoc tests showed that none of the doses of 7-OH-
DPAT decreased number of licks significantly on post-shift day 1, while on post-
shift day 2 both the low and the high (0.1 and 1.0) doses achieved a significant 
decremental effect when compared to vehicle controls, (p<£.05 and p<0.01 
respectively), (see Figure 7.5). 
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Mean bout duration 
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Figure 7.6 Mean (+ S.E.M.) bout duration of licking for sucrose over 10 min 
during the post-shift period as a function of drug condition in shifted (32-4%) and 
unshifted (4-4%) rats, a) post-shift day 1; b) post-shift day 2 -Plus indicates 
significantly different f rom vehicle +p<0.01. 
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The data represented in Figure 7.6 reveals that on post-shift day 1, there 
was a highly significant interaction between drug dose and shift condition for mean 
bout duration: (F 3 4 0 = 5.365, p<0.005). Differences between the shifted and 
unshifted groups in mean bout duration became smaller as doses of 7-OH-DPAT 
increased. A t the highest dose (1.0 mg/kg) mean bout duration for both groups 
were almost equal. A similar trend existed for this parameter on post-shift day 2. 
However, there was no significant interaction between shift condition and drug 
dose for mean bout duration on the second post-shift day: (F 3 4 0 = 1.812, n.s.). 
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Number of bouts 
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Figure 7.7 Average (+ S.E.M.) number of bouts of licking for sucrose over 10 
min during the post-shift period as a function of drug condition in shifted (32-4%) 
and unshifted (4-4%) rats, a) post-shift day 1; b) post-shift day 2. 
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Differences in mean bout frequency between the shifted and unshifted 
groups did not vary systematically as a function of dose 7-OH-DPAT. 
Nevertheless, there was a significant interaction between drug dose and shift 
condition on post-shift day 1: (F 3 4 0 = 4.112, p<0.05). There was no such 
interaction between dose and shift on post-shift day 2, (see Figure 7.7). 
Drug effectiveness ratios 
Table 7.6 Drug effectiveness ratios (DERs) obtained f rom data f rom 
a 10-min o f licking test on the first and second post-shift days as a 
function of dose 7-OH-DPAT (0.1-1.0 mg/kg). 
Dose 7-OH-DPAT (mg/kg) 
0.1 0.3 1.0 
Post-shift day 
1 1.90 1.07 2.20 
2 0.87 1.59 0.72 
n= 6 per dose group per day 
The method of computing drug effectiveness ratios derived for shifted 
animals are described in section 7.2. These ratios give a measure of the ability of a 
drug to reduce contrast in shifted rats. Therefore, Table 7.6 shows that on post 
shift day 1 the highest dose of 7-OH-DPAT (1.0 mg/kg) was most effective in 
reducing contrast overall, while on post-shift day 2 contrast was most reliably 
reduced by the medium dose (0.3 mg/kg 7-OH-DPAT). 
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b) in the first min of a 10-min test session 
Table 7.7 The average (+ S.E.M.) of feeding parameters at each dose of 7-OH-
DPAT collapsed over shift condition in the first min of a 10-min licking test on the 
first and second post-shift days. 
Dose 7-OH-DPAT (mg/kg) 
0.0 0.1 0.3 1.0 
Post-shift day 
1 
Number of 
licks 
123.5+15.8 86.4±9.7 46.1±7.1 41.2±5.9 
2 114.0±17.0 85.1±19.7 64.3±16.0 28.4±7.9 
1 
Mean bout 
duration (s) 
2.8+0.4 2.3±0.3 1.3±0.2 1.0±0.1 
2 4.0+0.7 2.0±0.4 1.6±0.5 0.8+0.2 
1 
Number of 
bouts 
6.3±0.7 5.9±0.7 5.9±1.1 5.3±0.9 
2 4.3±0.5 5.4±0.9 5.9±1.2 3.3+0.8 
n= 12 per dose group per day 
Table 7.7 shows that, in the first minute, both number of licks and mean 
bout duration were dose-dependently decreased by 7-OH-DPAT and this was 
apparent on both post-shift days. On the first post-shift day number of licks were 
significantly and dose-dependently decreased: (F 3 w = 17.972, rxO.0001). The 
same trend was observed on the second post-shift day: (F 3 4 0 = 11.039, 
p<0.0001). Mean bout duration was also significantly and monotonically reduced 
in the first minute on the first post-shift day: (F 3 w = 23.763, p<0.0001) and the 
second post-shift day: (F 3 w = 9.429, p<0.0001). Number of bouts in the first 
minute hardly varied at all as a function of 7-OH-DPAT on the first post-shift day: 
(F 3 ^ =0.184, n.s.). On the second post-shift day, mean bout frequency in the 
first min increased systematically as a function of the low and medium doses of 7-
OH-DPAT (0.1 and 0.3 mg/kg) but this trend was not borne out in relation to the 
highest dose (1.0 mg/kg). Therefore, this result did not reach statistical 
significance: (F 3 w = 2.167, n.s.). 
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Table 7.8 The average (+ S.E.M.) of feeding parameters in shifted and unshifted 
groups collapsed over dose conditions in the first min of a 10-min licking test on the 
first and second post-shift days. 
Sucrose condition 
Shifted (32-4%) Unshifted (44%) 
Post-shift 
day 
1 
Number of 
licks 
59.6±7.7 91.9+10.6 
2 37.5±7.3 108.5±12.7 
1 
Mean bout 
duration (s) 
1.3±0.1 2.4+0.2 
2 1.2±0.3 2.9+0.4 
1 
Number of 
bouts 
5.5±0.6 6.3±0.6 
2 3.2+0.5 6.2+0.6 
n=24 per shift group per day 
Unshifted animals generated more licks and licked with longer bout 
durations than those which were shifted. This trend was observed on both post-
shift days. Unshifted animals also initiated more bouts than unshifted animals on 
both post-shift days. However, the difference in mean bout frequency for shifted 
and unshifted animals was more profound on the second post-shift day. 
The effect of shift condition on number of licks in the first minute was 
significant on post-shift day 1: (F x ^ = 15.071, p<0.0005) and also on post-shift 
day 2:(Fl 40 = 42.919, p<0.0001). There was a highly significant main effect of 
shift on mean bout duration in the first minute on post-shift day 1: (F u 4 0 = 44.046, 
p<0.0001) and on post-shift day 2: (F t 4 0 = 14.287, p<0.005). In the case of 
mean bout frequency, there was no significant main effect of shift condition on the 
first post-shift day: (F, ^ =0.793, n.s.) but mean bout frequency was significantly 
affected by shift on the second post-shift day: (F t ^ = 13.613, p<0.005). 
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Figure 7.8 Average (+ S.E.M.) number of licks for sucrose in the first min 
during the post-shift period as a function of drug condition in shifted (32-4%) and 
unshifted (4-4%) rats, a) post-shift day 1- Asterisk indicates significantly different 
from vehicle *p<0.05; Plus indicates significantly different from vehicle +p<0.01; 
b) post-shift day 2. 
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Figure 7.8 shows that for number of licks, there was no significant 
interaction between shift and drug dose on the first post-shift day: (F 3 w = 2.257, 
n.s). On the first post-shift day dose-response curves for shifted and unshifted 
groups were parallel (see Figure 7.8 a). In the absence of significant interactions, 
post-hoc tests revealed that within the unshifted group number of licks were 
decreased significantly by all doses of 7-OH-DPAT (0.1-1.0 mg/kg) on post-shift 
day 1 when compared to vehicle controls (p<0.01 for 0.3 and 1.0 mg/kg; p<0.05 
for 0.1 mg/kg). On the second post-shift day there was a significant interaction 
between shift and drug dose for this parameter: (F 3 ^ = 3.537, p<0.05) (see 
Figure 7.8 a or b). 
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Mean bout duration 
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Figure 7.9 Mean (+ S.E.M.) bout duration of licking for sucrose over 10 min 
during the post-shift period as a function of drug condition in shifted (32-4%) and 
unshifted (4-4%) rats, a) post-shift day 1; b) post-shift day 2-Asterisk indicates 
significantly different from vehicle *p<0.05; Plus indicates significantly different 
from vehicle +p<0.01. 
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On post-shift day 1, there was a highly significant interaction between drug 
dose and shift condition for mean bout duration: (F 3 4 0 = 5.995, p<0.0001) which 
was probably due to the equivalence of responding after the highest dose of 7-OH-
DPAT (1.0 mg/kg) in the shifted and the unshifted groups (see Figure 7.9 a). As 
with the 10-min results, differences between the shifted and unshifted groups in 
mean bout duration became smaller as doses of 7-OH-DPAT increased. There was 
no significant interaction between shift condition and drug dose for mean bout 
duration on the second post-shift day: (F 3 4 0 = 0.621, n.s.). 
In the absence of a significant interaction, post-hoc tests were used and 
revealed that in the unshifted group, both medium and high doses (0.3 and 1.0 
mg/kg) of 7-OH-DPAT decrease mean bout duration significantly when compared 
to vehicle controls, (p<0.05 and p<0.01 respectively). In the unshifted group it 
appeared that in the first minute, all doses of 7-OH-DPAT (0.1-1.0 mg/kg) 
decreased mean bout duration to a similar extent when compared to vehicle controls, 
(p<0.01). 
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Number of bouts 
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Figure 7.10 Average (+S.E.M.) number of bouts of licking for sucrose in the 
first min during the post-shift period as a function of drug condition in shifted (32-
4%) and unshifted (4-4%) rats, a) post-shift day 1; b) post-shift day 2. 
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There was no significant interaction between drug dose and shift condition 
on post-shift day 1 : (F 3 w = 1.396, n.s.). There was also no significant 
interaction between dose and shift on post-shift day 2: (F 3 ^ = 0.966, n.s.). 
Drup effectiveness ratios 
Table 7.9 Drug effectiveness ratios (DERs) obtained from data from 
the first min of a 10-min licking test on the first and second post-shift 
days as a function of dose 7-OH-DPAT (0.1-1.0 mg/kg). 
Dose 7-OH-DPAT (mg/kg) 
0.1 0.3 1.0 
Post-shift day 
1 1.70 1.90 3.00 
2 0.67 1.30 3.50 
n= 6 per dose group per day 
The drug effectiveness ratios derived for shifted animals are described in 
Section 7.2. On post-shift day lthere was a dose-dependent increase in the 
effectiveness of 7-OH-DPAT to reduce contrast in shifted rats. This dose-dependent 
trend also existed on post-shift day 2 and at the highest dose (1.0 mg/kg) 7-OH-
DPAT was more effective at reducing contrast than it was on post-shift day 1. 
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Summary 
Table 7.10 The occurrence (+) or absence (-) of a significant 
interaction (rx0.05) between drug dose and shift condition on 
licking parameters: Data from the first min of a 10-min test 
session and from the full 10-min test session over post-shift day 
1 and post-shift day 2. 
Data collected from: 
First min Full 10-min 
Number of licks 
day 1 _ 
day 2 + 
Mean bout duration (s) 
day 1 + + 
day 2 
Number of bouts 
day 1 + 
day 2 
n=48 per post-shift day 
Table 7.10 illustrates that significant interactions between drug dose and 
shift condition were found in the first minute of the 10-min test session for number 
of licks on post-shift day 2 and mean bout duration on post-shift day 1. When data 
was analysed from the full 10-min test session, there were significant interactions 
for mean bout duration and number of bouts, both of these findings from post-shift 
day 1. 
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7.4 Discussion 
Overall, the results of this experiment show that shifting reward from 32% 
sucrose to 4% sucrose produced a successive negative contrast effect This was 
reflected in the microstructure of licking as a decrease in mean bout duration rather 
than a decrease in mean bout frequency. This result is consistent with findings by 
Grigson et al. (1993) who originally characterised successive negative contrast 
effects in terms of licking microstructure. Contrast effects rely on the comparison 
of post-shift rewards with the memory of pre-shift reward. 7-OH-DPAT reduced 
the successive negative contrast effect More concisely, 7-OH-DPAT succeeds in 
reducing successive negative contrast This is contrary to previous findings such as 
Flaherty et al. (1992) whereby contrast effects remained unimpaired under the 
influence of haloperidol and chlorpromazine. Haloperidol and chlorpromazine are 
non-selective dopamine antagonists whereas 7-OH-DPAT has at least some 
specificity for the D3 receptor. Therefore, D3 receptors may be involved in the 
mediation of relative reward value as well as absolute reward value of both pre- and 
post-shift solutions. 
The effects of sucrose concentration on licking, as reflected in the terminal 
pre-shift measures were somewhat unexpected. In general, before the shift, 
animals licking for the high sucrose concentration (32%) were licking less and with 
shorter bouts than those animals who had access to the lower sucrose concentration 
(4%). Although unexpected, this result is not unprecedented; nor does it preclude 
the possibility of a contrast effect post-shift Grigson and colleagues noted that 
during the preshift period of numerous experiments investigating contrast, rats 
generally make more licks for higher concentrations. They insert the caveat that this 
effect does not always develop and is not necessary for the occurrence of a contrast 
effect when the sucrose concentration is reduced (Grigson et al., 1992,1994). 
One explanation of the pre-shift measures may be in terms of procedural 
detail such as test duration. In the present experiment, animals were trained and 
tested for lC^min daily. This relatively long training duration coupled with the eight 
day training regime could have led to a conditioned satiating effect of the higher 
concentration of sucrose (as described by Smith, 1996) towards the latter end of the 
training period. It is from this portion of the training period that terminal pre-shift 
measures are necessarily derived. A shorter training and testing duration could help 
to eliminate this explanation. Also, analyses of licking microstructure have shown 
that more concentrated fluids are not always more palatable or reinforcing (Davis 
and Levine, 1977 and see Chapter 2). 
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Successive negative contrast effects were apparent in the changes in total 
number of licks over the 10-min test session. Animals that were shifted from 32% 
to 4% sucrose licked significantly less post-shift than they did pre-shift The 
licking patterns associated with successive negative contrast were manifest as 
significant decreases in mean bout duration rather than any change in bout number. 
As the size of bouts can be interpreted as a measure of palatability (Davis and 
Smith, 1992), it is inferred that negative contrast effects are, at least in part, based 
on the "hedonic inferiority" of the post-shift solution as compared with the pre-shift 
solution (Flaherty et al., 1990, pp.88). Results from the first minute of the 10-min 
test session are not so well defined. The decreases seen in feeding parameters in 
this early portion of the test session were similar to data from the full test session 
but did not reach significance. It may be that a minute is not long enough for a 
contrast effect to be expressed behaviourally. 
These temporal differences in expression of behaviour related to reward 
contrast also impinge upon the interpretation of drug effects on successive negative 
contrast It has been observed frequently that when drugs are adminstered on the 
first post-shift day, effects on contrast are not apparent However, attenuation of 
contrast does appear if drugs are administered on the second post-shift day. For 
example, the benzodiazepine, chlordiazepoxide, effectively eliminates negative 
contrast when the drug is administered for the first time on the second post-shift day 
(Flaherty et al., 1980). This led Flaherty (1990,1991) to speculate that different 
processes may be involved in the initial occurrence of contrast and the subsequent 
recovery from contrast Moreover, drug treatments may be differentially effective 
in these dissociable circumstances. 
•v One hypothesis which has been offered to explain these temporal differences 
in drug effectiveness post-shift is the following: it is possible that the process of 
comparing the post-shift solution with the memory of the pre-shift solution, (thus 
determining that the post-shift solution is hedonically inferior) requires a certain 
amount of time and experience with the post-shift solution (Flaherty et al., 1980). 
Chlordiazepoxide does not become effective in reducing contrast until the reward 
difference is detected and responded to (Flaherty et al., 1980). To test this 
hypothesis, Flaherty et al., (1986) allowed animals access to the post-shift solution 
of 4% sucrose for 20-min rather than the usual 5-min. Before access, animals were 
injected with chlordiazepoxide and the drug became effective during the second five 
minutes of the extended test period. This period would normally correspond to the 
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second post-shift day, therefore, this hypothesis was supported in the case of 
chlordiazepoxide. 
In the present experiment, there were significant interactions between shift 
and drug dose on feeding parameters on both post-shift days and these were, in the 
case of mean bout duration, apparent even within the first minute of the first post-
shift day. Therefore, it seems that recovery from contrast as produced by 7-OH-
DPAT was almost immediate. 
Other hypotheses exist to explain the differential effectiveness of drugs early 
and late in the post-shift period. One explores the possibility that negative contrast 
is not stressful on the first post-shift day, but is stressful on the second post-shift 
day (Flaherty et al., 1985). This hypothesis was tested by measuring 
corticosterone levels on post-shift days as this chemical signal correlates highly with 
a stress response. Flaherty found that corticosterone is elevated on the second post-
shift day and postulates that the rise in corticosterone is reflecting an anticipatory 
frustration response and/or uncertainty and anxiety based on the experience of the 
previous day (Flaherty et al., 1985). 
It is therefore not surprising that many of the drug treatments which have 
been found to reduce contrast are anxiolytics \vhich produce their best effects on 
contrast on the second post-shift day (see Figure 1.11). Further, it is possible that 
it is this anxiolytic property of 7-OH-DPAT which makes it effective in reducing 
contrast, as the D3 receptor receptor has been recently implicated in the regulation of 
anxiety (Rodgers etal., 1996, Steineretal., 1997, Bartoszyk, 1998, also see 
Chapter 1). 
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Figure 7.11 Drug effectiveness ratios (DERs) obtained in a series of 
dose/reponse studies utilizing the consummatory negative contrast procedure. The 
values plotted represent the results obtained with the most effective dose of each 
drug. The larger the DER value, the greater the contrast reduction. Scop = 
scopolamine; Pyr = pyrilamine; Clon = clonidine; Amph = amphetamine; Prop = 
propanolol; Meth = methysergide; Imip = imipramine; Busp = buspirone; Morph 
= morphine; Flur = flurazepam; ABS = amobarbital sodium; ETOH = ethanol; 7-
OH = 7-OH-DPAT; CDP = chlordiazepoxide; MDZ = midazolam, (Figure 7.11 
adapted from Flaherty, 1991, with the inclusion of data from the present 
experiment). 
From Figure 7.11 it is interesting to compare the effectiveness of 7-OH-
DPAT in reducing successive negative contrast to other drugs which have been 
tested within the same paradigm. 7-OH-DPAT is more effective than ethanol at 
reducing contrast and is marginally less effective than chlordiazepoxide at achieving 
this result Of the ineffective drugs tested, many are dopaminergic compounds 
(either indirect or non-selective). Therefore, it may be 7-OH-DPAT's status as a 
putative D3 receptor agonist and/or anxiolytic which sets it apart from this class of 
drugs in this paradigm. 
The DER gives a convincing picture of the ability of 7-OH-DPAT to reduce 
contrast. If the interpretation of the apparent reduction in contrast relied solely on 
the measurement of microstructural parameters (see pages 255-272) then an 
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alternative explanation might be in terms of the emergence of a "floor" effect after 
the administration of 7-OH-DPAT post-shift. 
However, there is a potential confound in many drug studies in the contrast 
paradigm in that a number of the drugs which are effective in reducing contrast also 
have appetite stimulating effects. For example, it is well-established that the 
benzodiazepines induce hyperphagia in virtually all experimental settings (Cooper 
and Estall, 1985). Analysis of the microstructure of hyperphagic effects of 
benzodiazepines show that these drugs achieve their effect by increasing mean bout 
duration (Higgs and Cooper, 1996; 1997). Therefore it is difficult to eliminate 
appetite-stimulating effects when explaining the ability of drugs such as 
benzodiazepines and barbiturates to reduce contrast A further benefit of applying a 
microstructural analysis to recovery from contrast would be to eliminate the 
hyperphagic effects of drugs such as benzodiazepines. Hence, what the figure 
(above) cannot reveal is whether these effective compounds reduce negative contrast 
in the same way as it was achieved here. To answer this question it is necessary to 
appeal to the drug-induced changes in microstructural variables during contrast and 
the subsequent recovery from contrast As yet there is no evidence that the 
microstructural changes associated with benzodiazepine-induced recovery from 
contrast are not manifest as an increases in mean bout duration. Consequently, it 
may be the case that drugs which have hyperphagic effects are reducing contrast by 
reinstating pre-shift levels of ingestion through increasing bout duration; a basic 
behavioural effect of benzodiazepines in the absence of any change in shift Further 
experimentation, using microstructural methodology needs to be undertaken to 
solve this problem. 
Flaherty has reason to believe that recovery from contrast is not simply 
related to appetite stimulation because although drugs such as chlordiazepoxide is 
relatively ineffective in reducing contrast on the first post-shift day, even though it 
often has an appetite-stimulating effect on that day (Flaherty et al., 1986,1990b). 
However, microstructural analysis should help to elucidate the underlying changes 
in feeding parameters associated with benzodiazepine-induced recovery from 
contrast In the present experiment, the confound of appetite-stimulation does not 
exist. 7-OH-DPAT has been repeatedly shown to reduce ingestion by shortening 
mean bout duration (see Experiments 1 and 4) and therefore reducing the palatability 
of solutions. In this experiment it is decreases in mean bout duration which are 
most strongly associated with successive negative contrast However, although 
there are significant interactions between shift condition and drug dose for mean 
bout duration over 10-min and in the first min of the test session on post-shift day 
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one it does not seem that it is on this parameter that 7-OH-DPAT is exclusively 
having its contrast reducing effects. 
Further evidence of this assertion comes from the examination of mean bout 
frequency data. Although this parameter is virtually unchanged as a function of 
shift there is a significant interaction between shift condition and drug dose on 
number of bouts. This is apparent on the first post-shift day over the full 10-min 
test session. If a successive negative contrast can be achieved (as revealed by 
number of licks) without changes in mean bout frequency then 7-OH-DPAT -
induced recovery from contrast might be expected to be successful without any 
changes in this parameter. The interactions for mean bout frequency are evidence 
that this may not be the case. 
Another possibility offered by Flaherty as to the differential effectiveness of 
anxiolytics in the post-shift period is that the differences reflect the operation of 
different psychological processes underlying contrast at these discrete stages of the 
post-shift period. For example, the initial response to reward reduction may 
involve the activation of a search process to locate the "missing" reward (Flaherty et 
al., 1978, 1979). Subsequently, as the missing reward is not located, the animals 
may enter a conflict period triggered by the drive to consume the post-shift reward 
(especially in food deprived animals) balanced a^gainst the preference for the 
remembered pre-shift reward. It may be that this conflict stage is stressful and 
during this stage that anxiolytics such as CDP and ethanol (Becker and Flaherty, 
1982) become effective in reducing contrast 
The idea of a search process might well be reflected by an increase in bout 
frequency on the first post shift day where animals are repeatedly "trying out" the 
solution in order to match it with the memory of the pre-shift solution. This seems 
to be the case for shifted animals in this experiment but only in the first min of the 
test and on the first post-shift day. On post-shift day 2 this effect is no longer 
apparent 
* Inasmuch as the drug-induced recovery from contrast may be an artefact of 
appetite-stimulation, the results of this experiment constitute the first evidence that a 
drug which reduces contrast is not stimulating appetite and may not be promoting 
recovery from contrast in the same way as it was achieved. 7-OH-DPAT is 
effective in reducing contrast on both the first and the second post-shift day, 
though, overall, it is marginally better on the first post-shift day and more especially 
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when data is analysed from the first minute. Therefore, this experiment also 
provides evidence of a reduction in contrast by 7-OH-DPAT in animals which do 
not seem to need a great deal of time to recognise and act upon the presentation of a 
contrasting stimulus. This is a result which may have been obscured had 
dependent variables been limited to a more composite measure such as total intake 
or total licks. However, more work needs to be done to discover the exact 
pharmacological properties of putative D3 receptor agonists such as 7-OH-DPAT. 
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Chapter 8: Genera! discussion 
8.1 Aims of the General discussion 
This final chapter is subdivided into the five following sections. The 
empirical findings of the experimental chapters are summarised in Section 8.2, and 
are discussed in relation to the aims of the thesis (Chapter 2, Section 2.13). They 
are also juxtaposed with additional experiments which would help to address still 
unresolved issues (i.e. a motor versus a motivational role for dopamine). In Section 
8.3, the present data are discussed within the framework of Berridge's (1996) 
theory of dopamine's involvement in food reward. The validity of his theory will 
also be evaluated briefly. Section 8.4 has two purposes: firstly, it deals witht the 
clinical implications of the work; secondly, it examines the extent to which findings 
on the bases of food reward per se are relevant to broader aspects of reward and 
addiction. Section 8.5 briefly proposes future directions for research into the 
functional role of dopamine in information-processing related to rewards. 
8.2 Summary of empirical findings and future experiments 
Microstructural analysis of licking can provide detailed information as to the 
components of ingestive behaviour which may be affected by either 
pharmacological manipulation and/or manipulation of the properties of the ingested 
diet as well as the .motivational state of the animal. These observations have been 
incorporated in a model for the control of ingestion (Davis and Levine, 1977; Davis 
and Smith, 1992). As has been repeatedly stated throughout the thesis, this model 
predicts that increasing carbohydrate solution concentration leads to the selective 
lengthening of bouts of licking and also leads to an increase in the initial rate of 
licking. Changes in these parameters, as a result of changing concentration or drug 
treatment may best reflect changes in palatability of the liquid diet (Davis and 
Levine, 1977; Davis and Smith, 1992). 
Throughout the thesis, many of the results showed that increasing 
concentration led to an increase in the mean bout duration of licking which helps to 
confirm the notion that this parameter represents a measure of palatability. 
However, for both sucrose and the fat emulsion Intralipid, a linear relationship 
between concentration and mean bout duration was not always evident and so doubt 
remains as to the validity of this parameter as a measure of palatability. Also, in 
previous reports not all types of tastant produce a robust and linear relationship 
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between increasing concentration and mean bout duration. Davis (1995) could not 
replicate these effects with corn oil and so speculated that it may be a property of 
this particular stimulus other than "taste" palatability (e.g. such as texture or 
temperature) which leads to these anomolous results. Further microstructural 
analyses using a wide range of macronutrient solutions need to be conducted in 
order to further verify the model. Also, the range of concentrations used in the 
experiments in Chapters 4,5 and 6 is narrow (1-10%) and so the full behavioural 
implications of a stimulus' properties cannot be fully explored or explained as a 
consequence of the results from these chapters. 
In Chapter 7, terminal preshift measures of mean bout duration did not 
reflect the "absolute reinforcer value" of the sucrose solutions used even when these 
durations were measured from the first minute of the test session. More precisely, 
animals licking for a 32% sucrose solution did not engage in longer bouts of licking 
than those animals which had access to a 4% sucrose solution. This affirms the 
idea that behavioural responses are far from stimulus bound (Grill and Berridge, 
1985) and that previous experience and motivational state as well as the animals' 
representation of the stimulus response relationship (i.e. what leads to what) 
(Dickinson and Balleine, 1994) are important factors in the control of licking and 
therefore ingestion. Concept definitions and operationalisable measures of 
palatability must reflect these considerations. _ 
To further explore the limits to which a given stimulus value might reliably 
affect ingestive behaviour it would be informative to microstructurally analyse the 
development of responses to tastants of differing reinforcer value. In this way, 
from tiie initial introduction of the tastant, parametric changes in licking could be 
measured longitudinally (i.e. over days). For example, licking patterns during 
training in the lickometer are assumed to reach stable levels at a rate which is not 
significantly affected by the stimulus properties per se. However there has been 
little effort to systematically investigate Ihe contribution of absolute or relative 
reinforcer value to the establishment of this asymptotic behaviour. 
Experiments which try to uncover this relationship could go further in 
addressing the original Hullian question of "does more pleasure equal more 
learning?". The extent to which a stimulus can be construed as a "goad" with a 
relatively stable value, would be more apparent when the behavioural responses to 
it were examined at such a detailed level. The "goad" of course could be 
manipulated not only in terms of the physical stimulus properties but also by 
motivational state (see Dickinson and Balleine, 1994). By using this type of 
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paradigm it would be possible to examine what learning about the stimulus-
response relationship "looks like" microstructurally. 
One of the primary aims of this thesis was to further examine whether 
dopamine agonists and antagonists, selective for different dopamine receptor 
subtypes decrease the intake of liquid diets in the same or in different ways. By 
adopting a microstructural analysis, this was investigated in Experiments 1, 2 and 
3. 
The experiments reported in Chapter 4 constituted preliminary evidence that 
a D3 receptor agonist (7-OH-DPAT), a mixed D2/D3 receptor agonist (quinpirole) 
and a D2 receptor antagonist (raclopride) were decreasing the palatability of the diet 
as reflected by a decrease in the mean bout duration of licking and the initial rate of 
licking, rather than significantly decreasing the number of bouts. This is the first 
set of experiments to compare 7-OH-DPAT, quinpirole and raclopride at such a 
detailed ingestive behavioural level. Nevertheless, these compounds did not affect 
these parameters to the same extent; 7-OH-DPAT seemed to be most potent in this 
test, followed by quinpirole then raclopride. 
These experiments clearly showed that drugs which putatively exert their 
effects through separate dopamine receptor subtypes (i.e. D2 and D3 receptor 
subtypes) are capable of decreasing the initial hedonic evaluation of the tastant. 
This conclusion is further confirmed by the observation that drug-induced changes 
in parameters which reflect palatability were most profound in the first min of the 
20-minute test session used for the experiments in Chapter 1. Results from 
experiments 9 and 10 also support the idea that licking responses in the first minute 
of the test session are of greater interpretative strength as drug and concentration 
effects are more profound when data are analysed from this portion of a longer test. 
v Measures of motoric competence such as intrabout lick rate/average interlick 
interval and latency were included as dependent variables for the experiments in 
Chapter 5. This reflected the specific aims of the experiments in this chapter which 
were to further examine the possibility of the primacy of a motor deficit in 
explaining the decreases in licking parameters that had been observed in Chapter 4. 
A dopamine D l antagonist was employed in Experiment 6 providing a further 
comparison of the effects of drugs acting at D2 and D3 receptors on licking 
microstructure. To increase the interpretive strength of the test with regards to 
palatability, a brief contact test was used. Also a different type of macronutrient 
fluid was used in the form of an Intralipid emulsion. 
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Again increasing concentration led to an increase in mean bout duration of 
licking in Experiments 4, 5 and 6 which further validates the model of Davis and 
Levine. These conclusions extended also to increasing concentrations of Intralipid 
which adds to the generalisability of this model and follows further work in the 
same vein reported in Chapter 2. The consistent observation that concentration has 
little or no effect on either intrabout lick rate and/or average interlick interval 
provides us with the inference that any changes in these parameters are due to 
changes that are not related to the palatability of the diet 
However, in Experiment 4, there was an effect of concentration on average 
interlick interval which was monotonic yet small. It has been suggested that when 
more viscous solutions are used there can be a concomitant increase in 
average interlick interval (Davis, 1996). Higgs (PhD Thesis, 1996) suggested an 
appropriate experiment with which to test whether viscosity was having an effect on 
intrabout lick rate (and therefore average interlick interval). The addition of texture 
enhancing constituent to the tastant (such as guar gum) would increase viscosity 
without affecting the taste palatability of the diet. The effect of concentration on 
intrabout lick rate did not appear for either test fluid in Experiments 5 or 6. 
Therefore, the increase in average interlick interval as a result of increase 
concentration observed in Experiment 4 does not serve to seriously question the 
validity of the above interpretation of this measure (i.e. that intrabout lick rate is 
insulated from changes in concentration). Taken together these results represent 
further confirmation of the validity of the model for the control of ingestion of Davis 
and Levine (1977). 
There were no reliable effects of test fluid concentration on latency from the 
experiments in Chapters 5,7 and 8. This suggests that this measure is not sensitive 
to factors associated with changes in tastant concentration (i.e. palatability) and so 
may best be construed as a more valid measure of motoric competence. However, 
this is not always reflected in the literature as there are many researchers who define 
latency in motivational terms (e.g. Wilson et al., 1995). Indeed, approach 
behaviour has become a meaningful dependent variable in reward research and one 
which has been shown to covary with dopaminergic activity (see Chapter 1). 
Ill-defined measures such as latency reflect the ambiguity which surrounds 
the "motor versus motivation" hypotheses which proliferate throughout reward 
research. The point at which dopamine involvement in "motor" evolves into an 
involvement in "motivational" remains contentious. For some, such as Salamone, 
this dichotomy is false and it is in the functional and anatomical overlap between 
283 
Chapter 8 
these two aspects of behaviour where we may find answers to the precise role of 
dopamine in rewarded behaviour (Salamone, 1996). Therefore, it is difficult to 
make any strong claims as to the effects of the drugs used in these experiments on 
latency measures. 
While the findings presented in Chapter 5 further validate the effects of 
concentration within the framework of the model of the control of ingestion, drug 
effects in this set of experiments are less clear cut than those presented in Chapter 4. 
In general, Experiments 4,5 and 6 do not present a strong argument for a specific 
effect of these compounds on palatability when a short test session is used. 
Although 7-OH-DPAT decreased mean bout duration of licking for both test 
solutions and SCH-23390 decreased this parameter for Intralipid, these compounds 
alsa produced changes in licking parameters and latency measures which may be 
seen as being consistent with a motoric deficit (i.e. increases in latency and 
decreases in intrabout lick rate). Raclopride seems, at the doses used, to be having 
a non-specific effect on licking parameters in the shorter test session. The data 
presented in Chapter 5 cannot be used to resolve the issue of whether the dose of 7-
OH-DPAT which is most effective in reducing mean bout duration is reflecting a 
separate motor impairment or a more selective effect on palatability. 
One explanation of neuroleptic-induce4 decreases in intrabout lick rate has 
been to invoke an explanation in terms of an orolingual motor deficit (Gramling and 
Fowler, 1985; Fowler, 1990). They noted that the neuroleptic-induced deficit was 
manifest as "missed licks" which effectively doubled the length of the interlick 
intervals in their experiment Further examination of the interlick interval after the 
administration of 7-OH-DPAT, SCH-23390 and raclopride revealed that mis 
explanation does not apply to the data in Chapter 5 (results not shown). Nor did 
any of the drugs used in Chapter 5 shift the distribution of the average interlick 
intervals to the left or to the right. These data could suggest that these drugs may be 
affecting licking behaviour at the level of interbout intervals which would be 
consistent with the effects of 7-OH-DPAT on cocaine self-administration (i.e. Caine 
and Koob, 1995). Further work needs to be conducted with an analytical focus at 
the level of interbout intervals to further confirm this hypothesis. 
As was referred to in Chapter 4, Pecina and Berridge (1997) explained the 
effects of pimozide on taste reactivity measures in terms of producing a 
sensorimotor deficit which was primarily characterised by temporal characteristics 
of responding (i.e. a progressive motor dysfuction emerged rather than an 
immediate effect on taste reactivity). However, results from Chapter 5 show that 
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raclopride SCH-23390 and 7-OH-DPAT had their most profound effects on the 
initial hedonic evaluation of the stimulus. 
In order to further assess the extent to which the data presented in this thesis 
fits with the "sensorimotor" hypothesis let us recapitiluate the basic predictions of 
this hypothesis. The idea that nucleus accumbens dopamine represents a 
sensorimotor interface incorporates the idea that interference with nucleus 
accumbens dopamine (i.e. via phamacological blockade) alters the allocation of 
responses away from more vigourous or effortful responses towards the selection 
of less effortful responses. The most compelling evidence that the drugs used in 
Chapter 5 produce a motor deficit is from the slowing of intrabout lick rate. The 
slowing of intrabout lick rate could feasibly represent "the selection of a less 
effortful response". However, in order to operationalise a concept such as effort or 
Vigour, there must be some distinction between rate and, for instance "force" of 
licking as is examined by Fowler and colleagues (see Chapter 2). One way in which 
novel dopaminergic agonists and antagonists (especially those with an atypical 
profile) have been characterised behaviourally is by the measurement of lick force or 
vigour. These measurements would be especially informative in examining the 
extent to which such compounds induce a specifically "sensorimotor" deficit. 
Another way to test this hypothesis can be seen in the most recent work by 
Salamone (1997) who has employed experimental "cost-benefit" strategies after the 
manipulation of dopamine transmission. In this way, it is possible to carefully 
control and manipulate the "size" of energy barriers to be crossed as well as the size 
of rewards to be gained. With the help of more specific pharmacological tools it 
would be possible to manipulate specific dopamine receptor subtype populations in 
distinct regions of the nucleus accumbens, thereby postulating a role for these 
subtypes in the mediation of specifically "sensorimotor" function. These 
conceptualisations of the function of dopamine in reward veer research away from 
ill-defined dichotomies of motor and reward capacity. Rather they help to focus on 
the overlap between what are traditionally seen as discrete functions in which 
dopamine had a specific part to play. 
The Experimental aims of Chapter 6 were to elucidate the pharmacological 
specificity of the effects of 7-OH-DPAT on licking microstructure. This aim was 
achieved by using two drugs which purportedly blocked the action of 7-OH-DPAT 
in other behavioural paradigms. These were PNU-99194A and amisulpride. A 
further aim of Chapter 6 was to examine these putative D3 receptor antagonists 
alone using microstructural analysis. PNU-99194A was ineffective in blocking the 
effects of 7-OH-DPAT in this paradigm but due to recent evidence (Clifford and 
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Waddington, 1998) we had reason to believe that the doses employed in Experiment 
7 were too low to be effective. We favoured this interpretation in the stead of one 
which might question the extent to which PNU-99194A or 7-OH-DPAT exert their 
effects through an a action at D3 receptors. Amisulpride produced most interesting 
results in that not only did it completely attenuate the effects of 7-OH-DPAT on 
licking behaviour at higher doses but also produced a hyperphagic or "prohedonic" 
effect (Experiments 8 and 9). In terms of the pharmacological specificity of the 
attenuation of the effects of 7-OH-DPAT by amisulpride, it seems that amisulpride 
achieved this effect only at those doses which purportedly act postsynaptically at D2 
receptors (Sanger, 1996). Therefore, any claim that the results of 7-OH-DPAT's 
effects on feeding are mediated solely by D3 receptors would not be justified on the 
basis of the results presented in Chapter 6. 
Central injections into putative presynaptic and postsynaptic sites of D3 
receptor using a wide range of doses of 7-OH-DPAT would go some way to 
clarifying this issue. For example, Meyer (1996) used such a method in order to 
establish the pharmacological specificity of the effects of 7-OH-DPAT on locomotor 
behaviour. He also questioned the hypothesis that the D3 receptor is both a 
presynaptic and a postsynaptic receptor. He found that microinjections of 7-OH-
DPAT directly into the nucleus accumbens resulted in the potentiation of 
locomotion. These data supported the hypothesis that the D3 receptors are 
postsynaptic receptors. However, microinjections of 7-OH-DPAT directly into the 
ventral tegmental area did not result in the attenuation of locomotor behaviours, but 
rather resulted in the potentiation of the behaviour. These behavioural data did not 
support the hypothesis that the D3 receptor in the VTA functioned as an 
autoreceptor. Therefore, it seems that distinctions between the functional 
significance of a presynaptic and a postsynaptic D3 receptor is not clearly definable. 
Chapter 1 presented a host of data which is testament to the last statement. 
The issue of whether the D3 receptor functions as an autoreceptor remains 
contentious but may be further clarified by centrally measuring dopamine synthesis 
and release in conjunction with the central administration of D3 receptor specific 
compounds and the measurement of simple physiological and/or behavioural 
correlates. 
Chapter 7 represented the first report of a drug which is specific for a 
dopamine receptor subtype, successfully reducing successive negative contrast; an 
effect which was initially brought about by a reward downshift What remains 
enigmatic is that those drugs which most effectively reduce contrast (such as the 
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benzodiazepines) also increase palatability whereas, 7-OH-DPAT reliably reduces 
palatability and yet still reduces contrast. It could be that 7-OH-DPAT reduces 
contrast by virtue of its anxiolytic properties. This is an explanation which cannot 
be fully confirmed or disputed by the results in Chapter 7. Nevertheless, 7-OH-
DPAT reduces contrast significantly and therefore, inasmuch as it stimulates D3 
receptors and/or D2 receptors, these results constitute evidence for dopamine 
receptor subtypes in relative reward. 
Another possibility is that 7-OH-DPAT is having effects elsewhere. Indeed, 
some of the behavioural effects of 7-OH-DPAT have been attributed to this 
compound's interaction at a binding sites (Wallace and Booze, 1995). Bevins 
(1997) recruits an action of 7-OH-DPAT on a binding sites in explanation of the 
capability of 7-OH-DPAT to induce a conditioned taste aversion. Selective a 
ligands have been shown to induce taste aversions expressed as a selective o-
mediated emetic response in pigeons (Hudzigetal., 1993). Therefore, it could be 
the anxiolytic effects of o receptor stimulation which give this putatively 
dopaminergic compound its unique characteristic in the contrast paradigm. Until 
these details of pharmacological specificity are clarified it is difficult to ascribe a 
certain role for the dopamine D3 receptor subtype in the reduction of contrast and 
more broadly, in the mediation of relative reward. Further employment of the 
contrast paradigm,in conjunction with more specific receptor subtype ligands could 
help to resolve this enigma. 
Finally, an interesting finding from Chapter 6 was that higher doses of 
amisulpride gave rise to licking patterns (i.e. increased the number of licks, 
increased mean bout duration but had no effect on the number of bouts) which were 
exactly like generated after the administration of benzodiazepines (Higgs and 
Cooper, 1998). Therefore, it might be predicted that this compound would also 
reliably reduce contrast. 
Summary 
A general point warranted here is that the pharmacological specificity of 
compounds such as 7-OH-DPAT is of immense importance, not least because of the 
prototypical status that this compound has gained in the search for a behavioural 
effect of D3 receptor stimulation. The development and application of novel 
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selective compounds for dopamine receptor subtypes is imperative. A wide range 
of behavioural tests and dose ranges will help to elucidate the role for individual 
receptor subtypes in food reward. Nevertheless, inasmuch as dopamine receptor 
ligands are specific for individual receptor subtypes, from the summaries above it 
is clear that the experiments presented in this thesis have gone some way to 
fulfilling the experimental objectives delineated in Chapter 2. 
8.3 Implications of results for Berridge's (1996) theory of food 
reward 
Berridge (1996) and also Berridge and Robinson (1993, 1998) nominate 
mesolimbic and mesostriatal dopamine systems to play a part in mediating the 
incentive salience of rewards. They also claim that these dopamine systems 
modulate the motivational value of rewards in a manner separable from hedonia and 
reward learning. Also, it should be noted that the various kinds of theoretical 
formulation, including that of Berridge (1996) and Berridge and Robinson (1993, 
1998), that have emerged to address the actions of neuroleptics have not yet 
effectively integrated the findings associated with the now many categories of 
dopamine receptor ligands. 
Berridge and Robinson (1998) focus on the functional role of the 
mesostriatal dopamine projections in general rather than addressing the question of 
individual subtype contribution to components of reward. This emphasis may 
reflect an underestimation by these authors of the heterogeneity of dopamine 
systems and functional disparity of these systems and their constituent receptor 
subtypes. The experiments presented in this thesis aimed to help to redress this 
balance. Perhaps central injections of a wide dose range of selective dopamine 
agonists and antagonists would produce taste reactivity patterns which would be 
incompatible with their current model. 
Berridge (1996) criticises many of the manipulations of behaviour which 
have been deemed as revealing dopamine's function in reward. He sees much of 
the data representing support for a role for dopamine in hedonia as, at best, 
correlational evidence and at worst compatible with several of the theories outlined 
in the Chapter 2 which postulate dopamine's involvement in hedonic evaluation of 
stimuli. He criticises many of the traditional measures of reward (such as those of 
instrumental behaviour or choice paradigms) claiming that they are confounded in 
that conclusions about whether an incentive stimulus is liked is inferred based on 
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behavioural evidence that it is wanted (i.e. whether an animal will choose it, 
consume it, or work to acquire it). Berridge claims that this inference is grounded 
in the assumption that rewards are always "wanted" to the same degree that they are 
"liked" (Berridge and Robinson, 1998). 
This point of criticism is seen by Berridge to be justifiably levelled at the 
licking microstructure paradigm. In a personal communication, Berridge states: "... 
licking can be (perhaps always is) an instrumental act when its directed at 
something. Palatability affects licking, I imagine, much as it affects instrumental 
performance in general: liking controls wanting. Our conclusion is only that 
dopamine doesn't mediate the liking part itself. That it mediates liking related 
wanting11 would have no problem with." (Kent Berridge, 1997, personal 
communication) In the light of this statement, Berridge seems to believe that 
measures of palatability such as mean bout duration and initial rate of licking 
confound the two psychological functions. In using licking microstructure as a 
methodology and in assuming the validity of models for the control of ingestion 
such as that of Davis and Levine we presume to separate parameters of behaviour 
which are directly associated with discrete psychological functions such as liking 
(i.e. we assume that we can manipulate and measure hedonic value). The effects of 
test fluid concentration presented in the experimental chapters have gone some way 
to validating the model of Davis and Levine (1977). However, that initial rate of 
licking and/or mean bout duration are pure measures of palatability cannot be fully 
confirmed until more experimental work has been conducted. 
As was mentioned in Chapter 2, Berridge relies almost exclusively on the 
taste reactivity paradigm for data collection. As is appreciated in science as whole, 
the generality of any functional principles derived from a paradigm will ultimately 
depend on the number of different experimental contexts in which the data are 
collected. Further, there are assumptions underlying the conceptual validity of the 
taste reactivity paradigm which are contentious. Briefly, Wise (1992) has noted that 
this methodology was originally viewed as a measure of taste-elicited fixed action 
patterns of ingestion (Grill and Norgren, 1978; Grill and Berridge, 1985) but has 
increasingly become to be construed as a measure of subjective hedonic responses 
to food (Berridge and Grill, 1984; Berridge and Valenstein, 1991). Indeed, in their 
recent paper assessing the effects of pimozide on taste reactivity measures, Pecina 
and Berridge, (1997) refer to these responses as "affective reaction measures" (pp. 
801); a reference which confirms Wise's earlier criticism. 
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Studies using human subjects can give insight to the general applicability of 
the theoretical assumptions underlying the taste reactivity paradigm. Consistent 
with previous reports of taste reactivity in human newborns (Blass et al., 1989) 
Graillon et al. (1997) have recently shown that crying newborns respond 
differentially to intraoral orogustatory stimuli. Increased mouthing has been shown 
to be a robust response to positive hedonic stimuli, such as intraoral sucrose, as has 
initial crying reduction. However, by extending the range of stimuli used to quinine 
water and corn-oil as well as sucrose solutions, these authors showed that "taste 
salience" rather than positive hedonic valence account for increased mouthing and 
initial crying reduction. Therefore, the interpretation of taste reactivity measures in 
humans may constitute problematic data for theories which are built upon data from 
taste reactivity measures in animals. 
8.4 Clinical Implications 
Chapter 1 illustrates that, traditionally, antipsychotic drugs were thought to 
achieve their effects through their action at postsynaptic D2 receptors. Since the 
reclassification of dopamine receptor subtypes, compounds which were found to be 
selective for the EX3 receptor were also nominated as potential antipsychotic agents 
with low extrapyramidal side-effects owing to their limbic selectivity (Sokoloff et 
al., 1990). Since mese early claims, there have been many attempts to include me 
D3 receptor in the genetic aetiology of schizophrenia however, these results are 
inconsistent A discussion of the involvement of dopamine receptor subtypes in the 
aetiology and treatment of schizophrenia is beyond the scope of this thesis. 
However, there are other clinical implications which are more germaine to the thesis 
as a whole. 
8.4.1 Dopamine receptor subtypes and feeding behaviour in humans 
There is little definitive evidence of the precise role of dopamine receptor 
subtypes in the regulation of human ingestion. However, based on predictions 
from the animal reward literature, the D3 receptor was recently postulated as a 
candidate in abnormal eating behaviours such as anorexia nervosa. Despite a fairly 
well established role in the mediation of reward, Bruinslot et al. (1998) have 
recently found a lack of association between the D3 receptor gene and anorexia 
nervosa Despite the fact mat the number of patients tested was small, they believe 
that there is good evidence that the Bal IDRD3 polymorphism does not play a major 
role in the genetic component of anorexia nervosa. 
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Despite the paucity of data on the effects of specific dopamine agonism and 
antagonism on feeding in human subjects, there are a few reports on the effects of 
chronic administration of classical antipsychotic compounds in the clinical 
population. However, Stanton (1995) has found a relationship between chronic 
classical antipsychotic treatment and a tendency toward obesity. Traditionally, 
typical and atypical antipsychotics were differentiated in terms of their 
extrapyramidal side effect liability. However, there is reason to believe that these 
classes of drugs may be dissociable in terms of their effects on feeding behaviour 
(see Lee and Clifton, 1998; Baptista et al., 1997, Chapter 6). Atypical 
antipsychotics have now been differentiated from typical antipsychotics in several 
reward paradigms. Therefore, it would be interesting to compare the feeding 
patterns and weights of clinical populations who are undergoing chemotherapy in 
the form of these two types of dopaminergic compound. 
8.4.2 From "appetite" to "hyper-appetite": A similar role of 
dopamine in responding for conventional and non-conventional 
reinforcers? 
Dopamine receptor subtypes have been nominated to have, to varying 
extents a part to play in the mediation of reward for food, but have also been 
heaviliy implicated in the acquisition and maintenance of drug addiction. Habit 
forming drugs of various pharmacological classes increase extracellular dopamine in 
the dorsal and ventral striatum as indicated by brain microdialysis (DiChiara, 1995). 
As such, various dopaminergic compounds have been suggested to be potential 
treatments for drug abuse (i.e. 7-OH-DPAT, Caine and Koob, 1995). In the case 
of the D3 receptor the relationship between its function and the modulation of drugs 
of abuse has been further strengthened due to observations such as those of Staley 
and Mash (1996). Their post mortem analyses revealed that there were adaptive 
increases in dopamine D3 receptors in the mesolimbic "reward circuits" of human 
cocaine fatalities. 
^ This remainder of this section deals with how far the "ingestion" of foods 
and drugs of abuse are analogous in terms of behaviour and of the neurochemical 
precursors and consequences of commerce with both types of reinforcer. More 
concisely, the clinical implications of the experiments reported in this thesis depend 
at least, in part, upon the neurochemical homology of both conventional and non-
conventional reinforcers. 
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Self administration studies provided much of the support for the anhedonia 
hypothesis (see Chapter 2) and therefore, traditionally, the effects of food and 
drugs on nucleus accumbens dopamine were hypothesised as being functionally 
equivalent This equivalence has been seen to be, by some, over-emphasised, 
(Salamone, 1996) and by others as incorrect (Roberts, 1977). For example, 
cocaine self-administration is severely disrupted by nucleus accumbens dopamine 
depletions. The same depletions have little effect on lever pressing for food 
reinforcement (Roberts etal., 1977). Nevertheless, Wise (1997) and others 
(Berridge and Robinson, 1993,1998) make use of many tenets in their theories 
which are equally applicable to food and drugs of abuse. 
In particular, Wise (1997) has recently attempted to assess the reliability of 
this analogy. Comparing instrumental responding for the two types of reinforcer, 
Wise notes that animals regulate the intake of drugs of abuse (psychomotor 
stimulants and opiates) much as they regulate food intake. Although Wise points to 
several obvious differences between the ingestion of food and drugs of abuse, he 
also draws many parallels between the two behaviours. For example, he notes that 
just as it has often been hypothesised that feeding is deficit driven, so has it been 
hypothesised that addiction is deficit driven. Parameters of ingestion are also 
compared. Wise asks us to consider self-administered injections as a drug "meal" 
and notes that meal size and frequency control the intake of the drug just as they 
control the intake of foodstuffs. In response to the alteration of meal size by the 
experimenter (dose per injection) the animal adjusts meal frequency to compensate. 
He also claims that it is obvious that the presence of exteroceptive food stimuli plays 
an important role in food-seeking that is similar to the role played in drug-seeking 
by interoceptive drug stimuli. Wise also specifies a similar role for dopamine in 
aspects of these analogous behaviours (see Wise, 1997). 
If, as Wise suggests, dopamine can be construed as common reward 
currency, this would obviate the need for "currency exchange" despite crossing into 
new stimulus territory, as it were. Such claims are now being examined by 
researchers such as DiChiara (1998). DiChiara (1998) uses the similarities and 
differences in the neurochemical correlates of the two types of reinforcer to 
formulate a motivational learning hypothesis of the role of the mesolimbic dopamine 
in drug addiction and compulsive drug use. This hypothesis differs from that of 
Berridge and Robinson, (1993) in several ways. This thesis is not the correct forum 
from which to provide an exhaustive analysis of these theories but some points are 
pertinent to the General discussion in that they dictate the extent to which one might 
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extrapolate present conclusions from food reward research to wider clinical theory 
on drug abuse and addiction. The following section evalutes some of the most 
recent evidence to suggest that drugs of abuse may not act as neurochemical 
surrogates for conventional reinfoncers. 
Di Chiara (1998) fully acknowledges that while there is much evidence that 
does not preclude the subservance of the dopamine system in responding to both 
types of reinforcer, there are differences in the specific portion of the dopamine 
system which is affected by their "ingestion" and the type of dopamine activity 
which may be most closely associated with them. Since the compartmentalisation 
of the nucleus accumbens (see Chapter 1 and 2), it has been repeatedly 
demonstrated that drugs of abuse such as cocaine, morphine, nicotine and 
amphetamine, produce selective (or depending on the dose, preferential) increases 
in extracellular dopamine in the nucleus accumbens "shell" (Alheid and Heimer, 
1988; Heimer etal., 1991). 
Assuming that drugs of abuse act as neurochemical surrogates for 
conventional reinforcers, a prediction from the above results would be mat 
conventional reinforcers should also activate specifically dopamine transmission in 
the portion of the mesolimbic dopamine system that projects to the nucleus 
accumbens "shell" as opposed to the "core". This hypothesis was supported by 
results from a study by Tanda and Di Chiara (-1998). They showed that a palatable 
snack food (Fonzies) increased extracellular dopamine selectively in the "shell" of 
the nucleus accumbens as opposed to the core of the nucleus accumbens in rats fed 
ad libitum with standard food. However, the consumption of Fonzies has also been 
shown to increase extracellular dopamine in the prefrontal cortex (Bassareo and Di 
Chiara, 1997). This feature of responding by dopamine neurons is not a property 
of non-psychostimulant drugs of abuse (Bassareo et al., 1996). 
Another way in which DiChiara and colleagues have empirically 
differentiated between the two types of reinf orcer has been by thoroughly 
examining the conditions under which dopamine neurons adaptively respond to 
conventional reinforcers. DiChiara states "..although it is commonly assumed that 
mesolimbic dopamine neurons are responsive to conventional reinforcers, this 
responsiveness is the exception rather than the rule, being related to particular 
experimental conditions" (1998, pp. 57). He notes that only modest increases in 
extracellular dopamine in the nucleus accumbens are observed when animals are 
non-deprived (Wilson et al., 1995) and that in undeprived conditions it seems that 
novelty appears to be an important factor in determining the responsiveness of 
dopamine transmission. An example of this last point came from experiments 
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wherein animals, fed ad libitum with standard laboratory food are presented with a 
novel snack food (Fonzies, as above). Feeding of Fonzies led to an immediate 
increase in extracellular dopamine in the nucleus accumbens and prefrontal cortex. 
The neurochemical effects of eating a novel, palatable food were selectively blunted 
in the nucleus accumbens if animals had eaten a previous fonzies meal (Bassareo 
and DiChiara, 1997). In addition, DiChiara (1998) reviews a wealth of data which 
suggest that conditional stimuli can also activate mesolimbic dopamine 
transmission, again depending upon the type of stimulus used and the motivational 
state of the animal. 
Drawing upon the above evidence, the claim that mesolimbic dopamine 
neurons code for generic motivational salience (Robinson and Berridge, 1993) 
irrespective of the class of reinforcer, may be too strong. DiChiara (1998) notes 
that even within a class of reinforcer (i.e. conventional reinforcers) mesolimbic 
dopamine neurons seem to code for specific stimuli which are of high motivational 
impact associated with at least several factors (i.e. novelty, unpredictability, 
deprivation state). These and other results (see Di Chiara, 1998) show that there is 
at least preliminary evidence to suggest a more topographically heterogenous profile 
of responding for mesolimbic dopamine neurons than previously thought As 
dopamine receptor subtypes become more fully understood, the factors affecting the 
responsiveness of mesolimbic dopamine will -burgeon. 
8.5 Future directions 
It was outlined in Chapter 2 that recent evidence gathered from studies using 
single-unit recording, have clarified and extended theorising on the aspects of 
reward processing which might be best associated with discrete dopaminergic 
substrates. In the light of the recent functional segregation of dopamine systems by 
Schultz (1998) (see Chapter 2), it becomes possible to hypothesise as to the effects 
of absolute and relative reward values on aspects of reward processing in fronto-
basal ganglia systems. 
According to Schultz, dopamine neurons do not discriminate well between 
different rewards, rather they "apparently signal a scalar value that does not provide 
information about the reward other than its goodness relative to prediction" (pp. 
427). Reward prediction is also a capacity of striatal neurons but of a different 
form. Neurons in this area seem to produce sustained activations reflecting the 
expectations of rewards established through experience in a particular behavioural 
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situation. A further capacity of striatal neurons is apparent in their ability to adapt 
the "reward expectation-related activity" in response to changes in the environmental 
situation lead to modified reward expectations. Neurons of the orbitofrontal cortex 
produce differential responses to stimuli predicting rewards which are different (i.e. 
in terms of reinforcer value). Schultz (1998) speculates that neurons in the 
orbitofrontal cortex may be involved in the detailed analysis of the particular reward 
objects. 
Therefore manipulations which impair dopamine transmission at these 
discrete stages of reward-related information processing would lead to very 
different behavioural consequences. These behavioural consequences would best be 
studied at a detailed level of analysis. Behavioural differences predicted using 
Schultz's framework would be amenable to testing using microstructural analysis of 
licking. For example, significant effects of changing concentration on mean bout 
duration of licking might not be expected if midbrain dopamine neurons are ablated 
but may be predicted if selective lesions of the orbitofrontal cortex are performed 
A way in which such functional dissociations could be further validated 
would be by measuring dopamine efflux in the relevant brain sites in response to 
absolute or relative variation in reinforcer value. Not only would this methodology 
further test the specific predictions of Schultz-(1997) but it would also represent a 
shift from the reliance upon a single paradigm which may limit the utility of the data 
collected. Examples of evidence using this paradigm do not always fit neatly with 
Schultz's basic predictions and significant increases in striatal dopamine efflux have 
been bom associated with (Wilson et al., 1995) and dissociated from (e.g.) the 
changing hedonic value of the stimulus. 
Therefore, brain microdialysis is an appropriate methodology to apply to 
mis problem in an attempt to reveal the extent to which dopaminergic neurons in the 
ventral striatum code for relative incentive value. Below are a selection of particular 
experiments which I propose to conduct in the light of these findings. 
An appropriate experimental question might be: Does dopamine efflux in the ventral 
striatum change in response to an unpredicted up or downshift in incentive 
magnitude (i.e. sucrose concentration)? In the case of a reward "downshift" an 
appropriate procedure would be as follows. Animals would be trained to ingest a 
30% sucrose solution and then implanted with dialysis probes. After training they 
would be assigned to 4 groups: No shift, shift to 10%, to 3% or to 1% sucrose 
respectively. Dopamine efflux would be measured prior to and after the shift 
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As mentioned earlier, conditioned stimuli repeatedly associated with primary 
rewards, can when presented alone, also produce an increase in dopamine efflux 
(Phillips et al., 1991; Schultz, 1997). Therefore, the aim of the following 
experiment would be to provide preliminary data on the ability of conditioned 
stimuli repeatedly paired with differing sucrose concentrations to produce a 
differential change in ventral striatal dopamine efflux. Animals would be assigned 
to 4 groups and trained to drink 1%, 3% 10% and 30% sucrose respectively. At the 
same time, they would be trained to associate a tone (CS) with the primary reward 
(US) of the respective sucrose solution. After training each group will be presented 
with the appropriate (CS) alone and dopamine efflux would be measured and 
compared between sucrose concentration groups. 
After having tested the ability of the (CS) to produce absolute changes in 
dopamine efflux dependent upon the reward value of the (US) (i.e. sucrose 
solution) it would be sensible to investigate whether dopamine efflux is 
differentially altered by relative shifts in reward which are not predicted by the 
(CS). In doing this we may test Schultz's (1997) prediction that responses of 
dopamine neurones depend entirely on the unpredictability of stimuli. Further, it 
might be suggested that these neurons should code for the magnitude of 
discrepancy (error) between actual and anticipated incentive value. We are able to 
vary the (USs) (decreased or increased sucrose concentration) therefore 
manipulating their similarity to a constant (CS). Experiments such as those above 
would provide further evidence as to the functional capacity of anatomically discrete 
dopaminergic substrates. The outcomes of the above studies would have relevance 
to a range of important issues, including neural and behavioural mechanisms of 
drug addiction and craving. 
Caveat 
A caveat which is applicable to the entire thesis is best laid out here. Schultz 
emphasises the need to model, not only reward information from the various 
dopaminergic nodal points of the brain but also reward relevant information from 
other neurotransmitter systems. It would be naive to discount the contributions of 
other neurotransmitter systems to the mediation of food and other reward. In fact 
the previously well established relationship between dopamine and both food 
reward and drug addiction is now being teased apart, de-emphasised and indeed has 
been stongly questioned recently due to evidence gathered using genetic 
modification techniques (Caine, 1998). Therefore, although this thesis focuses 
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strongly on the functional significance of dopamine in the mediation of food 
reward, this does not preclude an appreciation of the contributions of distributed 
non-dopaminergic signals in the negotiation of reward 
8.5.1 Towards explicit models of reward 
Despite the above caveat, Schultz's framework, due to its explicit nature, 
provides a parsimonious computational account of the roles of different dopamine 
receptor populations. Schultz has been able to replicate the "teaching signal" 
emitted by dopamine neurons, by applying an algorithm, formulated in the light of 
his empirical work, to a neural network. Neural networks are obviously useful in 
falsifying empirical data collected from on-line measures of neuronal activity and 
constitute a majornew direction in reward research. It is clearly necessary to 
delineate the nature of dopamine activity in several functionally important brain 
sites. One way in which the computational approach might benefit this research area 
is in helping to specify the realtionships among dopamine release in these various 
sites (Smith, 1996). In doing this, it may become possible to pinpoint the stage of 
processing by dopamine neurons, at which the affective sign becomes adhered to 
stimuli and in turn how this affect laden stimuli modifies behaviour in various 
experimental situations. 
The recent proliferation of dopamine receptor subtypes and new information 
regarding molecular and genetic aspects of cellular function will lead to the 
metamorphosis of many psychological constructs such as "reward". As Smith 
(1996) so elegantly predicts, words such as "network" and "processing" "will begin 
to pass from their current vague, logical status to a precise description of dopamine 
receptor-mediated effects" (pp. 135). 
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